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Introduction  1−Pluripotent Embryonic Stem Cells: Criteria and Definitions
1− Pluripotent Embryonic Stem Cells: Criteria and
Definitions
Embryonic  stem (ES)  cells  are  derived  from the  inner  cell  mass  (ICM)  of  an  embryo  at  the
blastocyst stage and have the extraordinary capacity to differentiate into every cell type of the adult
body.  For  this  reason,  ES cells  have  been considered  promising  sources  in  cell  transplantation
therapies for various diseases and injuries, such as spinal cord injury, neurodegenerative diseases
and  myocardial  infarction.  In  this  introduction  chapter,  I  will  briefly  describe  the  principal
characteristics of embryonic stem cells, focusing on replication capacity, clonality, and potency.
ES cells  are defined as cells  that have the capacity to proliferate rapidly and self-renew, while
maintaining pluripotency, which is the ability to differentiate into all cell types of the adult body.
Through  an  asymmetric  cell  division,  stem cells  can  generate  daughter  cells  identical  to  their
mother  (self-renewal)  as  well  as  produce  progeny  with  more  restricted  potential  (committed
progenitor cells) (Figure 1.1).  The self-renewal capacity assures a supply of stem cells  for the
tissue homeostasis. However, stem cells can also divide symmetrically: in this case both daughter
cells maintain the potential and the self-renewal capacity of the mother cell.
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Most somatic cells cultured in vitro display a finite number (often less than 80 in both human and
mouse cell lines) of population doublings prior to senescence or replicative arrest/differentiation.
On  the  contrary,  stem  cells  in  culture  display  a  seemingly  unlimited  proliferative  capacity.
Therefore,  it  is  reasonable to say that  a cell  that  can undergo more than twice this  number of
population doublings (160) without oncogenic transformation can be termed “capable of extensive
proliferation.” In a few cases, this criteria has been met, most notably with embryonic stem (ES)
cells, derived from either humans or mice, as well as with adult neural stem cells (NSCs).
A second parameter, perhaps the most important characteristic of ES cells, is the idea that stem cells
are clonogenic entities, that is single cells with the capacity to create more stem cells (Figure 1.2).
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Figure  1.1. The  definition  of  a  stem  cell.  A  stem  cell  can  be  defined  as  an
undifferentiated cell that can divide asymmetrically to produce one cell that retains its
undifferentiated character (another stem cell) and another cell that can undergo one or
more paths of terminal differentiation (committed stem cell). In many cases, the daughter
that  opts  for  differentiation  undergoes  additional  cell  divisions  before  the  terminal
differentiation is completed. (Modified from Alberts, Molecular Biology of the Cell).
Figure  1.2.  Clonality  of  mammalian  ES
cells  in  culture. ES  cells  derived  from an
early  mouse  embryo  can  be  cultured
indefinitely as a monolayer. When they reach
confluence,  they  must  be  detached  and
replated  to  avoid  the  loss  of  pluripotency;
single  cells  are  able  to  proliferate  and
originate ES cell colonies (photo). A culture
medium containing serum and the cytochine
Leukemia Inhibitory Factor (LIF) allows to
maintain  embryonic  stem  cells  in  a
undifferentiated  state.  (Image  credit:
http://www.c-mtechnologies.com ).
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Another characteristic that should be considered is  potency (Figure 1.3), that is the ability of a
particular stem cell to generate numerous different types of differentiated cells. 
• In mammals, totipotent stem cells are capable of forming every cell in the embryo and, in
addition, the trophoblast cells and the placenta. The only totipotent cells are the zygote and
(probably) the first 4-8 blastomeres to form prior to compaction. By the time the zygote has
reached the blastocyst stage, the developmental potential of certain cells has been restricted:
the outer cells of the embryo have begun to differentiate to form the trophectoderm. 
• For this reason ES cells coming from the inner cell mass of the blastocyst, being no longer
able to generate the trophoblast lineage, are considered pluripotent stem cells and no more
totipotent cells. Thus, pluripotent cells have the ability to become all the cell types of the
embryo (Figure 1.4),  except trophoblast.  Some special  types of pluripotent  cells  can be
obtained from germ cells and tumors (such as teratocarcinomas).
• Multipotent stem cells  are stem cells whose commitment is limited to a relatively small
subset  of  all  the  possible  cells  of  the body.  A multipotent  stem cell  sits  atop a  lineage
hierarchy  and  can  generate  multiple  types  of  differentiated  cells,  each  with  distinct
morphologies and gene expression patterns. Multipotent stem cells are usually adult stem
cells, which are found in the tissues of organs after the organ has matured. These stem cells
are  usually  involved  in  replacing  and  repairing  tissues  of  that  particular  organ.  The
hematopoietic stem cell, for instance, can form the granulocyte, platelet, and red blood cell
lineages.
• Some adult stem cells are unipotent stem cells, which are found in particular tissues and are
involved in regenerating a particular cell type. Whereas pluripotent stem cells can produce
cells of all three germ layers (as well as producing germ cells), the multipotent and unipotent
stem cells can be considered committed stem cells, since they have the potential to become
relatively few cell types. 
• A self-renewing cell that can only produce one type of differentiated descendant (unipotent
stem  cell)  is  very  similar  to  (and  can  be  confused  with)  a  progenitor  cell.  However,
progenitor cells are not capable of unlimited self-renewal; they have the capacity to divide
only a few times before terminal differentiation. Progenitors are typically the descendants of
stem cells, only they're more constrained in their differentiation potential or capacity for
self-renewal and are often more limited in both senses.
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Figure 1.4. Pluripotency of mouse embryonic stem cells in culture. Embryonic stem cells derived from an early
mouse embryo can be cultured indefinitely as a monolayer, or allowed to form aggregates called embryoid bodies,
in which the cells begin to specialize. Cells from embryoid bodies, cultured in media with different factors added,
can then be driven to differentiate in various ways. Being able to generate different types of specialized cells of the
embryo, except trophoblast, ES cells are defined as “pluripotent”. (Alberts, Molecular Biology of the Cell)
Figure  1.3.  Stem  cell  potency. Example  of  the
maturation series of stem cells, here applied to the
differentiation along the neuronal lineage. (Gilbert,
Developmental Biology).
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In  conclusion,  the  basic  characteristics  of  ES  cells  include  self-renewal,  multi-lineage
differentiation  both  in  vitro  and  in  vivo,  clonogenicity,  a  normal  karyotype,  extensive  in  vitro
proliferation under  well-defined culture  conditions,  and the  ability to  be  repeatedly frozen and
thawed. 
At a molecular level, ES cells are characterized by the expression of pluripotency markers, Oct4,
Nanog, Klf4 and Sox2, which have been demonstrated to be fundamental for the maintenance of an
undifferentiated state. Especially  Oct4 and Nanog are crucial components of the genetic circuitry
necessary and sufficient to maintain ES cells in an undifferentiated state of pluripotency (Mitsui et
al., 2003; Figure 1.5).
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Figure  1.5:  Proposed functions of Nanog and Oct4 in preimplantation embryos (upper) and ES cells (lower).
Homeoprotein Nanog can maintain self-renewal and pluripotency in both ICM and ES cells independently of the
LIF/gp130/Stat3 pathway. The primary function of Oct3/4 is to prevent trophectoderm differentiation of ICM and
ES cells. In contrast, Nanog independently prevents differentiation into extraembryonic endoderm and actively
maintains pluripotency. ES cells derived from ICM require both Oct3/4 and Nanog to prevent differentiation into
trophectoderm and primitive endoderm, respectively. However, a normal expression level of these two transcription
factors is not sufficient for prolonged ES cell self-renewal. Additional factor(s), such as Stat3 activated by LIF, are
required to support extended maintenance of pluripotency. (Mitsui et al., 2003).
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Additionally, Oct4, Klf4 and Sox2, have been demonstrated to be fundamental for the induction of
pluripotency in adult somatic stem cells (reprogramming), to obtain induced pluripotent stem (IPS)
cells (Takahashi and Yamanaka, 2006). Among other markers of an undifferentiated state, Alcaline
Phosphatase (AP) and SSEA-1 are often used to evaluate pluripotency.
Mouse  and  human  ES  cells  are  derived  directly  from  the  inner  cell  mass  of  preimplantation
embryos after the formation of the blastocyst (Figure 1.6). This population of cells would normally
produce the epiblast and then all adult tissues. ES cells appear to be the in vitro equivalent of the
epiblast, as they have the capacity to contribute to all somatic lineages and to produce germ line
chimeras in mice.
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Figure  1.6.  Generation  of  mouse
embryonic stem cell  cultures. ES cells are
derived from the inner cell mass of an early
mouse  embryo  (blastocyst).  They  can  be
cultured indefinitely as a monolayer, using a
layer  of  mitotically  inactive  muose
fibroblasts  as  feeding  cells.  Fibroblasts
provide  ES  cells  with  the  cytochine  LIF,
which is essential for their maintenance. It is
now possible to use feeder-free ES cell lines,
where  recombinant  mouse  LIF  is  added
directly to the culture medium. 
(Winslow and Duckwall, 2001).
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The critical  in vivo test for pluripotency is whether the cells yield widespread, if not ubiquitous,
somatic and germ line chimerism in offspring following introduction into the early embryo, either
by injection into standard blastocysts or aggregation with morulae. ES cell genome can be altered
during  in vitro culture, by the addition of a cloned gene and a resistance gene for selection via
antibiotic treatment, prior to injection in a host mouse embryo. For this reason, chimera generation
can be considered not only a test for ES cells pluripotency, but also a useful tool for the study of
genes in transgenic mice (Figure 1.7).
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Figure  1.7.  Production  of  transgenic  mice. A:
Embryonic  stem  cells  from  a  mouse  can  be
cultured in vitro. Their genome can be altered in
this step by the addition of a cloned gene, plus a
resistance  gene  for  selection  via  antibiotic
treatment. B: The cells can be injected back into
the early stages of a host mouse embryo, where
they  can  perfectly  integrate,  partecipating  to
normal tissue development. Embryos are placed
in  the  uterus  of  a  pregnant  mouse,  were  they
develop into chimeric mice.  Donor ES cells are
pluripotent and can contribute to every organ of
the host embryo; they can also become part of the
germ  line  of  the  mouse,  and  this  raise  the
possibility  to mate chimeric mice and to obtain
homozygous transgenic mice carrying two copies
of the inserted gene. Given these characteristics,
chimera generation can be considered both a test
for ES cells pluripotency, and a protocol for the
study of genes in transgenic mice. 
(Scheme credit: Dr. Annika Rohl).
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Another important assay to test ES cell pluripotency is the formation of teratomas. In vitro cultured
ES cells are transplanted under the skin (ectopic graft) of histocompatible or immunosuppressed
adult  mice.  In  this  case,  ES cells  develop a  teratoma,  a  tumor  where  stem cells  are  mixed to
randomly differentiating cell types, such as pieces of bones, nervous tissue, muscles and epithelia
(Figure 1.8).
These criteria to test pluripotency are not appropriate for human ES cells, where chimerism cannot
be tested; consequently, these cells must be tested to be able of differentiating in multiple cell types
in vitro by using embryoid body-based differentiation protocols. Additionally, they must be tested to
be able of generating teratomas when injected under the skin of immunodeficient mice; teratomas
must be containing differentiated cells of all three germ layers. Moreover, as a stringent  in vivo
assessment of pluripotency is impossible, human ES cells must be shown to be positive for well-
known molecular markers commonly used to characterize mouse pluripotent stem cells.
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Figure  1.8.  Teratoma formation after mouse ES cell transplantation in ectopic position.  Embryonic stem cells
from a mouse can be injected into the early stages of a host mouse embryo, where they can perfectly integrate,
participating to normal tissue development. Viceversa, if they're transplanted in a different microenvironment, they
give rise to teratomas (A-F), tumors where stem cells are mixed to randomly differentiating cell types. Inside the
tumoral mass, pieces of bones (A), cartilage (B), nervous tissue (C), muscles (D), adipose tissue (E) and epithelia
(F) can be found. Teratoma formation assay is used as a test for ES cell pluripotency; to this purpose in vitro
cultured ES cells are transplanted under the skin of immunodeficient mice, where they develop these type of tumors.
A B C
D E F
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Mouse pluripotent embryonic stem (ES) cells are usually derived and maintained by using various
empirical combinations of feeder cells, conditioned media, cytokines, growth factors, hormones,
fetal calf serum, and serum extracts. ES-cell self-renewal is generally considered to be dependent on
the activation of STAT3 by LIF (Leukemia inhibitory factor, a cytokine). ES cells cultured in serum
containing medium are not homogeneous, and consist of a mixed population of Oct4-positive and
Nanog-positive naïve pluripotent stem cells and Oct4-positive Nanog-negative stem cells, this latter
type being already primed for differentiation (Figure 1.9).
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Figure 1.9. Markers of ES cell pluripotency. A-D: Immunofluorescence staining for Oct4 (A) and Nanog (B), and
nuclear staining with DAPI (C); D shows an overlay of A-C. Oct4 and Nanog are crucial components of the
genetic circuitry necessary and sufficient  to maintain ES cells in an undifferentiated state of  pluripotency. In
mouse ES cells,  Oct4 staining appears to be relatively homogeneous, whereas Nanog expression levels differ
substantially within individual ES cells. (Image credit: Austin Smith; www.dev.biologists.org). 
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Austin Smith's laboratory, however, has recently revealed that ES cells have an innate program for
self-replication that does not require extrinsic instruction. The authors demonstrated that ES cells in
which  mitogen-activated  protein  kinase  signaling  and  glycogen  synthase  kinase-3  (GSK3)  are
double-inhibited are homogeneous and pluripotent when cultured in a medium containing LIF but
devoid of serum. In this condition,  they consist  in a pure population of both Oct4 and Nanog-
positive naive pluripotent stem cells (Silva et al., 2008; Ying et al., 2008).
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2− The Emergence of the Ectoderm: 
Formation of the Neural Plate and Neural Tube
In the vertebrate embryo, after fertilization, a series of rapid cell divisions (known as cleavages)
divides the fertilized egg into blastomeres. The embryo, now called blastula, then undergoes the
process of gastrulation, in which the three primary or “germ” layers are formed: the mesoderm, the
endoderm and the ectoderm. The fates of the vertebrate ectoderm are shown in Figure 2.1. Briefly,
the embryo ectoderm will form the neural tissue, the neural crests and the epidermis.
The point of initiation of the gastrulation is identified on the embryo as a small invagination of the
smooth  surface  of  the  blastula;  this  is  called  the  blastopore.  In  amphibians  the  first  cells  to
invaginate occur at the dorsal site of the blastopore. The involuting cells will ultimately give rise to
mesodermal derivatives (muscle and bone). At this point in development, a portion of the dorsal
ectoderm is specified to become neural ectoderm, and its cells become distinguishable to surface
ectoderm  (destined  to  form  the  skin)  by  their  columnar  appearance  and  by  their  molecular
characteristics.  This  region  of  the  embryo  is  called  the  neural  plate (NP),  a  single-layered
pseudostratified epithelium that will form the entire brain (Figures 2.2 and 2.3). As much as 50% of
the ectoderm is included in the neural plate. 
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The process of neural induction and neural plate formation begins  soon after gastrulation, when
neural induction takes place, and the underlying dorsal mesoderm (and pharyngeal endoderm in the
head region)  signals  the ectodermal  cells  above it  to  elongate  into columnar  neural  plate  cells
(Smith and Schoenwolf, 1989; Keller et al. 1992 ). Subsequently, the NP it is divided into domains
along the antero-posterior and medio-lateral axes characterized by specific gene expression patterns,
which  will  eventually  give  rise  to  brain  structures  at  later  stages  of  development.  In  the  next
Chapter, I will describe from the molecular point of view how the ectoderm is instructed to form the
vertebrate nervous system and epidermis.
The neural plate is shaped by the intrinsic movements of the epidermal and neural plate regions; it
lengthens along the anterior-posterior axis, narrowing itself so that subsequent bending will form a
tube.  In  both  amphibians  and amniotes,  the  neural  plate  lengthens  and narrows  by convergent
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Figure  2.1:  Major  derivatives  of  the  ectoderm  germ
layer. The ectoderm is divided into three major domains:
the surface ectoderm (that will primarily form epidermis),
the neural crest (future peripheral neurons, pigment, and
facial cartilage) and the neural tube (presumptive brain
and spinal cord). (Gilbert, Developmental Biology).
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extension, intercalating several layers of cells into a few layers. In addition, the cell divisions of the
neural plate cells are preferentially in the  rostral-caudal  (anterior-posterior) direction (Jacobson
and Sater, 1988; Schoenwolf and Alvarez, 1989; Sausedo et al., 1997). These events will occur even
if the tissues involved are isolated.
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Figure  2.2: The development of the central nervous system, brain and spinal cord, in a vertebrate embryo is
shown from the egg cell to the adult frog. After a series of a cleavage divisions produces a blastula, a group of cells
known as the involuting marginal zone grows into the interior of the embryo at a point known as the blastopore.
This process of gastrulation is shown here in two cross sections. The involuting cells will form mesodermal tissues
and will induce the cells of the overlying ectoderm to develop into neural tissue, labeled here in red. After the
process of neural induction, the neurogenic region is known as the neural plate and is restricted to giving rise to
neural tissue. A cross section of the embryo at the neural plate stage shows the relationships between the tissues at
this stage of development. The neural plate goes on to generate the neurons and glia in the adult plate and spinal
cord. (Sanes, Reh, Harris; Development of the Nervous System).
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Shortly after its formation, the neural plate begins to fold onto itself to form a tube-like structure,
the neural tube (Figures 2.2, 2.3 and 2.4). This tube of cells gives rise to nearly all the neurons and
glia of vertebrates. The process by which the neural plate tissue forms a neural tube, the rudiment of
the nervous system, is called  neurulation,  and an embryo undergoing such changes is called a
neurula (Figure 2.3). The neural tube forms the brain anteriorly and the spinal cord posteriorly. 
26
Figure 2.3: Neurulation in the amphibian embryo. Neurulation is shown here at early (left), middle (center) and
late (right) neurulae. A: Looking down on the dorsal surface of the whole embryo. B: Midsagittal section through
the medial plane of the embryo. C: Transverse section through the center of the embryo. (Modified from Gilbert,
Developmental Biology).
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There are two major ways of forming a neural tube. In the primary neurulation, the neural plate
cells proliferate, invaginate, and pinch off from the surface to form a hollow tube. In the secondary
neurulation,  the  neural  tube  arises  from a  solid  cord  of  cells  that  sinks  into  the  embryo  and
subsequently forms a hollow tube by cavitation. In general, the anterior portion of the neural tube is
made by primary neurulation, while the posterior portion of the neural tube is made by secondary
neurulation. The complete neural tube forms by joining these two separately formed tubes together
(Figure 2.4).
The events of primary neurulation in the the frog and in the chicken are illustrated in Figures 2.3
and 2.4, respectively. During primary neurulation, the original ectoderm is divided into three sets of
cells: (1) the internally positioned neural tube, which will form the brain and spinal cord, (2) the
externally positioned epidermis of the skin, and (3) the neural crest cells. The neural crest cells form
in the region that connects the neural tube and the epidermis, but then migrate elsewhere; they will
generate the peripheral neurons and glia, the pigment cells of the skin, and several other cell types.
The  process  of  primary  neurulation  appears  to  be  similar  in  amphibians,  reptiles,  birds,  and
mammals (Gallera, 1971). Shortly after the neural plate has formed, its edges thicken and move
upward to form the  neural folds, while a U-shaped  neural groove  appears in the center of the
plate, dividing the future right and left sides of the embryo (Figures 2.3 and 2.4). The neural folds
migrate toward the midline of the embryo, eventually fusing to form the neural tube beneath the
overlying ectoderm.
27
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Figure  2.4: Neurulation in a 24-hour chick embryo (dorsal view).  The cephalic (head) region has
undergone  neurulation,  while  the  caudal  (tail)  regions  are  still  undergoing  gastrulation.  (Gilbert,
developmental Biology).
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The differentiation of the neural tube into the various regions of the central nervous system occurs
simultaneously in three different ways. At the anatomical level, the neural tube and its lumen form
the chambers of the brain and the spinal cord. At the tissue level, the cell populations within the
wall of the neural tube rearrange themselves to form the different functional regions of the brain and
the spinal cord. Finally, on the cellular level, the neuroepithelial cells themselves differentiate into
the numerous types of nerve cells (neurons) and supportive cells (glia) present in the body.
The early mammalian neural tube is a straight structure. However, even before the posterior portion
of the tube has formed, the most anterior portion of the tube is undergoing drastic changes. In this
region,  the  neural  tube  balloons  into  three  primary  vesicles  (Figure  2.5):  forebrain
(prosencephalon), midbrain (mesencephalon), and hindbrain (rhombencephalon).
The  prosencephalon  becomes  subdivided  into  the  anterior  telencephalon  and  the  more  caudal
diencephalon.  The  telencephalon  will  eventually  form  the  cerebral  hemispheres,  and  the
diencephalon will form the thalamic and hypothalamic brain regions that receive neural input from
29
Figure  2.5:  Early human brain development. The three primary brain vesicles are subdivided as development
continues. At the right is a list of the adult derivatives formed by the walls and cavities of the brain. 
(Modified from Gilbert, Developmental Biology). 
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the  retina.  Indeed,  the  retina  itself  is  a  derivative  of  the  lateral  wall  of  the  diencephalon.  The
mesencephalon  does  not  become  subdivided,  and  its  lumen  eventually  becomes  the  cerebral
aqueduct. The rhombencephalon becomes subdivided into a posterior myelencephalon and a more
anterior  metencephalon. The myelencephalon eventually becomes the medulla oblongata, whose
neurons  generate  the  nerves  that  regulate  respiratory,  gastrointestinal,  and  cardiovascular
movements. The metencephalon gives rise to the cerebellum, the part of the brain responsible for
coordinating movements, posture, and balance. The rhombencephalon develops a segmental pattern
that specifies the places where certain nerves originate. Periodic swellings called  rhombomeres
divide  the rhombencephalon into  smaller  compartments.  These  rhombomeres  represent  separate
developmental “territories”: the cells within each rhombomere can mix freely within it, but not with
cells from adjacent rhombomeres (Guthrie and Lumsden, 1991). Moreover, each rhombomere has a
different developmental fate and will form ganglia  clusters of neuronal cell bodies whose axons
form a nerve.
The neural tube is polarized along its dorsal-ventral axis. In the spinal cord, for instance, the dorsal
region is the place where the spinal neurons receive input from sensory neurons, while the ventral
region is  where  the  motor  neurons  reside.  In  the  middle  are  numerous  interneurons  that  relay
information between them. The polarity of the neural tube is induced by signals coming from its
immediate environment. The dorsal pattern is imposed by the epidermis, while the ventral pattern is
induced by the notochord (Figure 2.6).
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Figure 2.6: Dorsal-ventral specification of the neural tube. A: The newly formed neural tube is influenced by two
signaling centers. The roof of the neural tube is exposed to BMP4 and BMP7 from the epidermis, and the floor of
the neural tube is exposed to Sonic hedgehog protein (Shh) from the nothocord. B: Secondary signaling centers are
established in the neural tube. BMP4 is expressed and secreted from the roof plate cells; Shh is expressed and
secreted from the floor plate cells. C: BMP4 establishes a nested cascade of TGF-β factors, spreading ventrally
into the neural tube from the roof plate. Shh diffuses dorsally as a gradient from the floor plate cells. D: The
neurons of the spinal cord are given their identities by their exposure to these gradients of paracrine factors. The
amounts and types of paracrine factors present cause different transcription factors to be activated in the nuclei of
these cells, depending on their position in the neural tube. (Modified from Gilbert, Developmental Biology). 
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One agent of ventral specification of the neural tube is the  Sonic hedgehog  protein, originating
from the notochord; another agent specifying the ventral neural cell types is retinoic acid, which
probably comes  from the  adjacent  somites  (Pierani  et  al.,  1999).  Sonic hedgehog establishes  a
gradient,  and  different  levels  of  this  protein  cause  the  formation  of  different  cell  types.  Sonic
hedgehog is initially synthesized in the notochord. The secreted Sonic hedgehog induces the medial
hinge cells to become the floor plate of the neural tube. These floor plate cells also secrete Sonic
hedgehog, which forms a gradient highest at the most ventral portion of the neural tube (Roelink et
al.,  1995;  Briscoe  et  al.,  1999).  Those  cells  adjacent  to  the  floor  plate  that  receive  high
concentrations of Sonic hedgehog become the ventral (V3) neurons, while the next group of cells,
exposed to slightly less Sonic hedgehog, become motor neurons (Figure 2.6). The next two groups
of  cells,  receiving progressively less  of  this  protein,  become the V2 and V1 interneurons.  The
different concentrations of Sonic hedgehog function by causing the different groups of neurons to
express  different  types  of  transcription factors.  These transcription  factors,  in  turn,  activate  the
genes  whose  protein  products  control  the  cellular  identity.  Sonic  hedgehog  may also  work  by
repressing the expression of genes encoding dorsal neural tube transcription factors, which would
otherwise be expressed throughout the neural tube.
The importance of Sonic hedgehog in inducing and patterning the ventral portion of the neural tube
can be shown experimentally. If notochord fragments are taken from one embryo and transplanted
to the lateral side of a host neural tube, the host neural tube will form another set of floor plate cells
at its sides (Figure 2.7). The floor plate cells, once induced, induce the formation of motor neurons
on either side of them. The same results can be obtained if the notochord fragments are replaced by
pellets of cultured cells  secreting Sonic hedgehog (Echelard et  al.,  1993; Roelink et  al.,  1994).
Moreover,  if  a piece of notochord is  removed from an embryo, the neural tube adjacent to the
deleted region will have no floor plate cells (Placzek et al., 1990; Yamada et al., 1991, 1993).
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The dorsal fates of the neural tube are established by proteins of the TGF-β superfamily, especially
the bone morphogenetic proteins 4 and 7, dorsalin, and activin (Liem et al., 1995, 1997). Initially,
BMP4  and  BMP7  are  found  in  the  epidermis.  Just  as  the  notochord  establishes  a  secondary
signaling center the floor plate cells on the ventral side of the neural tube, the epidermis establishes
a secondary signaling center by inducing BMP4 expression in the  roof plate  cells of the neural
tube. The BMP4 protein from the roof plate induces a cascade of TGF-β superfamily proteins in
adjacent  cells.  Different  sets  of  cells  are  thus  exposed  to  different  concentrations  of  TGF-β
superfamily proteins at different times (the most dorsal being exposed to more factors at higher
concentrations  and  at  earlier  times).  The  temporal  and  concentration  gradients  of  the  TGF-β
superfamily proteins induce different types of transcription factors in cells at different distances
from the roof plate, thereby giving them different identities.
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Figure 2.7: Cascade of inductions initiated by the notochord in the ventral neural tube.  A: Relationship between
Sonic  hedgehog  concentrations,  the  generation  of  particular  neuronal  types  in  vitro,  and  distance  from  the
notochord. B: Two cell types in the newly formed neural tube. Those closest to the nothocord become the floor
plate neurons; motor neurons emerge on the ventrolateral sides. C: If a second notochord, floor plate, or any other
Shh-secreting cell is placed adjacent to the neural tube, it induces a second set of floor plate neurons, as well as
two other sets of motor neurons. (Modified from Gilbert, Developmental Biology). 
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3− Neural Induction and 
Antero-Posterior Axis Formation
Research from the last 15 years has provided a working model for how the neural tissue is induced
and specified along the anterior-posterior (A-P) axis during the early stages of embryogenesis. The
study of neural plate specification, neural induction, and antero-posterior (A-P) axis formation are
intimately linked. This model relies on three basic processes: 
(1) induction of the neural plate from naive ectoderm requires the inhibition of BMP/TGFβ
signaling;
(2) induced neural tissue initially acquires an anterior identity (i.e., anterior forebrain); 
(3) maintenance  and  expansion  of  the  anterior  forebrain  depends  on  the  antagonism  of
posteriorizing signals that would otherwise transform this tissue into posterior neural fates.
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Progressive Determination of the Amphibian Axes: 
the Organizer and the Primary Embryonic Induction
The story about the discovery of neural induction starts in 1903, when Spemann demonstrated that
early newt blastomeres have identical nuclei,  each capable of producing an entire larva. Shortly
after fertilizing a newt egg, Spemann used a baby's hair taken from his daughter to “lasso” the
zygote in the plane of  the first  cleavage.  He then partially constricted the egg,  causing all  the
nuclear divisions to remain on one side of the constriction. Eventually, often as late as the 16-cell
stage, a nucleus would escape across the constriction into the non-nucleated side. Cleavage then
began  on  this  side,  too,  whereupon  Spemann  tightened  the  lasso  until  the  two  halves  were
completely separated. Twin larvae developed, one slightly more advanced than the other. Spemann
concluded from this experiment that early amphibian nuclei were genetically identical and that each
cell was capable of giving rise to an entire organism (Figure 3.18).
However, when Spemann performed a similar experiment with the constriction still longitudinal,
but perpendicular to the plane of the first cleavage (separating the future dorsal and ventral regions
rather than the right and left sides), he obtained a different result altogether.
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Figure 3.1: Spemann's demonstration of nuclear equivalence in newt cleavage. A: When a fertilized egg of the
newt Triturus taeniatius was constricted by a ligature, the nucleus was restricted to one half of the embryo. The
cleavage on that side of the embryo reached the 8-cell stage, while the other side remained undivided. B: At the 16-
cell stage, a single nucleus entered the as-yet undivided half, and the ligature was further constricted to complete
the separation of the two halves.  C: After 14 days, each side had developed into a normal embryo. (Gilbert,
Developmental Biology).
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The nuclei continued to divide on both sides of the constriction, but only the future dorsal side of
the embryo gave rise to a normal larva. The other side produced an unorganized tissue mass of
ventral cells, which Spemann called the Bauchstück, the belly piece. This tissue mass was a ball of
epidermal  cells  (ectoderm)  containing  blood  and  mesenchyme  (mesoderm)  and  gut  cells
(endoderm), but no dorsal structures such as nervous system, notochord, or somites.
One possibility to explain why these two experiments gave different results was that when the egg
was divided perpendicular to the first cleavage plane, some cytoplasmic substance was not equally
distributed  into  the  two halves.  Fortunately,  the  salamander  egg was  a  good place  to  test  that
hypothesis. There are dramatic movements in the cytoplasm following the fertilization of amphibian
eggs, and in some amphibians these movements expose a gray, crescent-shaped area of cytoplasm in
the region directly opposite the point of sperm entry. This area has been called the gray crescent
(Figure 3.2).
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Figure 3.2: Asymmetry in the amphibian egg. A: When the egg is divided along the plane of first cleavage into two
blastomeres,  each of  which gets half  of  the gray crescent,  each experimentally  separated cell  develops into a
normal embryo. B: When only one of the two blastomeres receives the entire gray crescent, it alone forms a normal
embryo. The other blastomere produces a mass of unorganized tissue lacking dorsal structures such as nervous
system. (Gilbert, Developmental Biology).
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Moreover,  the  first  cleavage  plane  normally  splits  the  gray  crescent  equally  into  the  two
blastomeres. If these cells are then separated, two complete larvae develop. However, should this
cleavage plane be aberrant (either in the rare natural event or in an experiment), the gray crescent
material  passes  into  only  one  of  the  two  blastomeres.  Spemann  found  that  when  these  two
blastomeres  are  separated,  only the  blastomere  containing  the  gray crescent  develops  normally
(Figure 3.2). It appeared, then, that something in the gray crescent region was essential for proper
embryonic development.
The most important clue came from the fate map of this area of the egg, because it showed that the
gray crescent region gives rise to the cells that initiate gastrulation. These cells form the dorsal lip
of the blastopore. The cells of the dorsal lip are committed to invaginate into the blastula, thus
initiating  gastrulation  and  the  formation  of  the  notochord.  Because  all  future  amphibian
development depends on the interaction of cells rearranged during gastrulation, Spemann speculated
that the importance of the gray crescent material lies in its ability to initiate gastrulation.
In 1962, Hans Spemann found that neural induction (and more in general, crucial changes in cell
potency) occurred during the gastrula stage in the amphibian embryo. Spemann's demonstration
involved exchanging tissues between the gastrulae of two species of newts whose embryos were
differently pigmented:  the  darkly pigmented Triturus  taeniatus  and the  non-pigmented  Triturus
cristatus. When a region of prospective neural tissue cells from an early gastrula of one species was
transplanted into an area in the early gastrula of the other species and placed in a region where
epidermal  tissue  normally formed,  the  transplanted  cells  gave  rise  to  epidermal  tissue  (Figure
3.3A). Thus, cells of the early gastrula exhibited regulative development, because their ultimate fate
depended on their location in the embryo. However, when the same transplantation experiments
were  performed  on  late  gastrulae,  Spemann  obtained  completely  different  results.  Rather  than
differentiating in accordance with their new location, the transplanted cells turned out to have a
determined fate. Specifically, prospective neural cells now developed into brain tissues even when
placed in  the  region of  prospective  epidermis  (Figure  3.3B).  Cells  were already committed to
epidermal and neural fates at this stage.
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Experiments by Hans Spemann and Hilde Mangold in 1924 demonstrated that an entire ectopic axis
extending from the forebrain to the spinal cord could be induced in a host newt embryo by a group
of cells from the dorsal blastopore lip (Figure 3.4). This ectopic axis was complete in that a neural
tube encompassing forebrain (i.e.,  ectopic eyes) and spinal cord had developed over an ectopic
notochord and was flanked by somites. Once again, in these experiments newt species with white or
dark pigments were used to discriminate the contribution of the host and the donor tissues to the
ectopic axis. When the dorsal lip of an early T. taeniatus gastrula was removed and implanted into
the region of an early T. cristatus gastrula fated to become ventral epidermis (belly skin), the dorsal
lip  tissue  invaginated  just  as  it  would  normally  have  done  (showing  self-determination),  and
disappeared  beneath  the  vegetal  cells. The  pigmented  donor  tissue  then  continued  to  self-
differentiate into the chordamesoderm (notochord) and other mesodermal structures that normally
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Figure 3.3: Determination of the ectoderm during newt gastrulation. Presumptive neural ectoderm from one newt
embryo is transplanted into a region in another embryo that normally becomes epidermis. A: When the tissues are
transferred between early gastrulae, the presumptive neural tissue develops into epidermis, and only one neural
plate is seen. B: When the same experiment is performed using late-gastrula tissues, the presumptive neural cells
form neural tissue, thereby causing two neural plates to form in the host. (Gilbert, Developmental Biology).
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form from the dorsal lip. As the donor-derived mesodermal cells moved forward, host cells began to
participate in the production of the new embryo, becoming organs that normally they never would
have formed. In this secondary embryo, a somite could be seen containing both pigmented (donor)
and unpigmented (host) tissue. Even more spectacularly, the dorsal lip cells were able to interact
with the host tissues to form a complete neural plate from host ectoderm. Eventually, a secondary
embryo formed, conjoined face to face with its  host  (Figure  3.4).  The ectopic neural axis was
comprised of mostly host cells, demonstrating that the donor cells have inducing properties. Thus,
of  all  tissues  of  the  early  gastrula,  only  one  had  its  fate  autonomously determined.  This  self-
determining tissue is the dorsal lip of the blastopore,  the tissue derived from the grey crescent
cytoplasm, and was named “the Organizer”. 
Spemann  (1938)  referred  to  the  dorsal  lip  cells  and  their  derivatives  (notochord,  prechordal
mesoderm) as the Organizer because (1) they induced the host's ventral tissues to change their fates
to form a neural tube and dorsal mesodermal tissue (such as somites), and (2) they organized host
and donor tissues into a secondary embryo with clear anterior-posterior and dorsal-ventral axes.
He proposed that during normal development, these cells organize the dorsal ectoderm into a neural
tube and transform the flanking mesoderm into the antero-posterior body axis. It is now known
(thanks  largely  to  Spemann  and  his  students)  that  the  interaction  of  the  chordamesoderm and
ectoderm is not sufficient to “organize” the entire embryo. Rather, it initiates a series of sequential
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Figure  3.4: Dorsal blastopore lip tissue of the early gastrula displays organizing activity. Excision of  dorsal
blastopore lip tissue from the pigmented newt Triturus taeniatus and transplantation in the region of presumptive
ventral  epidermis  in  a  non-pigmented  Triturus  cristatus  at  early  gastrula  stage.  The  donor  tissue  induces  a
secondary invagination in the host embryo and exerts organizing activity to surrounding host tissues. A secondary
embryo forms where the donor tissue contributes mainly to notochord and prechordal mesoderm structures and re-
organizes the normally ventral surrounding host  tissues,  which are dorsalized into neural tube and mesoderm
(Andonadiuo et al., 2013; adapted from Gilbert, Developmental Biology).
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inductive events. Because there are numerous inductions during embryonic development, this key
induction wherein the progeny of dorsal lip cells  induce the dorsal  axis  and the neural  tube is
traditionally called primary embryonic induction.
Moreover, the abilities of the Organizer were found to be stage dependent, as dorsal blastopore lip
cells from younger embryos were capable of inducing an entire ectopic neural axis (heads, eyes,
brain and spinal cord),  but  older ones gave rise to ectopic axes lacking the eyes  and the most
anterior structures (Figure 3.5). These results show that the first cells of the Organizer to enter the
embryo induce the formation of brains and heads, while those cells that form the dorsal lip of later-
stage embryos induce the cells above them to become spinal cords and tails. This gave support to a
model whereby the activities of the organizer can be divided into the “head” and “trunk” organizers,
with early activities inducing anterior neural identity and late  activities  inducing only posterior
neural fates. 
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Figure 3.5: Temporal specificity of inducing ability. A: Young dorsal blastopore lips (which will form the anterior
portion of the Organizer) induce anterior dorsal structures when transplanted in early newt gastrulae. F: Older
dorsal blastopore lips transplanted into early newt gastrulae produce more posterior dorsal structures. (Gilbert,
Developmental Biology).
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The Formation of the Organizer
The experiments of Spemann and Mangold  showed that the dorsal lip of the blastopore, and the
notochord that forms from it, constituted an “Organizer” that could instruct the formation of new
embryonic axes. But the mechanisms by which the Organizer was constructed, and the factors being
secreted from the Organizer to cause the formation of the neural tube and to create the embryo axes
remained a mystery.
The major clue in determining how the dorsal blastopore lip obtained its properties came from the
experiments of Pieter Nieuwkoop and Osamu Nakamura. These studies showed that the properties
of  this  newly  formed  mesoderm  (the  Organizer)  were  induced  by  the  vegetal  (presumptive
endoderm) cells beneath it. 
Nakamura and his colleagues removed the equatorial cells (i.e.,  presumptive mesoderm) from a
blastula  and  showed  that  neither  the  animal  cap  (presumptive  ectoderm)  nor  the  vegetal  cap
(presumptive  endoderm)  produced  any  mesodermal  tissue.  However,  when  the  two  caps  were
recombined, the animal cap cells were induced to form mesodermal structures such as notochord,
muscles, kidney cells, and blood cells (Figures 3.6A,B).
The  polarity  of  this  induction  (whether  the  animal  cells  formed  dorsal  mesoderm  or  ventral
mesoderm) depended on the dorsal-ventral polarity of the endodermal (vegetal) fragment. While the
ventral  and  lateral  vegetal  cells  (those  closer  to  the  side  of  sperm  entry)  induced  ventral
(mesenchyme, blood) and intermediate (muscle, kidney) mesoderm, the dorsal-most vegetal cells
specified dorsal mesoderm components (somites, notochord), including those having the properties
of the organizer. These dorsal-most vegetal cells of the blastula, which are capable of inducing the
Organizer, have been called the Nieuwkoop center (Gerhart et al., 1989) (Figure 3.6C).
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The  existence  of  the  Nieuwkoop  center  was  demonstrated  in  the  32-cell  Xenopus  embryo  by
transplantation and recombination experiments. First, Gimlich and Gerhart (Gimlich and Gerhart,
1984;  Gimlich,  1985,  1986) performed an experiment  analogous to  the Spemann and Mangold
studies, except that they used blastulae rather than gastrulae. When they transplanted the dorsalmost
vegetal  blastomere  from  one  blastula  into  the  ventral  vegetal  side  of  another  blastula,  two
embryonic axes were formed (Figure 3.7).
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Figure 3.6: Mesodermal induction by vegetal endoderm. A: Isolated animal cap cells become a mass of ciliated
ectoderm, isolated equatorial (marginal zone) cells become mesoderm, and isolated vegetal cells generate gut-like
tissue. B: If animal cap cells are combined with vegetal cap cells, many of the animal cells generate mesodermal
tissue. C. Simplified model for mesoderm induction in Xenopus. A ventral signal (probably a complex set of signals
from activin-like TGF-β factors and FGFs) is released throughout the vegetal region of the embryo. This signal
induces the marginal cells to become mesoderm. On the dorsal side, higher concentrations of activin-like TGF-β
signals are released by the vegetal cells of the Nieuwkoop center and induce the formation of the Organizer in the
overlying marginal zone cells. (Gilbert, Developmental Biology).
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Second, Dale and Slack (1987) recombined single vegetal  blastomeres from a 32-cell  Xenopus
embryo with the uppermost animal cell layer of a fluorescently labeled embryo of the same stage.
The dorsalmost vegetal cell, as expected, induced the animal pole cells to become dorsal mesoderm.
The remaining vegetal  cells  usually induced the animal  cells  to  produce either  intermediate  or
ventral mesodermal tissues. Thus,  dorsal vegetal cells can induce animal cells to become dorsal
mesodermal tissue.
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Figure  3.7:  Transplantation  experiments  on  Xenopus  embryo
demonstrate  that  the  vegetal  cells  underlying  the  prospective
dorsal  blastopore  lip  region  are  responsible  for  initiating
gastrulation.  A new body axis forms after the transplantation of
the  most  dorsal  vegetal  cells  of  a  64-cell  embryo  into  the
ventralmost  vegetal  region  of  another  embryo.  (Gilbert,
Developmental Biology).
Introduction  3−Neural Induction and Antero-Posterior Axis Formation
Molecular Mechanisms of Amphibian Axis Formation: BMP-inhibitors Mediate the
Induction of Neural Ectoderm and Dorsal Mesoderm
While the Niewkoop center cells remain endodermal, the cells of the Organizer become the dorsal
mesoderm and migrate underneath the dorsal ectoderm. There, the dorsal mesoderm induces the
central nervous system to form. Evidence from experimental embryology showed that one of the
most critical properties of the Organizer was its production of soluble factors. 
Scientists were searching for molecules secreted by the Organizer and received by the ectoderm that
then  converted  it  into  neural  tissue.  However,  experimental  evidences  showed  an  opposite
mechanism: The ectoderm is actually induced to become epidermal tissue by soluble morphogens
called bone morphogenetic proteins (BMPs). The nervous system forms from that region of the
ectoderm that is  protected from this epidermal induction (Hemmati-Brivanlou and Melton, 1994,
1997). In other words, (1) the “default fate” of the ectoderm is to become neural tissue; (2) certain
parts of the embryo induce the ectoderm to become epidermal tissue by secreting BMPs, and (3) the
Organizer  tissues  act  by  secreting  molecules  that  block  this  induction,  thereby  allowing  the
ectoderm to be “protected” by these factors and thus to become neural tissue.
Three of the major BMP-inhibitors secreted by the Organizer are Noggin, Chordin and Follistatin.
In  1992,  the  first  of  the  soluble  organizer  molecules  was  isolated.  Smith  and  Harland  (1992)
constructed a cDNA plasmid library from dorsalized (lithium chloride-treated) gastrulae. Messenger
RNAs synthesized from sets of these plasmids were injected into ventralized embryos (having no
neural tube) produced by irradiating early embryos with ultraviolet light. Those sets of plasmids
whose mRNAs rescued the dorsal axis in these embryos were split into smaller sets, and so on, until
single-plasmid clones were isolated whose mRNAs were able to restore the dorsal axis in such
embryos (Figure 3.8). One of these clones contained the noggin gene (Figures 3.8 and 3.9).
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Figure 3.8: The identification of noggin as a neural inducer was accomplished through the use of an
expression cloning strategy in Xenopus embryos. UV light treatment of the early embryo inhibits the
development of dorsal structures by disrupting the cytoskeleton rearrangements that pattern the dorsal
inducing molecules prior to gastrulation (ventralized). Lithium treatment of the early embryo has the
opposite effect; the embryo develops more than normal dorsal tissue (hyperdorsalized). If  messenger
RNA is extracted from the hyperdorsalized embryos and injected into a UV-treated embryo, the messages
encoded in the mRNA can “rescue” the UV-treated embryo and it develops relatively normally. Similarly,
cDNA from the Organizer region of a normal embryo can rescue a UV-treated embryo. The noggin gene
was isolated as a cDNA from the Organizer region that could rescue the normal development of UV-
treated embryos. Subsequently, recombinant protein was made from noggin cDNA and shown to induce
neural tissue from isolated animal caps without any induction of mesodermal genes. (Sanes, Reh and
Harris; Development of the Nervous System).
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Noggin is a secreted protein that is able to accomplish two of the major functions of the Organizer.
It  induces  dorsal  ectoderm to  form neural  tissue,  and it  dorsalizes  mesoderm cells  that  would
otherwise contribute to the ventral mesoderm. Noggin binds to BMP4 and BMP2 and inhibits their
binding to receptors (Zimmerman et al., 1996). Smith and Harland (1992) have shown that newly
transcribed  noggin  mRNA is first localized in the dorsal blastopore lip region and then becomes
expressed in the notochord.
The second organizer protein found  was  Chordin.  It was isolated from clones of cDNA whose
mRNAs were present  in dorsalized,  but  not in ventralized,  embryos (Sasai  et  al.,  1994).  These
clones were tested by injecting them into ventral  blastomeres and seeing whether they induced
secondary axes.  One of  the  clones  capable  of  inducing  a  secondary neural  tube  contained  the
chordin gene. The chordin mRNA was found localized in the dorsal blastopore lip and later in the
45
Figure  3.9: The soluble protein Noggin dorsalizes the amphibian embryo.  Figure shows the rescue of dorsal
structures by Noggin protein. When Xenopus eggs are exposed to ultraviolet radiation, cortical rotation fails to
occur, and the embryos lack dorsal structures (top). If such an embryo is injected with noggin mRNA, it develops
dorsal structures in a dosage-related fashion (top to bottom). (Gilbert, Developmental Biology).
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dorsal mesoderm of the notochord (Figure 3.10). Like Noggin, chordin binds directly to BMP4 and
BMP2 and prevents their complexing with their receptors (Piccolo et al., 1996).
The mRNA for  a  third  organizer-secreted  protein,  Follistatin,  is  also  transcribed in  the  dorsal
blastopore lip and notochord. Follistatin was found in the Organizer through the unexpected result
of an experiment that was looking for something else. Ali Hemmati-Brivanlou and Douglas Melton
(1992, 1994) wanted to see whether the protein Activin was required for mesoderm induction, so
they  constructed  a  dominant  negative  Activin  receptor  and  injected  it  into  Xenopus  embryos.
Remarkably, the ectoderm of these embryos began to express neural-specific proteins. It appeared
that the Activin receptor (which also binds other structurally similar molecules such as the BMPs)
normally functioned by inhibiting neural induction. When its function was blocked, all the ectoderm
became neural. Follistatin, such as Noggin and Chordin, is a secreted protein capable of inhibiting
BMP, and additionally able to block Activin. In 1994, Hemmati- Brivanlou and Melton proposed a
“Default model of neural induction”: under normal conditions, ectoderm becomes neural unless
induced to become epidermal by BMPs. The Organizer functioned by producing inhibitors of anti-
neuralizing factors such as BMPs and Activin.
This model was also supported and explained by cell dissociation experiments. Three studies, by
Grunz and Tacke (1989), Sato and Sargent (1989), and Godsave and Slack (1989) showed that when
whole embryos or their animal caps were dissociated, they formed neural tissue. This result would
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Figure  3.10:  Localization  of  chordin mRNA.  A: Whole-mount  in  situ  hybridisation shows that  just  prior  to
gastrulation, chordin mRNA (dark area) is expressed in the region that will become the dorsal blastopore lip. B: As
gastrulation begins, chordin is expressed at the dorsal blastopore lip. C: In later stages of gastrulation, the chordin
mRNA is seen in the Organizer tissues. (Gilbert, Developmental Biology).
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be explainable if the "default state" of the ectoderm was not epidermal, but neural, and the tissue
had  to  be  induced  to  have  an  epidermal  phenotype.  The  Organizer,  then,  would  block  this
epidermis-inducing induction by inactivating BMPs.
In Xenopus, the epidermal inducers are bone morphogenetic protein BMP4 and its close relatives
BMP2 and BMP7. There is an antagonistic relationship between these BMPs and the Organizer
(Figure 3.11). 
If the mRNA for BMP4 is injected into  Xenopus eggs, all the mesoderm in the embryo becomes
ventrolateral mesoderm, and no involution occurs at the blastopore lip (Dale et al., 1992; Jones et
al.,  1992).  Conversely,  overexpression  of  a  dominant  negative  BMP4  receptor  resulted  in  the
formation  of  two  dorsal  axes  (Graff  et  al.,  1994;  Suzuki  et  al.,  1994).  In  1995,  Wilson  and
Hemmati-Brivanlou demonstrated that BMP4 induced ectodermal cells to become epidermal. By
1996, several laboratories had demonstrated that Noggin, Chordin, and Follistatin each was secreted
by the organizer and that each prevented BMP from binding to the ectoderm and mesoderm near the
organizer (Piccolo et al., 1996; Zimmerman et al., 1996; Iemura et al., 1998) (Figure 3.11).
BMP4 is expressed initially throughout the ectodermal and mesodermal regions of the late blastula.
However,  during  gastrulation,  bmp4  transcripts  become  restricted  to  the  ventrolateral  marginal
zone. In the ectoderm, BMPs repress the genes (such as neurogenin) involved in forming neural
tissue, while activating other genes involved in epidermal specification (Lee et al., 1995).
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Figure 3.11: Model for the action of the Organizer. BMP4 (along with other molecules) is a powerful ventralizing
factor. Organizer protein such as Noggin, Chordin and Follistatin block the action of BMP4; their inhibitory effect
can be seen in all three germ layers. (Gilbert, Developmental Biology).
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In 2005, two important sets of experiments confirmed the default  model and the importance of
blocking BMPs to specify the nervous system. First, Khokha and colleagues (2005) used antisense
morpholinos  to  eliminate  the  three  BMP antagonists  (i.e.,  Noggin,  Chordin  and  Follistatin)  in
Xenopus. The resulting embryos had catastrophic failure of dorsal development and lacked neural
plates  and  dorsal  mesoderm  (Figures  3.12A,B).  Second,  Reversade  and  colleagues  (2005)
performed the opposite experiment by blocking BMP activity with antisense morpholinos. When
they simultaneously blocked the formation of BMPs 2, 4 and 7, the neural tube became greatly
expanded, taking over a much larger region of the ectoderm (Figures 3.12C,D). These experiments
also  highlighted  a  significant  degree  of  functional  redundancy concerning the  activity of  these
genes.
These findings fit well with the concept that inhibition of BMP/TGF-β signaling is a prerequisite for
neural  induction.  BMP inhibitors  such as  Noggin  and Chordin  are  expressed  in  the  vertebrate
Organizers  and  play  a  role  in  neural  induction  by preventing  BMP signaling.  However,  BMP
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Figure  3.12:  Control  of  neural
specification  by  the  levels  of  BMPs.
A,B:  Lack  of  dorsal  structures  in
Xenopus embryos whose BMP-inhibitor
genes (Noggin, Chordin and Follistatin)
were  eliminated  by  antisense
morpholino  oligonucleotides.  Control
embryo in A has neural folds stained for
the expression of the neural gene Sox2.
Embryo in B shows lack of neural tube
and  Sox2  expression  after  treatment
with the morpholinos against all three
BMP-inhibitors.  C:  Expanded  neural
development.  The  neural  tube,
visualized  by  Sox2  staining,  is  greatly
enlarged  in  embryos  treated  with
antisense  morpholinos  that  destroy
BMPs  2,  4  and  7.  D:  Complete
transformation  of  the  entire  ectoderm
into neural ectoderm by inactivation of
ADMP (anti-dorsalizing morphogenetic
factor, a BMP-like paracrine factor) as
well  as  BMPs  2,  4  and  7.  (Gilbert,
Developmental Biology).
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signaling  appeared  not  to  be  the only player  in  neural  induction.  FGF signaling  has  also been
involved in the initiation of neural induction. Activation of FGF signaling has been proposed to be
required prior to, or independent to, the inhibition of BMP signaling. Likewise, WNT signals have
also been proposed to be required for neural induction in chick embryos. However, there is also
evidence suggesting that  FGF signals are  dispensable for the process  of  neural  induction.  FGF
signaling plays multiple and often contrasting roles in the early embryo as well as in pluripotent
stem cells, and conclusions may vary depending on the particular experimental conditions and the
assays used. Reconciling, at  least partially,  these discrepancies, elegant experiments have led to
propose a model by which the activation of the FGF and WNT signaling pathways inhibits BMP
signaling  (Andonadiou  and  Martinez-Barbera,  2013). Together,  these  studies  suggest  that  the
activation of both the FGF and WNT pathways converge with the inhibition of BMP signaling at the
levels  of  Smad1  and  reinforces  the  idea  that  BMP signaling  inhibition  may  be  a  conserved
requirement for neural induction.
Thus, embryonic cells appear to acquire neural potential if they avoid a series of signaling events
that promote their differentiation along non-neural lineages; these and other observations led to the
proposition of  a process called the Default Model for Neural Induction (Figure 3.13). According
to this view, BMPs play a key role by antagonizing a neural default differentiation program.
Antagonists of BMP signaling such as Noggin would ensure low levels of BMPs in the presumptive
neuroectoderm thus allowing neural development (See Wilson & Houart, 2004, for a review).
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Figure 3.13: Default model of neural induction. Following fertilization, a region of the early embryo gives rise to
the ectoderm or epiblast, which responds to inductive signals as development progresses (from left to right). At
gastrulae stages,  ectoderm on the ventral side is induced to become epidermis by BMP signaling. However, a
region of ectoderm avoids BMP signaling via inhibitors produced by the Organizer, giving rise to neural tissue.
FGFs promote a “prospective” or “pre” neural state prior to gastrulation. Other signaling molecules possibly
playing a direct role in neural induction are Wnt, Insulin-like Growth factor (IGF) and Retinoic acid (RA). This
neural  tissue  (uncommitted  neural  progenitors)  responds  to  a variety  of  patterning  signals  that  divide  it  into
different neural fates along the Antero-Posterior axis and Dorso-Ventral axis (See below, in this Chapter). (Scheme
was adapted from Lanza et al., Essentials of Stem Cell Biology).
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Regional Specificity of Neural Induction
One of the most important phenomena in neural induction is the acquisition of a regional identity of
the newly produced neural structures. Forebrain, hindbrain and spinocaudal regions of the neural
tube must be properly organized in a anterior-to-posterior direction. The Organizer tissue not only
induces  the  neural  tube,  it  also  specifies  the  regions  of  the  neural  tube.  This  region-specific
induction was demonstrated by Hilde Mangold's husband, Otto Mangold, in 1933. He transplanted
four successive regions of the archenteron roof of late-gastrula newt embryos into the blastocoels of
early-gastrula embryos (Figure 3.14). The most anterior portion of the archenteron roof (containing
head mesoderm) induced balancers and portions of the oral apparatus (Figure 3.14A); the next most
anterior section induced the formation of various head structures, including nose, eyes, balancers,
and otic vesicles (Figure 3.14B); the third section (including the notochord) induced the hindbrain
structure (Figure 3.14C); and the most posterior section induced the formation of dorsal trunk and
tail mesoderm (Figure 3.14D).
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Figure  3.14:  Regional  specificity  of  induction. A-D:  Regional  specificity  of  structural  induction  can  be
demonstrated by implanting different regions of the archenteron roof into early Triturus gastrulae. The resulting
embryos  develop  secondary  dorsal  structures.  A:  Head  with  balancers.  B:  Head  with  balancers,  eyes  and
forebrain. C: Posterior part of the head, diencephalon, and otic vesicles. D: Trunk-tail segment. (Adapted from
Gilbert, Developmental Biology).
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Moreover, the abilities of the Organizer were found to be stage dependent, as dorsal blastopore lip
cells from younger embryos were capable of inducing an entire ectopic neural axis (heads, eyes,
brain and spinal cord),  but  older ones gave rise to ectopic axes lacking the eyes  and the most
anterior structures (Figure 3.5).
The molecules secreted by the Organizer in a regional fashion are indicated in  Figure  3.15 and
described  in  detail  in  the  text.  The  first  cells  involuting  through  the  blastopore  lip  (the
endomesoderm) induce head structures, while the next portion of involuting mesoderm (notochord)
produces trunk and tail structures.
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Figure  3.15:  Antagonists from the Organizer are able to block specific paracrine factors to distinguish head
from tail.  A: The pharyngeal endoderm that underlies the head secretes Dickkopf, Frzb and Cerberus. Dickkopf
and Frzb block  Wnt  proteins;  Cerberus blocks  Wnt,  Nodal-related  proteins  and BMPs.  The  prechordal  plate
secretes  the  Wnt-blockers  Dickkopf  and Frzb,  as  well  as  BMP-blockers  Noggin and Chordin.  The  notochord
contains BMP-blockers Chordin, Noggin and Follistatin, but it does not secrete Wnt-blockers. IGF from the head
endo-mesoderm  probably  acts  at  the  junction  of  the  notochord  and  prechordal  mesoderm.  B:  Summary  of
paracrine  antagonist  function  in  the  ectoderm.  Brain  formation  requires  inhibiting  both  the  Wnt  and  BMP
pathways. Spinal cord neurons are produced when Wnt functions without the presence of BMPs. When both Wnt
and BMP pathways are operating, epidermis is formed. (Gilbert, Developmental Biology).
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
It had been thought that all the neural tissue induced by the Organizer was induced to  become
forebrain, and that the notochord represented the most anterior portion of the Organizer. However,
the most anterior regions of the head and brain are underlain not by notochord, but by pharyngeal
endoderm and head (prechordal) mesoderm. This “endomesoderm” constitutes the leading edge of
the dorsal  blastopore lip.  Recent  studies have shown that  these cells  not  only induce the most
anterior head structures, but that they do it by blocking the Wnt pathway as well as blocking BMP4
(Figure 3.15).
In  1996,  Bouwmeester  and  colleagues  showed  that  the  induction  of  the  most  anterior  head
structures could be accomplished by a secreted protein called Cerberus. Unlike the other proteins
secreted by the Organizer, Cerberus promotes the formation of the cement gland (the most anterior
region  of  tadpole  ectoderm),  eyes,  and  olfactory (nasal)  placodes.  When  cerberus  mRNA was
injected into a vegetal ventral Xenopus blastomere at the 32-cell stage, ectopic head structures were
formed (Figure 3.16).  These head structures were made from the injected cell  as well  as from
neighboring cells. The cerberus gene is expressed in the pharyngeal endomesoderm cells that arise
from the deep cells of the early dorsal lip, and the Cerberus protein has a triple activity, as it can
bind (inhibit) both Nodal, BMPs and Xwnt8 (Glinka et al., 1997; Piccolo et al., 1999).
52
Figure  3.16: Cerberus mRNA injected into a single ventral vegetal balstomere of a 32-cell Xenopus embryo
induces head structures, as well as duplicated heart and liver. The secondary eye (a single cyclopic eye) and
olfactory placode can be readily seen. (Modified from Gilbert, Developmental Biology).
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Shortly after the attributes of Cerberus were demonstrated, two other proteins, Frzb and Dickkopf,
were discovered to be synthesized in the involuting endomesoderm. Frzb (pronounced “frisbee”) is
a small,  soluble form of Frizzled,  the Wnt receptor,  that is  capable of binding Wnt proteins in
solution  (Leyns  et  al.,  1997;  Wang  et  al.,  1997).  It  is  synthesized  predominantly  in  the
endomesoderm cells beneath the head (Figure 3.17A,B). If embryos are made to synthesize excess
Frzb, Wnt signaling fails  to occur,  and the embryos lack ventral  posterior structures, becoming
solely head. The Dickkopf (German; “big head”) protein also appears to interact directly with Wnt
proteins in the extracellular space (Figure 3.17A). Injection of antibodies against Dickkopf protein
into the blastocoel causes the resulting embryos to have small, deformed heads with no forebrain
(Glinka et al., 1998).
Glinka  and  colleagues  (1997)  have  thus  proposed  a  new model  for  embryonic  induction.  The
induction of trunk structures may be caused by the blockade of BMP signaling from the notochord.
However,  to  produce  a head,  both the BMP signal  and the Wnt  signal  must  be blocked.  This
blockade  comes  from  the  endo-mesoderm,  now  considered  the  most  anterior  portion  of  the
Organizer.
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Figure  3.17: A:  Xenopus Wnt8 (Xwnt8) is made throughout the
marginal zone and is capable of ventralizing the mesoderm and
preventing anterior head formation in the ectoderm.  B: Double
in  situ  hybridisation  localizing  Frzb  (dark  stain)  and  chordin
(reddish stain) mRNAs. The Frzb mRNA is seen to be transcribed
in  the  head  endo-mesoderm  of  the  Organizer,  but  not  in  the




Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
In addition to those proteins that block BMPs and Wnts by physically binding to these paracrine
factors, the head region contains yet another set of proteins that prevent BMP and Wnt signals from
reaching the nucleus. Pera and colleagues (2001) showed that insuline-like growth factors (IGFs)
are required for the formation of an anterior neural tube, including the brain and sensory placodes
(Figure 3.18). IGFs accumulate in the dorsal midline and are especially prominent in the anterior
neural  tube  (Figure  3.18A).  When  injected  into  ventral  mesodermal  blastomeres,  IGF  mRNA
causes the formation of ectopic heads, while blocking the IGF receptors results in the lack of head
formation (Figure 3.18B,C). IGFs appear to work by initiating a signal transduction cascade that
interferes with the signal transduction pathways of both BMPs and Wnts.
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Figure  3.18:  Insuline-like growth factors enhance anterior neural development. A: Expression pattern of Igf3,
showing protein accumulation in the anterior neural tube. B: An ectopic head-like structure (complete with eyes
and cement gland) formed when Igf2 mRNA was injected into ventral marginal zone blastomeres. C: Anterior of 3-
day control tadpole (left) compared with a tadpole whose 4-cell embryonic blastomeres were injected with an IGF
inhibitor. The cement gland and eyes are absent.(Gilbert, Developmental Biology).
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In the 1950s, evidence accumulated for the existence of two gradients in amphibian  embryos: a
dorsal  gradient  of  “neuralizing”  activity  and  a  caudal  gradient  of  “posteriorizing”  activity
(Nieuwkoop, 1952; Toivonen and Saxén, 1955). The neuralizing activity came from the Organizer
and induced the ectoderm to be neural. The posteriorizing activity originated in the posterior of the
embryo and weakened anteriorly. Recent studies have extended this model and provided candidates
for the posteriorizing molecules. As predicted, the two signaling systems work independently (Kolm
and  Sive,  1997).  Chordin,  Noggin,  and  the  other  molecules  discussed  above  constitute  the
neuralizing factors secreted by the Organizer. The candidates for the posteriorizing factor include
FGF, Retinoic acid (RA), and Wnt factors (Wnt3a and Wnt8).
It appears that a gradient of Wnt proteins is necessary for specifying the posterior region of the
neural  plate  (the  trunk  and  tail;  Niehrs,  2004).  In  Xenopus,  an  endogenous  gradient  of  Wnt
signaling is highest in the posterior and absent in the anterior. Moreover,  if  Xwnt8 is added to
developing embryos, spinal cord-like neurons are seen more anteriorly in the embryo, and the most
anterior markers of the forebrain are absent. Conversely, suppressing Wnt signaling (by adding Frzb
or Dickkopf to the developing embryo) leads to the expression of the anterior-most markers in more
posterior neural cells. 
Another candidate as a caudalizing factor is Xenopus Wnt3a (McGrew et al., 1995). This protein is
found  in  the  neural  ectoderm of  the  early  neurula.  When  ectoderm is  isolated  from  Xenopus
gastrulae but remains connected to the dorsal blastopore lip, the ectoderm develops an anterior-
posterior array of neural markers. If the embryo is first injected with Xwnt3a mRNA (causing the
overexpression of this protein), the anterior markers are lost.
Fibroblast growth factors are able to turn anterior neural tissue into posterior neural  tissue. When
early-gastrula ectoderm (which has not yet been underlain by dorsal mesoderm) was isolated and
neuralized  by Noggin,  Chordin,  or  Follistatin,  anterior-type  neural  markers  were  found in  that
tissue. However, when isolated early-gastrula ectoderm was incubated with a neural inducer plus
FGF2, it expressed more posterior neural markers. FGF2 also induces forebrain tissue to express
hindbrain-specific  genes  (Cox  and  Hemmati-Brivanlou,  1995;  Lamb  and  Harland,  1995).
Furthermore, when FGF signaling is blocked  in vivo by a dominant negative FGF receptor, the
resulting tadpoles lack their posterior segments (Amaya et al.,  1991). FGF2 is probably not the
natural posteriorizing FGF in Xenopus, since it is not secreted by the embryo at this site, and it is
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not localized to any side of the embryo. However, embryonic FGF (eFGF, a Xenopus FGF similar
to mammalian FGF4) is found in  Xenopus  posterior and tailbud mesoderm, and it has the same
effects  as  FGF2 (Isaacs  et  al.,  1992).  Overexpression  of  eFGF up-regulates  several  posteriorly
expressed genes, including the Xenopus homologue of caudal. These genes, in turn, encode proteins
that  appear to  regulate the Hox genes  controlling the specification of body segments along the
anterior-posterior axis. This leads to the more posterior specification of the caudal nervous system
(Pownall et al., 1996). Interestingly, eFGF may be induced by the posterior notochord (Taira et al.,
1997).
Retinoic acid is also likely to play a role in posteriorizing the neural tube. 
In  vivo,  Retinoic  acid  is  synthesized  from  vitamin  A  (retinol)  by  the  action  of  retinol
dehydrogenases, which are expressed in the posterior regions of the embryo, but not in the anterior
neural plate at the time of neural induction. In contrast, enzymes such as CYP26, a cytochrome
P450  enzyme  that  degrades  RA,  is  expressed  at  high  levels  in  the  anterior  neural  plate.  This
differential expression of synthesis and degradation enzymes is thought to create a RA signaling
gradient along the AP axis (low-anterior and high-posterior).
If  Xenopus  neurulae are  treated with nanomolar  to  micromolar  concentrations  of  Retinoic  acid
(RA), their forebrain and midbrain development is impaired in a concentration-dependent fashion
(Figure  3.19;  Papalopulu et  al.,  1991;  Sharpe,  1991).  When lower concentrations are  used,  the
actual induction of neural tissue does not appear to be inhibited, but fewer forebrain structures are
produced (Durston et al., 1989; Sive et al., 1990). Retinoic acid appears to affect both the mesoderm
and the ectoderm. Ruiz i Altaba and Jessell (1991) found that anterior dorsal mesoderm from RA-
treated gastrulae was unable to induce head structures in host embryos, and Sive and Cheng (1991)
found  that  RA-treated  ectoderm was  unable  to  respond  to  the  anterior-inducing  mesoderm of
untreated gastrulae. An RA gradient (tenfold higher in the posterior than in the anterior) has been
detected in the dorsal mesoderm of early Xenopus neurulae (Chen et al., 1994). Like eFGF, retinoic
acid has been shown to activate the expression of more posterior Hox genes (Cho et al., 1991; Sive
and Cheng, 1991; Kolm and Sive, 1997).
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The relationship between these three pathways of posteriorization has yet to be worked out. They
may play different roles in different regions of the embryo, and they may work together. Retinoic
acid  has  its  major  effect  on  hindbrain  patterning,  while  eFGF  is  more  important  in  the
regionalization of the spinal cord (Blumberg et al., 1997; Kolm et al., 1997; Godsave et al., 1998).
By  interacting  with  FGFs,  RA signaling  is  able  to  activate  posterior  Hox  genes.  Wnt3a  may
suppress  anterior  genes  and be a  permissive factor  allowing the other  two proteins  to  function
(McGrew et al., 1997).
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Figure 3.19: Effects of increasing doses of Retinoic acid on Xenopus brain development. 
(Papalopulu et al., 1991).
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The basic model of neural induction, then, looks like the diagram in Figure 3.20.
In summary, all the above described factors (such as Wnts, Retinoic acid and FGFs) are thought to
convert neuroepithelial cells from an anterior ground state to a more posterior position along the
neuraxis.  In many assays, whenever neural tissue is induced, it expresses transcripts that are later
restricted to forebrain and midbrain territories. Expression of these “anterior markers” raises the
possibility  of  an  obligate  link  between induction  of  neural  identity  and acquisition  of  anterior
character (discussed in Foley and Stern, 2001). In such a scenario,  neural inducing  signals are
proposed to impart both neural and anterior identity to the ectoderm while the generation of the
full range of CNS structures would be the result of later events that posteriorize anterior neural
tissue (Figure 3.21; See Wilson and Houart, 2004 as a Review, and Beccari et al., 2013).
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Figure 3.20: Model of the organizer function and axis specification in the Xenopus gastrula. 1: BMP inhibitors
from the Organizer tissue (dorsal mesoderm and pharyngeal mesendoderm) block the formation of  epidermis,
ventrolateral  mesoderm,  and ventrolateral  endoderm. 2:  Wnt  inhibitors  in  the anterior  area  of  the  Organizer
(pharyngeal mesendoderm) allow the induction of head structures. 3: A gradient of caudalizing factors (Wnts,
FGFs and Retinoic acid) causes the regional expression of Hox genes, specifying the regions of the neural tube.
Modified from Gilbert, Developmental Biology.
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Figure 3.21: Nieuwkoop and Faber model of neural induction and A-P patterning. Much of our knowledge on
neural induction and subsequent brain patterning has come from amphibian studies. This led to the development of
a  two step  Activation-Transformation  model: ectodermal  cells  initially  acquire  an  anterior  fate  upon neural
induction (activation), but they can subsequently be transformed into more caudal cell fates (transformation) to
obtain all of the different subdomains along the A/P axis, a process referred to as caudalization. (Reviewed in
Wilson and Houart, 2004).
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4− Mammalian Axis Formation 
Two Signaling Centers: the Node and the Anterior Visceral Endoderm
Neural induction and the formation of the anterior-posterior axis has been extensively studied in
mice. The structure of the mouse epiblast is cup-shaped. The dorsal surface of the epiblast (the
embryonic ectoderm) contacts the amniotic cavity, while the ventral surface of the epiblast contacts
the newly formed mesoderm. In this cup-like arrangement, the endoderm covers the surface of the
embryo on the “outside” of the cup (Figure 4.1A).
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The  mammalian  embryo  has  two  signaling  centers:  the  node (equivalent  to  the  amphibian
Organizer) and the  anterior visceral endoderm  (AVE; similar to the prechordal endomesoderm,
the head portion of the amphibian Organizer) (Figure 4.1B). The node, which is positioned at the
bottom of the cup in the mouse early embryo, is responsible for the specification of the body and,
together with the AVE, works to form the anterior region of the embryo (Bachiller et al., 2000). The
notochord forms by the dorsal infolding of the small, ciliated cells of the node.  Both the mouse
node and the anterior visceral endoderm express many of the genes known to be expressed in the
chick and frog Organizer tissue.  In mouse, the transplantation of the node led to similar results
compared  to  the  amphibian  Organizer  transplantation.  However,  it  came as  a  surprise  that  the
transplantation of the mouse node gave rise to an incomplete axis lacking the anterior forebrain.
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Figure 4.1: Axis and notochord formation in the mouse. A: In the 7-day mouse embryo, the dorsal surface of the
epiblast (embryonic ectoderm) is in contact with the amniotic cavity. The ventral surface of the epiblast contacts
the newly formed mesoderm. In this cup-like arrangement, the endoderm covers the surface of the embryo on the
“outside” of the cup. The node is at the bottom of the cup, and it has generated the chordamesoderm. The two
signaling centers, the node and the anterior visceral endoderm (AVE), are located on opposite sites of the cup.
Eventually, the notochord will link them. The caudal side of the embryo is marked by the presence of the allantois.
B: By embryonic day 8,  the AVE lines  the foregut,  and the prechordal  mesoderm is  now in contact  with the
forebrain ectoderm. The node is now farther caudal, largely as a result of the rapid growth of the anterior portion
of the embryo. The cells in the midline of the epiblast migrate through the primitive streak (white arrow). 
(Gilbert, Developmental Biology).
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 This happened because the second signaling center, the AVE, was necessary together with the node
for the specification of most anterior tissues.
The AVE originates from the visceral endoderm (hypoblast) that migrates forward (Figure 4.2).
As the AVE migrates, it secretes two antagonists of the Nodal protein, Lefty-1 and Cerberus. Lefty-
1 binds to the Nodal's receptor and blocks Nodal binding, while Cerberus binds to Nodal itself.
While the Nodal proteins in the epiblast activate the expression of posterior genes that are required
for mesoderm formation, the AVE creates an anterior region where Nodal cannot act. The AVE also
begins expressing the anterior markers that are necessary for head formation, such as transcription
factors Hesx1, Lim1,  Lhx1,  Foxa1 and  Otx2,  as well  as the gene coding for the  Wnt-inhibitor
Dickkopf. Dickkopf is expressed both in the AVE and in the node.
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Figure 4.2: Migration of the AVE cells during early mouse development. Figures show the specification of tissues
involved in patterning the anterior forebrain in the post-implantation mouse embryo and the establishment of the
antero-posterior axis. AVE cells are induced to form by signals from the epiblast acting on visceral endoderm at the
distal  tip of the embryo by 5.5 dpc. AVE cells migrate anteriorly at  5.5 dpc, reach the boundary between the
epiblast and extra-embryonic ectoderm in approximately 5–6 h and then start to move laterally. At 6.5 dpc, the
primitive streak elongates and the anterior movements of the anterior definitive endoderm (ADE) and anterior
mesendoderm (AME) displace and intermingle with the AVE. By 7.5 dpc, the prospective anterior forebrain neural
ectoderm overlies the ADE/AME and posterior neural tissue is underlied by the notochordal plate. VE visceral
endoderm, AVE anterior visceral endoderm, ADE anterior definitive endoderm, AME anterior mesendoderm, np
notochordal plate, PS primitive streak, AF anterior forebrain primordium, Ec neural ectoderm. (Andoniadou and
Martinez-Barbera, 2013).
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Studies on mutant mice indicate that the AVE promotes anterior specification by suppressing the
formation of the primitive streak (a posterior structure) by Nodal and Wnt proteins (Perea-Gomez et
al., 2002). However, AVE alone cannot induce neural tissue, as the node can.
The placement of the node and the primitive streak appears to be due to the blocking of Nodal
signaling by the Cerberus and Lefty-1 from AVE.  The anterior visceral endoderm is established
before the node, and the primitive streak always forms on the side of the epiblast  opposite  this
anterior  site.  Once formed,  the node will  secrete Chordin (Figure  4.3A);  the head process and
notochord will later secrete also Noggin. These two BMP antagonists are not expressed in the AVE. 
While knockouts of either noggin or chordin genes did not affect development, mice missing both
genes lack forebrain, nose and other facial structures (Bachiller et al., 2000;Figures 4.3B-D).
It is probable that the AVE functions in the epiblast to restrict Nodal activity, thereby cooperating
with  the  node to  promote  the  expression  of  head-forming genes  in  the  anterior  portion  of  the
epiblast. Homozygosity for mutant alleles of any of the above-mentioned head-specific organizing
genes produces mice lacking forebrain.
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Figure  4.3: Expression of BMP antagonists in the mammalian node. A: Expression of Chordin during mouse
gastrulation is seen in the anterior primitive streak, node and axial mesoderm. It is not expressed in the AVE. B-D:
Phenotypes of  12.5-day embryos.  B: Wild-type embryo.  C: Embryo with the Chordin gene knocked out  has a
defective ear but an otherwise normal head. D: Phenotype of a mouse deficient in both Chordin and Noggin. There
is no jaw, and there is a single centrally located eye, over which protrudes a large proboscis (nose). (Bachiller et
al., 2000).
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Anterior-Posterior Patterning: Wnt, FGF and Retinoic acid Gradients
A clear scenario emerges from what so far reported: the head region of the mammalian embryo is
devoid  of  Nodal  signaling;  BMPs,  FGFs  and  Wnts  are  also  inhibited.  The  posterior  region  is
characterized by Nodal, BMPs, Wnts, FGFs and Retinoic acid (RA). There appears to be a gradient
of Wnt, BMP and FGF proteins that is highest in the posterior and that drops off strongly near the
anterior region (Figure 4.4).
Moreover, in the anterior half of the embryo, starting at the node, there is a high concentration of
antagonists that prevent BMPs and Wnts from acting (Figure 4.4).
The FGF8 gradient is created by the decay of mRNA: Fgf8 is expressed at the growing posterior tip
of the embryo, but the FGF8 message is slowly degraded in the newly formed tissues. Thus, there is
a gradient of FGF8 mRNA across the posterior of the embryo, which is then converted into an
FGF8 protein gradient (Figure 4.5; Dubrulle and Pourquié, 2004).
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Figure  4.4:  Anterior-posterior patterning in the mouse embryo.  Concentration gradients of  BMPs, Wnts and
FGFs are shown in the late gastrula mouse embryo (depicted as a flattened disc). The primitive streak and other
posterior tissues are the source of Wnt and BMP proteins, whereas the Organizer and its derivatives (such as the
notochord) produce antagonists. (Modified from Gilbert, Developmental Biology).
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In addition to FGFs, the late gastrula has a gradient of Retinoic acid too. RA levels are high in the
posterior regions and low in the anterior portions of the embryo. This gradient (like that of frog
embryos) appears to be controlled by the expression of RA-synthesizing enzymes in the embryo's
posterior and RA-degrading enzymes in the anterior parts of the embryo.
The FGF gradient patterns the posterior portion of the embryo by working through the Cdx family
of caudal-related genes. The Cdx transcription factors, in turn, integrate the various posteriorizing
signals (Retinoic acid, FGF8 and Wnt3a) by activating and regulating the activity of Hox genes,
whose expression regulates anterior-posterior patterning in all vertebrates.
In general, the activation-transformation model created after experiments in frogs, was found to be
valid also for mammalian embryos:  Neural tissue develops anterior  character unless exposed to
caudalizing signals. (Figure 4.6).
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Figure 4.5: FGF8 is expressed in the posterior tip of the gastrula and continues to be made in the tail bud.  Its
mRNA decays, creating a gradient across the posterior portion of the embryo. Figure shows the FGF8 gradient in
the tailbud region of a 9-day mouse embryo. The highest amount of FGF8 (red) is found near the tip. The gradient
was determined by in situ hybridisation of an FGF8 probe and staining for increasing amounts of time. (Dubrulle
and Pourquié, 2004).
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Figure 4.6: A host of signals act in concert to confer anterior forebrain identity. Signals such as Wnts, FGFs, and
BMPs exert a posteriorizing action on the neural plate (blue arrows). Counteracting activation of the respective
pathways in the anterior forebrain, secreted inhibitors such as Cerberus, Lefty1, Dkk1, Noggin, and Chordin (red
arrows) are released by the underlying anterior visceral endoderm (AVE), anterior definitive endoderm (ADE), and
prechordal plate. Within the prospective anterior forebrain, intrinsic factors such as HESX1, SIX3, and TCF3, aid
in regulating the competence of neural tissue to not respond to posteriorizing signals, possibly by preventing the
expression of target genes of these pathways, hence maintaining anterior forebrain identity. AF: anterior forebrain,
PF: posterior forebrain, MB: midbrain, HB: hindbrain, SC: spinal cord, AVE: anterior visceral endoderm, ADE:
anterior definitive endoderm, pp: prechordal plate. (Andoniadou and Martinez-Barbera, 2013).
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5− Tissue Architecture of the Central Nervous System:
Development of the Cerebral Cortex.
The neurons of the brain are organized into layers (cortices) and clusters (nuclei), each having
different  functions  and  connections.  The  original  neural  tube  is  composed  of  a  germinal
neuroepithelium, a layer of rapidly dividing neural stem cells, one cell layer thick.
Sauer (1935) and others have shown that all the cells of the germinal epithelium are continuous
from the luminal surface of the neural tube to the outside surface, but that the nuclei of these cells
are at different heights, thereby giving the superficial impression that the neural tube has numerous
cell layers (Pseudostratified Neuroepithelium) (Figure 5.1).
The nuclei move within their  cells as they go through the cell  cycle. DNA synthesis  (S phase)
occurs  while  the  nucleus  is  at  the  outside  edge  of  the  neural  tube,  and  the  nucleus  migrates
luminally as the cell cycle proceeds (Figure 5.1). Mitosis occurs on the luminal side of the cell
layer.  If  mammalian  neural  tube  cells  are  labeled  with  radioactive  thymidine  during  early
development,  100% of  them will  incorporate  this  base  into  their  DNA (Fujita,  1964).  Shortly
thereafter, certain cells stop incorporating these DNA precursors, thereby indicating that they are no
longer participating in DNA synthesis and mitosis. These neuronal and glial cells then migrate and
differentiate outside the neural tube (Fujita, 1966; Jacobson, 1968).
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If dividing cells in the germinal neuroepithelium are labeled with radioactive thymidine at a single
point in their development, and their progeny are found in the outer cortex in the adult brain, then
those neurons must have migrated to their cortical positions from the germinal neuroepithelium.
When a cell of the germinal neuroepithelium is ready to generate neurons (instead of more neural
stem cells),  the  plane  of  cell  division  shifts.  The  neuroepithelial  stem cell  divides  "vertically"
instead of "horizontally." Thus, the daughter cell adjacent to the lumen remains connected to the
ventricular surface (and usually remains a stem cell), while the other daughter cell migrates away
and differentiates (Chenn and McConnell, 1995).
The time of this vertical division is the last time the migrating cell will divide, and is called that
neuron's birthdate. Different types of neurons and glial cells have their birthdates at different times.
Labeling cells at different times during development shows that cells with the earliest birthdays
migrate the shortest distances. The cells with later birthdays migrate through these layers to form
the more superficial regions of the cortex. Subsequent differentiation depends on the positions these
neurons occupy once outside the germinal neuroepithelium (Letourneau, 1977; Jacobson, 1991).
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Figure  5.1:  Neural stem cells in the germinal epithelium.  A: Scanning electron micrograph of a newly formed
chick neural tube, showing cells at different stages of their cell cycles. B: Schematic section of a chick embryo
neural tube, showing the position of the nucleus in a neuroepithelial cell as a function of the cell cycle. Mitotic
cells are found near the inner surface of the neural tube, adjacent to the lumen. (Gilbert, Developmental Biology).
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As the cells adjacent to the lumen continue to divide, the migrating cells form a second layer around
the original neural tube. This layer becomes progressively thicker as more cells are added to it from
the germinal neuroepithelium. This new layer is called the mantle (or intermediate) zone, and the
germinal epithelium is now called the  ventricular zone  (and, later, the  ependyma)  (Figure 5.2,
left). The mantle zone cells differentiate into both neurons and glia. The neurons make connections
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Figure 5.2: Differentiation of the walls of the neural tube.  A section of a 5-week human neural tube (left) reveals
three  zones:  ventricular  (V;  ependymal),  intermediate  (I;  mantle),  and  marginal  (M).  In  the  spinal  cord  and
medulla (top row) the ventricular zone remains the sole source of neurons and glial cells; it will originate the
ependyma (E). In the cerebellum (middle row), a second mitotic layer, the external granular layer (EG), forms at
the  region  farthest  removed  from  the  ventricular  zone.  Neuroblasts  from  this  layer  migrate  back  into  the
intermediate zone to form the internal granule layer (GL). In the cerebral cortex (bottom row), the migrating
neuroblasts and glioblasts form a cortical plate containing six layers (CP), placed between the molecular layer
(M; marginal zone) and the white matter (I; intermediate zone). (Gilbert, Developmental Biology).
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among  themselves  and  send  forth  axons  away  from  the  lumen,  thereby  creating  a  cell-poor
marginal zone. Eventually, glial cells cover many of the axons in the marginal zone in myelin
sheaths, giving them a whitish appearance. Hence, the mantle zone, containing the neuronal cell
bodies, is often referred to as the gray matter; the axonal, marginal layer is often called the white
matter. In the spinal cord and medulla, this basic three-zone pattern of ependymal, mantle, and
marginal layers is retained throughout development (Figure 5.2).
In the brain,  cell  migration,  differential  neuronal proliferation,  and selective cell  death produce
modifications of the three-zone pattern. The development of spatial organization is critical for the
proper functioning of the cortices (cerebellum and cerebrum). For this to happen, the proper cells
must differentiate at the appropriate place and time.
One  mechanism thought  to  be  important  for  positioning  young  neurons  within  the  developing
mammalian brain is glial guidance (Rakic, 1972; Hatten, 1990). In the cerebellum, the granule cell
precursors travel on the long processes of the  Bergmann glia  (Figure 5.3;  Rakic and Sidman,
1973; Rakic, 1975).
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Figure 5.3: Neuron-glia interaction in the mouse. A: Diagram of a newly generated neuron migrating on a glial
cell process. B: Sequential photographs of a neuron migrating on a cerebellar glial process. The leading process
has several filopodial extensions. (Modified from Gilbert, Developmental Biology).
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Throughout the cortex, neurons are seen to ride a “glial monorail” to their respective destinations:
newly generated cortical neurons reach their destinations thanks to the radial glia. These glial cells
have long processes that extend from the ventricular zone all the way to the pial surface.
This  neural-glial  interaction is  a  complex and fascinating series  of  events,  involving reciprocal
recognition between glia and neuroblasts (Hatten, 1990; Komuro and Rakic, 1992). The neuron
maintains its  adhesion to the glial  cell  through a number of proteins, one of them an adhesion
protein called astrotactin. If the astrotactin on a neuron is masked by antibodies to that protein, the
neuron will fail to adhere to the glial processes (Edmondson et al., 1988; Fishell and Hatten, 1991).
Cerebral organization
The three-zone arrangement of the neural tube is also modified in the cerebrum. The cerebrum is
organized in two distinct ways. First, like the cerebellum, it is organized vertically into layers that
interact with one another (see Figure 5.2, bottom row). Certain neuroblasts from the mantle zone
migrate on glial processes through the white matter to generate a second zone of neurons at the
outer surface of the brain. This new layer of gray matter is called the neocortex. The specification
of the neocortex is  accomplished largely through the Lhx2 transcription factor,  which activates
numerous other cerebral genes. In Lhx2-deficient mice, the cerebral cortex fails to form (Mangale et
al., 2008). The neocortex eventually stratifies into six layers of neuronal cell bodies; the adult forms
of these layers are not completed until the middle of childhood. Each layer of the neocortex differs
from the  others  in  its  functional  properties,  the  types  of  neurons  found there,  and the  sets  of
connections that they make. For instance, neurons in layer 4 receive their major input from the
thalamus (a region that forms from the diencephalon), while neurons in layer 6 send their major
output back to the thalamus.
Second, the cerebral cortex is organized horizontally into over 40 regions that regulate anatomically
and functionally distinct processes. For instance, neurons in cortical layer 6 of the “visual cortex”
project axons to the lateral geniculate nucleus of the thalamus (for vision processing), while layer 6
neurons of the auditory cortex (located more anteriorly than the visual cortex) project axons to the
medial geniculate nucleus of the thalamus (for hearing). 
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Neither  the vertical  nor  the horizontal  organization of  the cerebral  cortex is  clonally  specified.
Rather, the developing cortex forms from the mixing of cells derived from numerous stem cells.
After their final mitosis, most of the neuronal precursors generated in the ventricular (ependymal)
zone migrate outward along glial processes to form the  cortical plate  at the outer surface of the
brain. As in the rest of the brain, those neuronal precursors with the earliest “birth dates” form the
layer  closest  to  the  ventricle.  Subsequent  neurons  travel  greater  distances  to  form  the  more
superficial layers of the cortex. This process forms an “inside-out” gradient of development (Figure
5.4; Rakic, 1974).
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Figure 5.4: Birthdating studies in monkey demonstrate the inside-out pattern of cerebral cortical histogenesis.
In the monkey, where the histogenesis of the cerebral cortex is more protracted than in the rat, the production of the
cortical neurons takes place over a 50-day time period. By labeling the pregnat female with [3H]-thymidine at
progressively later gestational ages, it is possible to determine the period of embryonic development when each
cortical layer is generated. (Gilbert, Developmental Biology).
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Cortical cell migration.
The first cortical neurons to be generated migrate out of the germinal zone to form the transient
preplate. Subsequently generated neurons migrate into the preplate and separate it into two layers:
the  Cajal-Retzius  layer and  the  subplate (Figure  5.5). The  Cajal-Retzius  layer  becomes  and
remains  the  most  superficial  layer  of  the  neocortex,  and  its  cells  express  the  cell  surface
glycoprotein  Reelin  (Figure  5.7).  The  subplate  remains  the  deepest  layer  through  which  the
successive waves of neuroblasts travel to form the cortical plate.
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Figure 5.5: Histogenesis in the cerebral cortex proceeds through three stages. In the first stage of histogenesis,
the wall of the cerebral cortex is made up of the progenitor cells, which occupy the ventricular zone (VZ). In the
next stage of development, the first neurons exit the cell cycle (red) and accumulate in the preplate, adjacent to the
pial surface. The neurons of  the preplate can be divided into the more superficial Cajal-Retzius cells and the
subplate cells. In the next stage of cortical histogenesis, newly generated neurons (red) migrate along radial glial
fibers to form a layer between the Cajal-Retzius cells and the subplate. This layer is called the cortical plate, and
the majority of the neurons in the cerebral cortex accumulate in this layer. (Sanes, Reh and Harris; Development of
the Nervous System).
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The Reelin-producing cells of the Cajal-Retzius layer are critical in the separation of the preplate. In
Reelin-deficient mice, the preplate fails to split, and the neurons produced by the germinal layers
pile up behind the previously generated neurons (instead of migrating through them). The fact that
neural stem cells express Reelin, together with other proteins thought to be glial-specific, caused
them to be called the radial glial cells. 
A single stem cell in the ventricular layer can give rise to neurons (and glial cells) in any of the
cortical layers (Walsh and Cepko, 1988). McConnell and Kaznowski (1991) have shown that the
determination of laminar identity (i.e., which layer a cell migrates to) is made during the final cell
division (Figure 5.6). Newly generated neuronal precursors transplanted after this last division from
young brains  (where  they would  form layer  6)  into  older  brains  whose  migratory neurons are
forming layer 2 are committed to their fate, and migrate only to layer 6  (Figure 5.6A,C). However,
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Figure  5.6: Determination of  cortical  laminar identity  in  the  ferret
cerebrum. A: “Early” neuronal precursors (birthdays at embryonic day
29)  migrate  to  layer  6.  B:  “Late” neuronal  precursors  (birthdays  at
postnatal day 1) migrate farther,  into layers 2 and 3. C: When early
neuronal precursors (dark blue) are transplanted into older ventricular
zones after their last mitotic S phase, the neurons they form migrate to
layer 6. D: If these precursors are transplanted before or during their
last S phase, however, they migrate (with the host neurons) to layer 2.
(McConnel and Kaznowski, 1991).
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if  these  cells  are  transplanted  prior  to  their  final  division  (during  mid-S  phase),  they  are
uncommitted, and can migrate to layer 2  (Figure 5.6B,D). The fates of neuronal precursors from
older brains are more fixed. While the neuronal precursor cells formed early in development have
the potential to become any neuron (at layers 2 or 6, for instance), later precursor cells give rise
only to upper-level (layer 2) neurons (Frantz and McConnell,  1996) (Figure  5.6). Although the
molecular  code  of  cell  diversity  in  the  cortex  begins  to  be  discovered,  and more  markers  and
effectors of different neuronal identities are emerging in the cortex (Figure  5.7), we still do not
know exactly the molecular mechanisms that activate different programs in the cortical progenitor
cell as it becomes committed.
Figure 5.7 indicates key markers for layer-specific differentiation of cortical nuerons as in Gaspard
et al., 2008.
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Figure  5.7:  Scheme depicting patterns of the layer-specific markers in cortical neurons, and their timing of
generation in vivo. Key markers for layer-specific differentiation of cortical nuerons are indicated. (Modified from
Gaspard et al., 2008).
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Not all neurons, however, migrate radially. O'Rourke and her colleagues (1992) labeled young ferret
neurons with fluorescent dye and followed their migration through the brain. While a great majority
of the young neurons migrated radially on glial processes from the ventricular zone into the cortical
plate, about 12% of them migrated laterally from one functional region of the cerebral cortex into
another.  These observations meshed well  with those of Walsh and Cepko (1992),  who infected
ventricular stem cells with a retrovirus and were able to stain these cells and their progeny after
birth.
They found that the neural descendants of a single ventricular stem cell were dispersed across the
functional regions of the cortex. Thus, the specification of the cortical areas into specific functional
domains occurs after neurogenesis. Once the cells arrive at their final destination, it is thought that
they produce particular adhesion molecules that organize them together as brain nuclei (Matsunami
and Takeichi, 1995).
One  of  the  major  questions  in  developmental  neurobiology is  whether  the  different  functional
regions of the cerebral cortex are already specified in the ventricular region, or if specification is
accomplished  much  later  by  the  synaptic  connections  between  the  regions.  Evidence  that
specification  is  early  (and  that  there  might  be  some  “proto-map”  of  the  cerebral  cortex)  is
suggested by certain human mutations that destroy the layering and functional abilities in only one
part of the cortex, leaving the other regions intact (Piao et al., 2004). 
The  early  regionalization  of  of  the  neocortex  is  thought  to  be  organized  by paracrine  factors
secreted by the epidermis and neural crest cells at the margin of the developing brain (Rakic et al.,
2009).  The paracrine factors induce the expression of transcription factors  in the specific  brain
regions, which then mediate the survival, differentiation, proliferation and migration of the newly
generated  neurons.  For  instance,  Fgf8  protein  is  secreted  by  the  anterior  neural  ridge  and  is
important  for  the  A/P patterning  of  the  cerebral  cortex.  If  Fgf8  is  overexpressed  in  the  ridge,
specification of the telencephalon is extended caudally, whereas if  Fgf8 is ectopically added to the
caudal region of the cortex, part of the caudal region of the cortex will acquire an anterior cortical
fate (Figure 5.8). 
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The orphan nuclear receptor COUP-TFI is a transcription factor expressed in a caudomedial-high to
rostrolateral-low gradient in the developing neocortex. The rostralization of the neocortex in the
absence  of  COUP-TFI,  and  the  established  role  for  COUP-TFI  as  a  transcriptional  repressor,
suggest that COUP-TFI acts to specify caudal neocortical identity by repressing a rostral fate. The
gradient of COUP-TFI in the developing neocortex lies in opposition to the rostral-high to caudal-
low gradient of FGF signaling (Figure 5.8), and it is natural to ask whether these gradients regulate
one another. There is good evidence that FGF signaling regulates COUP-TFI expression. The ability
of  FGF  to  repress  the  expression  of  COUP-TFI  indicates  that  the  Fgf-signaling  gradient  is
responsible for establishing the caudal-high to rostral-low gradient of COUPTFI in the neocortex
(see Sansom and Livesey, 2009, as a Review).
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Figure 5.8: Building the proto-map of the cerebral cortex. A: Day 13 mouse embryo at the point of the formation
of the two telencephalic vesicles. Fgf8 is secreted from the anterior neural ridge and the commissural plate; Wnts
and BMPs are secreted from the cortical hem; and Shh is secreted from the medial ganglionic eminence. These
result  in  a  graded  expression  of  transcription  factors  that  translates  into  a  molecular  regionalization  of  the
germinal zone. B: Fgf signaling affects the identity of cortical regions. Ectopic expression of Fgf8 in the caudal
pole  of  the  neocortex  generates  a  partial  duplication  of  the  S1  barrel-field  (the  receptive  field  for  whisker
responses) usually seen in the anterior. (Gilbert, developmental Biology).
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6− Development of the Vertebrate Eye
The  neural  retina  generates  form  the  posterior  part  of  the  embryonic  prosencephalon,  the
diencephalon,  as  a  lateral  evagination  of  neuroepithelium,  the  optic  vesicle.  The  optic  vesicle
extends from the lateral walls of the diencephalon, and where it meets the head ectoderm, it induces
the formation of a lens placode, which then invaginates to form the lens (Figure 6.1). As the optic
vesicle becomes the optic cup, its two layers differentiate in different ways. The cells of the outer
layer produce melanine pigment (being one of the few tssues other than the neural crest cells that
can form this pigment) and ultimately become the pigmented retina. The cells of the inner layer
proliferate rapidly and generate a variety of glia, ganglion cells, interneurons, and light-sensitive
photoreceptor neurons. Collectively, these cells constitute the neural retina. The retinal ganglion
cells are neurons whose axons send electric impulses to the brain. Their axons meet at the base of
the eye and travel down the optic stalk, which is then called the optic nerve.
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Formation of the Eye Field
A group of genes coding for transcription factors, Six3, Pax6, and Rx1, is expressed in the most
anterior tip of the neural plate and plays a key role in specifying the retinal identity. The expression
of these three genes identifies a domain that is initially single and  will later split into the bilateral
regions that form the optic vesicles.
Eye  formation  has  been  studied  in  several  organisms,  but  hystorically  the  amphibian  eye  has
received the most attention. Using in situ hybrydisation and injection of transcription factors mRNA
into developing Xenopus embryos, Zuber and colleagues were able to outline the mechanisms by
which the amphibian eye field becomes specified (Figure 6.2).
The formation of the eye field begins with the specification of the neural tube. The anterior portion
of  the  neural  tube,  where  both  BMP and  WNT pathways  were  inhibited,  is  specified  by  the
expression of the Otx2 genes (Figure 6.2A). Noggin is especially important in blocking BMPs, as
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Figure  6.1:  Development of the vertebrate eye. A: The optic vesicle evaginates from the brain and contacts the
overlying ectoderm, inducing a lens placode. B,C: The overlying ectoderm differentiate into lens cells as the optic
vesicles invaginates. The lens placode appears as a local thickening of the surface ectoderm near the optic vesicle.
The lens placode then becomes the lens vesicle. C: The optic vesicle become subdivided into neural retina (inner
layer)  and pigmented retina (outer  layer).  D: The lens vesicle  induces the overlying ectoderm to become the
cornea. (Gilbert, Developmental Biology).
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this not only allows Otx2 expression but also inhibits expression of the transcription factor ET, one
of the first proteins expressed in the eye field. However, once Otx2 protein accumulates, it blocks
Noggin's ability to inhibit the ET gene, so ET protein is produced (Figure 6.2B).
One of the genes controlled by ET is Rx1 (called Rax in mouse), whose product helps specify the
retina. Rx1 is a transcription factor that acts first by inhibiting Otx2, and second by activating Pax6,
the major gene in forming the eye field in the anterior neural plate. The Pax6 protein is especially
important in the specification of the lens and retina. Indeed, it appears to be a common denominator
for photoreceptive cells in all  phyla. When the mouse Pax6 gene is inserted into the Drosophila
genome and activated randomly, Drosophila eyes form ectopically (Halder et al., 1995).
Transcription factors of the nascent eye field show a concentric organization in the anterior portion
of the neural plate of the Xenopus embryo (neurula stage), having domains of decreasing size: Six3
> Pax6 > Rx1 > Lhx2 > ET (Zuber et al., 2003) (Figure 6.2C).
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Figure  6.2: Dynamic formation of the eye field in the anterior neural plate of Xenopus.  A shows
formation of the eye field. Light blue represents the neural plate; moderate blue indicates the area of
Otx2 expression (forebrain);  and dark blue indicates  the  region of  the  eye field as  it  forms in  the
forebrain. B: Dynamic expression of transcription factors leading to the specification of the eye field.
Prior to stage 10 of Xenopus development, Noggin inhibits ET expression but promotes the expression of
Otx2. Otx2 protein then represses the inhibition of ET by Noggin signaling. The ET transcription factor
activates Rx1, which encodes a transcription factor that blocks Otx2 and promotes Pax6 expression.
Pax6 protein initiates the cascade of gene expression constituting the eye field. C shows the location of
the transcription factors  in  the  nascent  eye field of  stage 12.5 (early  neurula)  and stage  15 (mid-
neurula) Xenopus embryos, showing a concentric organization of transcription factors having domains
of decreasing size. (Gilbert, Developmental Biology).
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Pax6 is also expressed in the mouse forebrain, hindbrain and nasal placodes, but the eyes seem to be
most sensitive to its absence. Humans and mice heterozygous for loss-of-function mutations in Pax6
have small eyes, while homozygous mice, humans and Drosophila lack eyes altogether (Jordan et
al.,  1992;  Glaser et  al.,  1994; Quiring et  al.,  1994).  In both flies and vertebrates,  Pax6 protein
initiates a cascade of transcription factors that mutually activate one another to constitute the eye
field.
In  vertebrates,  separation  of  the  single  eye  field  into  two  bilateral  eye  fields  depends  on  the
secretion  of  Sonic  hedgehog  (Shh;  Figure  6.3).  If  the  mouse  Shh  gene  is  mutated,  or  if  the
processing of this  protein is  inhibited,  the single median eye field does not  split.  The result  is
cyclopia, a single eye in the center of the face, usually below the nose (Figure 6.3B). Shh from the
prechordal plate suppresses Pax6 expression in the center of the embryo, dividing the field in two.
The phenomenon of human cyclopia also involves loss-of-function mutations that prevent Shh from
functioning.
Conversely, if too much Shh is synthesized by the prechordal plate, Pax6 is suppressed in a too
large area and the eyes fail to form at all.
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Figure 6.3: A: Sonic hedgehog is shown by in situ hybridisation to
be expressed in the nervous system (red arrow), gut (blue arrow)
and limb bud (black arrow) of a three-day chick embryo. B shows
the  head  of  a  cyclopic  lamb  born  of  a  ewe  that  ate  Veratrum
californicum early in pregnancy. The alkaloid made by this plant
inhibits cholesterol synthesis, which is needed for Shh production
and reception.  The cerebral hemispheres fused,  resulting in the
formation of a single central eye and no pituitary gland. (Modified
from Gilbert, Developmental Biology).
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Cell Differentiation in the Vertebrate Eye.
Rax (retinal and anterior neural fold homeobox) gene is the key gene for retinal development, and
it's  expressed  in  the  eye  field  of  the  early  neurula  embryo  (Figure  6.4A).  Rax  expression  is
upregulated by Otx2 protein, which specifies the anterior head region and encodes a transcription
factor that activates numerous genes; among these genes are Pax6 and Six3, both of which help
specify the retinal neurons. While initial expression of Pax6 and Six3 is not dependent on Rax
expression, their  continued expression in the retinal progenitor cells  requires Rax protein.  Pax6
protein is critical for specification of the retinal ganglion cells (which transmit visual information to
the brain),  while Six3 is necessary for coordinating the number of times retinal precursor cells
divide before they differentiate.
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Figure  6.4:  Expression of Rax genes in vertebrate retina development. A shows the expression pattern of the
Xenopus Xrx1 gene in the single eye field of the early neurula (left) and in the two developing retinas after the eye
field was slitted in two of a newly hatched tadpole (right). Xrx1 gene is also expressed in the ventral diencephalon
and in the dorsal pineal, an organ that has a presumptive retina-like set of photoreceptors. B: Eye development in a
normal mouse embryo (left) and lack of eyes in a mouse embryo whose Rax gene has been knocked out (right).
Rx1-/- mutants are anophtalmic and do not develop any early eye structure such as the optic vesicles or the optic
cups. (Mathers et al., 1997). C: Absence of ocular tissue in a human patient with mutant Rax genes. (Gilbert,
Developmental Biology).
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As in Xenopus, the murine Rax gene is first activated in the anterior neural plate at stage E7.5, in a
region that will give rise to the eyes, the pineal gland, and the diencephalon (Figure 6.4B left). At
stage E10.5, expression of Rax is confined to the developing retina and the ventral forebrain. There
is a uniform expression in the entire neural retina of E15.5 embryos.  At later stages there is a
progressive reduction  of  Rax  expression in  the retina,  which initiates  in  the  ganglion cells  and
proceeds in accordance with the loss of proliferative activity in the retinal cell layers. 
Expression in the eye at stage P6.5 is restricted to photoreceptors and the inner nuclear layer; at
stage P13.5 no Rax expression is detected (Mathers et al., 1997). Rx1-/- human and mouse mutants
are anophtalmic and do not develop any early eye structure such as the optic vesicles or the optic
cups (Mathers et al., 1997) (Figures 6.4B right and 6.4C), while small eye/small eye homozygous
mutants, carrying a mutation in  Pax6, develop anomalous optic vesicles.  Rx1-/- mutants show a
gradual phenotype: in the mild phenotype the prosencephalon is present, but optic vesicles are not
and the putative eye field region lacks also the expression of  Pax6,  Otx2  and  Six3  (Zhang et al.,
2000);  in  the  severe  phenotype  the  animals  lack  completely  the  prosencephalon  and  the
mesencephalon seems missing to a variable extent (Mathers et al., 1997). 
Like the cerebral and cerebellar cortices, the neural retina develops into a layered array of different
neuronal types.  These layers include the light- and color-sensitive photoreceptor cells (rods and
cones); the cell bodies of the ganglion cells; and bipolar interneurons that transmit electric stimuli
from rods and cones to the ganglion cells (Figure 6.5).
Early neuroblasts  of  the  retina  are  competent  to  generate  all  seven retinal  cell  types.  Classical
studies of cell lineage tracing by retroviral vectors performed in rat showed the clonal origin of the
different retinal cell types (Turner and Cepko, 1987). The key genes specifying distinct retinal cell
identities, and the mechanisms by which a multipotent retinal progenitor generates different types of
neurons following a temporal schedule that is conserved among vertebrates, have been described in
many studies over the last two decades (reviewed in Livesey and Cepko, 2001).
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Figure 6.5: Retinal neurons sort out into functional layers during development.  A: The three layers of neurons in
the adult retina and the synapses between them can be seen in a schematic section of the retina. B shows a scheme
of the major neuronal pathway in the retina. Light traverses the layers until it is received by the photoreceptors.
Photoreceptors synapse with bipolar neurons, which constitute a first step where visual information is processed;
bipolar cells transmit electric signals to the ganglion cells. The axons of the ganglion cells join to form the optic
nerve,  which  enters  the  brain.  Thus,  the three-neuron  chain  constituted  by  photoreceptors,  bipolar  cells,  and
ganglion cells provides the most direct route for transmitting visual information to the brain. Horizontal cells and
amacrine cells mediate lateral interactions in the outer and inner plexiform layers, respectively. The terms inner
and outer designate relative distances from the center of the eye (inner, near the center of the eye; outer, away from
the center, or toward the pigment epithelium). (Purves et al., Neuroscience).
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7− Focus on BMP
A Well-known Role in Neuralization and a Possible Role in Brain Patterning
BMP and his antagonist Noggin are key molecules in neural conversion. The neural plate is derived
from  the  dorsal  ectoderm  and  induced  by  “Organizer”  signals  coming  from  the  underlying
notochord. The dominant model of neural induction is the default hypothesis. This hypothesis states
that  neural  tissue  is  formed  spontaneously  in  the  absence  of  BMP  signaling  during  early
gastrulation, while exposure to BMP signals causes epidermal differentiation. Accordingly, signals
emanating from the Organizer, essential for neural induction, are BMP inhibitors such as Chordin
and Noggin (both BMP-inhibitors), Follistatin (an inhibitor of BMPs and Activin), and Cerberus (a
molecule able to inhibit BMP, Wnt and Activin/Nodal).
Of  particular  importance  in  determining  specific  neural  fates  are  signals  that  provide  regional
identity, both in the antero–posterior (A–P) and dorso–ventral (D–V) axis, and define domains of
distinct expression of homeodomain proteins and bHLH transcription factors. 
D–V identity is determined by the antagonistic action of Sonic hedgehog (Shh) secreted ventrally
from the notochord and floor plate, and BMPs and WNT signals dorsally. There is ample evidence
from explant and ES cell differentiation studies that confirm a concentration-dependent role of Shh
to define specific progenitor domains within the neural tube.  A role for BMPs in dorsal neural
patterning has been suggested from explant and ES cell differentiation studies. Gain of function
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studies in mice overexpressing the BMP receptors under control of the regulatory elements of the
nestin gene are pointing to a role for BMPs in dorsal patterning. 
However, loss-of-function studies of the BMP receptors suggest a much more limited role for BMPs
in dorsal patterning. BMPs could play a role in the specification of telencephalic progenitor cells
toward the most dorsal fate, the choroid plexus (Hébert et al., 2002). 
Focusing on A-P patterning, the leading hypothesis of A–P axis specification states that anterior
fates are the default ones during early neural induction, while FGF, WNT, and Retinoid signals
actively posteriorize cell fates. 
Early  studies  in  lower  vertebrates  suggested  that  BMP  factors  could  play  a  key  role  in
anterior/posterior patterning. BMP antagonism on pluripotent cells of Xenopus animal caps induces
cement glands, which are the most anterior ectodermal structures in  Xenopus, and anterior brain
markers such as the fore-midbrain marker Otx2, but not hindbrain or spinal cord markers (Hawley
et al., 1995; Lamb et al., 1993; Sasai et al., 1995). Simultaneous inhibition of Wnt, Nodal and BMP
by Cerberus was shown to be sufficient for head induction in Xenopus and also in mammals; BMP
antagonism  is  essential  for  the  formation  of  the  forebrain  (Piccolo  et  al.,  1999;  Yang  &
Klingensmith,  2006).  More recent  studies  highlight  that  the BMP-inhibitor  Noggin has a dose-
dependent patterning effect on Xenopus animal caps. At lower doses, Noggin supports neuralization
without the expression of diencephalic markers, which are instead activated at higher doses (Lan et
al., 2009). 
It was recently shown that the cell-intrinsic expression of the zinc-finger nuclear protein Zfp521,
which is inhibited by BMPs, plays a pivotal role in promoting a default neural state of ES cells.
Furthermore, a role of Zfp521 in supporting an anterior identity of neurons generated by ES cells
was hypothesized (Kamiya et al., 2011). 
Moreover, in Xenopus embryos the specification of the forebrain requires isolation of its cells from
BMP, Activin/Nodal and Wnt signaling by high concentrations of Noggin produced in cells at the
anterior margin of the neural plate (Bayramov et al., 2011). 
These observations suggest that in vivo the concentration of endogenous BMPs might be relevant in
the control of the positional identity of neurons. 
Concerning  mouse  development,  it  was  also  proposed  that  BMPs  play  a  role  in the  regional
morphogenesis of mouse dorsal telencephalon, by the control of specific gene expression, cell
proliferation and local cell death (Furuta et al., 1997). Furthermore, mice that are double mutant for
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the BMP antagonists Chordin and Noggin, have severe defects in the most anterior part of the brain,
indicating  that  BMP  antagonism  is  essential  for  the  proper  development  of  the  anterior
neurectoderm (Bachiller et al., 2000; Figure 7.1).
Though the role of BMP in dorso-ventral patterning is well established, its role in A-P patterning is
less  clear.  Early effects  of  BMP  signaling  on the anterior-posterior patterning are not well
characterized. BMP role as a possible morphogen, acting not only during neural induction but also
in the second step of neural patterning, has never been investigated in a systematic way.
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Figure 7.1: Phenotype of Noggin-Chordin double mutant mice.  A wild-type E12.5 mouse embryo (left) can be
compared to Chd-/-;Nog+/+ embryo (center) and to Chd-/-;Nog-/- embryo (right). Single mutant shows a normal
head and defective ear (arrowhead). Double mutant is showing extensive anterior deletions of forebrain, eye, nose
and facial structures. White arrowhead indicates the rhombic lip (future cerebellum). (Bachiller et al., 2000).
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8− An in Vitro Approach
Neural Differentiation Protocols Using Embryonic Stem Cells
The  recent  development  of  embryonic  stem  cells  biology  has  fueled  the  idea  that  restricted
progenitors or differentiated cell types can be generated  in vitro  from these pluripotent cells, and
then used in a therapeutic setting to repair human tissue damaged by trauma or disease. Human ES
cells successfully converted into the appropriate neural cell types might be used, for instance, to
repair neural tissue that is damaged in such human conditions as Multiple Sclerosis, Parkinson’s,
Alzheimer’s, Amyotrophic Lateral Sclerosis, or spinal cord injury. Given this goal, one approach is
to  apply  differentiation  protocols  to  mouse  and  human  ES  cells  that  mimic  the  extrinsic  and
intrinsic cues that underlie the formation of neural cell types in the embryo. Indeed, one of the more
successful protocols for differentiating mouse ES cells into transplantable motor neurons is based
on a systemic understanding of the developmental mechanisms that underlie the formation of the
embryonic spinal cord. Similar logic has also guided subsequent attempts to differentiate ES cells
into other specific classes of neurons, including retinal photoreceptors, cerebellar granular neurons,
or cerebral-type neurons that use glutamate, GABA or dopamine as their principle neurotransmitter.
However, the use of ES cells in protocols of in vitro differentiation has in some cases reversed the
logical of the experimental strategy, as ES cells differentiating in chemically defined media can
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serve as a model to dissect the signals required to specify distinct fates of differentiation, bypassing
the  use  of  a  whole  embryo.  This  might  be  a  winning  strategy,  for  instance,  when  aiming  at
investigating the role of a specific growth factor in a well defined temporal window of embryonic
development. In fact, blocking or inducing the signaling of a given factor by adding its agonist or
antagonist to the medium of a cell culture at a specific time of in vitro differentiation is much easier
than targeting the same signaling in vivo.
There are at least three main strategies for the neural induction of ES cell in vitro: (1) mimicking the
environment  that  produces  neurectoderm  in  the  embryo  by  providing  appropriate  cell-cell
interactions and signals through embryoid body (EB)-based systems; (2) depriving the ES cells of
both cell-cell  interactions  and signals by low density culture in  serum-free medium, evoking a
default mechanism for NSC differentiation into neural fates; and the (3) stromal feeder mediated
neural induction. 
Some protocols combine aspects of the first two approaches, promoting cell-cell interactions to
facilitate formation of all three primary germ layers followed by neural lineage-specific selection
under defined conditions. (See as a review Cai and Grabel, 2007).
Embryoid-body Based Protocols
EBs are formed by aggregation of ES cells in suspension culture (Figure 8.1). The interaction of
cells within the EB causes cell differentiation, mimicking early embryonic development processes
that include the induction of early extraembryonic endoderm and various aspects of gastrulation.
EBs thus represent a useful assay to generate derivatives of all three germ layers in vitro. Various
modifications of the basic protocol have been developed to drive neural induction, and to select and
expand EB-derived neural precursors.
The first EB-mediated neural differentiation protocol was based on exposure to Retinoic acid (RA)
for four days, following four days of EB formation in the absence of RA (so called 4/4 protocol). In
addition  to  neural  induction,  RA treatment  also  exhibits  a  strong  caudalizing  effect  on  A–P
patterning mediated through activating the Hox gene cascade  (Aubert  et al.,  2002; Verani  et al.,
2007).
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An  alternative  EB-based  strategy  is  the  exposure  to  conditioned  medium  derived  from  a
hepatocarcinoma  cell  line  (HepG2),  which  appears  to  directly  induce  neuroectodermal  fate.
Accordingly,  HepG2-treated aggregates do not express endodermal or mesodermal markers, but
appear to give rise directly to neural progeny. The active component within HepG2-conditioned
medium is not known, although data suggest that at least two separable components are responsible
for this activity.
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Figure 8.1: Basic embryoid body techniques for inducing neural differentiation in ES cells in vitro.
Over the last years, several  reports have described methods for the generation of  neural cells  from
mouse ES cells (Ying et al., 2003; Bibel et al., 2007; Eiraku et al., 2008; Gaspard et al., 2008; Watanabe
et al., 2005; Wataya et al., 2008). Embryoid-body based protocols are initiated by the aggregation of
undifferentiated ES cells. Neural differentiation (represented in blue) is promoted either by exposure to
RA, HepG2 (hepatocarcinoma cell line) conditioned medium, or via neural selection in defined medial.
The SFEB (serum-free embryoid body) protocol  combines  aspects  of  EB formation with the  default
induction strategy (Watanabe et al., 2005; Wataya et al., 2008).
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A third EB-based strategy makes use of neural-selective growth conditions. EB progeny is kept
under minimal growth conditions in serum-free medium containing insulin, transferrrin and selenite
(ITS medium).  Under  these conditions,  most  EB-derived cells  die  and a  distinct  population of
immature cells emerges that expresses increasing levels of the intermediate filament Nestin. These
Nestin-positive precursors  can be replated and directed towards various neuronal and  glial fates
using a combination of patterning, survival and lineage promoting factors. 
The most recent variation of an EB-like differentiation protocol is the so-called SFEB (serum-free
EB) protocol by Yoshiki Sasai's Lab. The SFEB approach is distinct from other EB-based strategies,
as it does not involve a gastrulation-equivalent intermediate stage but directly yields neural progeny
in the absence of serum or other inducing signals. Therefore, SFEB-based protocols combine ES
cell aggregation with the default neural induction concept discussed below. SFEB-based protocols
are particularly attractive for generating anterior neural fates, such as cortical or ventral forebrain
fates. However, variations of this approach can be adapted to the derivation of many neuron types,
including spinal motorneurons.
Stromal Feeder Mediated Neural Induction 
Bone marrow-derived stromal cell lines have been used for many years to support the growth of
undifferentiated hematopoietic stem cells. Over the last 10 years, it has become evident that several
stromal cell lines also exhibit neural-inducing properties in co-culture with mouse ES cells (Figure
8.2). Stromal cell lines with the highest efficiencies of neural induction are typically at the pre-
adipocytic stage of differentiation and are isolated from the bone marrow (e.g., PA-6, MS5, S17) or
from the aorta-gonad-mesonephros (AGM) region. The molecular nature of this stromal-derived
inducing activity remains unknown. However,  the efficiency and robustness of neural induction
using stromal feeder approaches is high compared with alternative protocols, and differentiation can
be directed towards specific regional fates in response to extrinsic factors, despite the fact that these
protocols have been particularly useful for the derivation of midbrain dopamine neurons from ES
cells.
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Figure  8.2: Basic techniques for stromal feeder-induced neural  differentiation in embryonic stem
cells in vitro. Neural differentiation is represented in blue. Stromal feeder mediated differentiation is
obtained upon plating undifferentiated ES cells at low density on stromal feeder cell lines derived from
the bone marrow of  the  aorta-gonad-mesonephros  region  of  the  embryo.  Serum-free  conditions  are
required throughout the protocol. Conditions can be readily adapted to achieve neural subtype-specific
differentiation for a large number of CNS cell  types. Classic studies made use of PA6 and MS5 cell
mediated differentiation (Kawasaki et al., 2000; Barberi et al., 2003). 
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Neural Differentiation by Default 
Different methods exist to generate neural cells from mouse ES cells and more and more evidence
is found in favor of the default model of neural induction in this system as well (Figure 8.3): co-
culture-free direct neural differentiation protocols are based on the default hypothesis: the absence
of signals in primitive ectodermal cells will lead to neural differentiation. This can be obtained by
culturing embryonic stem cells in serum-free conditions (free of the many growth factors present in
serum) and at relatively low cell density (to limit the cell to cell signaling). Several neural induction
approaches in mouse and human ES cells have been developed based on this approach (Tropepe et
al. 2001; reviewed in Munoz-Sanjuan & Brivanlou 2002; Bouhon et al. 2005; Smukler et al. 2006).
Under  these  conditions,  rapid  expression  of  neural  markers  is  observed  in  the  few  surviving
colonies.
Tropepe et al. were the first to show that ES cells cultured in chemically defined serum-free and
feeder layer-free low density culture conditions readily acquire a neural identity, originating Nestin-
positive neural precursors. The marker Nestin was strongly expressed after only 4 hours of culture
in  their  protocol. However,  the  cells  expressing  neural  markers  were  reported  to  represent  a
“primitive” neural progenitor population, distinct from fully committed neural progeny. 
Direct adherent monolayer culture conditions (with no aggregation step) have been developed for
neural induction of mouse and human ES cells in the presence of N2 medium supplemented with
B27 and FGF2. One example of this is the mono-adherent culture method in a defined serum-free
medium, N2B27 that leads to more than 70% Sox-1 (an early pan-neurectoderm marker) expressing
cells  by  day  4  (Ying  et  al.  2003a).  However,  these  protocols  need  to  be  validated  critically,
addressing  the  contribution  of  neural  induction  versus  selective  survival  of  spontaneously
differentiating neural progeny. 
Most recent work in human ES cells suggests that adherent monolayer cultures can be developed
that are extremely efficient at driving neural induction under simple serum-free conditions in the
presence of inhibitors that block both the BMP and TGFβ/Activin branch of SMAD signaling.
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Figure 8.3: Basic techniques for inducing neural differentiation in embryonic stem cells in vitro, by
exploiting an intrinsic default differentiation program. Neural differentiation is represented in blue.
Default  differentiation:  neural  differentiation  is  achieved  by  reducing  endogenous  BMP signals  via
plating cells at low density under minimal medium conditions (Ying et al., 2003a), or in the presence of
the BMP antagonist Noggin. Neurally-committed cells can also be mechanically isolated and propagated
from plates exhibiting spontaneous neural differentiation after overgrowth of ES cells.
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Studying Patterning Signals during Neural Differentiation in Vitro
The dissection of diffusible signals that orchestrate neural induction and regulate regional brain
patterning has recently been made easier by the study of embryonic stem cells (ES cells) in vitro
differentiation.  The fundamental strategy for achieving neuronal subtype specification is based on
mimicking patterning events that define A–P and D–V patterning in vivo.
Spontaneous differentiation into neurons occurs rapidly on neural induction of mouse ES cells, and
several recent reviews have examined the conditions required to produce specific neuronal and glial
subtypes. First of all, neuronal subtype specification can be influenced by the mode of neuronal
induction. This is particularly the case for direct neural induction protocols using Retinoic Acid: in
addition  to  neural  induction,  RA treatment  also  exhibits  a  strong  caudalizing  effect  on  A–P
patterning. Using defined growth media, it has been possible to investigate the diffusible factors that
affect the anterior-posterior (A/P) as well as the dorso-ventral (D/V) identity of in vitro generated
neurons. Among these, not  only  Retinoic Acid (RA), but  also  BMPs, Wnts, Fibroblast Growth
Factors (FGFs) and Sonic Hedgehog (SHH) have been described (Chatzi et al., 2011; Eiraku et al.,
2008; Gaspard & Vanderhaeghen, 2010; Hendrickx et al., 2009; Li & Lee, 1993; Watanabe et al.,
2005).
Addition of caudalizing signals, such as retinoic acid (RA) or FGF2 can promote a spinal cord
identity and subsequent production of motor neurons (Wichterle et al., 2002), whereas addition of
Wnt  and  Nodal  antagonists  promotes  production  of  telencephalic  progenitors  (Watanabe  et  al.,
2005).
The following protocol, concerning the derivation of midbrain dopamine neurons, provides a classic
example of how developmental pathways can be harnessed to direct ES cell fate in vitro. Derivation
of midbrain dopamine neurons from ES cells has been of particular interest,  due to the clinical
potential for dopamine neuron transplants in Parkinson’s disease. Protocols for the dopaminergic
differentiation of mouse ES cells are based on studies in explants that identified FGF8 and Shh as
critical factors in midbrain dopamine neuron specification. Consistently, they found that treatment
with FGF8 and Sonic Hedgehog promote production of ventral midbrain precursors and subsequent
differentiation  of  dopaminergic  neurons  (Lee  et  al.,  2000;  Barberi  et  al.,  2003).  The  effect  of
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Shh/FGF8  on  ES-derived  neural  precursors  was  first  described  using  an  EB-based  five-step
differentiation  protocol.  Under  these  conditions,  up  to  34% of  all  neurons  expressed  tyrosine
hydroxylase (TH), the rate-limiting enzyme in the synthesis  of dopamine.  A further increase in
dopamine  neuron  yield  (nearly  80%  of  all  neurons  expressing  TH)  was  obtained  in  Nurr1
overexpressing ES cells. Midbrain dopaminergic differentiation was also obtained using co-culture
of ES cells on the stromal feeder cell line (PA6) with 16% of all neurons expressing TH in the
absence of Shh and FGF8. These results  were initially interpreted as PA6 exhibiting a  specific
patterning action that promotes dopamine neuron fate. However,  later studies demonstrated that
neural precursors induced on stromal feeders can be shifted in A–P and D–V identity, and reach a
yield of up to 50% of all neurons expressing TH without a need for transgenic Nurr1 expression.
98
Introduction  9−Focus on Cortical Differentiation in Vitro
9− Focus on Cortical Differentiation in Vitro
The cerebral cortex is  the most  complex structure in  the mammalian brain,  and displays  many
different  neuronal  subtypes.  This  complexity  is  established  sequentially,  starting  with  the
differentiation of the cortical primordium in the most anterior area of the brain (the Forebrain).
Forebrain identity is thought to constitute a primitive pattern of neural identity: The anterior default
fate is retained through the inhibition of caudalizing morphogen signals, such as Wnt and FGF
factors, according to the two step activation-transformation model (see Introduction, Chapter 3).
The forebrain then undergoes further patterning along the dorso–ventral axis, mainly through the
induction of ventral identity by sonic hedgehog (Shh), secreted from the ventral neural tube and
underlying tissue, and through the reinforcement of a dorsal identity by BMP and Wnt signaling.
This leads to the specification of the two main populations of cortical neurons, pyramidal neurons
(generated from the dorsal part of the telencephalon) and interneurons (generated ventrally).
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A next  level  of  complexity emerges  through the  specification  of  different  subtypes  of  cortical
neurons that will populate specific cortical layers; every neuron subtype exhibits specific patterns of
gene  expression  and  connectivity.  This  specification  follows  a  coordinated  temporal  pattern:
Neurons from different layers are generated sequentially, but the underlying mechanisms remain
poorly known. As a general rule, neurons that will populate deep cortical layers are generated early,
followed lately by neurons that will constitute superficial cortical layers.
Gaspard et al. have showed that mouse embryonic stem cells, cultured at low density without any
morphogen, recapitulate in vitro the major milestones of cortical development (Figure 9.1). In their
hands, ES cells need treatment with Cyclopamine, a Shh-inhibitor, to efficiently generate cortical
neurons. They lead to the sequential generation of a diverse repertoire of neurons that display most
salient  features  of  genuine  cortical  pyramidal  neurons,  both  from  the  molecular  and  electro-
physiological  point  of view (Figure 9.1).  When grafted into the cerebral  cortex,  these neurons
correctly develop patterns of axonal projections corresponding to a wide range of cortical layers.
From the technical point of view, in Gaspard's protocol ES cells were plated at low density on
gelatin-coated dishes and cultured in a chemically defined minimal medium devoid of morphogens
or serum derivatives. Cyclopamine treatment was performed from day 2 to day 10 of differentiation.
For  longer  differentiation,  neural  progenitors  were re-plated at  day 14 on polylisine/laminin  in
N2B27 medium.  This  kind  of  approach (neural  differentiation  of  ES cells  in  minimal  medium
devoid  of  serum)  and the  final  outcome (anterior  cortical  differentiation)  strongly supports  the
default hypothesis for anterior neural development.
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Figure  9.1: Corticogenesis from ES cells using Gaspard's protocol. With this differentiation protocol, ES cells
differentiate  into  multipotent  cortical  progenitors  that  follow  the  major  milestones  of  cortical  development,
including  the  sequential  generation  of  neurons  displaying  distinct  layer-specific  identities.  This  sequential
generation of cells is similar to the in vivo development. A: Scheme depicting patterns of the layer-specific markers
in cortical neurons, and their timing of generation in vivo. B: Evolution in time of the proportion of β-Tubulin-III-
positive neurons expressing layer-specific markers in chemically defined minimal medium, plus Shh-inhibition by
Cyclopamine.  Colored  arrows  indicate  the  first  day  of  appearance  of  each  marker.  C:  Birthdating  analysis.
Cultures were pulse-labeled with BrdU for 24 h at  various time points (x axis).  Cultures were stopped by the
Authors at day 21, and the proportion of BrdU fully labeled nuclei was quantified among  β-Tubulin-III-positive
neurons expressing each specific marker. 
(Gaspard et al., 2008).
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In Sasai's lab, Eiraku et al. not only obtained cortical neurons in vitro from mouse ES cells, but also
developed  a  three-dimensional  aggregation  culture  (serum-free  culture  of  embryoid  body-like
aggregates;  SFEB culture)  for  the  self-organized  generation  of  apico-basally  polarized  cortical
tissues (Figure 9.2). The generated cortical neurons are functional, transplantable and capable of
forming proper long-range connections in vivo and in vitro. 
Furthermore,  their  protocol  can  be  considered  very  plastic  in  terms  of  responsiveness  to
exogenously added morphogens: As an example,  the majority of the SFEB-induced telencephalic
progenitors express the pallial marker Pax6, but Shh treatment suppresses Pax6 and induces the
expression  of  sub-pallial  markers  such  as  Nkx2.1.  Furthermore,  the  regional  identity  of  the
generated pallial  tissues can be selectively sub-specified into olfactory bulb,  rostral  and caudal
cortices, hem, and choroid plexus by the secreted patterning factors FGF, Wnt, and BMP. 
In this case, dissociated ES cells were quickly reaggregated and then cultured in suspension in KSR
containing medium, supplemented with the Wnt-inhibitor Dkk-1 and the Activin/Nodal-inhibitor
Lefty-1. This suggested that efficient ES cell anteriorization could be obtained by Wnt signaling
inhibition, during culture in a minimal medium where serum is replaced by KSR.
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Figure  9.2:  Generation  of  polarized  cortical  neuroepithelia  from  serum-free  culture  of  embryoid  body-like
aggregates. The figure describes the improved three-dimensional aggregate culture protocol  that  allows highly
efficient differentiation of ES cells into cortical progenitors. The protocol generated uniformly sized aggregates on
day 7 and high percentages of Bf1+/Emx1+ cells on day 10. (Eiraku et al., 2008).
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The Authors state that neural differentiation in the SFEB culture occurs tissue-autonomously and
does not require extrinsic inducers. Despite of this statement, the culture medium includes some
morphogens, whose exact role/effect is not described by the Authors. The Activin-inhibitor Lefty-1
could contribute to avoid mesoderm induction and facilitate neural conversion of embryoid body-
like aggregates. The medium was also supplemented with Wnt-inhibitor Dkk-1, probably to protect
a default anterior fate of differentiating ES cells.
SFEB-cultured mouse ES cells differentiated into Bf1 (FoxG1)+ telencephalic progenitors at high
frequency. In dissociation culture, the SFEBq-induced neural progenitors (dissociated on day 12)
differentiated  into  Tuj1+ postmitotic  neurons  expressing  characteristic  cortical  markers  such as
Emx1 (82% positive cells) and vGlut1 (83% positive cells), as well as CamKIIa and GluR1. 
SFEB-cultured mouse ES cells also expressed subtype-specific markers such as Tbr1, Ctip2, and
Brn2.  Again,  the  protocol  showed  the  in  vivo-mimicking  birth  order  of  distinct  layer-specific
cortical neurons (Figure 9.3).
Although very efficient, the two protocols by Gaspard et al. and by Eiraku et al. are exposed to
some criticisms. 
First, in Gaspard's protocol ES cells are cultured at very low density (1.000 cells per cm² at the
beginning  of  the  protocol);  this  situation  is  artificial  and  cannot  be  found  in  nature,  where
embryonic stem cells always differentiate together with neighboring cells and tissues. This could
lead to the selection of a surviving subpopulation inside the culture. We do not know if this could be
responsible for the strong endogenous Shh expression/production and for the unusual need to block
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Figure  9.3: Sequential generation of cortical neuron subtypes from serum-free culture of embryoid body-like
aggregates. Layer-specific  cortical  neurons  are  generated  in  the  temporally  controlled  manner  that  mimics
corticogenesis  in  vivo.  A:  The  expression  onset  of  distinct  cortical  neuronal  markers  is  schematized.  B–D:
Immunostaining of Citp2 and Emx1 on day 10 (B), Brn2 and Ki67 on day 13 (C) and Brn2 and Tuj1 on day 15 (D).
(Eiraku et al., 2008).
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Shh  pathway  (by  Cyclopamine  treatment)  to  obtain  a  default  (anterior  and  dorsal)  neural
differentiation fate. 
Second, Eiraku's protocol makes use of embryoid bodies. The formation of a three-dimensional
structure is  interesting,  however  this  could also lead to  the uncontrolled generation of  intrinsic
gradient of autocrine factors produced by differentiating cells themselves. A 3D structure could also
obstacle the treatments with exogenous morphogens added to culture medium. Additionally, KSR
(knock-out serum replacement supplement) was used in Eiraku's protocol during neural induction;
the composition of this patented supplement is not completely known, and its possible contribution
to neural tissue patterning has never been thoroughly investigated.
Notably,  in  both  protocol  a  detailed  investigation  on  endogenous  production  of  diffusible
morphogens  is  almost  completely  missing.  Gaspard's  protocol  includes  a  treatment  with
Cyclopamine, but the authors never investigated in detail the expression/secretion of endogenous
Shh, nor the reason for this anomalous expression inside their culture system. Eiraku's protocol
focuses on setting-up the exogenous addition of reagents, never asking which endogenous factors
are the differentiating cells possibly producing.
Overall, the two protocols focus on the “cortical outcome” of ES cell differentiation, but fail to
investigate  the  biological  mechanisms  underlying  this  phenomenon,  or  the  production  of
endogenous morphogens possibly influencing it.
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Diversification during neural patterning is particularly complex in the forebrain (Telencephalon +
Diencephalon), where cells in nearby locations within the early neural plate become differentially
specified  to  give  rise  to  structures  such  as  the  cerebral  cortex  (telencephalon)  and  the  retina
(diencephalon). The eye morphogenetic field (or “Eye field”) is located in the diencephalon and is
demarcated by the expression of the key retinal gene Rax (called Rx in lower vertebrates, Rx1 in
Xenopus  laevis;  see  Introduction,  Chapter  6).  The  eye  field  give  rise  to  an  epithelial  vesicle
evaginating laterally from the diencephalon; subsequently, its distal portion invaginates to form a
cup-like  structure,  the  optic  cup,  which  develops  into  the  outer  layer  (the  future  pigmented
epithelium) and inner layer (the neurosensory organ) of the retina.
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Several  reports  have  described ES cell  specification  to  retinal  fate  (Hicks  and Courtois,  1992;
Lamba et al., 2006; Ikeda et al., 2005; Kelley et al., 1994; Levine et al., 1997). Moreover, following
the generation of human embryonic stem cells and that of human induced pluripotent stem cells, it
has proved possible, as in the mouse, to direct their differentiation towards the retinal lineage and
generate both retinal pigmented epithelium (RPE) and retinal neurons (Lamba et al., 2006; Osakada
et al., 2008; Lamba et al., 2010). Some experiments not only produced retinal precursors in vitro,
but successfully used this cells to restore vision in blind mice after transplantation (MacLaren et al.,
2006; Lamba et al., 2009).  However, in one of this works retinal cells were not produced using
embryonic stem cells, but were obtained from early postnatal mouse eyes; this option is not optimal
for future therapeutic application in humans because of ethical problems (Maclaren et al., 2006).
Furthermore, the existing protocols have been mainly focused on cell-type production (especially
concerning Rhodopsin-positive photoreceptor cells) and were based on empirical combinations of
culturing media and growth factor treatments.  To date,  few existing studies has focused on the
molecular mechanisms leading to retinal fate specification (Lupo et al., 2013). Very often, the final
differentiation of ES cells into retinal progenitors and/or fully differentiated retinal cells has been
achieved by co-culture experiments, where differentiating ES cells are cultured together with retinal
tissues obtained from embryos (Ikeda et al., 2005; Lamba et al., 2006); in such experiments, the
dissection of instructive signals acting on ES cell differentiation is far from easy.
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Figure  10.1:  Efficient generation of Rax+/Pax6+/Six3+ retinal precursors from mouse ES cells by serum-free
culture of embryoid body-like aggregates. The figure shows immunocytochemical analysis of  cells cultured with
Dkk, Lefty, FCS, and Activin. The majority of colonies contained significant numbers of Rax-positive cells. Induced
Rax-positive  cells  (in  red)  frequently  co-expressed  Pax6  (green  in  A)  and  Six3  (green  in  B).  Scale  bar:  20
micrometers. (Ikeda et al., 2005).
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Bona fide Rax+/Pax6+ retinal precursors were generated in vitro from ES cells by Yoshiki Sasai's
Lab  (Figure  10.1A;  Ikeda  et  al.,  2005).  The  Authors  reported  for  the  first  time  the  efficient
generation of neural retinal precursors, capable of producing photoreceptors. The first step was to
obtain  Six3-positive  rostral  forebrain  cells;  this  was  followed  by the  attempt  to  switch-on  the
expression of the eye field marker Rax, together with other transcription factors (Pax6 and Otx2)
which are co-expressed with Rax in retinal precursors in vivo (Figure 10.1A,B). Retinal progenitors
obtained in vitro by Sasai's Lab were able to differentiate into photoreceptor cells when co-cultured
for longer periods (up to 17 days) with dissociated neural retina cells.
From the technical point of view, the protocol consisted in a three-dimensional aggregation culture
(serum-free culture of embryoid body-like aggregates;  SFEB culture;  Figure  10.2) similar to that
used  for  the  formation  of  polarized  cortical  tissues.  Cell  aggregates  were  cultured  in  GMEM
containing 5% KSR, supplemented with Activin/Nodal-inhibitor Lefty-1 and Wnt-inhibitor Dkk-1,
to promote (presumably, because this was not indicated by the Authors) ES cell neuralization and
anterior fate specification, respectively. FCS was added to medium starting from day 3, and was
followed by exogenous Activin addition at day 4. Floating cell aggregated were re-plated at day 5
on  polylisine/laminin/fibronectin  coated  culture  slides  and  allowed  to  differentiate  for  longer
periods.
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Figure 10.2: Schematic representation of the protocol for retinal precursor generation. The scheme shows how
ES cells are cultured in Sasai's protocol to obtain retinal progenitors. It is not clear from the text how the Authors
decided the components of the morphogen cocktail that was added to culture medium, nor the need to add Activin
together with its own inhibitor Lefty at day 4. D: culture day. (Ikeda et al., 2005).
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In 2011, Yoshiki Sasai's Lab developed a new astonishing protocol for retinal differentiation in
vitro.  The  Authors  reported  the  autonomous  formation  of  the  optic  cup  (retinal  primordium)
structure from a serum-free three-dimensional culture of mouse ES cell aggregates (Figure 10.3).
Embryoid  bodie-like  aggregates  differentiated  into  Rax-positive  retinal  epithelium,  which
spontaneously formed a structure reminiscent of the optic cup, with a proximal pigment epithelium
and a distal  neural  retina.  The distal  portion progressively folded inward and then generated a
stratified neural  retina tissue.  The formed Rax-positive tissues were also positive for Pax6 and
Chx10, and this was consistent with retinal marker expression in vivo.
108
Introduction  10−Focus on Retinal Differentiation in Vitro: high efficiency protocols, poor mechanism comprehension
109
Figure  10.3:  Self-formation of an optic-cup-like structure in 3D culture of ES cell aggregates.  A-E:
SFEBq/matrigel culture. Self-formation of vesicles expressing Rax–GFP (A-C) and Pax6 (D), but not
Sox1–GFP (E). F-I: Rax–GFP1 eye-cup structures on day 9 (strongly and weakly in the neural retina
(NR) and RPE portions, respectively). H,I: The inner portion strongly expressed Chx10 (H) and Rax and
moderately expressed Pax6 (I) on day 9. J,K: The outer epithelial shell of the cup expressed Mitf (J; day
9)  and  accumulated  pigment  on  day  12  (K).  L:  The  apical  marker  aPKC  and  laminin1  basement
membrane. M: E11.5 mouse eye. N: Schematic of optic-cup self-formation. SE, surface ectoderm. Scale
bars: 200 mm (B, E-F, K), 50 mm (D, H, I, L), 100 mm (M). (Eiraku et al., 2011).
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When  isolated  and  cultured  for  10-14  days  of  differentiation,  the  Rax+  tissues  spontaneously
formed  large,  continuous  epithelial  structures  with  clear  stratification,  reminiscent  of  the  early
postnatal  retina.  Multiple  layers  of  distinct  cellular  components  consisted  of  photoreceptors
(Rhodopsin+ and Recoverin+),  ganglion  cells  (Brn3+ and Calretinin+),  bipolar  cells  (Chx10+),
horizontal cells (Calbindin+), amacrine cells and Muller glia cells. These cellular subtypes were
spatially arranged into the correct apical-basal order as seen  in vivo, and were generated with the
right temporal order (as seen by birth-dating analysis with Brdu incorporation; Figure 10.4).
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Figure  10.4:  Generation  of  stratified  neural  retina  tissues  from  ES-cell-derived  invaginated  epithelia.  A:
Isolation of the optic cups from the SFEBq aggregates at day 10  (A; left). Eversion of the RPE hinge occurring
after  excision  (A;  middle).  Floating  tissues  on  day  20  are  shown  (A;  right).  B:  Uniformly  extending  retinal
epithelium in day 24 culture. C-L: Neural retina markers in cross-sections on day 24. BP, bipolar cells; GCL,
ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; PR, photoreceptors. L: pNrl-DsRed2 was
electroporated (apically) on day 16, and analysed on day 24. M: Temporal expression profile of  neural retina
markers. N-P: BrdU was incorporated on the given day and the BrdU-retaining cell types were analysed on day 24.
(Eiraku et al., 2011).
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From the technical point of view, the procedure consisted in dissociating and quickly re-aggregating
ES cells in GMEM supplemented with 1.5% KSR. 
Matrigel (or alternatively Laminin/Entactin/Nodal)  was added at  day 1. Differentiating ES cells
were incubated under 40% O2 and 5% CO2 conditions. For long-term neural retina culture, medium
consisted in DMEM/F12 supplemented with N2 + 10% FBS + 0.5 μM all-trans retinoic acid (RA) +
1 mM L-taurine.
To sum up, Sasai's Lab shared with the scientific community two important ES cell differentiation
protocols for the generation of retinal cells in vitro. Especially the second - more recent - protocol,
is really interesting and opens up new avenues for the transplantation of artificial  retinal tissue
sheets, rather than simple cell grafting. However, as in the case of cortical differentiation protocols
showed  in  the  previous  Chapter,  again  the  Authors  have  been  mainly  focused  on  cell-type
production,  rather  than  on  the  molecular  mechanisms  leading  to  cell  fate  specification.  The
experimental  procedures  and the  culture  media always  seemed to be  chose empirically,  testing
different  combinations  of  morphogens,  and  the  exact  role  for  each  molecule  used  during
differentiation  was  not  precisely  dissected.  As  an  example  of  the  confusion  generated  by this
approach, one should notice that the culture medium of the first protocol (Figure 10.2), contained
the Activin/Nodal inhibitor Lefty from day 0 to day 5 of differentiation, followed by Activin itself
starting from day 4, with an unexplainable overlapping of this two opposite treatments during the
third day of culture. The Authors do not explain the need for this anomalous overlapping.
Furthermore, both protocols made use of supplements whose composition and possible contribution
to retinal differentiation were not investigated, as KSR (knock-out serum replacement supplement)
and Fetal Bovine Serum (whose composition and morphogen content is far from being simple and
well-defined).
While much information can be found about A/P neural patterning of differentiating ES cells and
about cortical fate acquisition, the regulation of forebrain regionalization remains poorly understood
(Wilson  and  Houart,  2004;  Beccari  et  al.,  2013).  The  molecular  mechanisms  controlling  the
diversification of the presumptive telencephalon and the eye field has not been elucidated so far.
The use of a different scientific approach, focusing not only on the final outcome of the protocol but
especially on the systematic analysis of signaling pathways and molecular mechanisms required for
retinal differentiation, will be essential to gain new insights on retinal development.
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11− Focus on Activin
The formation of three germ layers (endoderm, mesoderm and ectoderm) is the most important
event in early vertebrate development. Classical studies showed that Activin plays a pivotal role in
the induction of mesodermal and endodermal tissues.
Xenopus laevis animal cap assay can be used to reproduce the in vivo induction of amphibian tissues
in order to investigate the differentiation processes that occur in normal embryonic development.
Animal caps explants (which are made of pluripotent stem cells, similar to mouse ES cells) are
treated  with  morphogens,  then  the  differentiation  fate  is  investigated  by  RT-PCR,
immunohistochemistry  or  in  situ hybridisation.  By performing  animal  cap  assays,  Activin  was
found to be a potent inducer of various types of mesodermal and endodermal tissue (Figures 11.1
and 11.2). 
Dissociated animal cap cells express different genes when exposed to Activin, whose effects were
found to be dose-dependent (Figure 11.1). 
• Without any treatment (culture in saline solution), animal cap cells became epidermal cells
(expressing keratin). 
• At low/moderate concentrations of Activin, animal cap cells switched-on the expression of
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the  key  gene  for  mesodermal  induction,  Brachyury,  and  also  expressed  genes that
characterize the posterior and lateral plate mesoderm (XlHbox6, Xhox3). They developed
ventral mesoderm derivatives such as blood cells. 
• At moderate/high concentrations, Activin triggered the differentiation of dorsal mesoderm
derivatives:  beating  heart,  pronephros,  pancreas  and  cartilage  can  be  induced  by
microsurgical manipulation and simultaneous treatment with high Activin doses and other
factors (Ariizumi and Asashima, 2001; Okabayashi and Asashima, 2003). 
• At  high  doses,  Activin  induced  the  Organizer  genes  to  become  expressed  (Gilbert,
Developmental Biology; Okabayashi and Asashima, 2003), driving the differentiation of the
dorsal-most  mesoderm of  the  embryo,  the  Notochord.  The cells  became vacuolated and
expressed notochord markers such as Mz15 and low amounts of Goosecoid. (After Green et
al., 1992.) 
• Adding other factors to Activin also produced interesting results, such as the development of
endodermal  tissues.  The  addition  of  Retinoic  acid  to  the  concentration  of  Activin  that
usually induces the formation of notochord, for example, will cause the formation of kidney
tubules. When insulin-like growth factor is added to the concentration of Activin that can
produce muscles, ear and eye vesicles form.
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Figure 11.1:  Dissociated animal cap cells express different genes when exposed to different concentrations of
Activin. At low concentrations, they become epidermal cells (expressing keratin). However, after a sharp threshold,
they  begin  expressing  genes  that  characterize  the  posterior  and  lateral  plate  mesoderm  (XlHbox6,  Xhox3,
Brachyury). If exposed to higher concentrations of Activin, the cells express notochord markers such as Mz15 and
low amounts of Goosecoid. (After Green et al., 1992).
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Activin is now principally employed in mammalian ES cell differentiation protocols as an efficient
inducer of both mesodermal identity (Cerdan et al., 2012) and endodermal identity (Teo et al., 2012;
Iwao  et  al.,  2013;  Vosough  et  al.,  2013)  during  mammalian  ES  cell  differentiation  in  vitro.
Additionally, Activin was found to have a role in maintenance of stem cell pluripotency (Tomizawa
et al., 2013; Sakaki-Yumoto et al., 2013).
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Figure  11.2: In  vitro  methods  of  tissue  induction  using  Xenopus  animal  caps.  A:  Animal  cap  assay.  The
blastocoelic  roof  of  amphibian  blastula  (animal  cap)  is  excised  and  cultured  in  saline  solution  containing
morphogens. B: Schematic array of the tissue types induced in amphibian animal caps by Activin and other factors.
(Okabayashi and Asashima, 2003).
Introduction  11−Focus on Activin
In summary, Activin plays important roles in the maintenance of stem cell pluripotency and in stem
cell differentiation (for the induction of mesodermal/endodermal tissues). Some new studies suggest
that Activin could play additional roles in ES cell patterning during neural differentiation. To date,
few evidence has been provided for a possible role of Activin as an inducer of retinal identity. A cue
in this direction has been given by Sasai's Lab (Ikeda et al., 2005); their protocol for the  in vitro
generation of retinal progenitors makes use of Activin-A in the culture medium. Unfortunately, the
experimental procedures described in this work did not allow to infer neither the exact role for each
of molecules used nor the temporal competence of cells to specifically respond to the different
signals. In particular, the role of Activin in patterning neural fate toward a retinal identity was not
dissected.  A detailed  comparison  between  cells  treated  with  Activin  and  cells  differentiated  in
absence of it, for example, was completely missing. 
Conversely, Lupo et al. showed the importance of both BMP and Activin/Nodal signaling for the
induction  of  eye  field  genes  in  differentiating  human  ES  cells,  separately  investigating  their
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Figure  11.3:  Activin/Nodal  and  BMP antagonists  hinder  eye  field  specification  in  anterior  neuroectoderm
derived from adherent human ES cell cultures. Graph shows Real-time RT-PCR quantification of gene expression
in human ES cells treated for 12–16 days with the Wnt-inhibitor Frizzled-8 (Δ8), with or without the Activin/Nodal-
inhibitor SB431542 (SB) and/or Noggin (N), as indicated. Results are shown as the mean of the log10-transformed
ratio between differentiated and undifferentiated human ES cells in four biological replicates.  Undifferentiated
human ES cells were cultured in Activin + FGF2 containing medium (A + F). The expression of eye field genes
(Six3,  Six6,  Rax  and Vsx2)  is  repressed  by  SB and  Noggin  treatments,  which  instead  promote  expression  of
telencephalic/diencephalic  genes  (FoxG1,  Emx2,  Vax1 and Nkx2.1).  Two-tailed  Student’s  t-test  was  performed
between cells differentiated with or without SB and Noggin. (Lupo et al., 2013).
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contribution and time of action on the transcription of early retinal markers (Lupo et al.,  2013;
Figure 11.3). They found that levels of Activin/Nodal and BMP signaling have a marked influence
on forebrain patterning and that the inhibition of these pathways represses expression of eye field
genes (Figure 11.3).
The regulation of forebrain regionalization remains poorly understood (Wilson and Houart, 2004).
In  particular,  the  molecular  mechanisms  controlling  the  diversification  of  the  presumptive
telencephalon and the eye field have not been elucidated so far. The systematic analysis of signaling
pathways (such as Wnt, BMP, and Activin/Nodal pathways) and the study of their early contribution
for the patterning of the forebrain will  be essential to gain new insights on cortical and retinal
development.
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12− Aim of research
The aim of this work was to directly show the endogenous production of morphogens (BMP,
Wnt, FGF and Activin/Nodal factors) by differentiating ES cells  and to characterize their
effects on the differentiation and positional identity of ES cell-generated neurons, focusing on
cortical and retinal differentiation.
The use of factor-free chemically defined media has allowed for  the investigation of  the
differentiation fate of ES cells in the absence of exogenous signals, showing that it is predominantly
neural (Tropepe et al., 2001, Gaspard et al., 2008; 2009). The first step in my work was to set up a
novel neural differentiation protocol, using chemically defined minimal medium, suitable to
study  the  default  differentiation  identity  of  mouse  ES  cells  and  to  unravel  the  possible
production of endogenous factors during neural differentiation.  I  therefore established an in
vitro differentiation protocol that minimizes exogenous signals, and analyzed ES cell differentiation
by performing RT-PCR, immunohistochemistry and genome-wide expression analysis. I created a
new  efficient  neuralization  protocol,  where  ES  cells cultured in the absence of any added
morphogen efficiently differentiate into neuronal cells, which  is  consistent with previous
observations (Cai and Grabel, 2007; Smukler et al., 2006).
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The absence of morphogens inside the culture medium does not assure a completely morphogen-
free system. We reasoned that  ES cells  could  express  and produce  morphogens such as  Wnts,
BMPs,  FGFs  and  Activin/Nodal  during  neural  differentiation  in  vitro.  These  molecules  could
actively  affect  ES  cell  neuralization  and  positional  identity.  I  therefore investigated  for  the
production of endogenous morphogens by RT-PCR analysis at different time points in our protocol,
and I found that mouse ES cells express different morphogens during neural differentiation in
vitro,  especially  BMPs,  Wnts  and  FGFs.  These  morphogens  could  act  in  an  autocrine  or
paracrine  way,  affecting  ES  cell  differentiation  and  the  acquisition  of  distinct  positional
identities. 
Effects  of factors endogenously produced by ES cells  on their  neural  differentiation have been
suggested.  BMPs sustain self-renewal and inhibit  neural differentiation of ES cells (Ying et  al.,
2003).  The  BMP-inhibitors  Noggin and  Chordin  triggers in vitro neuronal differentiation of
mammalian ES cells cultured in growth factor-free chemically defined medium (Chambers et al.,
2009; Gratsch & O'Shea, 2002). Additionally, Activin/Nodal-inhibitors are often used to drive ES
cell neural differentiation (and at the same time to inhibit mesodermal differentiation) (Ikeda et al.,
2005). Wnt-inhibitors (such as Dkk-1) are exploited to protect the anterior default differentiation
fate of differentiating ES cells (Eiraku et al., 2008; Ikeda et al., 2005; Verani et al., 2007; Nicoleau
et  al.,  2013).  These data  suggest that ES cells produce, and are sensitive to, BMPs, Wnts  and
Activin/Nodal factors with an autocrine/paracrine mechanism. However, to our knowledge, there is
no direct measurement of BMP, Wnt and Activin/Nodal production by differentiating ES cells. 
At first, I decided to focus on BMP and to test if endogenously produced BMP factors could affect
ES cell neuralization and/or the regional identity of ES cell-generated neurons. I found that BMP-
inhibitor  Noggin,  in  addition  to  its  known role  as  neural  inducer,  plays  a  major role  in
establishing  an  anterior,  cortical  fate.  Blocking  the  BMP pathway  by  Noggin  or  by  other
inhibitors selectively affects the A/P positional identity of the generated neurons. Control ES cells,
differentiated with our protocol, spontaneously acquired a mesencephalic differentiation fate, while
at the highest doses of Noggin-treatment that I tested, the fate of neurons produced by ES cells was
predominantly dorsal telencephalic. These neurons have a gene expression profile that clusters with
that of early cerebral cortical cells and express telencephalic differentiation markers. In summary,
Noggin acted at  two distinct  levels of ES cell  differentiation:  it  strengthened their  spontaneous
neural differentiation in a minimal medium, and it strongly induced a telencephalic/cortical identity.
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Having  defined  the  role  of  BMP in  fate  choice  between  forebrain  (predominantly cortex)  and
midbrain,  we  then  asked  whether  endogenously  produced  Wnts  could  contribute  to  mask  an
intrinsic cortical fate of neuralizing ES cells. Double BMP/Wnt inhibition showed an even stronger
down-regulation of midbrain genes and more efficient up-regulation of cortical genes, compared to
single  treatments,  suggesting  a  synergistic  effect  of  BMP and  Wnt  pathway inhibition  for  the
acquisition of a cortical fate. All in all, we concluded that Wnt inhibition plays a fundamental
role in establishing an anterior, telencephalic (in our case, cortical) fate during ES cell neural
differentiation in vitro, consistently with previous findings (Eiraku et al., 2008; Ikeda et al., 2005;
Verani et al., 2007; Nicoleau et al., 2013).
While many information can be found about A/P neural patterning of differentiating ES cells and
about cortical fate acquisition, regulation of forebrain regionalization remains poorly understood.
The molecular mechanisms controlling the diversification of the presumptive telencephalon and the
eye field have not been elucidated so far (Wilson and Houart, 2004; Andonadiou et al., 2013). As
the final goal of my project, I decided to exploit the plasticity of my protocol and the previously
acquired information on ES cell differentiation, to steer stem cell fate choice between telencephalon
(cortex) and diencephalon (retina). In particular, I studied how the manipulation of Activin/Nodal
signaling can lead to a further patterning inside the forebrain, triggering retinal specification
at the expense of cortical differentiation. I found that a low dose (10 ng/ml) of Activin was able
to drive the expression of retinal markers Rax, Six3, Pax6, Otx2 and Six6, some of which were
previously shown to play a fundamental role as eye field transcription factors (Zuber et al., 2003).
At the same time, Activin could inhibit the expression of cortical (Emx2 and FoxG1) and midbrain
(En1 and Irx3) genes.
Activin retinal inducing action was exerted only on cells that previously acquired a forebrain fate
via Wnt-inhibition or double Wnt/BMP-inhibition; Activin was not effective as a retinal inducer
when used alone. This suggests that a previous anteriorization to a forebrain fate was necessary to
acquire  the  competence  to  respond  to  Activin-mediated  retinal  induction,  consistently  to  what
happens in in vivo development (Zuber et al., 2003).
Our experiments (this Thesis and Bertacchi et al., manuscript in preparation) are the first description
and full characterization of an Activin new role as inducer of retinal identity at the expense of a
more anterior, telencephalic one, on mouse ES cells.
Additionally,  I  found that  different  morphogens  were  able  to  switch-on Rax  expression:  while
Activin  was  able  to  induce  the  formation  of  Pax6/Rax  double  positive  cells,  which  can  be
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considered  as  bona  fide retinal  progenitors,  SAG  (Shh-agonist)  was  driving  efficient  Rax  co-
expression together with Nkx2.1 and Vax1, which is consistent with a ventral diencephalic identity
(rostral hypothalamus cells; Wataya et al, 2008; Ikeda et al., 2005). Notably, Shh-agonist was able
to induce the expression of Rax only if used in combination with Wnt-inhibitor. This suggested that
only  anteriorized forebrain  cells  were  competent  to  respond to  Shh-mediated  Rax  induction.  I
concluded that different morphogens (such as  Activin and Shh) are able  to switch-on Rax
expression, in the context of anterior forebrain-like cells.
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Cells cultures
Murine embryonic stem (ES) cell lines E14Tg2A (passages 25-38), 46C (transgenic Sox1-GFP ES
cells kindly provided by A. Smith, University of Cambridge, UK, passages 33-39) and K/l-EB5
(transgenic Rax-GFP ES cells kindly provided by Y. Sasai, Riken Center, Japan) were cultured on
gelatin-coated tissue culture dishes at a density of 40,000 cells/cm2. ES cell  medium, which was
changed daily, contained GMEM (Sigma), 10% Fetal Calf Serum, 2mM Glutamine, 1mM sodium
Pyruvate, 1mM non-essential amino acids, 0.05mM β-mercaptoethanol, 100 U/ml
Penicillin/Streptomycin and 1000 U/ml recombinant mouse LIF (Invitrogen), the latter avoiding the
need of  a  feeder  cell  layer. Cells were passaged using Trypsin dissociation and re-plated at a
dilution of 1:3 to 1:4, to avoid cell confluence and to maintain pluripotency. 
RAW 264.7 (mouse leukemic monocyte macrophage cell line, kindly supplied by Diana Boraschi,
Institute of Medical Biotechnology,  CNR of Pisa) were cultured in Dulbecco's modified Eagle's
Medium with 4mM L-glutamine and 4.5 g/L glucose, supplemented with 10% fetal bovine serum.
Cells were split every two days at a confluence of approximately 10% (1·106 and 3·106 cells in 100-
mm and 150-mm plates, respectively) and grown to a confluence of approximately 80%. 
Mouse mesenchymal stromal  cells (MSCs) primary cultures (kindly supplied by Cristina Magli,
CNR of Pisa) were established from B6D2F1 (BDF1) mice (Charles River) as described (Nadri et
al., 2007).
Mouse neuronal  primary cultures or paraformaldehyde-fixed brain slices to test  antibodies  were
obtained from wild-type mice as described (Malatesta et al., 2000).
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Neural induction
We recently published the  full  description  of  the neural  induction protocol  used in  this  Thesis
(Bertacchi  et  al.,  2013).  Chemically defined minimal medium (CDMM) for  neural  induction
consisted of DMEM/F12 (Invitrogen), 2mM Glutamine, 1mM sodium Pyruvate, 0.1mM non-
essential amino acids, 0.05mM β-mercaptoethanol, 100 U/ml Penicillin/Streptomycin supplemented
with N2/B27 (no vitamin A; Invitrogen). Protocol outline is shown in Figure 1.1.
• Step-I: dissociated ES  cells were washed with DMEM/F12, aggregated in agar-coated
culture dishes (65,000 cells per cm2) and cultured as floating aggregates in CDMM for 2
days. The second day 75% of CDMM was renewed. 
• Step-II: ES cell aggregates were dissociated and cultured in adhesion (65,000 cells per cm2)
on Poly-ornithine (Sigma; 20 μg/ml in sterile water, 24 hours coating at 37°C) and natural
mouse Laminin (Invitrogen; 2.5 μg/ml in PBS, 24  hours coating at 37°C) for 4 days,
changing CDMM daily. In some cases, Step-II was further prolonged up to a maximum of 8
days of culture without any re-dissociation and re-plating.
• Step-III:  After a second dissociation, ES cells were cultured 4 additional days in CDMM
devoid of B27 supplement to drive terminal differentiation, using the same type of seeding
density and coated surface. Serum employed for Trypsin inactivation was carefully removed
by several washes in DMEM/F12. 
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Figure 1.1. ES cell differentiation protocol outline. Step-III can be further prolonged for long term differentiation.
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The following factors were tested by addition during Step-II: Recombinant Mouse Noggin (R&D;
ranging from 5 nM to 400 nM), Recombinant Human/Mouse/Rat Activin-A (R&D; ranging from 1
ng/ml to 100 ng/ml), BMP4 (R&D; 50 ng/ml), Recombinant Mouse BMPRIA/Fc Chimera (R&D;
3.75 nM and 37.5 nM), Dorsomorphin (Sigma-Aldrich; 5 μM), Retinoic Acid (Sigma-Aldrich; 0.1
to 10 μM), Cyclopamine (Sigma-Aldrich; 5 μM), SAG (Santa Cruz Biotechnology; 100/150 nM),
SB431542 (Sigma-Aldrich; 10 μM),  IWR-1-endo  (Calbiochem;  5/10  μM). Cell viability and
proliferation, which were monitored by trypan blue exclusion test and cell counting, respectively,
were not significantly affected by most common treatments (Figure 1.3 and Figure 1.2). 
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Figure  1.2. Cell  death
quantified  by  trypan
blue  exclusion  test
during  Step-II  after
treatments with different
chemical  drugs  or
recombinant proteins.
































Figure 1.3. Cell proliferation during Step-II after treatments with different chemical drugs/recombinant proteins.
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Semiquantitative real-time PCR
Total  RNA was  extracted  from ES  cells  or  tissue  samples  with  NucleoSpin  RNA II  columns
(Macherey-Nagel). ES cells from at least two-three different wells of 24-well plates / 6-well plates
were always pooled together to compensate for variability in cell seeding. RNA quantity and RNA
quality were assessed with Nanodrop and gel electrophoresis. For each sample, 200/500 ng of total
RNA were  reverse-transcribed. Amplified cDNA was quantified using GoTaq qPCR Master Mix
(Promega) on Rotor-Gene 6000 (Corbett) with the primers listed in Table 1,  at  the end of this
Chapter. Amplification take-off values were evaluated using the built-in Rotor-Gene 6000 relative
quantitation analysis function, and relative expression was calculated with the 2-ΔΔCt method,
normalizing to the housekeeping gene β-Actin. Standard errors were obtained from the error
propagation formula as described in (Nordgård et al., 2006) and statistical significance was probed
with randomization test, taking advantage of REST Software (Pfaffl et al., 2002).
Immunocytodetection
Cells prepared for immunocytodetection experiments were cultured on Poly-ornithine/Laminin
coated  round glass coverslips.  Cells were fixed using 2% paraformaldehyde  for 10-15 minutes,
washed twice with PBS, permeabilized using 0.1% Triton X100 in PBS and blocked using 0.5%
BSA in PBS. Primary antibodies used for microscopy included Oct3/4 (1:200; Santa Cruz DBA),
Nanog (1:300;  Novus Biologicals), acetylated N-Tubulin (1:500; Sigma), Neuronal Class III β-
Tubulin (1:500; Covance), Doublecortin (1:500; Abcam), Musashi-1 (1:200; Cell Signaling), Nestin
(1:200; Millipore), Synaptophysin (1:100; Santa Cruz DBA), α-Internexin (1:100; Santa Cruz
DBA), phospho-Smad1/5/8 (1:100; Millipore), FoxG1 (1:200; Abcam), Tbr1 (1:400; Millipore),
Satb2 (1:200; Abcam), Ctip2 (1:400; Abcam), GFP (rabbit polyclonal; 1:1,000; Invitrogen), GFP
(chicken polyclonal;  1:1,000;  Aves Lab),  Rhodopsin  (1:1,000;  Sigma), vGlut2 (1:300; Abcam),
GAD65  (1:500; Chemicon), Pax6 (1:400; Covance), Nkx2.1 (1:400; Abcam) and  GFAP (1:100;
Dako). Primary antibodies were incubated 2 hours at room temperature; cells were then washed
three times with PBS (10' each). Alexa Fluor 488 and Alexa Fluor 568 anti-guinea pig, anti-goat,
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anti-mouse, anti-rabbit or anti-chicken IgG conjugates (Molecular Probes, 1:500) were incubated 1
hr at RT in PBS containing 0.1% Triton X100 and 0.5% BSA for primary antibody detection,
followed by three PBS washes (10' each). Nuclear staining was obtained with DAPI. The protocol
varied for Tbr1, Satb2, Ctip2 and FoxG1, which antibodies were incubated over-night at 4°C using
0.3% Triton X100.
BMP2 ELISA
Cells were seeded into 24-wells and cultured as described. When cells reached 70-80% confluence,
each well was washed with PBS, and fresh medium (DMEM/F12 containing 2mM Glutamine and
1mM sodium Pyruvate) was replaced. After 24h, supernatant was collected, centrifuged (10,000 g,
5') to remove particulates and assayed for BMP2 content with a commercially available ELISA kit
(Quantikine, BMP-2 Immunoassay, R&D Systems, Minneapolis, MN USA), according to the
manufacturer's instructions. This assay could measure BMP-2 concentrations as low as 50 pg/ml in
a linear range (Pearson correlation coefficient of linear regression R2=0.999, see Figure 1.4. A 1.2%
cross-reactivity was observed with 50 ng/mL recombinant human BMP-4. BMP-2 concentrations of
triplicate samples were determined from the optical densities at 450 nm in relation to standard
curves of the recombinant antigen provided in the kit.
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Figure  1.4.  BMP2  ELISA
calibration. Standard  curve
showing  linear  correlation
between BMP2 concentration and
absorbance  at  450  nm,  after
colorimetric  solid  phase  ELISA
quantification  in  the  range  0-
1000 pg/ml. (Pearson correlation
coefficient  of  regression
R2=0.999).
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FACS analysis
Adherent cells were detached by trypsinization, washed and resuspended in PBS at RT, then
analyzed with a FACSCalibur cytometer (BD). At least 10,000 events per sample were collected.
Data were processed with the free software WinMDI 2.9 (The Scripps Research Institute).
Microarray hybridization and data analysis
Cortex, midbrain and hindbrain were dissected from n=3 mouse embryos  (C57BL/6  strain)  at
embryonic day (E)16.  Total  RNA was extracted with NucleoSpin RNA II columns (Macherey-
Nagel). RNA from three different sets of experiment was pooled. RNA quality was assessed with
Agilent Bioanalyzer RNA 6000 Nano kit; 500 ng of RNA were labeled with One Color Quick amp
labeling kit (Agilent), purified and hybridized overnight onto an Agilent Mouse Gene Expression
Microarray chip (4x44K v2) before detection, according to the manufacturer’s instructions. Three
slides were hybridized with Noggin-treated ES cell RNA and two slides were hybridized with RNA
from all the other conditions. Agilent DNA Microarray scanner was used for slide acquisition and
spot analysis was performed with Feature Extraction software (Agilent). 
For GSEA analysis, genes  differentially expressed between Noggin  treatment  and  CDMM
(Supplemental Table 2), or between RA treatment and CDMM (Supplemental Table 3; fold-change
greater or equal than 2), were analyzed by the GeneSpring GX11.0 software using BROAD Gene
Ontology collection (C5; www.broadinstitute.org/gsea). A  complete GSEA list with enrichment
scores of gene sets with q-value <0.3 is shown in Supplemental Table 4 (On-line material; Bertacchi
et al., 2013). 
To select a gene-set representing the anterior-posterior regionalization of the developing brain, we
compared gene expression profiles of E16 cortex and hindbrain using Genespring GX11.0 software
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(Agilent). A set of  592 genes with an absolute fold-change greater or equal than 10 (p<0.05) was
selected (see Supplemental Table 5, on-line material; Bertacchi et al., 2013). Significance of the
data was proven by one-way ANOVA and Tukey post hoc test with Bonferroni  correction for
multiple comparisons. The content of this set of genes was explored by hierarchical clustering and
Principal Component analysis, taking advantage of Cluster software (Eisen et al., 1998). Single
linkage algorithm was employed for hierarchical clustering. Trees were generated using absolute
correlation for genes and Euclidean distance for arrays, and visualized with java TreeView
(Saldanha, 2004).
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List of primers for Real Time RT-PCR.







































FGF15 antisense TCTACATCCTCCACCATCCTG 
FGF4 TCTTCGGTGTGCCTTTCTTT 
FGF4 antisense CACTCGGTTCCCCTTCTTG  
FGF5 GTCAATGGCTCCCACGAA 
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FoxH1 CGCCACAACCTTTCCTCTAA  






















Lhx2 antisense CCTGCCGTAAAAGGTTGC 
Lhx8 AAACACGTCAGTCCCAACCA 














antisense ATGCTCAGTGGCTTGGTCTT  
Oct4 TCAGCTTGGGCTAGAGAAGG
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Tbx3 antisense ACCATCCACCGAGAGTTGTG 
GTTCAGGGTCTTCCGCTTG  




Vax1 antisense GTATTGGCAACGCTGGAAC 
WNT1 ACAGCAACCACAGTCGTCAG 













WNT8b antisense CAACGGTCCCAAGCAAAC 
WNT9a GGGACAACCTCAAGTACAGCA 
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Markers for the study of brain patterning
Table 2: Most important genes used as markers for the study of brain patterning.  All images were found
on-line on Allen Developing Mouse Brain Atlas (developingmouse.brain-map.org) and/or on Edinburgh
Mouse Atlas Project (emouseatlas.org/emap), as indicated.
Ctip2 Ctip2 Em x2
Cortex Cortex (medium-late generated neurons) Forebrain (Cortex)
E stage 10.5 E stage 13.5 E stage 10.5
EMAP Edinburgh Mouse Atlas Allen Mouse Atlas EMAP Edinburgh Mouse Atlas
En1 En1 FoxG1
Midbrain - Hindbrain Midbrain - Hindbrain Forebrain
E stage 9.5 E stage 13.5 E stage 13.5
EMAP Edinburgh Mouse Atlas Allen Mouse Atlas Allen Mouse Atlas
Gad65 Gata4 HoxB4
Gabaergic neurons Extraembryonic Endo-Mesoderm Hindbrain – Spinal cord
E stage 13.5 E stage 7.5 E stage 10.5
Allen Mouse Atlas EMAP Edinburgh Mouse Atlas EMAP Edinburgh Mouse Atlas
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
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Otx2 Otx2 Pax6
Midbrain – Retina Midbrain – Retina Neural tissue (Anterior, Dorsal and Retina)
E stage 11.5 E stage 13.5 E stage 10.5
EMAP Edinburgh Mouse Atlas Allen Mouse Atlas EMAP Edinburgh Mouse Atlas
Pax6 Rax Rax
Neural tissue (Cortex and Retina) Forebrain Diencephalon (Ventral + Retina)
E stage 11.5 E stage 8.7 E stage 10.5
Allen Mouse Atlas EMAP Edinburgh Mouse Atlas EMAP Edinburgh Mouse Atlas
SatB2 Shh Six3
Cortex (late generated neurons) Ventral nervous tissue Forebrain (Retina)
E stage 15.5 E stage 9.5 E stage 9.5
Allen Mouse Atlas EMAP Edinburgh Mouse Atlas EMAP Edinburgh Mouse Atlas
Materials and Methods  1−Materials and Methods
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Six6 Tbr1 Tbr1
Retina Cortex Cortex (early generated neurons)
E stage 10.5 E stage 10.5 E stage 13.5
EMAP Edinburgh Mouse Atlas EMAP Edinburgh Mouse Atlas Allen Mouse Atlas
Vax1 vGlut2 Wnt7b
Forebrain (Ventral) Glutamatergic neurons Forebrain (Cortex)
E stage 13.5 E stage 15.5 E stage 9.5
Allen Mouse Atlas Allen Mouse Atlas EMAP Edinburgh Mouse Atlas
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1− A Novel Neural Induction Protocol
Chemically Defined Minimal Medium (CDMM) 
Allows Efficient Neurogenesis of Embryonic Stem (ES) Cells.
In  order  to  measure  the  endogenous  production  of  morphogens  during  differentiation,  and  to
investigate  the default  positional identity of neurons generated from ES cells,  we established a
culture method that allows neurogenesis minimizing the influence of exogenous signals. 
This method consists of a three-step procedure of culture in a chemically defined minimal medium
(CDMM; see Materials and Methods; Figure 1.1) devoid of serum or morphogens but allowing cell
survival by insulin.
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Figure 1.1: Three-step protocol of ES cell neuronal differentiation. ES cell differentiation protocol outline.
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Undifferentiated mouse embryonic stem cells are the starting point of the protocol. The condition of
pluripotency can be tested by immunostaining of the crucial stem cell markers, Oct4 and Nanog
(Figure 1.2). 
Upon LIF and serum withdrawal, dissociated ES cells  were initially grown as aggregates (Figure
1.3) in CDMM for 2 days. This step (Step-I), which minimizes cell death, follows a procedure
adapted from previously described methods (Bibel et al., 2007; Lee et al., 2000; Watanabe et al.,
2005). As many protocols use serum-containing medium (SCM) during ES cell aggregation, we
assayed also this condition in the preliminary set-up of our protocol. As additional control, we used
undifferentiated ES cells cultured in LIF+serum (ES cell medium).
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Figure 1.2: Oct4 (green) and Nanog (red) immunocytodetection of undifferentiated ES cells cultured in serum-
and LIF-contaning medium. In our culture,  the vast  majority of  cells  were positive to Oct4 staining; Nanog
showed a strong signal only in a subset of Oct4-positive cells. This heterogeneity of serum-cultured ES cells is
consistent with Austin Smith's Lab observation (Silva et al., 2008).
Figure 1.3:  ES cell aggregates at Step-I. Undifferentiated embryonic
stem  cells  are  trypsinized  and  replated  in  suspension  on  an  agar-
coated surface, where they form embryoid body-like aggregates. Step-I
reaggregation can be performed in serum-containing medium (SCM)
or  directly  in  chemically  defined  minimal  medium  (CDMM);  this
difference  will  influence  subsequent  neural  induction  efficiency,  see
below in the text.
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ES cell  aggregates were subsequently dissociated and cultured in adhesion for 4 days on Poly-
ornhitine/Laminin-coated wells in CDMM (Step-II). All  additional  treatments  (e.g.  Noggin,
chemical drugs, etc), when applied, were performed during this step (Figure 1.1), unless specified.
During Step-II, ES cells turned off the expression of the stem cell marker Oct4 (Niwa et al., 2000)
and activated the expression of the pan-neuronal markers β-Tubulin-III and Ncam, as seen by RT-
PCR (Figure 1.4). This activation was higher in ES cells aggregated in CDMM than in ES cells
aggregated in SCM, as the latter still expressed high levels of Oct4 and activated the mesodermal
marker GATA4 (Figure 1.4).
At the end of Step-II, immunostaining showed much higher expression of the neural progenitor cell
marker Musashi-1 (Okano et al., 2005) and robust down-regulation of Oct4 in ES cells cultured in
CDMM (Figure 1.5A) compared to ES cells cultured in SCM (Figure 1.5B). This was consistent
with RT-PCR data.
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Figure  1.4: RT-PCR mRNA analysis of expanding ES cells (undiff. ESCs), or of ES cells at the end of Step-II,
initially (Step-I) aggregated in two diverse conditions (SCM and CDMM, normalized on ES cells, see text). Oct4
pluripotent marker gradually switched-off during neural differentiation, but this process was very slow when serum
was maintained during Step-I. Vice versa, when ES cells were aggregated directly in serum-free minimal medium,
Oct4 expression rapidly decreased. A strong expression of the neural markers  β-Tubulin-III and Ncam could be
obtained in CDMM condition. Aggregation in serum seemed to facilitate the differentiation along the mesodermal
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Whereas ES  cells aggregated in CDMM started expressing β-Tubulin-III at Step-II, ES  cells
aggregated in SCM failed to show β-Tubulin-III labeling (Figure 1.6A,B). Similar results were
obtained when analyzing ES cell aggregates cultured for 5 days (Figure 1.6C,D). Our observations
indicate that aggregation (Step-I) in the absence of serum facilitates loss of stem cell pluripotency
and induces rapid neural differentiation (as evaluated at the end of Step-II).
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Figure 1.5: Oct4 (green) and Musashi-1 (red) immunocytodetection of ES cells at the end of Step-II. The figures
clearly show the difference of the neuralization efficiency after CDMM (A) or SCM (B) aggregation at Step-I. The
direct  reaggregation  of  mouse  embryonic  stem  cells  in  a  minimal  medium  allows  fast  and  efficient  neural
conversion.
A
Oct4  Musashi-1  DAPI Oct4  Musashi-1  DAPI
CDMM Step-II SCM Step-II
Figure 1.6: Nestin (green) and β-Tubulin-III (red) immunocytodetection of ES cells during neural conversion.
A-D show  β-Tubulin-III  and  Nestin  immunocytodetection  identifying  neurons  and  neural  progenitor  cells,
respectively, in ES cells aggregated (Step-I) in CDMM (A,C) or SCM (B,D) and then differentiated in CDMM.
Cells were analyzed at the end of Step-II (A,B) or after 5 days of culture as aggregates (C,D).
Nestin  β-Tubulin-III  DAPI Nestin  β-Tubulin-III Nestin  β-Tubulin-III  DAPI Nestin  β-Tubulin-III 
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After a second dissociation, cells were cultured for 4 days in CDMM. This additional step (Step-III)
allowed cells  to  undergo  terminal differentiation. Notably, the presence of serum during Step-I
profoundly affected the fate of cells produced at the end of Step-III, as the ratio of neural progenitor
cells immunostained by Nestin antibody was lower in cells aggregated in SCM (8±4.8%) compared
to cells aggregated in CDMM (44.3±8.7%; Figure 1.7A-C).
Consistently, mRNA expression of Nestin and of pan-neuronal markers Ncam and β-Tubulin-III, at
the end of Step-III, was significantly lower in cells that were aggregated in SCM than in cells that
were aggregated in CDMM (Figure 1.8). 
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Figure  1.7:  Nestin (green) and β-Tubulin-III (red) immunocytodetection of ES cells at the end of Step-III.
Nestin-positive neural progenitors formed rosette−like structures at the end of Step-III, which are typical of neural
progenitors in vitro. Again, the neural differentiation efficiency seemed strongly improved by early serum removal.
Nestin   β-Tubulin-III   DAPI Nestin   β-Tubulin-III   DAPI Nestin   β-Tubulin-III   DAPI
A B C
Figure  1.8:  RT-PCR  mRNA analysis  of  expanding  ES  cells
(undifferentiated ESCs), or of ES cells at the end of Step-III,
initially  (during Step-I)  aggregated in two diverse conditions
(SCM and CDMM). The figure shows mRNA fold changes of the
progenitor cell markers (Nestin) and the neuronal markers (β-
Tubulin-III,  Ncam)  as  evaluated  by  RT-PCR (normalized  on
expanding ES cells, undifferentiated) at the end of Step-III in
different culture conditions (SCM at Step-I or CDMM at Step-
I).  Error bars: standard error. Asterisks: * p < 0.05, ** p <
0.01, *** p < 0.001 (Randomization test, REST software).
Step-IIIStep-III
β-Tubulin-III
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Moreover, cells cultured in CDMM formed rosette-like structures at the end of Step-III, which are
typical of neural progenitors in vitro (Zhang et al., 2001;  Figure  1.7B), and generated high
proportions of neuronal cells immunostained by anti-acetylated-Tubulin (Ntub, Figure 1.9A) and β-
Tubulin-III antibodies (Figure 1.9B).
  
We further characterized the nature of the  differentiated ES  cells by immunocytodetection.
Neuronal morphology was heterogeneous, as we found multipolar cells, pyramidal-like cells,
bipolar and unipolar cells (Figure 1.10).
ES cell-generated neurons showed processes with varicosities positive to the neuronal intermediate
filament α-Internexin that are typical of neurons forming synapses (Figure 1.11A). Moreover, ES
cell-derived neurons showed a punctate staining of the synaptic marker Synaptophysin (Figure
1.11B). 
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Figure  1.9:  Ntub (A)
and  β-Tubulin-III  (B)
immuno-cytodetection
of ES cells at the end
of Step-III.
A B
Ntub   DAPI β-Tubulin-III   DAPI
CDMM Step-III
Figure 1.10: Immunocytodetection for β-Tubulin-III-positive neurons at the end of Step-III. A-D, Examples of β-
Tubulin-III marked multipolar (A), pyramidal-like (B), bipolar (C) and unipolar (D) neurons, respectively.
A B C D
β-Tubulin-III β-Tubulin-III β-Tubulin-III β-Tubulin-III
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We failed to detect GFAP-positive cells by immunostaining;  GFAP mRNA levels were very low
compared to the levels of P0 embryonic cortex, as evaluated by RT-PCR (not shown). This is
consistent with an early differentiation state of the cells, as gliogenesis is the latest step in ES cell
neural differentiation protocols (Gaspard et al., 2008). 
To better outline the neuralization process in our protocol, we decided to evaluate by RT-PCR the
expression  of  the  pluripotency  markers  Oct4  and  Sox2,  the  epiblast  marker  FGF5,  the  neural
progenitor  markers Nestin and Pax6, and the marker of differentiating/differentiated neurons  β-
Tubulin-III, at different time points of the protocol as indicated in  Figure 1.12. Additionally, we
evaluated the expression of the mesoderm markers T (Brachiury) and Gata4, to test for possible
presence of mesodermal cells in our neural differentiation protocol.
Oct4  was  strongly down-regulated  between Step-I  and Step-II,  as  differentiation  started.  Sox2,
which is  considered  both  an embryonic stem cell  pluripotency marker  and a  neural  progenitor
marker, behaved consistently with this definition, being strongly expressed by undifferentiated ES
cells and by neural progenitors. Nestin and Pax6 expression became strong during Step-II, while β-
Tubulin-III expression increased at Step-III. The expression of the meso/endodermal cell markers
(Gata4, Gata6 and T) was almost undetectable, suggesting again that the vast majority of ES cells in
our protocol adopted a neural fate, without mesodermal or endodermal “contamination” inside our
neural differentiation system. 
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Figure 1.11: Immunocytodetection for the synaptic markers at the end of Step-III. β-Tubulin-III-positive neurons
(red  immunocytodetection)  showing  α-Internexin-positive  (green)  varicosities  (white  arrows;  A)  or  punctate
Synaptophysin staining (green; B).
A B
Internexin   β-Tubulin-III   DAPI Synaptophysin   β-Tubulin-III
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On the contrary, Gata4 was strongly up-regulated by initial (Step-I) ES cell aggregation in serum-
containing medium (SCM), as showed at the beginning of this section (see Figure 1.4).
The results  of  RT-PCR analysis  showed that  the neural  progenitor  marker  Nestin  was strongly
expressed in our protocol  especially at the end of Step-II. Immunodetection of the stem cell or the
neuronal  cell  markers  during  Step-II  confirmed  RT-PCR data.  Nestin  labeling  appeared  at  the
second day of Step-II (mid-Step-II; Figure 1.13A) and reached very high levels at the end of this
step (end of the fourth day of Step-II; Figure 1.13B). This indicated a strong neuralization process
occurring  during  the  second  half  of  Step-II  and  leading  to  a  cell  culture  enriched  of  neural
progenitors.
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Figure 1.12: RT-PCR mRNA analysis of expanding ES cells (ES cells day0), or of ES cells at different steps of
the differentiation protocol. Figure shows mRNA fold changes of the indicated markers, as evaluated by RT-PCR.
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To confirm the appearance of neural progenitors during Step-II in our protocol, we took advantage
of a Sox1-GFP knock-in ES cell line (46C, Ying et al., 2003), analyzing GFP expression by flow
cytometry (Figure 1.14). The analysis of differentiating 46C ES line at different time points showed
how Sox1-positive neural progenitors appear at mid-Step-II (35.3% of total cells) and peak at the
end of Step-II (86.8%).
These  data  prompted us  to  always  focus  on  Step-II  for  any treatment  designed to  study early
patterning  of  neuronal  progenitors.  For  this  reason,  as  already  stated  before,  all  additional
treatments (e.g. Noggin, Activin and chemical drugs), when applied, were performed starting from
the second day of Step-II.
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Figure 1.13: Nestin (green) and β-Tubulin-III (red) immunocytodetection of ES cells at mid-Step-II (A) and at
the end of Step-II (B). Neural progenitors can be efficiently visualized by strong Nestin staining (green). Neural
rosettes (encircled by white dashed lines in  Figure  A) were formed by polarized Nestin-positive progenitor cells
and appeared at mid-Step-II (at the end of Step-II day2;  A) and dramatically increased in number during the
second half of this step (B).
A BMid-Step-II (day2) End of Step-II (day4)
Nestin  β-Tubulin-III  DAPI Nestin  β-Tubulin-III  DAPI
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We concluded that a short exposure to serum in the first days of differentiation  cultures (Step-I)
inhibits the acquisition of a neuronal fate and that ES cells cultured in the absence of any added
morphogen efficiently differentiate into neuronal cells, which  is  consistent with previous
observations (Gaspard et al., 2008; Smukler et al., 2006).
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Figure 1.14: Sox1-GFP expression analysis by flow cytometry during neural differentiation. Neural progenitor
percentage can be quantified using a ES cell line where the GFP coding region is inserted near the promoter of the
neural marker Sox1 (ES line 46C, kindly provided by Austin Smith). At the end of Step-II, the vast majority (up to
90%) of cells is expressing GFP under the control of Sox1 promoter.
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2− Endogenous Morphogen Expression
Mouse ES Cells Express Wnt, BMP and FGF Morphogens 
During in vitro Neural Differentiation.
Although our method of ES cell neuralization minimizes the influence of exogenous signals, the
absence of  morphogens inside the culture medium do not  ensure a  completely morphogen-free
system. We reasoned that ES cells could express and produce morphogens such as Wnts, BMPs,
FGFs and Activin/Nodal during neural differentiation in vitro. These molecules could actively affect
ES cell neuralization and positional identity.
We investigated the production of morphogen by RT-PCR analysis at different time points in our
protocol.
Wnt family factors showing high levels of expression are showed in  Figure 2.1. Members of the
Wnt family were expressed starting from the second day of Step-II, and Wnts expression peaked at
the end of Step-II. Notably, this was clearly correlated with the appearance of neural progenitors
inside the culture: As previously showed by immunocytodetection, by RT-PCR and by cell sorting,
Nestin- and Sox1-positive neural progenitors appeared at mid-Step-II (see Results, Figures 1.6-1.8;
1.12-1.14). Wnt7b and Wnt8b were the most expressed Wnt morphogens in our culture system.
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To identify the cell type (mitotic vs post-mitotic) responsible for the expression and production of
morphogens inside the culture,  we exploited the pyrimidine analog Aracytin (Arabinofuranosyl
Cytidine, or AraC; 5 μM) to kill all mitotically active cells (Grant et al., 1998) and obtain neuron
enriched-,  neural  progenitor-free  cultures.  Cells  were  differentiated  until  Step-III+4  days,  then
cultures were treated for two days with AraC. The effect of AraC treatment on cell populations was
analyzed by immunocytodetection and by RT-PCR. Compared to control cells, AraC treated cell
cultures showed a strong reduction of Nestin-positive or Musashi1-positive neural rosettes (Figure
2.2 and  data  not  shown).  Nestin  staining  was  detected  only  on  few  surviving  isolated  neural
progenitor cells. After AraC treatment, the cellular population was almost completely composed by
clusters of β-Tubulin-III-positive neurons (Figure 2.2B).
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Figure 2.1:  Analysis of Wnt factors during ES cell neuralization. mRNAs levels relative to β-Actin in expanding
(undifferentiated) ES cells, or in ES cells at the end of Step-I (Step-I), at mid-Step-II (Step-II day2), at the end of
Step-II (Step-II day4) and at the end of Step-III (Step-III). Wnt family factors were strongly expressed during Step-
II. Their expression started at mid-Step-II (when neural progenitors appear in culture) and peaked at the end of
Step-II (when the culture is almost completely composed by neural progenitors). Error bars: standard error.
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Figure 2.2: Effect of AraC on ES cell neuralization. Immunocytodetection shows Nestin (green) and β-Tubulin-
III (red; insets) positive cells at  Step-III+6 days.  A) Control ES cells (cultured in CDMM) originated a mixed
population of both Nestin-positive neural progenitors, often organized to form neural rosettes, and β-Tubulin-III-
positive neurons. B) Cultures treated for 2 days with 5 μM AraC  were mainly made of β-Tubulin-III-positive post-
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The effect of AraC treatment was confirmed by RT-PCR analysis: AraC-treated cells expressed high
levels  of  β-Tubulin-III  mRNA and  showed  a  strong  decrease  of  Nestin  mRNA expression,
compared to control CDMM-cultured cells (Figure 2.3). Data suggested that AraC treatment could
efficiently eliminate Nestin-expressing cells and enrich the culture in β-Tubulin-III-expressing cells.
 
RT-PCR analysis allowed us to compare morphogen expression between control  Step-III+6 days
culture and AraC-treated (neural progenitor-depleted and neuron-enriched) culture. The expression
of all Wnt factors analyzed, with the only exception of Wnt4, was significantly decreased after
neural progenitors removal by AraC treatment (Figure 2.4).  Thus, our results suggest that Wnt
factors  are  expressed  preferentially  by  Nestin-positive  neural  progenitors.  These  observations,
together with the temporal coincidence of the appearance of Wnt mRNA expression and of Nestin-
positive neural progenitors, strongly suggests that neural progenitors are the cell type responsible
for Wnt morphogen expression inside our culture system.
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Figure 2.3: Effect of AraC on ES cell neuralization. RT-PCR mRNA analysis of control ES cells (cultured in
CDMM) and ES cells cultured in CDMM supplemented with 5 μM AraC, at Step-III plus 6 additional days of
culture. AraC treatment was performed during the last 2 days of culture before analysis. Figure shows mRNA
fold changes of the progenitor cell marker Nestin and the neuronal marker β-Tubulin-III as evaluated by RT-
PCR (normalized on maximum expression) at Step-III+6 days. Error bars: standard error. 
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A similar analysis was performed to investigate the expression of endogenous BMP factors. ES cells
showed  detectable  expression  levels  of  BMP2 and  BMP7,  and very high  expression  levels  of
BMP4 and BMP6 (Figure 2.5). Other BMP factors were expressed at very low levels or were not
expressed  at  all  (data  not  shown).  BMP4  expression  was  high  in  undifferentiated  ES  cells,
consistently with previous findings (Silva et al., 2008), and its expression peaked again during Step-
II. BMP2, BMP6 and BMP7 showed high levels of expression at Step-II and at Step-III. 
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Figure 2.4: Effect of AraC on Wnt expression. RT-PCR mRNA analysis of Wnt factors in control ES cells and ES
cells treated with 5 μM AraC, at  Step-III plus 6 additional days of culture. The expression of all Wnt factors
analyzed, with the only exception of Wnt4, was significantly decreased after neural progenitors removal by AraC
treatment. Error bars: standard error.






















Figure  2.5:  Analysis of BMP factors during ES cell neuralization. RT-PCR mRNA analysis of BMP factors in
expanding (undifferentiated) ES cells, or in ES cells at the end of Step-I (Step-I), at mid-Step-II (Step-II day2), at
the end of Step-II (Step-II day4) and at the end of Step-III (Step-III). BMP4 and BMP6 are strongly expressed at the
end of  Step-II. Error bars: standard error.
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Again, AraC treatment allowed us to test if endogenous BMP morphogens were produced mainly by
neural progenitors or by differentiated neurons. RT-PCR analysis  showed that the expression of
BMP4 and BMP6 was significantly decreased after neural progenitors removal by AraC treatment.
This suggested that neural progenitors were the major responsible for the expression and production
of BMP4 and BMP6. On the contrary, BMP2 and BMP7 appeared to be expressed at similar levels
by both neural progenitors and neurons (Figure 2.6).
FGF factors were expressed at different time points in our neuronal differentiation culture (Figure
2.7). FGF4 expression was higher in undifferentiated ES cells, consistently with its role in ES cells
self-renewal  and  lineage  commitment  (Silva  et  al.,  2008).  FGF5  appeared  at  Step-I,  during
embryoid bodies formation. This is not surprising, as FGF5 is considered a bona fide marker of the
embryonic epiblast, an early tissue type derived from the inner cell mass in mammalian blastocyst.
The only FGF morphogens expressed at detectable levels at  Step-II and  Step-III were FGF8 and
FGF15,  whose  expression  increased  gradually  during  Step-II (ES  cell  neuralization).  FGF8
expression then decreased, while FGF15 expression continued to increase.
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Figure 2.6: Effect of AraC on BMP expression. RT-PCR mRNA analysis of BMP factors in control ES cells and
ES cells treated with 5 μM AraC, at Step-III plus 6 additional days of culture. Error bars: standard error.
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AraC treatment showed that FGF factors expressed during Step-II and Step-III (FGF8 and FGF15),
were produced mainly by neural progenitors (Figure 2.8).
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Figure  2.7: Analysis of FGF factors during ES cell neuralization. RT-PCR mRNA analysis of FGF factors in
expanding (undifferentiated) ES cells, or in ES cells at the end of Step-I (Step-I), at mid-Step-II (Step-II day2), at
the  end  of  Step-II  (Step-II  day4)  and  at  the  end  of  Step-III  (Step-III).  FGF4  was  strongly  expressed  in
undifferentiated ES cells, while the epiblast marker FGF5 peaked at Step-I and then was down-regulated. FGF8
and FGF15 were the only detectable FGF factor at Step-II and at Step-III. Error bars: standard error.

























Figure 2.8: Effect of AraC on FGF expression. RT-PCR mRNA analysis of FGF factors in control ES cells and ES
cells treated with 5 μM Aracytin, at Step-III plus 6 additional days of culture. The expression of FGF8 and that of
FGF15 were significantly decreased after neural progenitors removal by AraC treatment. Error bars: standard
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We then measured the expression of TGF-β and Activin/Nodal family of morphogens (Figure 2.9).
Nodal and Activin-A were expressed, even if at very low levels, by undifferentiated ES cells, while
TGF-β2 and TGF-β3 were expressed by differentiating cells. Notably, the expression level of these
molecules is quite low.  Figure 2.9 shows normalization over  β-Actin; Activin/Nodal and TGF-β
mRNA level  was  never  higher  than  0.0025,  which  was  from 10-fold  to  20-fold  lower  when
compared to BMP, Wnt and FGF expression levels showed before.
AraC treatment showed that  TGF-β2 and TGF-β3  were produced mainly by neural  progenitors
(Figure 2.10). Activin/Nodal factors were not detectable at Step-III+6 days.
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Figure 2.9: Analysis of TGF-β and Activin/Nodal factors during ES cell neuralization. RT-PCR mRNA analysis
of FGF factors in expanding (undifferentiated) ES cells, or in ES cells at the end of Step-I (Step-I), at mid-Step-II
(Step-II day2), at the end of Step-II (Step-II day4) and at the end of Step-III (Step-III). Activin/Nodal factors were
only expressed in undifferentiated ES cells. However, their expression level was quite low. Error bars: standard
error.
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Finally, we concluded our analysis by measuring the expression of Shh, which was expressed, even
if at very low levels, by differentiating ES cells (Figure 2.11). Neural progenitors removal by AraC
treatment showed that Shh was produced mainly by neural progenitors (Figure 2.11).
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Figure 2.11: Analysis of Shh during ES cell neuralization. RT-PCR mRNA analysis of FGF factors in expanding
(undifferentiated) ES cells, or in ES cells at the end of Step-I (Step-I), at mid-Step-II (Step-II day2), at the end of
Step-II (Step-II day4) and at the end of Step-III (Step-III). Shh was expressed by neural progenitors, starting at the
end of  Step-II.  Shh expression level  was quite  low,  never  higher than 0.0025 when normalized over  β-Actin
expression. Error bars: standard error.
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Figure 2.10: Effect of AraC on TGF-β and Activin/Nodal expression. RT-PCR mRNA analysis of FGF factors in
control ES cells and ES cells treated with 5 μM AraC, at Step-III plus 6 additional days of culture. Error bars:
standard error.
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Taken all together, these data suggest that mouse ES cells express different morphogens during
neural differentiation in vitro, especially BMPs, Wnts and FGFs. Thus, the concept of chemically
defined minimal medium must be carefully addressed:  Even when using a  morphogen-free culture
medium,  differentiating  cells  could  be  expressing  themselves  high  amounts  of  different  active
molecules.  These  morphogens  could  act  in  an  autocrine  or  paracrine  way,  affecting  ES  cells
differentiation and positional identity acquisition.
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3− A BMP Story
Simple Neural Induction or Brain Patterning?
ES cells cultured in the absence of any added morphogen efficiently differentiate into neuronal cells
(Results,  Chapter 1).  Even when differentiated in a chemically defined,  morphogen-free culture
medium, mouse ES cells expressed themselves different morphogens during neural differentiation
in vitro, especially BMPs and Wnts. These morphogens could act in an autocrine or paracrine way,
affecting ES cell  differentiation and positional  identity acquisition.  We therefore asked whether
endogenously produced BMP could affect ES cell neuralization and/or the regional identity of ES
cell-generated neurons. 
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Effects of Noggin as a Neural Inducer in ES Cells Culture.
The ability of the BMP-antagonist Noggin to support neuronal differentiation of ES cells has been
reported in different in vitro differentiation protocols (Chiba et al., 2005; Gratsch & O'Shea, 2002;
McNeish et al., 2010). We thus decided to start  our study by testing the well  known ability of
Noggin to function as a neural inducer also in our culture condition. Consistently, we found that
adding increasing doses of Noggin (5 nM to 400 nM) to  CDMM during Step-II  supported the
expression of the  pan-neuronal markers Ncam and Pax6, as  compared to cells grown in CDMM
without Noggin (Figure 3.1A). 
At the end of Step-III, ES cells treated with Noggin during Step-II slightly increased the expression
of  Doublecortin (Dcx, a general neuroblast marker;  Knoth et al., 2010) and of acetylated-Tubulin
(Ntub, pan-neuronal marker) compared to ES cells cultured in CDMM (Ctrl; Figure 3.1B,C).
Notably, Noggin did not significantly affect pan-neuronal markers expression when added at Step-I
or III, as evaluated by RT-PCR (Figure 3.2), except Ncam, that was induced by treatment at Step-
III.
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Figure 3.1: Effects of Noggin as a neural inducer on ES cell differentiation. (A): RT-PCR mRNA quantification
of pan-neuronal markers Ncam and Pax6 in expanding (undifferentiated) ES cells and ES cells at the end of Step-
III after differentiation in CDMM (0) or in CDMM+5–400 nM Noggin (expression normalized on undifferentiated
ES cells). Error bars show standard error. (B), (C): Doublecortin (Dcx, red) and acetylated-Tubulin (Ntub, green)
immunocytodetection of  ES cells  at  the end of  Step-III  after  differentiation in CDMM (Ctrl,  B)  or  in  CDMM
containing 150 nM Noggin (C). ESCs: ES cells.
Ntub  Dcx  DAPI Ntub  Dcx  DAPI
Ctrl Step-III Noggin Step-III
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We directly compared the neural  inducing activity of Noggin to SCM (differentiation in Serum
Containing Medium, see Results, Chapter 1) and CDMM (differentiation in Chemically Defined
Minimal Medium) conditions, as percentage of neural progenitors generated by ES cells. We took
advantage of a Sox1-GFP knock-in ES cell line (46C, Ying et al., 2003), analyzing GFP expression
by flow cytometry. This analysis showed that CDMM culture condition induced a massive increase
of Sox1-GFP positive neural progenitors at mid-Step-II (day2; 68.2%) compared to SCM condition
(14.4%), whereas Noggin (400 nM) induced a modest, although significant, increase compared to
CDMM (78.1%; Figure 3.3). A similar trend was observed also at early-Step-II (end of day 1;
SCM, 6.4%; CDMM, 27.9%; Noggin, 31.1%; not shown). 
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Figure 3.2: Effects of Noggin as a neural inducer on ES cell differentiation. RT-PCR mRNA quantification (B) of
pan-neuronal markers Ncam, β-Tubulin-III and Nestin in ES cells at the end of Step-III after differentiation in
CDMM or in CDMM+15 nM Noggin applied during different temporal windows as indicated in (A). Expression
was  normalized  on  CDMM  condition.  Neural  markers  expression  was  higher  when  Noggin  treatment  was
performed at Step-II. Error bars show standard error. **p < 0.01, (Student’s t test).
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Ratios of Sox1-GFP positive neural progenitors obtained in the different culture conditions  was
consistent with a differential expression of the key transcription factor of neural commitment
Zfp521, whose expression was highest in cultures with Noggin (400 nM; Figure 3.4). 
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Figure  3.3:  Flow-cytometry  analysis  of  Sox1-GFP ES  cells  at  day2  of  Step-II  after  culture  in  different
conditions. SCM: ES cells were aggregated (Step-I) in serum-containing medium and differentiated (2 days, Step-
II) without serum. CDMM: both ES cell aggregation (Step-I) and differentiation (2 days, Step-II) were carried out
without serum.  CDMM+Nog 400 nM: as CDMM condition, plus Noggin treatment during the first two days of
Step-II. Error bars show standard error; *** p < 0.001 (two-tailed Student’s t test).
Sox1-GFP FACS analysis at mid-Step-II
Figure  3.4: RT-PCR mRNA quantification (ratio over  β-Actin) of Zfp521 at  different time points and after
culture in different conditions, as indicated; treatments with Noggin (400 nM), BMP4 (50 ng/ml), RA (10 nM) and
serum (10%) were performed at Step-II. Error bars show standard error; *** p < 0.001 (two-tailed Student’s t
test).
mid-Step-IIStep-I
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We concluded that the majority of ES cells cultured in CDMM become neural progenitors at Step-II
and established CDMM culture condition as control for subsequent investigations on BMP
inhibition. We also demonstrated that Noggin can further increase neuronal differentiation of ES
cells in our in vitro differentiation protocol, as it does in many differentiation protocols already
available in the scientific literature.
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CDMM-Differentiating ES Cells Produce and Respond to BMPs.
As Noggin affects ES cell neuralization, but BMPs were not added to culture medium, we assayed
for the presence of BMPs that were endogenously produced by ES cells during differentiation. As
described in Results, Chapter 2, ES cells showed detectable expression levels of BMP2 and BMP7,
and very high expression levels of  BMP4 and BMP6, during neural differentiation. We focused our
attention on BMP factors that can efficiently be sequestered by Noggin: BMP2 and BMP4; BMP7
can also be sequestered by Noggin, but with lower affinity. We analyzed their mRNA expression
levels in proliferating ES cells, in CDMM-differentiating ES cells (during Step-II), in cells that
express high BMP levels (primary mouse mesenchymal stromal cells, MSCs) or in cells that express
low BMP2/4 levels (macrophage cell line RAW 264.7; Ralph & Nakoinz, 1977). 
We found that both undifferentiated and differentiating ES cells express high BMP2, BMP4 (Figure
3.5) and BMP7 levels (see Results, Chapter 2; and data not shown). Notably, ES cells transcribe
BMP2/4/7 also  at  Step-II,  when  Noggin addition  to CDMM exerts its effect on neuronal
differentiation. 
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Figure  3.5:  Endogenous  BMP  production  during  ES  cell  differentiation  in  CDMM. RT-PCR  mRNA
quantification (ratio over β-Actin) of BMP2 and BMP4 in expanding ES cells (undifferentiated), in ES cells at the
end of the second and fourth day of Step-II, in expanding RAW 264.7 cell line (RAW) and in mouse mesenchymal
stromal cells (MSCs, passage 3). Error bars: standard error.
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Moreover, ELISA showed that CDMM-differentiating ES cells secrete approximately 50% of the
BMP2 protein secreted by MSCs, but almost ten times more than the amount secreted by RAW cells
(Figure 3.6).
We found that CDMM-differentiating ES cells during Step-II express functional BMP receptors. In
fact, ES cells at Step-II expressed higher levels of BMPR1a-b mRNA than MSCs, which depend on
the binding of BMP2/4 to BMPR1a-b receptors for osteoblastogenesis (Abe et al., 2000) (Figure
3.7). 
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Figure  3.6: Secreted BMP2 quantification by ELISA in
expanding  ES  cells  (undifferentiated  ESCs),  ES  cells  at
mid-Step-II, ES cells at the end of Step-II, expanding RAW
264.7 cell  line (RAW)  and mouse mesenchymal  stromal
cells (MSCs). Error bars: standard error. * p < 0.05, ***
p < 0.001 (two-tailed Student’s t test).
Figure 3.7:  BMP  receptor  expression  in  differentiating  ES  cells. RT-PCR  analysis  shows  mRNA  relative
expression of BMP receptors 1A and 1B in ES cells at different steps of differentiation, MSC and RAW cells (ratio
over β-Actin). Error bars: standard error. Naive: undifferentiated ES cells.
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Interestingly,  Noggin decreased the expression of ID1, a downstream effector of the BMP-
responsive pathway (Hollnagel et al., 1999) in a dose-dependent manner (Figure 3.8). This is in
line with the ability of Noggin to block the BMP-responsive pathway in ES cells.
To test if endogenously produced BMPs were active on cultured cells, we further investigated the
activation  of  intracellular  transduction  pathway  in  response  to  BMP  signaling by analyzing
SMAD1/5/8 phosphorylation (phospho-SMAD,  Figure 3.9A-F).  Undifferentiated ES cells  were
used as a positive control (Figure 3.9D). Most nuclei of both undifferentiated ES cells and ES cells
at Step-II in different conditions showed phospho-SMAD immunostaining, with different degrees of
intensity.  Figure 3.9E shows the distribution of the immunostaining intensity, while  Figure 3.9F
reports the mean immunostaining intensity.  We found that control CDMM-differentiating ES cells
show intermediate levels of the phosphorylated form of SMAD1/5/8 during Step-II, as compared to
ES cells in other culture conditions (Figure 3.9A,F). This confirms the presence of an endogenous
BMP production and activity. Acute 5-hr treatment with Noggin (400 nM) or BMP4 (50 ng/ml)
during Step-II  significantly decreased or increased SMAD phosphorylation, respectively (Figure
3.9B-E). The pattern of phospho-SMAD immunodetection showed that virtually all cells responded
to BMP4 addition (Figure 3.9C).
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Figure 3.8: BMP signaling in differentiating ES cells. (A) shows BMP signaling pathway. Noggin, BMPR1A-Fc
and chemical drugs affecting signal transduction are indicated. RT-PCR in (B) shows the effects of Noggin and
Dorsomorphin on ID1 mRNA expression (normalized on CDMM). Error bars: standard error.
A B
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Consistently, BMP4 added exogenously to CDMM throughout Step-II (50 ng/ml), dramatically
repressed the expression of the pan-neuronal markers Nestin, NFL, β-Tubulin-III and Pax6, (Figure
3.10), thus confirming the ability of ES cells to specifically respond to BMP signaling during Step-
II. 
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Figure 3.9: Endogenous BMP production and BMP activity during ES cell differentiation in CDMM.  (A)-(C):
Ntub  (green)  and  phospho-SMAD1/5/8  immunocytodetection  (nuclear  red  staining  over  DAPI  nuclear
counterstaining) in ES cells at Step-II (day2) in CDMM (A), 5 h after the addition of 400 nM Noggin to CDMM (B)
and 5 h after the addition of 50 ng/ml BMP4 to CDMM (C). (D), Phospho-SMAD1/5/8 immunocytodetection (red
staining  over  DAPI)  in  undifferentiated  ES  cells  (undiff.  ESCs).  Scale  bars  30  um.  (E),  (F):  Pixel  intensity
distribution (fraction of nuclei with given pixel intensity (E) and mean pixel intensity (F) of immunodetection in
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Our data thus show that ES cells produce and are sensitive to BMPs during neuronal differentiation
in vitro.
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Figure  3.10: BMP signaling in differentiating ES cells.
Bars indicate mRNA relative expression of neural marker
(Nestin)  and  pan-neuronal  markers  (NFL,  β-Tubulin-III,
Ncam, Pax6) in undifferentiated ES cells (undiff. ESCs), in
ES cells at Step-III after differentiation in CDMM, or after
treatment  throughout  Step-II  with  50  ng/ml  BMP4
(normalized on expanding ES cells). Error bars: standard
error.
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In the Absence of Exogenous Signals, ES Cells Generate Neurons Expressing Midbrain
Dorsal Markers.
In  order  to  investigate  the  effect  of  endogenous  BMPs  on  ES  cell  positional  identity,  we
characterized our control culture (ES cell differentiated in CDMM), by analyzing the expression of
FoxG1 (Xuan et al., 1995), Wnt7b (Parr et al., 1993), Six3 (Oliver et al., 1995), Otx2 (Acampora et
al., 1998) and En1 (Wurst et al., 1994) genes at the end of Step-III. These genes display an ordered
(A/P) expression that covers the most anterior aspect of forebrain (FoxG1, Emx2), entire forebrain
(Six3), forebrain/midbrain (Otx2) and midbrain (En1). We also analyzed the expression of HoxB4
(Ramirez-Solis et al., 1993) and HoxB9 (Chen & Capecchi, 1997), which mark hindbrain and spinal
cord, respectively (Figure 3.11A). 
We compared the mRNA levels of these genes in CDMM-differentiated ES cells to the mRNA
levels  found in cortex (rostral-dorsal forebrain), mesencephalon (midbrain), rombencephalon
(hindbrain), spinal cord of embryonic day16 (E16) mouse and undifferentiated ES cells. Compared
to mouse brain, CDMM-differentiated  ES cells expressed very high levels of Otx2 and En1, low
levels of Wnt7b and Six3, and very low levels of both telencephalic (FoxG1) and posterior markers
(HoxB4 and HoxB9) (Figure 3.11B).
As ES cells cultured in CDMM failed to express high levels of hindbrain/spinal cord specific genes,
we wanted to assay for their ability to turn on these genes upon induction with the posteriorizing
factor RA. As expected, ES cells treated with RA during Step-II, and analyzed at the end of Step-III,
turned on the posterior markers HoxB4 and HoxB9 and down-regulated the anterior markers
FoxG1, Six3 and Otx2 in a dose-dependent fashion (Figure 3.12). 
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Figure 3.12:  A/P characterization of differentiating ES cells. A/P (color code) patterning of mouse embryonic
brain, identifying the regions of gene expression. Values indicate mRNA expression fold changes in ES cells at the
end of Step-III after exposure to different RA concentration throughout Step-II, as evaluated by RT-PCR (expression
normalized on control, Ctrl CDMM). This indicates that, in our protocol, RA treatment is able to posteriorize the
neural progenitor fate, switching-on the expression of specific Hox genes in a dose-dependent manner.
Figure  3.11:  Regional identity of ES cells differentiated in CDMM. (A): A/P (color code) and D/V (white-cyan
code) patterning of mouse embryo as identified by the expression of key patterning genes, elaborated from EMAP
(http://www.emouseatlas.org; see Materials and Methods) and articles cited in text. Fb forebrain, Mb midbrain, Hb
hindbrain, SC spinal cord, Te telencephalon, Di diencephalon, Met metencephalon, My myelencephalon. (B) shows
mRNA relative expression of A/P genes (as evaluated by RT-PCR, normalized on maximum expression) in brain
tissues of E16 embryos, undifferentiated ES cells (undiff. ESCs) and ES cells at the end of Step-III (Step-III ESCs).
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We then  analyzed the dorso-ventral (D/V) identity of ES cell-generated neural progenitors at the
end of Step-II by comparing the relative ratios of cells expressing the dorsal marker Pax6 (Stoykova
& Gruss, 1994) or the ventral marker Nkx2.1 (Pera & Kessel, 1997). A large fraction (53.1±7.6%)
of control CDMM ES cells expressed Pax6 protein and virtually no cells expressed Nkx2.1 protein
(Figure 3.13A,B). As the Pax6/Nkx2.1 D/V gradient is generated in response to a gradient of Sonic
Hedgehog (Shh) activity  (Briscoe et  al.,  2000), we assayed the effects  of a Shh agonist  (SAG,
DeCamp et al., 2000) or of a Shh antagonist (Cyclopamine; Taipale et al., 2000) on ES cells. Drugs
were added to CDMM throughout Step-II. SAG treatment dramatically repressed Pax6 (3.9±1.1%)
and  activated  Nkx2.1  protein  expression  in  a  very  large  fraction  of  cells  (79±2.9%),  whereas
Cyclopamine affected neither Pax6 nor Nkx2.1 (Figure 3.13A,B). The experiment showed how ES
cells spontaneously differentiate into Pax6-positive neural progenitors with our protocol. D/V fate
could be efficiently manipulated by SAG treatment  during Step-II.  RT-PCR analysis  confirmed
these results (Figure 3.14). 
Notably, the lack of any effect of Cyclopamine is consistent with the observation that Step-II ES
cells produced very low level of endogenous Shh (Figure 3.15).
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Figure  3.13:  D/V characterization of  differentiating ES cells.  (A), Immunocytodetection of  Pax6 and Nkx2.1
(nuclear  red  staining  over  DAPI  nuclear  counterstaining)  at  the  end  of  Step-II  in  ES  cells  differentiated  as
indicated. Values in (B) show fractions of Pax6-positive cells (light gray bars) and Nkx2.1-positive cells (dark gray
bars), in ES cells differentiated as in (A). D/V fate could be efficiently manipulated by SAG treatment during Step-
II. Cyc: cyclopamine.  Error bars: standard error. 
Pax6  DAPI Pax6  DAPI Pax6  DAPI
Nkx2.1  DAPI Nkx2.1  DAPI Nkx2.1  DAPI
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These data suggest  that in our protocol of differentiation ES cells mostly adopt a midbrain dorsal
identity when cultured in CDMM.  However, the protocol is plastic enough to respond to treatments
with morphogens, and differentiating cells can modulate the expression of A/P and D/V markers
accordingly to treatments.
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Figure  3.14:  D/V characterization of differentiating ES
cells. Graph shows V/D index, calculated as Nkx2.1/Pax6
mRNA ratio measured by RT-PCR at different time points
and  in  different  culture  conditions  or  brain  regions,  as
indicated  (expression  normalized  on  ventral  forebrain
level). The high variability of Nkx2.1/Pax6 mRNA ratio in
undifferentiated ES cells is  due to the very low levels of
expression  of  Nkx2.1  and  Pax6  mRNA  in  these  cells.
Undiff. ESCs: undifferentiated ES cells.
Figure  3.15:  D/V characterization of  differentiating ES cells. Graph shows RT-PCR analysis of  Shh relative
expression in ES cells at different times of differentiation and in different culture conditions, as indicated (ratio over
β-Actin).  Undiff. ESCs: undifferentiated ES cells;  Noggin: Noggin 400 nM;  SAG: Shh agonist (100 nM);  Cyc:
Cyclopamine 10 µM. Error bars: standard error.
CDMM Noggin CDMM Noggin SAG Cyc SAG+Cyc
Step-II day4 Step-III
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BMP Inhibition During Differentiation Supports the Expression of Telencephalic
Markers.
Our  in  vitro differentiation  protocol  allows  efficient  neural  conversion  of  ES cells,  originating
neural progenitors that predominantly show a midbrain/dorsal identity. BMP factors are produced
endogenously by differentiating cells, and BMP inhibition by Noggin treatment can further increase
neuronal differentiation of ES cells in our culture system.
We subsequently investigated  if endogenously produced BMPs can  affect not only neuralization,
but  also the regional identity of ES  cell-generated  neurons. To  this  purpose,  we  analyzed  the
expression of specific A/P markers after treatment with Noggin. Compared to control, the treatment
with  increasing doses of Noggin (5 to 400 nM) during Step-II induced the telencephalic  marker
FoxG1 and repressed the more posterior markers  Otx2 and En1 in a dose-dependent manner, as
evaluated at the end of Step-III (Figure 3.16). 
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Figure 3.16: Effects of BMP inhibition on the expression of A/P patterning genes. A/P (color code) patterning of
mouse embryonic brain by FoxG1, Otx2 and En1. Fb forebrain,  Mb midbrain,  Hb hindbrain,  SC spinal cord.
Graph shows RT-PCR mRNA quantification of  FoxG1,  Otx2 and En1 in ES cells  at  the  end of  Step-III  after
differentiation in CDMM (0) or in CDMM+5–400 nM Noggin (normalized on maximum expression). Error bars:
standard error.
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Moreover, Noggin induced the expression of  Wnt7b (a forebrain marker; Parr et al., 1993), Six3
(prosencephalic marker), Emx2 (early cortical marker; A. Simeone et al., 1992), Tbr1 and α-CamK-
II (late cortical markers; Bulfone et al., 1995; Kinney et al., 2006; Figure 3.17A), and repressed the
expression of the posterior marker Irx3, which is present in caudal diencephalon, midbrain and
more  posterior  regions  (Bosse  et  al.,  1997;  Figure  3.17B).  Noggin  was  ineffective  on  the
hindbrain/spinal cord markers Gbx2, HoxB4 and HoxB9, leaving their low expression levels almost
unchanged (Figure 3.17B).
The same positional markers were analyzed at earlier or later times of differentiation (end of Step-II
or Step-III+4 days, respectively;  Figure 3.18). As similar results were obtained, we excluded the
possibility  that  the  effect  of  Noggin  on  positional  identity  may  be  the  result  of  an
enhancement/acceleration  in  neural  fate  induction.  On  the  contrary,  we  concluded  that
differentiating  ES  cells  acquire  a  specific  A/P fate  after  treatments  with  morphogens  (always
performed  at  Step-II)  and maintain  their  identity  along  the  differentiation,  without  losing  their
positional memory.
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Figure  3.17: Effects of BMP inhibition on the expression of A/P patterning genes . (A), (B): RT-PCR mRNA
quantification of forebrain/ cortical markers (A) or hindbrain/spinal cord markers (B), in cells as in Figure 3.16
(ratio over β-Actin). Error bars: standard error.
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To confirm the specificity of action of Noggin, we used the chimeric protein BMPR1A-Fc, a BMP
inhibitor that binds to a BMP epitope outside the region recognized by Noggin (Keller et al., 2004;
Figure 3.19) and Dorsomorphin, a selective inhibitor of the BMP type I receptors ALK2, ALK3 and
ALK6 that blocks BMP-mediated SMAD1/5/8 phosphorylation (Yu et al., 2008; Figure 3.8A). 
175
Figure  3.18: Temporal analysis of BMP effects in differentiating ES cells.  (A):  Graph shows RT-PCR mRNA
quantification of FoxG1, Otx2 and En1 in ES cells at early stage (end of Step-II) after differentiation in CDMM ( 0)
or in CDMM+5-400 nM Noggin (normalized on maximum expression). (B),(C): RT-PCR mRNA quantification of
forebrain/cortical markers (B), normalized on maximum expression) or hindbrain/spinal cord markers (C, ratio
over β-Actin), in cells as in (A). At the end of Step-II, differentiating cells have already acquired a specific pattern
of  A/P  markers  expression,  even  if  with  a  lower  dynamic  range.  (D),  RT-PCR  mRNA  quantification  of
forebrain/cortical markers (blue colors) and mesencephalic markers (orange colors) in ES cells at the end of Step-
III  and  at  a  late  stage  of  differentiation  (Step-III+4  days),  after  differentiation  in  CDMM  (Control)  or  in
CDMM+150 nM Noggin (normalized on maximum expression). The cell identity established by treatments with
morphogens at Step-II is maintained and even reinforced several days later. Error bars: standard error.
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
BMPR1A-Fc induced an increase of Sox1-GFP positive neural progenitors at mid-Step-II (day2;
77.6%; Figure 3.20) that is comparable to the increase induced by Noggin (78.1%; Figure 3.3). 
Dorsomorphin or BMPR1A-Fc treatment during Step-II mimicked Noggin action also by inhibiting
ID1 expression (Figure 3.21A,B), by supporting FoxG1 expression and by repressing Otx2 and En1
(Figure 3.22A,B). 
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Figure  3.19:  BMPR1A-Fc  protein  structure. Protein  three-dimensional  structures  rendered  with  Pymol
(http://www.pymol.org/). Molecular coordinates of Noggin-BMP7 and BMPR1A-BMP2 complexes, as submitted by
Groppe et al., (2002) and Keller et al. (2004), were found in Protein Data Bank (http://www.pdb.org/).
Figure  3.20: BMPR1A-Fc protein mimes Noggin effect on ES cell neuralization. Flow-cytometry analysis of
Sox1-GFP ES cells at day2 of Step-II after culture in CDMM, or CDMM+37.5 nM BMPR1A-Fc.
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The specificity of BMPs in affecting ES cell differentiation fate is also suggested by the effects
exerted by treatment at Step-II with SB431542. While Dorsomorphin selectively inhibits the
BMP2/4 pathway, SB431542 suppresses the Activin/TGF-β receptors ALK4, ALK5 and ALK7 and
prevents BMP-independent, Activin/TGF-β mediated, SMAD2/3 phosphorylation (Figure  3.23;
Chambers et al., 2009). Compared to Noggin and Dorsomorphin, SB451243 acted by repressing,
rather than by inducing, FoxG1, slightly inhibited En1 and left Otx2 expression almost unchanged
(Figure 3.22A).
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Figure 3.21: Dorsomorphin and BMPR1A-Fc mimic Noggin effects on ES cell differentiation. RT-PCR in (A)
shows the effects of Noggin and Dorsomorphin on ID1 mRNA expression (normalized on CDMM). The chemical
drug mimes the effect  of  intermediate Noggin doses  on ID1 expression.  (B)  shows the effects of  BMPR1A-Fc
treatment on ID1 mRNA expression, as evaluated by RT-PCR analysis (normalized on CDMM).
BA
Figure 3.22: Dorsomorphin and BMPR1A-Fc mimic Noggin effects on ES cell differentiation.  Bars in (A) show
mRNA fold change of A/P patterning genes in ES cells at Step-III after differentiation in different culture conditions
(normalized on CDMM). Drugs were added throughout Step-II. (B) shows the effects of treatment during Step-II
with BMPR1A-Fc on FoxG1, Otx2 and En1 expression, as evaluated by RT-PCR at the end of Step-III. Error bars:
standard error.
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Our results indicate that the inhibition of endogenously produced BMPs alters the A/P positional
identity of the ES cell-generated neurons. BMP-inhibition induces a mixed population of neural
progenitor cells and differentiated neurons expressing cortical markers.
We further investigated the nature of cells generated by Noggin-treated ES cells. At the end of Step-
II  we found 79.2% Nestin-positive neural  progenitors in  CDMM-differentiating ES cells,  while
Noggin treatment  (150 nM) increased this  ratio to 90.5%.  Notably,  of  the  Nestin-positive
progenitors in CDMM cultures only 1.2% were positive for FoxG1, which labels telencephalic
neuronal progenitors (Regad et al., 2007), while Noggin treatment (150 nM) increased this ratio to
18.2% (Figure 3.24A-C). 
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Figure  3.23:  TGF-β  family  pathways. Noggin,
BMPR1A-Fc and chemical  drugs affecting BMP and
TGF-β signal transduction are indicated.
Figure 3.24: Effects of BMP inhibition on ES cell neural conversion and cell fate acquisition.  (A)-(C): double
immunocytodetection of Nestin (green) and FoxG1 (red) at the end of Step-II in ES cells cultured in CDMM (A) or
in CDMM+Noggin (150 nM,  B). FoxG1-positive cells were always co-labeled by Nestin. Numbers in (C) show
ratios of Nestin positive cells among total cells (light blue bars), or ratios of FoxG1-positive cells among Nestin-
positive cells (red bars). This experiment suggests that Noggin treatment can anteriorize cell fate in a direct way,
rather than simply increasing neural conversion. Error bars: standard error.
Nestin  FoxG1 Nestin  FoxG1
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This implies that the removal of serum from our culture is per se sufficient to induce a high degree
of neuralization and therefore the majority of ES cells in CDMM become neural progenitors also in
the control condition (without Noggin). Noggin induced only a slight increase of neural progenitor
ratio compared to control (79.2% Nestin-positive neural progenitors in CDMM-differentiating ES
cells, 90.5% after Noggin treatment), while supporting a dramatic increase of cells expressing the
telencephalic marker FoxG1 (See Figure 3.24B). Although significant, the small increase in neural
progenitors induced by high doses of Noggin cannot explain the dramatic increase of telencephalic
cells,  and this  clearly demonstrates that BMP inhibition is necessary to acquire a telencephalic
identity. These results suggest a novel mechanism, whose molecular nature is still unknown, by
which BMPs endogenously  produced  by differentiating  ES  cells  directly act on the positional
identity of the neural progenitors they spontaneously generate in a minimal medium.
The ratio of β-Tubulin-III positive neurons in cultures treated with Noggin (400 nM) was slightly
higher than the ratio in control cultures at the end of Step-III (Figure 3.26A). In both conditions, the
majority of cells negative for β-Tubulin-III staining were Nestin-positive progenitors (not shown). 
To define the biochemical identity of differentiated neurons, we performed an immunocytodetection
experiment  exploiting  vGlut2  (glutamatergic  neurons)  and  GAD65  (GABAergic  neurons)
antibodies;  both  antibodies  were  tested  on  mouse  brain  slices  and  mouse  primary  cultures  of
neuronal cells. (See as an example GAD65 staining on neuronal primary cultures obtained from P0
striatum; Figure 3.25A). vGlut2 staining appeared with a punctate distribution along β-Tubulin-III-
positive axons and soma, consistently with a vesicular localization inside the cell (Figure 3.25B).
Both control and  Noggin-treated ES cells generated high ratios  of VGlut2-positive glutamatergic
neurons (Figure 3.26A,B),  whereas the ratios of GAD65-positive GABAergic neurons either in
control or in Noggin-treated ES cells were lower (Figure 3.26A,C). Noggin induced the expression
of a number of genes coding for the isoforms of receptors for many different neurotransmitters,
including GABA (Table 3); GABA receptors are strongly expressed on pyramidal cortical neurons
in vivo. 
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Figure 3.25: GAD65 and Vglut2 immunocytodetection. (A) shows immunocytodetection of β-Tubulin-III (green)
and GAD65 (red) on primary cultures obtained from a P0 mouse striatum after 5 days of culture in CDMM. (B)
shows  immunocytodetection of acetylated-Tubulin (green) and VGlut2 (red) at the end of Step-III in control ES
cells cultured in CDMM.
β-Tubulin-III   GAD65   DAPI Ntub  VGlut2
Mouse P0 Striatum CDMM ES CellsA B
Figure  3.26: Effects of BMP inhibition on ES cell neural conversion and cell biochemical identity.  (A)-(C):
VGlut2 (red in  B),  β-Tubulin-III (green in  C),  and GAD65 (red in  C) immunocytodetection and cell counts in
Noggin-treated ES cells at Step-III+4 days. Arrow in (C) indicates a β-Tubulin-III/GAD65 double positive cell.
Graph in (A) shows the ratios of cells positive for the markers in (B) and (C). Error bars: standard error; 
*p < 0.05, (two-tailed Student’s t test).
β-Tubulin-III   GAD65VGlut2   DAPI
β-Tubulin-III VGlut2/β-Tubulin-III Gad65/β-Tubulin-III
A B C
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Table 3
Adora1 4,15 Up NM_001008533
Adra2a 3,31 Up NM_007417
Adrb1 2,2 Up NM_007419
Chrnb2 2,11 Up NM_009602
Cnr1 3,13 Up NM_007726
Gabrg2 6,92 Up NM_008073
Gabra2 4,43 Up NM_008066
Gabrg2 4,08 Up AK049857
Gabra4 3,3 Up NM_010251
Gabra5 2,46 Up NM_176942
Gabra2 2,33 Up AK048165
Gabrb3 2,09 Up NM_008071
Gabrb1 2,03 Up NM_008069
Glra2 3,53 Up NM_183427
Grm1 6,51 Up NM_016976
Grm8 3,57 Up NM_008174
Grin3a 2,45 Up ENSMUST00000076674
Grik2 2,35 Up NM_010349
Grik1 2,25 Up NM_146072
Gria2 2,18 Up NM_013540
Grik4 2,1 Up NM_175481
Grid2 2 Up AK032669
Grin2c 2,9 Down NM_010350
Expression fold change of genes coding for the neuronal receptorial apparatus after Noggin treatment 
See Materials and Methods for details
GeneName FoldChange Regulation SystematicName Description
ref|Mus musculus adenosine A1 receptor (Adora1), transcript variant 1, mRNA [NM_001008533]
ref|Mus musculus adrenergic receptor, α 2a (Adra2a), mRNA [NM_007417]
ref|Mus musculus adrenergic receptor, β 1 (Adrb1), mRNA [NM_007419]
ref|Mus musculus cholinergic receptor, nicotinic, β polypeptide 2 (neuronal) (Chrnb2), mRNA [NM_009602]
ref|Mus musculus cannabinoid receptor 1 (brain) (Cnr1), mRNA [NM_007726]
ref|Mus musculus gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2 (Gabrg2), transcript variant 1, 
mRNA [NM_008073]
ref|Mus musculus gamma-aminobutyric acid (GABA-A) receptor, subunit α 2 (Gabra2), mRNA [NM_008066]
gb|Mus musculus adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630004C13 
product:gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2, full insert sequence. [AK049857]
ref|Mus musculus gamma-aminobutyric acid (GABA-A) receptor, subunit α 4 (Gabra4), mRNA [NM_010251]
ref|Mus musculus gamma-aminobutyric acid (GABA-A) receptor, subunit α 5 (Gabra5), mRNA [NM_176942]
gb|Mus musculus 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130038H23 
product:gamma-aminobutyric acid (GABA-A) receptor, subunit α 2, full insert sequence [AK048165]
ref|Mus musculus gamma-aminobutyric acid (GABA-A) receptor, subunit β 3 (Gabrb3), transcript variant 1, mRNA 
[NM_008071]
ref|Mus musculus gamma-aminobutyric acid (GABA-A) receptor, subunit β 1 (Gabrb1), mRNA [NM_008069]
ref|Mus musculus glycine receptor, α 2 subunit (Glra2), mRNA [NM_183427]
ref|Mus musculus glutamate receptor, metabotropic 1 (Grm1), transcript variant 1, mRNA [NM_016976]
ref|Mus musculus glutamate receptor, metabotropic 8 (Grm8), mRNA [NM_008174]
ens|glutamate receptor ionotropic, NMDA3A Gene [Source:MGI (curated);Acc:Grin3a-002] 
[ENSMUST00000076674]
ref|Mus musculus glutamate receptor, ionotropic, kainate 2 (β 2) (Grik2), transcript variant 2, mRNA [NM_010349]
ref|Mus musculus glutamate receptor, ionotropic, kainate 1 (Grik1), transcript variant 1, mRNA [NM_146072]
ref|Mus musculus glutamate receptor, ionotropic, AMPA2 (α 2) (Gria2), transcript variant 2, mRNA [NM_013540]
ref|Mus musculus glutamate receptor, ionotropic, kainate 4 (Grik4), mRNA [NM_175481]
gb|Mus musculus 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:6530411F08 
product:glutamate receptor, ionotropic, delta 2, full insert sequence. [AK032669]
ref|Mus musculus glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350]
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To investigate in detail the nature of cells generated by Noggin-treated ES cells, at the end of Step-
III  we  analyzed  at  the  cellular  level  the  expression  of  FoxG1,  which  marks  telencephalic
progenitors, and Tbr1, which expression specifically identifies a sub-set of cortical neurons (Cajal-
Retzius cells, subplate cells and glutamatergic neurons of the deep layers of the cerebral cortex;
Hevner et al., 2001; the antibody was tested on a P7 mouse brain slice as positive control). 
We decided to compare the expression of the two proteins in control cells and in cells differentiated
in the presence of  high  doses  of  Noggin (150 and 400 nM).  We  also  included  some  control
treatment: cells treated with the chemical compound Dorsomorphin (5 µM), cells ventralized with
Shh agonist  SAG (100 nM) and cells posteriorized by RA treatment (10 µM) during Step-II. We
found that, compared to control (Figure 3.27A,E), ES cells treated at Step-II with Noggin produced
a higher ratio of both FoxG1-positive (Figure 3.27B,D) and Tbr1-positive cells at Step-III (Figure
3.27F,H). 
182
Figure  3.27:  Effects  of  BMP inhibition  on  ES  cells  neural  conversion  and  cell  fate  acquisition.  (A)-(H):
Immunocytodetection of FoxG1 (red in A-D), Tbr1 (red in E-H) and acetylated-Tubulin (green in A-H) in ES cells
at the end of Step-III after differentiation in CDMM (Control; A,E), CDMM plus Noggin (400 nM; B,D,F,H) and
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Consistently, the expression of both proteins was induced by Dorsomorphin and repressed by RA
(Figure 3.27C,G and Figure 3.28). Ventralization induced by SAG inhibited Tbr1 expression and
left FoxG1 expression almost unchanged (Figure 3.28).
Notably, Noggin-induced expression of Tbr1, which marks earlier cortical neurons, was followed by
the activation of Satb2 (Figure 3.29), which labels late-generated cortical neurons of layers 2/3. To
obtain late-generated neurons, cells were cultured for a longer period (up to a total of 18 days); N2
medium used for Step-III was gradually replaced with N2B27 starting from Step-III+4 days, to
promote cell survival in long-term culture.
These results suggest that Noggin-treated ES cells follow a differentiation schedule similar to that
of in vivo cortical neurons (Figure 3.29B), as previously reported by another group studying  in
vitro cortical differentiation (Gaspard at al., 2008).
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Figure 3.28: Effects of BMP inhibition on ES cell neural conversion and cell fate acquisition.  Graph shows cell
ratios of  FoxG1-positive and Tbr1-positive cells from different culture conditions:  control  CDMM-cultured ES
cells,  ES cells treated with SAG, RA, Dorsomorphin, 150 nM or 400 nM Noggin. The experiment shows how
Noggin treatment  is  able to increase the ratio of  FoxG1-positive and Tbr1-positive cells  in a dose-dependent
manner. This effect is mimicked by Dorsomorphin; a completely opposite effect can be obtained by RA treatment.
Error bars: standard error; *p<0.05, **p<0.01 (two-tailed Student’s t test).
Step-III
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Recent reports showed how ES cells cultured in serum-containing medium are not homogeneous,
and consist of a mixed population of Oct4-positive and Nanog-positive naïve pluripotent stem cells
and  Oct4-positive  Nanog-negative  stem  cells,  this  latter  type  being  already  primed  for
differentiation  (Silva  et  al.,  2008).  The  authors  demonstrated  that  ES  cells  in  which  mitogen-
activated protein kinase signaling and glycogen synthase kinase-3 (GSK3) are double-inhibited are
homogeneous and pluripotent when cultured in a medium containing LIF but devoid of serum, and
consist in a pure population of both Oct4 and Nanog-positive naive pluripotent stem cells (2i ES
cells; Silva et al., 2008; Ying et al., 2008). 
We considered the possibility that Noggin acts by selecting cells committed to a cortical identity,
which might be already present in the heterogeneous situation of ES cell cultures maintained in
serum+LIF. We thus assayed the effect of Noggin on ES cells selected in the absence of signals that
might influence their differentiation potential; to this purpose we performed key experiments using
ES cells cultured in 2i medium as starting material (2i ES cells).
The effect of 2i culture was controlled by Oct4 and Nanog immunocytodetection (Figure 3.30). ES
cells cultured in 2i medium for three passages formed colonies of naïve pluripotent stem cells as
showed in Ying et al., 2008, characterized by a very strong signal for both nuclear proteins. The
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Figure 3.29: Effects of BMP inhibition on ES cell neural conversion and cell fate acquisition. (A) shows a group
of neurons almost all positive for Satb2 nuclear staining (red). (B) Numbers show the ratios of Tbr1 or Satb2
positive cells over time in 150 nM Noggin-treated ES cell cultures. Error bars: standard error.
β-Tubulin-III   Satb2
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effect of culture in 2i medium and the signal homogeneity of 2i cultured colonies (Figure 3.30) can
be  easily  appreciated  by  comparison  with  the  heterogeneous  situation  of  serum-cultured  cells
showed in Results, Chapter 1, Figure 1.2.
We started the analysis by comparing the neuralization potential of ES cells previously cultured in
serum+LIF (ES cells) to the potential of ES cells previously cultured in 2i+LIF (2i ES cells).  RT-
PCR mRNA quantification of neuronal markers (β-Tubulin-III, Ncam and NFL) and progenitor cell
marker (Nestin) during differentiation protocol, showed no significant difference in the expression
of these markers between ES cells and 2i ES cells, except for the expression of Ncam, which was
slightly lower at Step-III in 2i ES cells (64%) compared to ES cells (Figure 3.31A).
Flow-cytometry analysis of Sox1::GFP ES cells at different time points of the neuralization protocol
showed how Sox1-driven GFP is almost not expressed in undifferentiated 2i ES cells and expressed
at low levels in undifferentiated ES cells, it is activated earlier in 2i ES cells compared to ES cells
by the differentiation protocol and it is expressed at similar levels at the end of Step-II. This is
consistent with a higher homogeneity and a faster neuralization of 2i ES cells compared to ES cells
(Figure 3.31B). We concluded that in our protocol, 2i ES cells neuralization was slightly faster than
the neuralization of ES cells maintained in serum+LIF (Figure 3.31). 
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Figure 3.30: Oct4 and Nanog immunostaining on ES cells after 2i culture. Images show immunocytodetection of
Oct4 (green) and Nanog (red) on mouse ES cells after three passages (5/6 days) of culture in 2i culture medium.
Nuclei counter-staining has been obtained with DAPI (blue). After 2i selection, ES cells formed colonies of naïve
pluripotent stem cells, where virtually all cells were characterized by a very strong signal for both nuclear proteins.
Compare this staining distribution with the “salt and pepper” Nanog staining of ES cells cultured in serum+LIF
medium, showed in the Results, Chapter 1, Figure 1.2.
DAPI Oct4 Nanog
Undifferentiated ES cells colony
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However,  the expression  of  A/P and D/V markers  in  neural  cells  obtained by 2i  ES cells  was
comparable to the expression in neural cells obtained by ES cells cultured in serum (Figure 3.32). 
Immunocytodetection of Pax6 (Figure 3.32A,B) and Nkx2.1 (Figure 3.32C,D) at the end of Step-II
in 2i ES cells differentiated in  CDMM (control), in CDMM+SAG and in CDMM+Cyclopamine
resulted in fractions of Pax6-positive cells and Nkx2.1-positive cells very similar to those obtained
with ES cells cultured in serum (see Figure 3.13A,B).
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Figure  3.31:  Neural  induction  of  2i  ES  cell-derived  neural  cells. (A),  Histogram  shows  RT-PCR  mRNA
quantification of  neuronal markers (β-Tubulin-III,  Ncam and NFL) and progenitor cell marker (Nestin) during
differentiation protocol, comparing the potential of ES cells previously cultured in serum+LIF (ES cells) to the
potential of ES cells previously cultured in 2i+LIF (2i ES cells). (B), Flow-cytometry analysis of Sox1::GFP ES
cells at different time points of the neuralization protocol, as indicated. ES cells cultured in serum+LIF (ES cells,
blue bars) are compared to ES cells cultured in 2i+LIF (2i ES cells, red bars). Error bars: standard error.
Figure 3.32: D/V identity of 2i ES cell-derived neural cells. A-C, immunocytodetection of Pax6 (A,B) and Nkx2.1
(C,D) at the end of Step-II in 2i ES cells differentiated in CDMM (control, Ctrl, A and C) or in CDMM+SAG (B,D).
Numbers in (E) show fractions of Pax6-positive cells (light grey bars) and Nkx2.1-positive cells (dark grey bars), in
2i ES cells differentiated in CDMM, CDMM+SAG and CDMM+Cyclopamine (Cyc). These results are consistent
with the results obtained with ES cells cultured in serum containing medium. Error bars: standard error.
Pax6 Pax6 Nkx2.1 Nkx2.1
Ctrl CtrlSAG SAG
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Concerning  A/P patterning,  we  evaluated  the  expression  of  forebrain/cortical  markers  (FoxG1,
Wnt7b, Emx2, Tbr1, CamKII, Six3 and Pax6) or of more posterior markers (En1, Irx3 and Otx2) by
RT-PCR at the end of Step-II, after differentiation of 2i ES cells in CDMM (Control) or in CDMM
plus 150 nM Noggin (Figure 3.33). We basically obtained the same results previously observed
using ES cells cultured in serum.
Moving at a protein level, cell percentages of FoxG1-positive and Tbr1-positive cells at the end of
Step-III, from control CDMM cells and cells differentiated with 150nM Noggin, were similar to
previous experiments (Figure 3.34).
For this reason, we can exclude that our results might be influenced by some heterogeneity of the
starting ES cell population due to culture and amplification in serum-containing medium.
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Figure  3.33: A/P identity of 2i  ES cell-derived neural cells. (A) shows FoxG1, En1 and Otx2 expression, as
evaluated by RT-PCR at the end of Step-II (normalized on maximum expression), after differentiation of 2i ES cells
in  CDMM  (Control)  or  in  CDMM+150  nM  Noggin.  (B),  histogram  shows  RT-PCR mRNA quantification  of
forebrain/cortical markers (blue colors) or more posterior marker Irx3 (orange color), in cells as in (A) at the end
of Step-III. Values are normalized on maximum expression. Error bars: standard error.
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Going back to serum-cultured ES cells, we decided to characterize the identity of Noggin-treated
cells in more detail by comparing their global gene expression profiles to the profiles of ES cells
differentiated in other culture conditions, or to the profiles of embryonic brain regions. To this
purpose, we performed microarray hybridization (see Materials and Methods). 
As RA is a potent inducer of neuronal differentiation (Guan et al., 2001), we compared its action to
that of Noggin on ES cell differentiation. We  analyzed gene expression profiles using Gene Set
Enrichment Analysis (GSEA). GSEA is a computational method which allows to identify, within
predefined groups of genes (gene sets associated with particular cellular functions) whether a
significant enrichment of regulated genes occurs when comparing two conditions (Subramanian et
al., 2005).  Figure  3.35 shows gene ontology categories implicated in neuronal
function/differentiation and cell cycle control. The color heat map displays gene set enrichment
scores for Noggin-treated (400 nM) versus control ES cells (first column) and for RA-treated (10
µM) versus control ES cells (second column). Comparing Noggin to RA reveals that both molecules
induce highly concordant effects, as seen by the up-regulation of gene sets associated to neuronal
differentiation and by  the  repression of gene sets related to cell proliferation and cell cycle
progression.
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Figure  3.34:  Figure 34.  A/P identity  of  2i  ES cell-derived neural  cells. Graph
shows the cell percentages of FoxG1-positive and Tbr1-positive cells at the end of
Step-III, from culture conditions as in Figure 3.33. Error bars: standard error.
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We then investigated the effect of Noggin on positional identity. Noggin induced the expression of a
number of dorsal-telencephalic markers and left almost unchanged the expression of intermediate-
lateral or ventro-basal markers. This was evaluated by comparing the mRNA expression profile of
ES cells treated with Noggin (400 nM) to that of control (CDMM-differentiating ES cells; Figure
3.36). 
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Figure  3.35:  Gene expression profiling of  differentiated ES cells. Gene Set  Enrichment  Analysis of  400 nM
Noggin-treated versus control ES cells (Nog/ CDMM, first column) and 10 µM RA-treated versus control ES cells
(RA/CDMM, second column),  filtered for neuronal function/differentiation and control  of cell  cycle.  Heat map
color scale indicates gene set enrichment scores.
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To study the effects of Noggin and RA on anterior/posterior (A/P) identity of ES cells, we selected a
predefined subset of developmental genes known to pattern the A/P axis of the CNS (See Materials
and  Methods),  and  we  analyzed  their  expression,  using  RA  treatment  as  a  control  for
posteriorization of ES cells. A number of these genes were coherently regulated in Noggin-treated
ES  cells and E16 cortex, or in RA-treated ES  cells and E16 hindbrain, suggesting a certain
similarity of treated ES cells and corresponding brain regions (Figure 3.37).
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Figure  3.36:  Gene expression profiling of  differentiated ES cells. Gene Set  Enrichment  Analysis of  400 nM
Noggin-treated versus control ES cells b Gene expression fold change of selected forebrain markers at Step-III in
Noggin-treated ES cells compared to control (CDMM).
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Figure 3.37: Gene expression clustering of ES cells and E16 brain tissues. Expression profiling of a predefined
subset of developmentally expressed genes known to pattern the A/P axis of the central nervous system (CNS). The
figure shows a heat map of the expression analysis of such genes, which are differentially regulated in Noggin-
treated cells compared to control (Nog/CDMM) and in E16 cortex compared to E16 midbrain (Cortex/Mid.), or
that are differentially regulated in RA-treated cells compared to control (RA/CDMM) and in hindbrain compared to
E16 midbrain (Hind/Mid.). Some of these genes were coherently regulated in Noggin treated ES cells and E16
cortex,  or  in  RA treated  ES  cells  and  E16  hindbrain,  suggesting  a  similar  identity  of  treated  ES  cells  and
corresponding brain regions.
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To further characterize ES cell positional identity, we extracted a list of genes that are differentially
expressed along the A/P axis of developing brain. We chose 592 genes that were differentially
expressed between E16 cortex and E16 hindbrain with absolute fold-change greater than, or equal
to, 10 fold. This gene set was first analyzed by Principal Component Analysis (PCA) to assay the
effect of Noggin on ES cell positional identity. PCA is an unbiased method of analysis that projects
data variability on a reduced number of orthogonal axes, such that the first axis captures the highest
degree of variance in gene expression (Component 1), and subsequent axes (Component 2, ... ,n)
correspond to successively decreasing variance. The Components capturing the highest degrees of
variance identify the qualities mostly discriminating among data populations. 
Figure  3.38 shows a  plot of the first two Principal components, which account for 64.15%
(Component 1) and for 18.64%  (Component 2) of variance  between  samples. Component 2
discriminates ES cells (cyan items) from brain tissues (orange items). As expected by the nature of
gene set selection, Component 1 discriminates the A/P identity  (dashed  lines  in  Figure  3.38).
Notably, Noggin-treated ES cells have more positive values on Component 1 than control ES cells,
confirming the anteriorizing effect of BMP inhibition. As an internal control of the analysis,  RA-
treated ES cells show an opposite trend, consistently with RA posteriorizing effect.
The same gene selection of 592 genes was used for hierarchical gene clustering analysis (see
Materials and Methods) of either Noggin-treated or RA-treated ES  cells, with the three brain
regions (Figure 3.39 and Figure 3.40). We found that the gene expression profile of Noggin-treated
ES cells clustered with that of cerebral cortex (0.44 correlation factor), whereas the RA profile
clustered with midbrain/hindbrain profile, although with a lower extent (0.14 correlation factor).
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Figure 3.38: Gene expression profiling of differentiated ES cells. Principal component analysis of ES cells and
E16 brain regions (see text for details).
Figure  3.39: Gene expression profiling of differentiated ES cells. Hierarchical gene clustering analysis of ES
cells and E16 brain regions. The first 390 genes are shown (complete clustering is displayed in  Figure 3.40).
Numbers over the branching report Euclidean distance correlation. Heat map color scale indicates normalized
gene expression.
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Regions of high concordance between the differentiated ES cells and the corresponding brain region
are shown in Figure 3.40 and correspond to known genes of A/P patterning, including those genes
whose expression was analyzed by RT-PCR.
We concluded that Noggin, in addition to its known role as neural inducer, plays a major role in
establishing an anterior, cortical fate.
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Figure 3.40: Gene expression clustering of ES cells and E16 brain tissues.  A-C, Hierarchical gene clustering
analysis of ES cells at Step-III, after differentiation in defined culture conditions, and E16 brain regions. Numbers
over the branching report Euclidean distance correlation. Enlarged aspects indicated by brackets are regions of
high  concordance  between differentiated ES cells  and the  corresponding  brain region.  Genes  shown in  these
enlarged  regions  are  mainly  developmental  genes  whose  expression  patterns  the  CNS  A/P  axis  and  that
significantly contributed to the clustering. Heat map color scale indicates normalized gene expression.
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4− The Making of a Cortex: Wnt vs. BMP
Efficient Corticogenesis in vitro by Double Inhibition 
of Endogenously Produced BMP and Wnt Factors.
We showed that mouse ES cells express different morphogens during neural differentiation in vitro,
especially BMPs and Wnts  (Results,  Chapter  2).  We demonstrated that  endogenously produced
morphogens  can  affect  ES cell  regional  fate  acquisition;  Noggin-mediated  BMP-inhibition  was
necessary and sufficient to acquire a telencephalic identity in our culture system (Results, Chapter
3). We then asked whether endogenously produced Wnts could contribute to pattern neuralizing ES
cells, by masking an intrinsic telencephalic differentiation fate.
As showed before (Results, Chapter 3), we characterized our control culture (ES cells differentiated
in CDMM), by analyzing  the expression of genes that display an ordered (A/P) expression that
covers the most anterior area  of forebrain (FoxG1, Emx2), entire forebrain (Six3),
forebrain/midbrain (Otx2) and midbrain (En1). Data suggested that in our protocol of differentiation
ES cells mostly adopt a midbrain / dorsal identity when cultured in CDMM. Compared to control,
BMP-inhibition  mediated  by  Noggin  or  by  the  chemical  drug  Dorsomorphin  induced  the
telencephalic marker FoxG1 and repressed the more posterior markers Otx2 and En1, as evaluated
at the end of Step-III (See Results, Chapter 3, Figure 3.16). We repeated this analysis at the end of
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Step-II,  confirming  the  data  (Figure  4.1).  Moreover,  Dorsomorphin  induced  the  expression  of
anterior markers Six3 and Emx2 (Figure 4.1).
Surprisingly, when the same analysis was performed after a Wnt-inhibition treatment (via treatment
with 10 µM IWR-1-Endo during Step-II), we noticed a very strong anteriorizing effect on ES cell
differentiation fate, compared to BMP-inhibition. Posterior markers En1 and Irx3 were strongly
down-regulated by IWR-1-Endo treatment, while anterior markers Six3, FoxG1 and Emx2 were up-
regulated up to 20-folds compared to control cells (Figure 4.2). 
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Figure 4.1. Effects of BMP-inhibition on the expression of A/P patterning genes. RT-PCR mRNA quantification
of forebrain/cortical markers (FoxG1, Six3, Emx2) or midbrain markers (En1, Irx3, Otx2), in ES cells treated with
5 µM Dorsomorphin (BMP-inhibition, BMPi), compared to control cells (CDMM). Cells were treated during Step-
II (at the beginning of day2) and analyzed at the end of Step-II (end of day4; see scheme on the top), which
corresponds  to  day3-6  of  total  differentiation  time  counting  from  the  starting  point  of  differentiation  (LIF
withdrawal). BMP-inhibition up-regulated anterior forebrain genes and down-regulated midbrain markers. Data




























Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
The expression of anterior/telencephalic marker FoxG1 was also evaluated by immunocytodetection
(Figure 4.3A,B). ES cells treated with Wnt-inhibitor during Step-II efficiently expressed FoxG1
(54.5% FoxG1-positive cells; Figure 4.3C), while labeling was almost absent in control cells (1.1%
FoxG1-positive cells). We found that FoxG1 expression rapidly switched-on during Step-II: at the
end of Step-II day2, only 24-hours after the starting point of Wnt-inhibition treatment, 24.2% of
cells were already showing FoxG1 nuclear staining (Figure 4.3C).
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Figure 4.2. Effects of BMP and Wnt-inhibition on the expression of A/P patterning genes. RT-PCR mRNA
quantification of forebrain/cortical markers (FoxG1, Six3, Emx2) or midbrain markers (En1, Irx3, Otx2), in
cells  treated  with  5  µM  Dorsomorphin  (BMP-inhibition;  BMPi)  or  with  10  µM  IWR-1-Endo  (Wnt-
inhibition; WNTi). Cells were treated during Step-II (starting from the beginning of day2) and analyzed at
the end of Step-II (end of day4), which corresponds to day3-6 of total differentiation time counting from the
starting point  of  differentiation (LIF withdrawal;  see  scheme on the  top).  Control  cells  (CDMM) were
cultured in medium containing the same amount of DMSO (0.1%) as treated cells. Wnt-inhibition was able
to up-regulate anterior/cortical markers more efficiently than BMP-inhibition. Data were normalized on
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Figure 4.3: Effects of Wnt-inhibition on FoxG1 expression. Immunocytodetection of FoxG1 (red in
A,B), in ES cells at the end of Step-II after differentiation in control medium (CDMM Ctrl; A) or in
CDMM plus  IWR-1-Endo  (10  µM;  WNTi;  B).  Cells  were  treated  during  Step-II  (starting  at  the
beginning of day2) and analyzed at the end of Step-II (end of day4), as indicated in the scheme. Nuclei
counterstaining was obtained with DAPI. ES cells treated at Step-II with Wnt-inhibitor were efficiently
anteriorized and showed high ratio of  FoxG1-positive telencephalic  progenitors.  C shows FoxG1-
positive cell ratios in control cells and in cells treated with Wnt-inhibitor, at different time points of
Step-II, as indicated. Error bars: standard error.
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Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
Then, we tested whether a double inhibition of BMP and Wnt pathways could strengthen ES cell
cortical conversion (Figure 4.4). Cells were treated during Step-II with 5 µM Dorsomorphin (BMP-
inhibition, BMPi), with 10 µM IWR-1-Endo (Wnt-inhibition, WNTi) or with the combination of
both chemical compounds (BMP/Wnt double inhibition, BMPi+WNTi), and A/P marker expression
was  evaluated  at  the  end  of  Step-III.  Single  inhibitions  were  both  efficient  for  ES  cell
corticalization, as seen by midbrain markers down-regulation and forebrain marker up-regulation.
Again, Wnt-inhibition was able to up-regulate anterior/cortical markers more efficiently than BMP-
inhibition  (see  FoxG1,  Emx2,  Tbr1  and  Six3  expression  levels).  However,  double  BMP/Wnt-
inhibition  showed  a  even  stronger  down-regulation  of  En1  and  Otx2  and  more  efficient  up-
regulation of cortical markers FoxG1, Ctip2, Tbr1 and CamKII-α, compared to single treatments.
These results suggest a synergistic effect of BMP and Wnt pathway inhibition for the acquisition of
a telencephalic fate (Figure 4.4).
To investigate in detail the nature of neural cells  generated by ES cells treated with BMP/Wnt-
inhibition, we analyzed the expression of the cortical marker  Tbr1,  which specifically identifies a
sub-set of early-generated cortical neurons, at the end of Step-III. Control cells were compared with
Dorsomorphin-treated  cells  (BMPi),  IWR-1-Endo-treated  cells  (Wnti)  and  double  treated  cells
(BMPi+WNTi). We found that, compared to control cells, ES cells treated with Dorsomorphin or
with IWR-1-Endo during Step-II produced a higher ratio of Tbr1-positive cells at the end of Step-III
(10% and 14,7%, respectively, compared to 3% of control). Tbr1-positive cell ratio was even higher
after double BMP/Wnt-inhibition (28.2% Tbr1-positive cells) (Figure 4.5 and 4.7). 
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Figure  4.4.  Effects  of  BMP-inhibition,  Wnt-inhibition  or  double  BMP/Wnt-inhibition  on  the
expression of A/P patterning genes. RT-PCR mRNA quantification of forebrain/cortical markers (Emx2,
Tbr1, Six3, FoxG1, CamKII-α, Ctip2) or midbrain markers (En1, Irx3, Otx2), in cells treated with 5 µM
Dorsomorphin (BMPi), with 10 µM IWR-1-Endo (WNTi) or with both chemical drugs (BMPi+WNTi).
Cells were treated during Step-II (starting from the beginning of day2) and analyzed at the end of Step-
III (see scheme on the top). Again, Wnt-inhibition was able to up-regulate anterior/cortical markers more
efficiently  than BMP-inhibition  (especially  Emx2 and Tbr1).  Wnt-inhibition  was  able  to  up-regulate
anterior/cortical markers more efficiently than BMP- inhibition, while the double inhibition showed a
synergistic effect on the expression of A/P markers. Data were normalized on maximum expression.
Error bars: standard error.



























Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
We obtained consistent results by analyzing the expression of another cortical marker, Ctip2, which
labels medium/early-generated cortical neurons of layer 5. Ctip2-positive cells were only 1.5% in
control cells and increased to 14.8% in cells treated with double BMP/Wnt-inhibition (Figure 4.6).
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Figure  4.5:  Effects  of  BMP-inhibition,  Wnt-inhibition and double BMP/Wnt-inhibition on Tbr1 expression.
Immunocytodetection of Tbr1 (red in A-D), in ES cells at the end of Step-III after differentiation in control medium
(CDMM; A), CDMM plus Dorsomorphin (5 µM;  BMPi;  B), CDMM plus IWR-1-Endo (10 µM;  WNTi;  C) and
CDMM plus both chemical drugs (WNTi+BMPi;  D). Cell were treated as indicated in the top scheme. Nuclei
counterstaining was obtained with DAPI. Tbr1-positive cell ratio was higher in ES cells treated at Step-II with both
chemical drugs. Single pathway inhibitions showed intermediate percentages of Tbr1-positive cells when compared
to control cells or double-inhibited cells (see Figure 4.7 for cell ratios).
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Again, single BMP or Wnt-inhibitions showed intermediate results (3.5% Ctip2-positive cells after
BMP-inhibition, 9.7% positive cells after Wnt-inhibition) (Figure 4.7).
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Figure 4.6: Effects of double BMP/Wnt-inhibition on Ctip2 expression. Immunocytodetection of Ctip2 (red in A
and B), in ES cells at the end of Step-III after differentiation in control medium (CDMM; A) or double pathway
inhibition (WNTi+BMPi;  B). Cell were treated as indicated in  Figure 4.5. Nuclei counterstaining was obtained
with DAPI. Ctip2-positive cell ratio was higher in ES cells treated at Step-II with both chemical drugs (see Figure
4.7 for cell ratios).
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Figure  4.7:  Effects  of  BMP-inhibition,  Wnt-inhibition  and  double  BMP/Wnt-inhibition  on  ES  cell  fate
acquisition. Cell ratios of Tbr1-positive and Ctip2-positive cells from different culture conditions, as indicated in
Figure 4.5 and  4.6. Single pathway inhibitions were both able to increase the ratio of Tbr1-positive and Ctip2-
positive  cells,  compared  to  control  CDMM cells.  The  simultaneous  block  of  BMP and Wnt  pathways  further
increased positive cell ratios, suggesting a synergistic effect of BMP and Wnt pathway inhibition for cortical fate
acquisition. Error bars: standard error.





























Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
Notably,  ES  cells  treated  with  double  BMP/Wnt-inhibition followed a differentiation schedule
similar to that of in vivo cortical neurons. The expression of Tbr1, which marks earlier cortical
neurons, was followed by the activation  of Ctip2, which labels medium/early-generated cortical
neurons of layer 5. Ctip2-positive cells reached their peak at Step-III+4 days of culture. To obtain
neurons positive for SatB2, which marks late-generated cortical neurons of layers 2/3, cells were
cultured for a longer period (up to a total of 18 days); N2 medium used for Step-III was gradually
replaced with N2B27 starting from Step-III+4 days, to promote cell survival in long-term culture
(Figure 4.8).
SatB2-positive cell ratio (late-generated neurons) increased over time, as the culture maturated, at
the expense of Tbr1-positive cell ratio (early-generated neurons) (Figure 4.9).
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Figure  4.8:  Effects of double BMP/Wnt-inhibition on ES cell fate acquisition. A shows Ctip2 (red) and SatB2
(green) immunohistochemistry, tested on a P7 mouse cortex slice (transverse section); SatB2 preferentially labels
layer 2/3 cells, while Ctip2 marks deep neurons of layer 5. Nuclei counterstaining was obtained with DAPI. B: the
same cortical markers were detected at Step-III+8 days on cells treated with double BMP/Wnt-inhibition during
Step-II. Some of the immunocytodetection experiments of cortical markers SatB2 and Ctip2 were independently
performed by the undergraduate student Alessandro Vanni, under my supervision.
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Notably, when we analyzed by RT-PCR the expression of cortical markers during differentiation,
we found that some of them were already highly expressed at the end of Step-III (Ctip2, green
columns in Figure 4.10) and even at the end of Step-II (SatB2, red columns in Figure 4.10). The
case  of  SatB2  was  particularly  interesting,  because  the  expression  of  this  marker  was  already
detectable  at  Step-II,  a  developing  time  where  SatB2-positive  neurons  cannot  be  detected  by
immunocytodetection (Figure 4.10). SatB2-positive neurons, as shown before, first appeared in our
culture only after a total of 14 days of differentiation, that is 8 days after the appearance of SatB2
mRNA expression  (Figure  4.9 and  Figure  4.10C,D).  These  data  show  that  SatB2  mRNA is
prematurely  expressed  by  differentiating  cortical  progenitors,  but  SatB2  protein  expression  is
switched-on  only  at  a  later  differentiation  phase.  This  temporal  difference  between  mRNA
expression  and  the  generation  of  SatB2-positive  neurons  could  be  possibly  due  to  a  post-
transcriptional regulation of SatB2 mRNA. A translational regulation of SatB2 mRNA was already
hypothesized in vivo (Britanova et al., 2005). 
A possible mechanism of SatB2 mRNA post-transcriptional regulation has not been investigated in
my PhD work, but this topic will deserve attention in future experiments in our Lab.
204
Figure  4.9:  Differentiation schedule followed by ES cells after double BMP/Wnt-inhibition. Values show the
ratios of Tbr1, Ctip2 or SatB2 positive cells over time in cells treated with double BMP/Wnt-inhibition. Treated ES
cells followed a differentiation schedule similar to that of in vivo cortical neurons, where the generation of Tbr1-


























Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
As the  positional  markers  analyzed  by RT-PCR and by immunocytodetection  can  change  very
rapidly their  expression  during  neural  differentiation,  both  in  vitro and  in  vivo,  we decided  to
analyze cell identity at earlier and later times of differentiation (end of Step-III or Step-III+4 days)
to test the maintenance of cell positional identity. Control CDMM-cultured cells were compared to
cells treated with double BMP/Wnt-inhibition; the expression level of midbrain genes (Otx2, En1
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Figure 4.10: Effects of double BMP/Wnt-inhibition on ES cell fate acquisition. A-E: Images show Ctip2 (green)
and SatB2 (red) immunocytodetection, performed over time in cells treated with double BMP/Wnt-inhibition. The
first image (A) shows cells at the end of Step-III; the same immunocytodetection was performed every two days,
and images are showed in a left-to-righ order (B-E).  F shows RT-PCR mRNA quantification of  layer-specific
cortical  markers  (Tbr1,  Ctip2 and SatB2) in  cells  treated with double  BMP/Wnt-inhibition.  RT-PCR data are
normalized on maximum expression. Error bars: standard error.
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and Irx3) and that of anterior/cortical genes (FoxG1, Six3, Emx2, Tbr1, Wnt7b) was analyzed. Cells
anteriorized  by  double  BMP/Wnt-inhibition  expressed  high  level  of  anterior  genes,  and  this
expression was further increased at Step-III+4 days, with the only exception of FoxG1 gene (this
was  not  surprising,  as  FoxG1  is  a  early  marker  that  decreases  its  expression  during  neural
differentiation).  On the  contrary,  control  cells  maintained a  high  expression  of  midbrain  genes
during differentiation, and never switched-on the expression of anterior/cortical markers (Figure
4.11).
As similar results were obtained by analyzing two different time points, we excluded the possibility
that  the  effect  of  double  BMP/Wnt-inhibition  on  positional  identity  may  be  the  result  of  an
enhancement/acceleration in neural fate induction: Differentiating ES cells acquire a specific A/P
fate after treatments with chemical drugs (always performed at Step-II) and maintain their identity
during differentiation, without losing their positional memory.
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Figure 4.11: Temporal analysis of double BMP/Wnt-inhibition effects in differentiating ES cells. Graph shows
RT-PCR mRNA quantification of midbrain markers (En1, Otx2, Irx3; yellow and red color code) and of anterior
cortical markers (FoxG1, Six3, Emx2, Tbr1 and Wnt7b; blue and green color code) in ES cells at Step-III an in ES
cells  at  Step-III+4  days,  after  differentiation  in  CDMM  or  in  CDMM  plus  BMP and  Wnt-inhibitors  (5  µM
Dorsomorphin and 10 µM IWR-1-Endo, respectively; see scheme on the top). The positional identity established by
treatments with chemical drugs at Step-II was maintained and even reinforced several days later, at Step-III+4
days.  Error  bars:  standard  error.  Data  were  normalized  on  maximum  expression.  This  experiment  was
independently performed by the undergraduate student Alessandro Vanni, under my supervision.
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Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
To confirm the specificity of action of chemical drug treatments, we quantified by RT-PCR the
expression of ID1, a downstream effector of the BMP-responsive pathway, and the expression of
LEF1, a bona fide marker of the canonical Wnt pathway activity. Cells were treated during Step-II
(starting at the beginning of day2) and analyzed at the end of Step-II. As expected, Dorsomorphin-
mediated BMP-inhibition, both in single and in double treatment, resulted in a strong decrease of
ID1 expression, compared to control cells. Similarly, LEF1 expression decreased when cells were
treated  with  IWR-1-Endo  (both  in  single  Wnt-inhibition  and  in  double  BMP/Wnt-inhibition).
Surprisingly,  LEF1  expression  showed  a  marked  decrease  also  in  Dorsomorphin-treated  cells,
indicating  that  BMP-inhibition  caused  a  secondary  down-regulation  of  Wnt  pathway  activity
(Figure 4.12). This suggested a cross-talk mechanisms between the two pathways.
To better understand this phenomenon, we cultured ES cells until the end of Step-II, then performed
an  acute  (12  hours)  treatment  with  chemical  drugs.  In  this  condition,  LEF1  and  ID1  levels
decreased in cells treated with IWR-1-Endo and Dorsomorphin, respectively, but LEF1 expression
level in Dorsomorphin-treated cells was comparable to that of control cells. The acute treatment
isolated the early effect on BMP and Wnt pathways, and avoided late regulations/cross-talks of the
two pathways (Figure 4.13).
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Figure 4.12: Effects of Wnt-inhibition, BMP-inhibition or double BMP/Wnt-inhibition on the expression of ID1
and LEF1 genes. RT-PCR mRNA quantification of ID1, a downstream effector of the BMP-responsive pathway,
and of LEF1, a bona fide marker of Wnt pathway activity. Cells were treated with chemical drugs during all Step-II
and analyzed at its end. Data normalized on CDMM (Ctrl). Error bars: standard error.
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The dissection of BMP and Wnt pathways and the study of possible cross-talks between the two
signaling  pathways  will  require  further  investigation.  At  this  point  of  the  analysis,  the  results
suggest  that  some  of  the  corticalizing effects  previously  seen  with  Noggin-mediated  BMP-
inhibition (Results, Chapter 3), may be, at least in part, due to a secondary modulation of the Wnt
signaling  pathway.  However,  the  molecular  nature  of  the  interaction  between  BMP and  Wnt
pathway was not further investigated in my work.
All in all, we concluded that Wnt-inhibition plays a fundamental role in establishing an anterior,
cortical  fate  during  ES  cell  neural  differentiation  in  vitro,  consistently  with  previous  findings
(Eiraku et al., 2008).
However,  some  of  the  markers  we  used  in  our  analysis  (FoxG1  and  Six3,  for  example)  are
expressed in vivo both in the ventral and in the dorsal area of the telencephalon. Thus, we can not
exclude that Wnt-inhibition steered ES cell differentiation fate towards a mixed dorsal (Cortical,
Emx2 and Tbr1-positive) and ventral (Subpallial, Dlx2-positive) telencephalic differentiation fate.
In fact,  we detected by RT-PCR the expression of ventral/telencephalic  (Dlx2)  and specifically
hypothalamic (Lhx2 and Lhx8) markers, after Wnt-inhibition (Figure 4.14).
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Figure 4.13: Effects of transient Wnt-, BMP- or double BMP/Wnt-inhibition (acute 12 hours treatment) on the
expression of ID1 and LEF1 genes. RT-PCR mRNA quantification of ID1, a downstream effector of the BMP-
responsive pathway, and of LEF1, a bona fide marker of Wnt pathway activity. Cells were treated with chemical
drugs only during the last 12 hours of Step-II. Data normalized on CDMM (Ctrl). Error bars: standard error.




















Results and Discussion  4−The Making of a Cortex: Wnt vs. BMP
In  conclusion,  we  can  state  that  WNT-inhibition  during  ES  cell  neural  differentiation  in  vitro
induces  a  telencephalic  fate,  generating  a  mixed cortical  and subpallial  cell  population,  that  is
consistent with previous findings (Ikeda et al., 2005; Verani et al., 2007; Nicoleau et al., 2013).
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Figure 4.14: Effects of BMP-inhibition, Wnt-inhibition or double BMP/Wnt-inhibition on the expression of D/V
telencephalic  genes. RT-PCR  mRNA  quantification  of  forebrain  marker  FoxG1  (A)  or  forebrain/ventral-
hypothalamic markers Lhx2, Lhx8 and Dlx2 (A and B), in cells treated with 5 µM Dorsomorphin (BMPi), with 10
µM IWR-1-Endo (WNTi) or with both chemical drugs (BMPi+WNTi). Cells were treated during Step-II (starting
from the beginning of day2) and analyzed at the end of Step-III (see scheme on the top). Wnt-inhibition was able to
up-regulate the ventral telencephalic markers Lhx2, Lhx8 and Dlx2. Data were normalized on maximum expression
(A) or over β-Actin expression (B). Error bars: standard error.
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5− Anterior Brain Patterning
How to Make a Retina 
Playing with BMP, Wnt and Activin/Nodal Pathways.
While much information can be found about cortical fate acquisition, the cellular and molecular
mechanisms that regulate the regionalization of the forebrain are largely unknown. As an example,
the molecular mechanisms controlling the diversification of the presumptive telencephalon and the
eye field have not been elucidated so far (Wilson and Houart, 2004; Andonadiou et al., 2013).
We therefore decided to exploit the plasticity of our differentiation protocol to steer stem cell fate
choice between dorsal telencephalon (Cortex) and lateral diencephalon (Retina). We reasoned that
the first step to achieve for retinal differentiation was necessarily to anteriorize differentiating ES
cells  (forebrain fate), as retinal cells  arise from the most anterior aspect of neural plate  in vivo
(Wilson and Houart,  2004).  We previously demonstrated that endogenously produced Wnts and
BMPs can affect  ES cell  regional  fate  acquisition;  control  ES cells,  under  the  effect  of   high
amounts of endogenously produced BMP and Wnt morphogens, expressed mesencephalic markers
such as Otx2 and En1 (Results, Chapter 3). On the contrary, ES cells treated with double BMP and
Wnt-inhibition were anteriorized, expressed high levels of FoxG1, Emx2 and Six3, and specifically
acquired a genuine cortical/telencephalic identity (Results, Chapters 3 and 4).
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The need for an anteriorization via Wnt and/or BMP-inhibition, in order to obtain retinal cells, was
supported by our experimental observation that ES cells treated with Wnt-inhibition expressed the
eye field marker Rax (Furukawa et al., 1997), even if at very low level (Figure 5.1A). 
After the first step of ES cell anteriorization, in which a low expression of Rax was already present,
the question was how to switch-off telencephalic genes (FoxG1, Emx2) and how to efficiently
switch-on eye field genes (Six6 and Rax), steering stem cell fate choice towards retinal fate at the
expense of cortical fate (Figure 5.2).
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Figure  5.1:  Effects of Wnt-inhibition on the expression of patterning genes.  RT-PCR mRNA quantification of
forebrain/cortical markers (FoxG1, Emx2, Six3), midbrain marker (En1) and retinal markers (Rax and Six3), in
cells treated with 10 µM IWR-1-Endo (WNTi). Cells were treated during Step-II (starting from the beginning of
day2) and analyzed at the end of Step-II, day4. Interestingly, cells anteriorized by Wnt-inhibition showed a low –


























Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
We previously showed that mouse ES cells expressed high levels of BMPs and Wnts during neural
differentiation in vitro (See Results, Chapter 2). Notably, in our system of neural differentiation, ES
cells do not express a large amount of Activin/Nodal signals compared to Wnts and BMPs (See
Results,  Chapter  2;  compare  RT-PCR  data  in  Figure  5.3).  This  prompted  us  to  consider  the
possibility  of  manipulating  Activin/Nodal  signaling  pathway,  by  adding  exogenous  Activin-A.
Additionally, a recently published work on human ES cells showed the importance of Activin/Nodal
signaling for eye field gene induction (Lupo et al., 2013).
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Figure  5.2:  Experimental  scheme for  retinal  induction on mouse ES cells  in  vitro. The scheme on the  top
represents sequential steps in neural differentiation, brain patterning and eye field induction (modified from Zuber
et al., 2003). After the initial neural induction step, the expression of A/P patterning genes FoxG1 and Engrailed-1
subdivides the future brain in anterior (forebrain) and posterior (midbrain-hindbrain) areas, respectively. As we
previously showed (See Results, Chapters 3 and 4; Bertacchi et al., 2013), forebrain induction in our in vitro system
could be efficiently induced by single or double BMP and Wnt pathway inhibitions (scheme at the bottom). The
second step to achieve for retinal induction requires subtle manipulation of morphogen signaling pathways,  to
switch-off telencephalic/cortical gene (FoxG1 and Emx2) expression and switch-on retinal gene (Rax and Six6)
expression.  The  molecular  pathways  involved  in  retinal  induction  have  never  been  deeply  investigated  so  far
(question marks label).
Results and Discussion  5−Anterior Brain Patterning
The  induction  of  Activin/Nodal  pathway  alone  down-regulated  both  anterior/cortical  markers
(Emx2 and FoxG1) and midbrain marker (En1), and up-regulated the retinal marker Tbx3 and the
anterior/retinal marker Six3. However, this effect was associated with a very low expression of the
eye field gene Rax (Figure 5.4). Activin/Nodal-inhibition via SB431245 treatment did not affect the
expression  of  the  positional  markers  analyzed,  consistently  with  the  absence  of  endogenous
Activin/Nodal production in our culture system (Figure 5.4).
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Figure  5.3:  RT-PCR mRNA analysis of Wnt factors and of Activin/Nodal factors in ES cells during neural
differentiation. (A) and (B) show mRNAs levels relative to β-Actin in expanding undifferentiated cells (ES cells), or
in ES cells at the end of Step-I (Step-I), at mid-Step-II (Step-II, day2), at the end of Step-II (Step-II, day4) and at the
end  of  Step-III  (Step-III).  Wnt  family  factors  were  strongly  expressed  during  Step-II  (A).  On  the  contrary,
Activin/Nodal factors, belonging to the TGF-β family, were not abundantly expressed in our in vitro culture (B).
Data were normalized on β-Actin expression. Error bars: standard error.


















































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Finally, as reported in the literature (Tomizawa et al., 2013; Sakaki-Yumoto et al., 2013), Activin
treatment  alone  promoted  the  maintenance  of  pluripotency  and  strongly  inhibited  ES  cell
neuralization  (see  also  Figures  5.9,  5.10,  5.19-5.21,  5.45,  5.46 and  text  below),  making  very
difficult  to  understand  the  identity  of  the  few  neural  progenitors  differentiated  in  this  culture
condition.
We  thus  decided  to  use  different  doses  of  Activin  in  combination  with  ES  cell  anteriorizing
treatments, obtained by means of BMP, Wnt or double Wnt/BMP-inhibitions (Figure 5.5). 
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Figure  5.4:  Effects of Activin pathway inhibition or activation on the expression of A/P patterning genes.  RT-
PCR mRNA quantification of forebrain/cortical markers (FoxG1, Emx2, Six3), midbrain marker (En1) and retinal
markers (Six3, Rax and Tbx3) in cells treated with 10 µM SB431245 (Activin-inhibition; ACTi) or with 10 ng/ml
Activin-A recombinant protein (signaling pathway activation; ACT+), compared to control cells (cultured in 0.1%
DMSO; CT). Cells were treated during Step-II (starting at the beginning of day2) and analyzed at the end of Step-II
(end of day4). Activin treatment up-regulated anterior/retinal markers Six3 and Tbx3; in this condition, we also






















Results and Discussion  5−Anterior Brain Patterning
The ED50 of Activin protein (that is the ability to induce hemoglobin expression in K562 cells, as
reported on R&D Systems information sheet) is 0.5-2 ng/ml. Three different doses of Activin (10,
50 and 100 ng/ml) were associated with three different anteriorizing treatments: Wnt-inhibition via
IWR-1-Endo  treatment  (10  µM;  WNTi),  BMP-inhibition  via  Dorsomorphin  treatment  (5  µM;
BMPi) and double Wnt/BMP-inhibition, previously used for optimal anteriorization and cortical
induction (See Results, Chapter 4; WNTi+BMPi). Cells were always treated during Step-II (see
scheme in Figure 5.5), starting from day2 of Step-II until the analysis point at the end of Step-II,
day4. Control cells were always cultured in CDMM supplemented with the same amount of DMSO
used for treatments (CTRL 0.1% DMSO). The effects of different treatments on gene expression
were evaluated by RT-PCR.
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Figure  5.5:  Experimental scheme for cortical/retinal induction on mouse ES cells  in vitro. The scheme lists
different combinations of Activin doses (10, 50 and 100 ng/ml Activin-A recombinant protein), tested in association
with different anteriorizing treatments (Wnt-inhibition, BMP-inhibition and double Wnt/BMP-inhibition). Cells were
treated with recombinant protein/chemical drugs starting at the beginning of Step-II, day2, and analyzed at the end
of Step-II, day4, for a total of 6 days of in vitro differentiation after LIF withdrawal. Control untreated cells were
cultured in 0.1% DMSO containing medium.
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As a read-out of Activin/Nodal signaling pathway activation, we measured the expression of FoxH1
by RT-PCR (Figure 5.6).  FoxH1 is  a  key target  gene  of  Activin/Nodal  signaling  pathway and
consistently its expression was switched-on by the addition of Activin-A protein in culture medium.
The  activation  of  Activin/Nodal  signaling  pathway  (FoxH1  expression)  showed  different
efficiencies when Activin treatment was associated with Wnt-inhibition, BMP-inhibition or double
Wnt/BMP-inhibition.  This  suggested  that  ES  cell  responsiveness  to  Activin  treatment  can  be
strongly influenced by the type of  anteriorizing protocol used at  the same time. Higher FoxH1
expression levels were obtained by associating Activin treatment together with Wnt-inhibitor alone.
FoxH1 expression reached high levels even after treatment with the lower Activin dose tested (10
ng/ml).  As FoxH1 expression level was already high in cells treated with 10 ng/ml Activin, we
reasoned that this dose could be considered already saturating for signaling pathway activation in
our culture system.
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Figure 5.6: RT-PCR mRNA quantification of FoxH1 expression after treatment with different combinations of
Activin/chemical drugs. Graph shows the expression level of FoxH1, a key target of Activin signaling pathway, in
cells treated with 10 µM IWR-1-Endo (WNTi),  with 5 µM Dorsomorphin (BMPi) or with both chemical drugs
(WNTi+BMPi), together with different doses of Activin-A recombinant protein (10, 50 or 100 ng/ml). Cells were
treated during Step-II (starting from the beginning of day2) and analyzed at the end of Step-II, day4, as previously
schematized (See Figure 5.5). Control untreated cells were cultured in 0.1% DMSO containing medium. Activin-A
treatment switched-on the expression of its target gene FoxH1; FoxH1 expression level was differing depending on
the type of concomitant cell anteriorization treatment (BMPi, WNTi or WNTi+BMPi). Data were normalized over














































Results and Discussion  5−Anterior Brain Patterning
We then focused our attention on cell identity, measuring by RT-PCR the expression of regional
markers  among  the  different  combinations  of  treatments  (Figure  5.7).  Single  Wnt-  or  BMP-
inhibitions were both efficient for ES cell corticalization, as seen by midbrain marker En1 down-
regulation (dark red columns in  Figure 5.7) and forebrain markers up-regulation (Emx2, FoxG1;
yellow and orange columns, respectively), when compared to control cells. Wnt-inhibition was able
to  up-regulate  anterior/cortical  markers  more  efficiently  than  BMP-inhibition,  and  the  best
corticalizing treatment was the combination of double Wnt/BMP-inhibition (as previously seen in
Results, Chapter 4). Activin treatment was able to silence cortical gene expression and to efficiently
switch-on the expression of eye field genes, such as Rax, Six6, Tbx3, Six3, Vsx2 and Otx2 (Figure
5.7).  The  prosencephalic  marker  Six3 and the  forebrain/midbrain  marker  Otx2 have  also  been
demonstrated to have a key-role as eye field transcription factors, and were used here as a read-out
of retinal induction; see Zuber et al., 2003.
Among different Activin doses tested, the 10 ng/ml dose was sufficient to inhibit cortical genes and
efficiently induce retinal  gene expression.  Higher  doses  (50 ng/ml  and 100 ng/ml)  had similar
effects on global gene expression, but were less efficient when compared to 10 ng/ml in terms of
retinal gene expression level (compare the expression level of retinal genes – green and blue color
code  –  in  WNTi+BMPi+10  ng/ml  Activin  to  that  of  same  genes  in  WNTi+BMPi+100  ng/ml
Activin).  This  was  presumably  due  to  high  Activin  doses  interfering  with  ES  cell  neural
differentiation (see below in this Chapter, Figures 5.9, 5.10 and 5.40) and thus reducing the number
of differentiating neural progenitors inside the cell culture.
As an exception to this, BMP-inhibition associated with higher Activin doses (50 and 100 ng/ml)
showed high retinal gene expression levels, giving better results if compared to BMP-inhibition plus
low dose (10 ng/ml) of Activin.  This difference between Wnt-inhibition and BMP-inhibition in
terms of  response to  Activin treatments  was not  further  investigated.  However,  BMP-inhibition
alone  was  not  used  as  a  treatment  in  later  experiments  because  of  the  high  expression  of
mesodermal markers in this condition (see below in this chapter, Figure 5.19). 
Concerning retinal markers, their expression levels were quite similar in different conditions except
Tbx3, whose expression was highest in Wnt-inhibition plus high Activin doses (see violet columns
in Figure 5.7). The key gene for retinal development, Rax, showed its highest expression level in
cells treated with WNTi+10 ng/ml Activin.
217
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
We  detected  some  residual  cortical  marker  (FoxG1  and  Emx2)  expression  even  after  Activin
treatment.  This  was  particularly  evident  with  low  Activin  dose  treatment  (see  cortical  marker
expression – yellow and orange color code in  Figure 5.7 – in WNTi, BMPi or WNTi+BMPi+10
ng/ml Activin); higher Activin doses completely silenced FoxG1 and Emx2 expression, but we do
not know to what extent this was due to an effect on cell  positional fate or rather to a simple
inhibition  of  the  neuralization  process  (see  the  effect  of  high  Activin  doses  on  neural  marker
expression Nestin and Pax6, below in this chapter, Figures 5.9 and 5.10).
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Figure 5.7: Effects of different Activin/chemical drugs combinations on the expression of key patterning genes.
RT-PCR mRNA quantification of forebrain/cortical markers (FoxG1, Emx2, Six3), midbrain marker (En1, Otx2)
and retinal markers (Otx2, Six3, Six6, Rax, Vsx2 and Tbx3) in cells treated with increasing doses of Activin (10, 50
or 100 ng/ml  Activin-A recombinant  protein)  together  with  anteriorizing chemical drugs (10 µM IWR-1-Endo,
WNTi; 5 µM Dorsomorphin,  BMPi; both chemical drugs,  WNTi+BMPi), compared to control cells (cultured in
0.1% DMSO). Cells were treated with recombinant protein/chemical drugs starting at the beginning of Step-II,
day2, and analyzed at the end of Step-II, day4, for a total of 6 days of in vitro differentiation after LIF withdrawal
(see Figure 5.5 for a scheme of the experiment). Activin was able to down-regulate both anterior/cortical markers
(Emx2 and FoxG1) and midbrain marker (En1) in a dose-dependent manner. On the contrary, Activin treatment
efficiently up-regulated anterior/retinal markers Six3, Otx2, Rax, Six6, Vsx2 and Tbx3. Data were normalized on









































Results and Discussion  5−Anterior Brain Patterning
Even if it was not easy to understand which was the best option to obtain retinal cells among all
these combinations, we concluded that Activin treatment, when associated with anteriorization via
Wnt/BMP-inhibition, was able to switch-on the expression of retinal markers, while suppressing the
expression of cortical/telencephalic genes, steering stem cell fate choice towards retinal fate at the
expense of cortical fate.
We performed RT-PCR followed by gel electrophoresis to better visualize the residual expression of
cortical  genes FoxG1 and Emx2 after Activin treatments (Figure 5.8).  This experiment showed
again that FoxG1 and Emx2 expression were down-regulated by Activin treatment. However, this
down-regulation was more efficient in cells treated with Wnt-inhibitor alone, than in cells treated
with double inhibition, where Emx2 and FoxG1 bands were still detectable after treatment with
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Figure  5.8:  Effects of different combinations of Activin/chemical drugs on the expression of key patterning
genes. RT-PCR,  followed  by  gel  electrophoresis,  of  forebrain/cortical  markers  (FoxG1  and  Emx2),  midbrain
marker (En1) and the key retinal gene (Rax) in cells treated with increasing doses of Activin (10, 50 or 100 ng/ml
Activin-A recombinant protein) together with  anteriorizing chemical drugs (10 µM IWR-1-Endo,  WNTi; 5 µM
Dorsomorphin, BMPi; both chemical drugs,  WNTi+BMPi), compared to control cells (cultured in 0.1% DMSO).
Cells were treated with recombinant protein/chemical drugs as described in  Figure 5.5. Control untreated cells
were cultured in 0.1% DMSO containing medium. Activin was able to down-regulate both anterior/cortical markers
(Emx2 and FoxG1) and midbrain marker (En1) in a dose-dependent manner. However, this effect was not complete
when Activin treatment, even at higher doses (50 and 100 ng/ml), was associated with double Wnt/BMP-inhibition;
in this particular case, some residual expression of cortical genes Emx2 and FoxG1 could be detected (see bands in
column number 12, and compare to column number 4).
RT-PCR+Gel Electrophoresis, Step-II





















Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
high doses of Activin (compare columns marked by blue arrows in Figure 5.8). This is consistent
with a higher FoxG1 and Emx2 expression in cells treated with double Wnt/BMP-inhibition, when
compared to single Wnt pathway inhibition; we reasoned that ES cell anteriorization/corticalization
obtained with double Wnt/BMP-inhibition might specify a cortical fate that can not be re-directed
toward retina by Activin. For this reason, we decided to focus on WNTi+Activin as an optimal
combination for subsequent experiments.
Activin is known to support the pluripotency of both ES and induced pluripotent stem (IPS) cell
(Tsuneyoshi et al.,  2012; Tomizawa et al., 2013) and to induce endoderm/mesoderm fate during
early fate choice of ES cell differentiation (Teo et al., 2012; Cerdan et al., 2012). For these reasons,
we asked whether  Activin  treatment  in  our  protocol  could  be responsible  for  slowing-down or
impairing neural conversion of differentiating ES cells. In fact, the down-regulation of the neural
markers  Nestin  and  Pax6  after  Activin  treatment  observed  by  RT-PCR  analysis  confirmed  an
Activin anti-neuralizing action (see Figure 5.9 and Figure 5.10).
Cells  treated  with  Wnt-inhibition  and  double  Wnt/BMP-inhibition  showed  a  higher  Nestin
expression level when compared to control (CDMM+0.1% DMSO cultured) cells, while increasing
doses of Activin (ranging from 10 ng/ml to 100 ng/ml) clearly inhibited Nestin expression in a
dose-dependent manner (Figure 5.9).  Cells  treated with BMP-inhibition alone showed a Nestin
expression level comparable to that of control cells, but also in this case increasing Activin doses
gradually silenced  Nestin  expression.  This  suggested  that  Activin  treatment  per  se inhibits  the
appearance of Nestin-positive neural progenitors in vitro.
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The RT-PCR analysis of neural marker Pax6 gave similar results, showing a relevant collapse of
Pax6 expression after Activin treatment (Figure 5.10). Pax6 deserves particular attention not only
as a pan-neuronal marker, but also in the quality of its role as a eye field transcription factor (Zuber
et al., 2003), which must be expressed by early retinal progenitors (See Introduction; Ikeda et al.,
2005). Pax6 expression was up-regulated by BMP-inhibition, Wnt-inhibition and particularly by
double Wnt/BMP-inhibition, compared to control cells. Activin treatment, even at the lower dose
tested (10 ng/ml), caused a marked reduction of Pax6 expression. Taken together with RT-PCR data
on Nestin expression, this data suggested that Activin treatment prevented the neural conversion
that ES cells normally undergo when cultured in a minimal medium.
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Figure 5.9:  RT-PCR mRNA quantification of Nestin expression after treatment with different combinations of
Activin/chemical drugs. Graph shows the expression level of Nestin, a marker of neural progenitor cells, after
treatment  with  10  µM IWR-1-Endo (WNTi),  with  5  µM Dorsomorphin  (BMPi)  or  with  both  chemical  drugs
(WNTi+BMPi), together with different doses of Activin-A recombinant protein (10, 50 or 100 ng/ml). Cells were
treated during Step-II (starting from the beginning of day2) and analyzed at the end of Step-II, day4, as previously
schematized (See Figure 5.5). Control untreated cells were cultured in 0.1% DMSO containing medium. Increasing
doses of Activin clearly inhibited Nestin expression in a dose-dependent manner. This suggested that Activin exerted

















































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Nestin  and  Pax6  were  studied  also  at  the  protein  level,  by  performing  immunocytodetection
experiments  (Figure  5.11-5.14).  Only  Pax6  nuclear  staining  was  quantified  by  cell  counting
(Figure 5.13), due to difficulty to count Nestin labeling, whose signal was distributed along the
soma of partially overlapping cells (Figure 5.14).
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Figure 5.10: RT-PCR mRNA quantification of Pax6 expression after treatment with different combinations of
Activin/chemical drugs. Graph shows the expression level of Pax6, which can be considered both a marker of
neural progenitor cells, and a marker of retinal progenitors. Pax6 expression levels was measured after treatment
with  10  µM  IWR-1-Endo  (WNTi),  5  µM  Dorsomorphin  (BMPi),  or  with  both  chemical  drugs  (double
WNTi+BMPi), together with different doses of Activin-A recombinant protein (10, 50 or 100 ng/ml). Cells were
treated during Step-II (starting from the beginning of day2) and analyzed at the end of Step-II, day4, as previously
schematized (See Figure 5.5). Control untreated cells were cultured in 0.1% DMSO containing medium. Increasing
doses of Activin clearly inhibited Pax6 expression in a dose-dependent manner, in a similar way to what previously














































Results and Discussion  5−Anterior Brain Patterning
Figure 5.11 shows Pax6 labeling on control (CDMM+0.1% DMSO cultured) cells, where Pax6
antibody staining revealed a salt-and-pepper mosaic of positive and negative groups of cells (as
previously seen in Results, Chapter 3); Pax6-positive cells were 37% among total cell number. 
Wnt-inhibition (both alone and together with BMP-inhibition) caused a strong increase of Pax6-
positive  cells  (Wnt-inhibition:  55.5%  Pax6-positive  cells;  double  Wnt/BMP-inhibition:  66.4%
positive cells; Figure 5.12A,B), and this was consistent with RT-PCR results (Figure 5.10). Activin
treatment  dramatically  repressed  Pax6,  which  ranged from 1.5  to  12% of  total  cell  number  in
different treatment combinations (Figure 5.13 and Figure 5.12B). A clear dose-dependent effect of
Activin  treatment  on Pax6 inhibition was evident:  WNTi+BMPi+10 ng/ml  Activin scored 12%
Pax6-positive  cells,   WNTi+BMPi+50  ng/ml  Activin  scored  4%  Pax6-positive  cells  and
WNTi+BMPi+100 ng/ml Activin scored only 3% Pax6-positive cells (Figure 5.13).
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Figure 5.11: Pax6 expression in control (DMSO-cultured) cells. Immunocytodetection of Pax6 (red), in ES cells
at the end of Step-II, day4, after differentiation in 0.1% DMSO-containing medium (Ctrl DMSO). Nuclei counter-
staining was obtained with DAPI.
Pax6  DAPI
Ctrl DMSO, Step-II
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
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Figure 5.12: Effects of Wnt-inhibition and Activin treatment on Pax6 expression. Immunocytodetection of Pax6
(red), in ES cells at the end of Step-II, day4, after treatment with Wnt-inhibitor (10 µM IWR-1-Endo; A) or with
Wnt-inhibitor  plus  10  ng/ml  Activin;  B).  Nuclei  counter-staining  was  obtained  with  DAPI.  Activin  treatment
dramatically repressed Pax6, as few Pax6-positive cell clusters were present in culture after Activin treatment.
Pax6  DAPI
Pax6  DAPI
WNTi, end of Step-II
WNTi+10 ng/ml Activin, end of Step-IIB
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Nestin immunostaining was analyzed only from the qualitative point of view. However, Figure 5.14
shows very clearly that Nestin staining followed a general trend consistent with RT-PCR data. A
strong staining was detected at the end of Step-II on control cells and on Wnt, BMP or double
Wnt/BMP inhibited  cells  (Figure  5.14 and  data  not  shown),  but  the  staining  was  markedly
decreased  by Activin treatment  in  a  dose-dependent  manner.  In  cells  treated with high Activin
doses, only few cell clusters maintained a strong Nestin staining (white arrow in Figure 5.14).
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Figure  5.14:  Effects  of  Wnt-inhibition  and  increasing  doses  of  Activin  treatment  on  Nestin  expression.
Immunocytodetection of Nestin (red), in ES cells at the end of Step-II, day4, after treatment with Wnt-inhibitor (10
µM IWR-1-Endo; A) or with Wnt-Inhibitor+10 or +50 ng/ml Activin ((B) and (C), respectively). Nuclei counter-
staining  was  obtained  with  DAPI.  Nestin  staining  was  markedly  decreased  by  Activin  treatment  in  a  dose-
dependent manner.
Nestin  DAPI
WNTi WNTi+10 ng/ml Activin WNTi+50 ng/ml Activin
A B C
Figure  5.13:  Pax6-positive  cell  ratio  after  treatment  with  different  combinations  of  Activin/chemical  drugs.
Graph shows fractions of Pax6-positive cells, in ES cells at the end of Step-II, day4, after differentiation in different
conditions  (Wnt-inhibition,  BMP-inhibition  and  double  Wnt/BMP-inhibition,  as  indicated  in  Figure  5.5).
Experimental results were consistent with RT-PCR data, showed in  Figure  5.10. Activin treatment dramatically














































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Taken all together, these data indicated that Activin had two different effects on our cultures:
• Activin treatment, when associated together with Wnt- and/or BMP-inhibition, was able to
inhibit cortical gene expression and sustain retinal gene expression, as seen by RT-PCR.
• ES cell neural conversion was partially prevented by Activin treatment, as seen by both RT-
PCR and immunocytodetection analysis of Nestin and Pax6 expression. This means that
Activin treatment reduced the neuralization efficiency of our protocol,  and the inductive
effect of Activin on retinal marker expression could be consequently underestimated.
A better characterization of Activin effect on ES cell neural conversion, and the modifications to our
protocol to reduce Activin side-effect on neuralization will be discussed later in this Chapter. 
To directly visualize Rax-positive cells, we took advantage of a Rax-GFP knock-in ES cell line (K/l
EB5,  a  kind  gift  of  Professor  Yoshiki  Sasai).  Cells  were treated  with WNTi+10 ng/ml  Activin
during Step-II, then fixed at the end of Step-II and analyzed by immunocytodetection.  Rax-GFP-
positive neural progenitors were not present in our control culture; on the contrary, we found GFP-
positive cells in WNTi+10 ng/ml Activin condition (Figure 5.37).
This first attempt to use K/l EB5 ES cell line was successful, as we obtained Rax-GFP staining after
WNTi+Activin treatment (10ng/ml), but this experiment highlighted again the low efficiency of our
protocol when associated with Activin treatment,  both in terms of neuralization (only 9.3 % of
Pax6-positive cells, compared to 36.7 % of Pax6-positive cells in control sample) and in terms of
Rax expression (only 8.8 % of Rax-GFP-positive cells inside the culture) (Figure 5.16).
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Figure 5.15: Effects of Wnt-inhibition+Activin treatment on GFP expression in the Rax-GFP knock-in cell line
K/l EB5. Immunocytodetection of Pax6 (red) and GFP (expressed under the control of Rax promoter; green), in K/l
EB5 ES cells at the end of Step-II, day4, after treatment with Wnt-inhibitor (10 µM IWR-1-Endo) plus 10 ng/ml
Activin (B), compared to control cells (A). Nuclei counter-staining was obtained with DAPI. As shown before, Pax6
staining was markedly decreased after Activin treatment. Interestingly, groups of Pax6-positive cells were often
showing GFP co-labeling. This demonstrated that Activin was able to drive Rax expression in neural progenitors,
consistently with RT-PCR data.
Rax-GFP  Pax6  DAPI
WNTi+10 ng/ml Activin
Rax-GFP  Pax6  DAPI
Ctrl DMSOA B
Figure 5.16: Pax6-positive and Rax-GFP-positive cell ratios after treatment with Wnt-inhibitor+Activin. Graphs
show fractions of GFP-positive cells (A) and Pax6-positive cells (B), in Rax-GFP knock-in cell line K/l EB5 at the
end of Step-II, day4, after differentiation in different culture conditions as described in Figure 5.37. Despite low
neuralization efficiency after Activin treatment (only 9.34% of Pax6-positive cells, compared to 36.65% of Pax6-
positive cells in control sample), Activin switched-on GFP expression under the control of Rax promoter (8.76% of








































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Previous studies demonstrated that cells  co-expressing the eye field marker Rax and the neural
marker Pax6 are bona fide retinal progenitors (Zuber et al., 2003; Ikeda et al., 2005). We performed
a double immunocytodetection of Rax-GFP together with Pax6, to test for a possible co-expression
also in our differentiation culture.
After treatment with WNTi+10 ng/ml Activin, the most represented population inside the culture
among immunolabeled cells (Pax6-positive cells, GFP-positive cells, or double Pax6/GFP-positive
cells)  was  the  one  expressing  both  proteins.  Pax6-positive/GFP-negative  cells  (red  column  in
Figure  5.17) were 30.15% over labeled cells, which correspond to 4.2% positive cells over total
cell population. Pax6-negative/GFP-positive cells (green column in Figure 5.17) were only 10.15%
over labeled cells, which correspond to a very small percentage (1.3% positive cells) of total cell
population. Finally, double Pax6/GFP-positive cells (yellow column in  Figure  5.17) were 59,7%
over labeled cells, which correspond to 7.5% positive cells over total cell population. Thus, Pax6
and Rax-GFP were often co-expressed (in the 59.7% of case). This result demonstrated that Activin
is able to induce the differentiation of bona fide Rax(+)/Pax6(+) retinal progenitors. However, the
ratio of double Rax/Pax6-positive neural progenitors among total cell population was quite low,
scoring only 7.5% positive cells.
To improve the protocol efficiency, we addressed the problem of inefficient neuralization, starting
with a more detailed characterization of the markers of pluripotency/neural identity by RT-PCR in
different conditions.
As  already described  in  Results,  Chapter  1,  differentiating  ES cells  gradually switched-off  the
expression of pluripotency/epiblast markers (Oct4 and FGF5), and up-regulated the expression of
neural  markers  (Nestin,  Pax6  and  Sox2)  during  differentiation  in  chemically  defined  minimal
medium (CDMM) (Figure 5.18).
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Oct4 was strongly down-regulated between Step-I and Step-II, as differentiation started (Figure
5.18). Sox2, which is considered both an embryonic stem cell pluripotency marker and a neural
progenitor  marker,  behaved  consistently  with  this  definition,  being  strongly expressed  by both
undifferentiated ES cells and neural progenitors. Nestin and Pax6 expression became strong during
Step-II, while β-Tubulin-III expression increased at Step-III.  The expression of mesodermal and
endodermal markers Gata4, Gata6 and Brachyury (T) was very low, almost undetectable, indicating
the absence of meso/endodermal differentiation inside our protocol.  Shh, which is produced by
ventral neural progenitors (Jessell, 2000) and lately in development acts as a mitogen for cortical
progenitors (Komada et al., 2008; 2012), was expressed at low levels starting at Step-II.
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Figure 5.17. Immunocytodetection of Pax6 (red) and GFP (expressed under the control of Rax promoter; green),
in K7l EB5 ES cells (Rax-GFP knock-in cell line K/l EB5) at the end of Step-II, day4, after treatment with Wnt-
inhibitor (10 µM IWR-1-Endo) plus 10 ng/ml Activin. Groups of Pax6-positive cells were often showing GFP co-
labeling (59.7% double Pax6/Rax-GFP-positive cells, yellow arrow in the immunocytodetection).
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Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
When  the  same  genes  were  analyzed  after  treatments  with  different  combinations  of
Activin/chemical drugs, we found that Activin presence in culture medium dramatically affected the
process of ES cell neuralization (Figure 5.19A,B). As a general trend, neuralization was achieved
spontaneously  in  our  control  condition  (ES  cell  differentiation  in  CDMM+0.1%  DMSO;  first
column group on the left in Figure 5.19B), and was even strengthened after Wnt-, BMP- or double
Wnt/BMP-inhibition (see Sox2, Pax6 and Nestin expression, green color code in  Figure 5.19B).
This was confirmed also by measuring the expression of pluripotency markers (blue color code in
Figure 5.19B): pluripotent stem cell marker Oct4 and epiblast marker FGF5 were silenced after ES
cell differentiation, both in control condition (CDMM DMSO) and in cells treated with Wnt, BMP
or Wnt/BMP inhibitors. Meso/endodermal marker Gata4, Gata6 and Brachyury (T) expression level
was almost undetectable in these conditions.
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Figure 5.18: RT-PCR mRNA analysis of expanding ES cells (undifferentiated), or of ES cells at different steps of
neural differentiation protocol. Figure shows mRNA fold changes of  pluripotent cell  markers Oct4 and Sox2,
progenitor cell markers Pax6 and Nestin, neuronal marker β-Tubulin-III, mesoderm markers T and Gata4, and
ventral marker Shh, as evaluated by RT-PCR at different time points, as indicated. Mesodermal marker expression
(T and Gata4) was almost undetectable, suggesting that the vast majority of ES cells in our protocol adopted a
neural fate. Shh was expressed at low levels starting from Step-II. Data were normalized on maximum expression.







































Results and Discussion  5−Anterior Brain Patterning
The situation after treatment with Activin was markedly different. Activin treatment switched-off
the expression of neural progenitor markers Pax6, Nestin and Sox2 in a dose-dependent manner
(see how green columns, corresponding to the expression level of neural markers, were lower when
compared to control CDMM condition). Vice versa, the presence of Activin in the medium impeded
the down-regulation of the pluripotency markers Oct4 and FGF5, which are ormally silenced as
differentiation starts in vitro. Oct4 expression level was particularly high in cells treated with Wnt-
inhibitor+Activin or with double Wnt/BMP-inhibition+Activin, while FGF5 expression peaked in
cells treated with BMPi+Activin. 
Concerning  the  meso/endodermal  markers  Gata4,  Gata6  and  Brachyury  (T)  (yellow  and  red
columns in Figure 5.19B), their expression was switched-on by Activin treatment, accordingly with
an Activin role  in  mesodermal  and endodermal  induction  (Cerdan et  al.,  2012).  Brachyury (T)
expression  was  particularly  high  in  cells  treated  with  BMP-inhibition+10  ng/ml  Activin.  This
sample was also characterized by a high expression level of the ventral marker Shh (violet columns
in Figure 5.19B). 
Dissecting the characteristics of each combination of treatments was far from easy. Anyhow, some
general trends were deduced:
• ES  neural  conversion  was  increased  by  Wnt,  BMP  or  double  Wnt/BMP-inhibition,
compared to control cells, but was strongly prevented by Activin treatment, as seen by the
dramatic down-regulation of Sox2, Nestin and Pax6 in cells treated with increasing doses of
Activin.
• Activin acted mainly by slowing down the neuralization process  that  normally ES cells
undergo in our protocol when cultured in a minimal medium. This was suggested by the
high expression levels of the pluripotency markers Oct4 and FGF5 in Activin-treated cells.
• As another side-effect of Activin treatment, the expression of mesodermal markers Gata4
and  Brachyury  was  induced.  The  “mesodermal  contamination” of  our  culture  was
particularly  evident  in  cells  treated  with  BMPi  plus  low  Activin  dose.  This  particular
combination also showed a high degree of ventralization, as suggested by the high level of
Shh expression. For this reason,  BMP-inhibition alone was not used as a retinal inducing
treatment in later experiments.
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The effect of Activin on ES cell neuralization was also investigated by immunocytodetection of the
neural  progenitor  marker  Musashi-1  (red  staining  in  Figure  5.20,  Panels  A-D)  and  of  the
pluripotency marker Oct4 (green staining in  Figure 5.20, Panels A-D), as detected at the end of
Step-II.
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Figure  5.19:  Experimental scheme showing different combinations of Activin/chemical drugs treatments, and
RT-PCR mRNA analysis of ES cells differentiated in diverse culture conditions as indicated. The upper scheme
(A) lists different combinations of Activin doses (10, 50 and 100 ng/ml Activin-A recombinant protein), tested in
association  with  different  anteriorizing treatments  (Wnt-inhibition,  BMP-inhibition  and  double  Wnt/BMP-
inhibition). Cells were treated with recombinant protein/chemical drugs starting at the beginning of Step-II, day2,
and analyzed at the end of Step-II, day4, for a total of 6 days of  in vitro differentiation after LIF withdrawal.
Control untreated cells were cultured in 0.1% DMSO containing medium. The lower graph (B) shows mRNA fold
changes of pluripotent cell markers Oct4 and Sox2, progenitor cell markers Pax6 and Nestin, neuronal marker β-
Tubulin-III, mesoderm markers T and Gata4, and ventral marker Shh, as evaluated by RT-PCR, in cells as in (A).
Activin slowed-down ES cell neuralization process and induced the expression of mesodermal markers. Data were
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Figure  5.20:  Effects  of  different  combinations  of  Activin/chemical  drugs on  ES cell  neural  differentiation.
Panels A-D show immunocytodetection of neural marker Musashi-1 (red) and stem cell marker Oct4 (green), in ES
cells  at  the  end  of  Step-II,  day4,  after  treatment  with  different  combinations  of  Activin/chemical  drugs,  as
schematized in Figure 5.5 and Figure 5.19. Nuclei counter-staining was obtained with DAPI. As showed before by
RT-PCR (Figure 5.19), the expression level of neural markers was markedly reduced after Activin treatment, while
that of pluripotency markers was increased.
Ctrl DMSO WNTi
BMPi WNTi+BMPi
Panel A Oct4  Musashi-1
WNTi WNTi+Act50
WNTi+Act10 WNTi+Act100
Panel B Oct4  Musashi-1
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This effect of Activin on neural differentiation was confirmed here by Oct4 and Musashi-1 immunostaining: the vast
majority of cell population remained in a undifferentiated (Oct4-positive) state after treatment with high doses of
Activin (50 and 100 ng/ml).  Musashi-1 immunostaining showed a signal intensity and distribution which were
complementary to those of Oct4. Concerning Activin effect on neural differentiation markers, see also Figure 5.12,
Figure 5.13 and Figure 5.14.
BMPi BMPi+Act50
BMPi+Act10 BMPi+Act100
Panel D Oct4  Musashi-1
WNTi+BMPi WNTi+BMPi+Act50
WNTi+BMPi+Act10 WNTi+BMPi+Act100
Panel C Oct4  Musashi-1
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The result was perfectly consistent with RT-PCR data, showing high ratio of Oct4-positive cells in
Activin-treated samples (Figure 5.20 and Figure 5.21). Oct4-positive cell ratio was low in control
cells (0.71% Oct4-positive cells) and was not strongly affected by Wnt-inhibition, BMP-inhibition
and double Wnt/BMP-inhibition (3.24%, 0.2% and 4.7% Oct4-positive cells,  respectively);  this
indicated that ES cells switched-off Oct4 expression when differentiated using our protocol. On the
contrary, Activin treatment dramatically increased Oct4-positive cell ratio.  As an example, Wnt-
inhibition+10 ng/ml Activin treated cultures scored 51.1% Oct4-positive cells, Wnt-inhibition+50
ng/ml Activin treated cultures scored 80.7% Oct4-positive cells  and this percentage was further
increased in Wnt-inhibition+100 ng/ml Activin treated cultures,  with 91.6% Oct4-positive cells.
This indicated that the vast majority of cell population was still in a undifferentiated state at the
fourth day of Step-II, after treatment with high doses of Activin  (Figure 5.20 and  Figure 5.21).
Moreover, this result is consistent with the reduced neuralization observed at later stages of in vitro
differentiation  after  Activin  treatment  (see  above).  Musashi-1  immunostaining  showed  signal
intensity and distribution that were complementary to those of Oct4 immunostaining (Figure 5.20).
Oct4-positive cell ratio in BMP-inhibition alone was not so high if compared to other conditions
(ranging from 15.3% in BMPi+10 ng/ml Activin treated cells to 57.2% in BMPi+100 ng/ml Activin
treated  cells);  this,  together  with  RT-PCR  data  showing  high  Gata4,  Gata6  and  Brachyury
expression  levels,  suggested  that  cells  treated  with  BMP-inhibition+Activin  followed  a
meso/endodermal differentiation fate instead of simply being slowed-down in differentiation.
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Figure  5.21:  Effects  of  different  combinations  of  Activin/chemical  drugs  on  ES cell  neural  differentiation.
Graph shows  Oct4-positive  cell  ratio  in  ES cells  at  the end  of  Step-II,  day4,  after  differentiation in  different
conditions as indicated in Figure 5.5 and Figure 5.19. Images are shown in Figure 5.20. Oct4-positive cell ratio
was low in control cells (0.71% Oct4-positive cells). On the contrary, Activin treatment dramatically increased
Oct4-positive cell ratio, even at the lowest dose tested (51.13% Oct4-positive cells after WNTi+10 ng/ml Activin, as
an example). This suggested that ES cell neural conversion was partially prevented by Activin treatment in a dose-




















































Results and Discussion  5−Anterior Brain Patterning
Taken together, all these data highlighted the effect of Activin on ES cell neuralization and possibly
explained the reason for the low efficiency of Rax-GFP-positive cell induction in our protocol (as
showed before in Figure 5.37 and Figure 5.16).
To  investigate  whether,  after  an  initial  delay,  Activin-treated  cells  could  efficiently  undergo
neuralization,  we  cultured  cells  for  a  longer  period  during  Step-II,  without  any  additional
dissociation/replating. For subsequent experiments, cells were then cultured until the end of Step-II
as  a  first  analysis  time  point  (fourth  day  of  the  canonical  Step-II,  for  a  total  of  6  days  of
differentiation  after  LIF  withdrawal)  and  simultaneously  until  a  new analysis  time  point  (two
additional days of culture in a prolonged Step-II, for a total of 8 days of differentiation after the
starting point of the protocol), to allow for more cells to gradually convert into neural progenitors
and express neuronal/regional markers.
Rax-GFP knock-in ES cell line was treated with WNTi+10 ng/ml Activin during Step-II, then fixed
and analyzed by immunocytodetection. This time some samples were cultured until the additional
analysis point at Step-II, day6, which corresponded to a total of 8 days of differentiation after LIF
withdrawal. A comparison between cells treated with Wnt-inhibitor+10 ng/ml Activin, analyzed by
immunocytodetection at the two different time points during neural differentiation, showed how the
vast majority of cells inside the culture were still expressing Oct4 at the end of Step-II, day4 (51.1%
Oct4-positive cells, as showed before in  Figure 5.20 and  Figure 5.21), and this expression was
down-regulated in the following two days, at the end Step-II, day6, even if not completely (18.9%
Oct4-positive cells) (Figure 5.22). Rax-GFP-positive cell ratio increased three-fold at Step-II, day6
(longer protocol, 8 days of differentiation; 24.4% Rax-GFP-positive cells), when compared to Step-
II, day4 (shorter protocol, 6 days of differentiation; 8.8% Rax-GFP-positive cells) (Figure 5.23).
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This was accompanied by a more than two-fold increase of the neuronal/retinal marker Pax6 (9.3%
Pax6-positive cells in WNTi+Activin at Step-II, day4; 21.7% Pax6-positive cells at Step-II, day6)
(Figure 5.24). This experiment suggested that Activin treatment delayed but did not completely
impaired neural differentiation. In fact, two additional days of differentiation allowed more efficient
neural  conversion  (as  seen  by Pax6-positive  cell  ratio  increase  and by Oct4-positive  cell  ratio
decrease) and higher retinal marker expression (evaluated by the increase of Rax-GFP-positive cell
ratio).
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Figure  5.22:  Effects of Activin treatment on ES cell differentiation. (A) and (B) show immunocytodetection of
stem cell marker Oct4 (red) in ES cells (Rax-GFP knock-in cell line K/l EB5) at the end of Step-II, day4 (6 days of
differentiation  after  LIF  withdrawal;  A)  or  at  the  end  of  Step-II,  day6  (8  days  of  differentiation  after  LIF
withdrawal; B), after treatment with Wnt-inhibitor (10 µM IWR-1-Endo) plus 10 ng/ml Activin. Activin was added
to culture  medium at  the beginning of  Step-II,  day2,  together  with Wnt-inhibitor.  Nuclei  counter-staining was
obtained with DAPI. The vast majority of cells inside the culture were still expressing Oct4 at the end of Step-II,
day4 (51.1% Oct4-positive cells, as showed before in Figure 5.20 and Figure 5.21), and this expression was down-
regulated in the following two days, at the end Step-II, day6, even if not completely (18.9% Oct4-positive cells; B).
Step-II day4 (overall day6) Step-II day6 (overall day8)
WNTi+Act10 STWNTi+Act10 ST
Pax6  DAPI Pax6  DAPI
A B
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Figure 5.23: Effects of a longer neural differentiation protocol on Rax expression. Immunocytodetection of GFP
(expressed under the control of Rax promoter in the Rax-GFP knock-in cell line K/l EB5; green), in cells at the end
of Step-II, day4 (A), or at the end of Step-II, day6 (B), after treatment with Wnt-inhibitor (10 µM IWR-1-Endo) plus
10 ng/ml Activin. Nuclei counter-staining was obtained with DAPI. Rax-GFP-positive cell ratio increased three-
fold at Step-II, day6 (longer protocol, 8 days of differentiation; 24.4% Rax-GFP-positive cells) when compared to
Step-II, day4 (shorter protocol, 6 days of differentiation; 8.8% Rax-GFP-positive cells).
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Figure 5.24: Effects of a longer neural differentiation protocol on Rax and Pax6 expression.  Graphs show cell
ratios after immunocytodetection of  Pax6 (orange/red columns) and GFP (expressed under the control  of  Rax
promoter in the Rax-GFP knock-in cell line K/l EB5; green columns), in cells at the end of Step-II, day4 (light color
code), or at the end of Step-II, day6 (dark color code), after treatment with Wnt-inhibitor (10 µM IWR-1-Endo) plus
10 ng/ml Activin. Images showing GFP immunocytodetection are shown in Figure 5.23. The increase of Rax-GFP-
positive cell  ratio at  Step-II,  day6 (longer protocol,  8 days of  differentiation),  was accompanied by a two-fold
increase  of  the  neuronal  marker  Pax6  (9.34% Pax6-positive  cells  in  Wnt-inhibition+Activin  at  Step-II,  day4;























































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
The analysis  of  Rax activation  in  the  K/l  EB5 ES cell  line  at  late  time of  differentiation  was
repeated for all the combinations of Activin doses plus Wnt and/or BMP pathway inhibitions. Wnt-
inhibition+10 ng/ml Activin turned out to be the best treatment to induce Rax-GFP-positive cells
(Figure 5.25A,B).
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Figure  5.25:  Effects of a longer neural differentiation protocol on Rax and Pax6 expression after treatments
with  different  combinations  of  Activin/chemical  drugs. Graphs  (A)  and  (B)  show  cell  ratios  after
immunocytodetection of Pax6 (orange/red columns, B) and GFP (expressed under the control of Rax promoter in
the Rax-GFP knock-in cell line K/l EB5; green columns,  A),  in ES cells at the end of Step-II, day4 (6 days of
differentiation; light color code), or at the end of Step-II, day6 (8 days of differentiation; dark color code), after
treatment with different combinations of Activin/chemical drugs. Wnt-inhibition+10 ng/ml Activin turned out to be
the best treatment to induce Rax-GFP-positive cells (24.4% Rax-GFP-positive cells at Step-II, day6). Error bars:
standard error.
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To better quantify the ratio of Rax-GFP-positive cells over time, and to explore the dynamic of Rax-
GFP expression at later time of differentiation, we  analyzed GFP expression by flow cytometry
during a differentiation protocol where Step-II was further prolonged (Figure 5.26).
Cells  were  treated  with  Wnt-inhibitor  +10 ng/ml  Activin,  and Rax-GFP-positive  cell  ratio  was
measured every 12 hours, starting from Step-I, day2 (2 days of differentiation  in vitro after LIF
withdrawal; 2 DIV), until Step-II, day8 (10 DIV). Non-treated cells, cultured in 0.1% DMSO, were
used as a negative control. GFP expression switched-on at Step-II, day3 (5 DIV; 15% GFP-positive
cells), increased at Step-II, day5 (7 DIV; 25% GFP-positive cells), peaking at Step-II, day6 (8 DIV;
34% GFP-positive cells). After Step-II, day6, GFP-positive cell ratio remained constant (39% GFP-
positive cells at 10 DIV; Figure 5.26). CDMM culture condition (control) induced no Rax-positive
neural progenitor (this is consistent with the predominantly mesencephalic identity of our control
cells,  see  Results,  Chapter  3).  This  data  reconfirmed  the  necessity  for  a  longer  time  of
differentiation when treating cells with Activin, to overcome for slow neural conversion in Activin-
treated samples.
We directly compared the retinal inducing activity of different culture conditions (Wnt and/or BMP-
inhibition,  plus  increasing  doses  of  Activin)  in  terms  of  percentage  of  Rax-positive  neural
progenitors  generated  by  ES  cells.  The  analysis  by  flow  cytometry  was  repeated  for  all  the
combinations of Activin doses (10 ng/ml and 50 ng/ml) plus chemical drugs (Wnt-inhibition, BMP-
inhibition and double Wnt/BMP-inhibition), processing samples at Step-II, day6 (longer protocol, 8
days  of  differentiation  after  LIF  withdrawal)  (Figure  5.27).  Again,  Wnt-inhibition+10  ng/ml
Activin was the best treatment to induce Rax-GFP expression (39.2% Rax-GFP-positive cells). The
lowest dose of Activin (10 ng/ml) gave good results also when associated together with double
Wnt/BMP-inhibition, scoring 30.9% Rax-GFP-positive cells at Step-II, day6.
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During the analysis of the Rax-GFP-positive cell ratio by flow cytometry, we noticed an interesting
phenomenon concerning Rax gene expression.  Cells  treated with Wnt-inhibition alone (without
concomitant  Activin treatment)  showed a transient  activation of  GFP under  the  control  of  Rax
promoter during the first days of differentiation (Figure 5.15). Rax-GFP-positive cells appeared at
Step-II, day2 (4 days of differentiation after LIF withdrawal, and only 24 hours after the starting
point of Wnt-inhibition treatment; 4 DIV; 10% Rax-GFP-positive cells). Rax-GFP-positive cells
scored their maximum percentage at Step-II, day3 (5.5 DIV; 28% Rax-GFP-positive cells), then
they started decreasing at Step-II, day4 (6.5 DIV; 19% Rax-GFP-positive cells). At later time points
of the analysis (Step-II, day6 and following days) Rax-GFP expression was almost disappeared and
was not significantly differing if compared to that of control untreated cells (Figure 5.15).
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Figure 5.26: Rax-GFP expression analysis by flow cytometry during neural differentiation. Quantification of the
Rax-positive cell ratio by flow cytometry during neural differentiation, using the Rax-GFP knock-in cell line K/l
EB5. Cells were differentiated in Wnt-inhibition+10 ng/ml Activin, and Rax-GFP-positive cell ratio was measured
every  12  hours  during  differentiation,  starting  at  Step-I,  day2  (2  days  of  in  vitro  differentiation  after  LIF
withdrawal; 2 DIV), until Step-II, day8 (10 DIV). Non-treated, 0.1% DMSO cultured cells were used as a negative
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Figure  5.27:  Rax-GFP expression analysis by flow cytometry after treatments with different combinations of
Activin/chemical drugs. Quantification of the Rax-positive cell ratio by flow cytometry at Step-II, day6 (8 days of
differentiation after LIF withdrawal), using the Rax-GFP knock-in cell line K/l EB5. Graph shows GFP-positive
cell  ratios  after  treatment  with  different  combinations  of  Activin/chemical  drugs.  Consistent  with
immunocytodetection data (see Figure 5.23), Wnt-inhibition+10 ng/ml Activin turned out to be the best treatment to
induce Rax-GFP-positive cells (39.2% GFP-positive cells). Good results were obtained also after treatment with
double Wnt/BMP-inhibition+10 ng/ml Activin (30.9% GFP-positive cells). Error bars: standard error. 














































Figure 5.28: Rax-GFP expression analysis by flow cytometry during neural differentiation.  Quantification of the
Rax-positive retinal progenitor percentage by flow cytometry during neural differentiation, using the Rax-GFP
knock-in cell line K/l EB5. Cells were differentiated in Wnt-inhibition (no concomitant Activin treatment), and Rax-
GFP-positive cell ratio was measured every 12 hours during differentiation, starting at Step-I, day2 (2 days of
differentiation after LIF withdrawal; 2 DIV), until Step-II, day8 (10 DIV). Non-treated, 0.1% DMSO cultured cells
were used as a negative control. Cells treated with Wnt-inhibition alone showed a transient activation of GFP
under the control of Rax promoter during the first days of differentiation (first GFP-positive cells were detected at 4




















































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
The precocious  and transient Rax expression during ES neural differentiation in  Wnt-inhibition
treatment was confirmed by both Rax-GFP immunocytodetection, performed on Rax-GFP knock-in
ES cell line, and RT-PCR, performed on control E14 ES cell line. Cells treated with Wnt-inhibition
showed a widespread Rax-GFP signal at Step-II, day3 (5 days of differentiation after the starting
point  of  the  protocol;  Figure  5.29A);  three  days  later  Rax-GFP signal  was  almost  completely
disappeared (Figure 5.29B).
Early  Rax  expression  during  differentiation  of  ES  cell  treated  with  Wnt-inhibition  was  also
detectable by RT-PCR, performed on control E14 ES cell line (Figure 5.30). As showed before (see
Results, Chapter 4), Wnt-inhibition established an anterior, cortical fate in ES cells differentiated in
vitro; consistently, cortical markers were gradually up-regulated during neural differentiation and
cortical fate acquisition. Interestingly, Wnt-inhibition triggered a wave  of Rax expression, which
anticipated the establishment of cortical marker expression. The wave of Rax expression started at
the end of Step-II, day2, after the first 24 hours of Wnt-inhibition treatment, and reached the highest
level at Step-II, day3. Rax was then rapidly down-regulated, and this was accompanied by robust
up-regulation of cortical gene markers (FoxG1, Tbr1, Ctip2 and Emx2). The expression of Six6 (a
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Figure  5.29:  Effects  of  Wnt-inhibition  on  Rax  expression  during  early  neural  differentiation.
Immunocytodetection of GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell line K/l
EB5; green), in ES cells at the end of Step-II, day3 (5 days of differentiation after LIF withdrawal, A), or at the end
of Step-II, day 6 (8 days of differentiation after LIF withdrawal,  B), after treatment with Wnt-inhibitor (10 µM
IWR-1-Endo), without concomitant Activin treatment. Nuclei counter-staining was obtained with DAPI.
Step-II day3 (overall day5) Step-II day6 (overall day8)
WNTiWNTiA B
Rax-GFP  DAPI Rax-GFP  DAPI
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retinal marker) followed the same dynamic of Rax expression.
These results indicate that early Rax expression was not an artifact regarding Rax-GFP knock-in
cell line, but could be detected even by using an unmodified ES cell line (E14  cell line).
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Figure 5.30: RT-PCR mRNA quantification of retinal/cortical marker expression during neural differentiation
in ES cells treated with Wnt-inhibition. Figure shows mRNA fold changes of retinal markers Rax and Six6, and of
cortical markers Emx2, FoxG1, Tbr1 and Ctip2, as evaluated by RT-PCR, in ES cells (E14 control ES cell line)
treated  with  Wnt-inhibitor  (10  µM IWR-1-Endo),  without  concomitant  Activin  treatment.  Cells  were  analyzed
starting at Step-II, day2 (4 days of differentiation after LIF withdrawal, and only 24-hours after the starting point of
Wnt-inhibition treatment), until Step-II, day6 (8 days of differentiation). Wnt-inhibition triggered a wave of retinal
marker (Rax and Six6) expression during early neural differentiation, which anticipated (by peaking at Step-II,
day3) the establishment of cortical marker expression, then gradually decreased (disappearing at Step-II, day5).
Data were normalized on maximum expression. Error bars: standard error. 
























Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
As previously described, Wnt-inhibited cells followed an anterior (cortical) differentiation fate (see
Results, Chapter 4). The reason for an early transient wave of Rax expression in cells that will then
follow a cortical differentiation fate was not further investigated. Anyhow, it should be noticed that
early  Rax  expression  in  early  FoxG1-positive  telencephalon  has  been  reported  both  in  lower
vertebrates and mouse (Furukawa et al., 1997; Lupo et al., 2002), and this suggest that early Rax
expression in our culture system might mimic a mechanism actually present in neural development
in vivo. This hypothesis in now the topic of an undergoing project in our Lab.
As the side-effect of Activin on neural differentiation efficiency is concerned, we tested if a change
of the starting point of Activin treatment could improve the neuralization efficiency. As showed
before (see Results,  Chapter  1),  Sox1-positive and Nestin-positive  neural  progenitors  started  to
accumulate at mid-Step-II, after 4 days of ES cell differentiation. The presence of Activin in the
culture medium starting from the Step-II,  day2,  could interfere with this  early phase of neural
induction, sustaining Oct4 and FGF5 expression (as showed in Figure 5.19). We reasoned that this
effect  could be possibly prevented or reduced by simply delaying Activin treatment  during the
differentiation period. We first treated cells with 10 ng/ml Activin starting at mid-Step-II (beginning
of the fifth day of total differentiation time), with a 24-hour delay when compared to normal Activin
treatment. Wnt-inhibition was performed as usual, starting at the beginning of Step-II, day2. We
then immunodetected Pax6 and Rax-GFP at the end of Step-II, day4 (Figure 5.31). We found that a
24-hour delay of Activin treatment increased the ratio of both Pax6-positive and Rax-GFP-positive
cells (Figure 5.31 and Figure 5.33).
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Rax-GFP signal was almost absent in control cells (0.02% Rax-GFP-positive cells; Figure 5.32). In
cells treated with Wnt-inhibition, Rax-GFP-positive cell ratio was 5.7%. These GFP-positive cells
were probably the queue of the early wave of Rax expression showed before (see  Figure 5.15,
Figure 5.29 and Figure 5.30).
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Figure 5.31: Effects of a 24-hour delay in Activin treatment on Rax and Pax6 expression. Immunocytodetection
of Pax6 (red) and GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell line K/l EB5;
green), in ES cells at the end of Step-II, day4 (6 days of differentiation), after treatment with Wnt-inhibitor (10 µM
IWR-1-Endo) plus 10 ng/ml Activin. Activin was added to the culture medium at the beginning of Step-II, day2, as
usual (Start protocol; A), or at the beginning of Step-II, day3, with a 24-hour delay compared to control protocol
(24h-delay protocol; B). Nuclei counter-staining was obtained with DAPI. Control untreated cells (cultured in 0.1%
DMSO containing medium) and cells treated with Wnt-inhibitor are showed in Figure 5.32.
Rax-GFP  Pax6  DAPI
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The Rax-GFP-positive cell ratio, which was 8.8% in normal protocol – Activin at the beginning of
second day of Step-II; Start protocol – underwent a two-fold increase and reached a score of 19%
positive cells when Activin was added later (24-hour Delay protocol – Activin at Step-II, beginning
of  day3) (Figure 5.33A). Pax6-positive cells were also increased by the 24-hour delay in Activin
treatment  (9.3% Pax6-positive  cells  in  normal  condition,  38.1% Pax6-positive cells  in  24-hour
delayed treatment), suggesting a higher neuralization (Figure 5.33B). The improvement of protocol
efficiency due to delay of Activin treatment was particularly relevant, especially considering that
the total time of treatment was shorter (only two days, while normal Activin treatment lasted for 3
days).
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Figure 5.32: Rax and Pax6 expression in control or Wnt-inhibited cells. Immunocytodetection of Pax6 (red) and
GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell line K/l EB5; green), in ES cells at
the end of Step-II, day4 (6 days of differentiation), after treatment with Wnt-inhibitor (10 µM IWR-1-Endo; B). (A)
shows control cells. Nuclei counter-staining was obtained with DAPI. Some groups of GFP-positive cells were
found after treatment with Wnt-inhibitor; these cells were probably about to switch-off Rax expression, as shown in
Figure 5.15, Figure 5.29 and Figure 5.30.
Rax-GFP  Pax6  DAPI
WNTi
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In parallel,  we decided to test different doses of Activin on ES differentiating cells. As showed
before (Figure 5.6), Activin/Nodal pathway target gene FoxH1 was strongly up-regulated by the
presence of Activin in the culture medium. FoxH1 expression did not increase with Activin doses
higher than 10 ng/ml, suggesting that this was already a saturating dose. Thus, we reasoned that
another  possible  way to improve our  retinal  differentiation  protocol  was to  reduce the  dose of
Activin in culture medium. Our idea was to test if lower doses of Activin were still able to induce a
retinal  differentiation fate,  without  affecting ES cell  neural  conversion.  Cells  were then treated
during  Step-II  with  lower  Activin  doses,  ranging  from  1  ng/ml  to  10  ng/ml,  including  an
intermediate dose of 5 ng/ml. Cells were analyzed after Rax-GFP/Pax6 immunocytodetection at
Step-II,  day4.  In this  experiment,  Activin doses  were added with a  24-hour  delay to  allow for
efficient neuralization.
Unfortunately, lower Activin doses were less efficient in switching-on Rax-GFP expression (Figure
5.34).
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Figure 5.33: Effects of a 24-hour delay in Activin treatment on Rax and Pax6 expression. Graphs (A) and (B)
show cell ratios after immunocytodetection of Pax6 (red columns) and GFP (expressed under the control of Rax
promoter in the Rax-GFP knock-in cell line K/l EB5; green columns), in ES cells at the end of Step-II, day4 (6 days
of differentiation),  after treatment with Wnt-inhibitor (10 µM IWR-1-Endo) plus 10 ng/ml Activin.  Activin was
added at the beginning of Step-II, day2 (Start protocol; WNTi+Act10 ST), or at the beginning of Step-II, day3, with
a 24-hour delay compared to normal protocol (24h-delay protocol;  WNTi+Act10 DL).  Control  untreated cells
(cultured in 0.1% DMSO containing medium) and cells treated with Wnt-inhibitor but no Activin, were included in
the experiment. Images showing GFP and Pax6 double immuno-labeling can be found in Figure 5.31 and Figure
5.32. When Activin was added with a 24-hour delay to culture medium, Rax-GFP-positive cell ratio increased two-
fold  (18.96% GFP-positive  cells)  compared  to  normal  Start protocol  (8.76% GFP-positive  cells).  Error  bars:
standard error.






















































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
250
Figure  5.34:  Effects  of  different  doses  of  Activin  on  Rax  and  Pax6  expression. Images  (A-D)  show
immunocytodetection of Pax6 (red) and GFP (expressed under the control of Rax promoter in the Rax-GFP knock-
in cell line K/l EB5; green), in ES cells at the end of Step-II, day4 (6 days of differentiation), after treatment with
Wnt-inhibitor (10 µM IWR-1-Endo;  A) or with Wnt-inhibitor plus increasing doses of Activin (1, 5 or 10 ng/ml;
(B), (C) and (D), respectively). Activin was added to culture medium at the beginning of Step-II, day3, with a 24-
hour delay  compared to  canonical  protocol  (24h-delay protocol,  WNTi+Activin DL;  see  scheme on the top).
Nuclei counter-staining was obtained with DAPI. While 10 ng/ml Activin treatment efficiently switched-on Rax
expression, lower Activin doses were not able to drive retinal differentiation.
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Rax-GFP  Pax6  DAPI
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Rax-GFP  Pax6  DAPI
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Pax6-positive cell ratio was increased when cells were treated with low Activin doses, compared to
10 ng/ml Activin treatment (47.8% Pax6-positive cells after 1 ng/ml Activin treatment, and a similar
percentage in cells treated with 5 ng/ml Activin;  Figure 5.35A), but Rax-GFP-positive cells were
only 4.6% after 1 ng/ml Activin treatment and 8.3% after 5 ng/ml Activin treatment (Figure 5.35B).
We decided to  keep 10 ng/ml  Activin  as  the lowest  effective dose for  retinal  induction  in  our
protocol.
We decided to better characterize the timing of Activin retinal induction properties, by analyzing
Rax-GFP expression after Activin treatment performed at different time windows. This was useful
not only to improve the protocol efficiency, but especially to delineate the window of competence
of differentiating ES cells to respond to Activin signal. Control cells were treated with 10 ng/ml
Activin as usual, starting at the second day of Step-II, together with 10 µM of Wnt-inhibitor IWR-
1-Endo. Some replicates samples were treated with 10 ng/ml Activin starting with a delay of 6, 12,
24 or 48 hours with respect to normal treatment (Figure 5.36). Wnt-inhibition always started at the
251
Figure  5.35:  Effects of different doses of Activin on Rax and Pax6 expression.  Graphs (A) and (B) show cell
ratios after immunocytodetection of Pax6 (A) and GFP (expressed under the control of Rax promoter in the Rax-
GFP knock-in cell line K/l EB5; B), in ES cells at the end of Step-II, day4 (6 days of differentiation), after treatment
with Wnt-inhibitor (10 µM IWR-1-Endo) or with Wnt-inhibitor plus increasing doses of Activin (1, 5 and 10 ng/ml
Activin). Activin was added to the culture medium at the beginning of Step-II, day3, with a 24-hour delay compared
to normal protocol (24h-delay protocol; WNTi+Act DL), to allow for efficient neuralization (see Figure 5.31 and
Figure  5.33).  Control,  untreated  cells  (cultured  in  0.1%  DMSO  containing  medium)  were  included  in  the
experiment. Images showing GFP and Pax6 double immuno-labeling can be found in Figure 5.34. Low doses of
Activin were not affecting ES cell neural conversion (as seen by Pax6 staining), but were not able to efficiently
induce Rax expression. Error bars: standard error.



























































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
beginning of the second day of Step-II. Cells were cultured until the sixth day of Step-II (8 days of
differentiation  after  LIF  withdrawal),  then  fixed  and  processed  by Rax-GFP and  Oct4  double
immunocytodetection, to quantify the ratios of Rax-positive neural progenitors and of Oct4-positive
undifferentiated cells, respectively. Cells treated with IWR-1-Endo but no Activin, together with
cells  treated  with  10  ng/ml  Activin  but  no  Wnt-inhibitor,  were  included  as  a  negative  control
(Figure 5.36).
Cells  anteriorized  by Wnt-inhibition  treatment  showed  no,  or  rare,  Rax-GFP-positive  cells,  as
already seen before.  When Activin was added together with Wnt-inhibitor,  26.9% of Rax-GFP-
positive  cells  appeared.  However,  Oct4  staining  showed  how  the  neuralization  efficiency  was
inhibited by Activin early treatment (Activin added at the beginning of the second day of Step-II):
18.9% of the cells were still Oct4-positive at the end of Step-II, day6 (8 days of differentiation).
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Figure 5.36: Experimental scheme to delineate the window of competence of differentiating ES cells to respond
to Activin-mediated retinal induction. The scheme lists different combinations of  Activin treatments (treatment
starting at the beginning of Step-II, day2, or with a 6, 12, 24, 48-hours delay; WNTi+Activin delayed-Xh), tested
together with Wnt-inhibition (WNTi). Cells were treated with Wnt-inhibitor at the beginning of Step-II, day2, and
analyzed at the end of Step-II, day6, for a total of 8 days of  in vitro differentiation after LIF withdrawal. Activin
recombinant protein (10 ng/ml) was added to culture medium as indicated. Control untreated cells were cultured in
0.1% DMSO containing medium.
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Oct4 and Rax-GFP signals were almost never overlapped, as can be easily appreciated at a higher
magnification (40X) (Figure 5.38).
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Figure 5.37: Window of competence of differentiating ES cells to respond to Activin-mediated retinal induction.
Immunocytodetection of the stem cell marker Oct4 (red) and GFP (expressed under the control of Rax promoter in
the Rax-GFP knock-in cell line K/l EB5; green), in ES cells at the end of Step-II, day6 (8 days of differentiation),
after treatment with Wnt-inhibitor (10 µM IWR-1-Endo; A) or with Wnt-inhibitor plus 10 ng/ml Activin (B). Activin
was added at the beginning of Step-II, day2 (Start protocol, WNTi+Act10 ST), together with Wnt-inhibitor. Nuclei
counter-staining was obtained with DAPI. When Activin was added together with Wnt-inhibitor, 26.9% of Rax-
GFP-positive cells appeared. However,  Oct4 staining showed that early Activin treatment  slowed-down neural
differentiation: 18.9% of the cells were still Oct4-positive at the end of Step-II, day6 (8 days of differentiation).
WNTi+Act10 ST
Rax-GFP  Oct4  DAPI
WNTi
A B
Figure  5.38:  Oct4  and  Rax-GFP
immunostaining.
Immunocytodetection of the stem cell
marker  Oct4  (red)  and  GFP
(expressed under the control  of  Rax
promoter  in  the  Rax-GFP  knock-in
cell line K/l EB5; green), in ES cells
at the end of Step-II, day6 (8 days of
differentiation),  after  treatment  with
Wnt-inhibitor  (10  µM  IWR-1-Endo)
plus 10 ng/ml Activin. 
Oct4  and  GFP signals  were  almost
never  overlapped.  Nuclei  counter-
staining was obtained with DAPI.
Rax-GFP  Oct4  DAPI
WNTi+10 ng/ml Activin
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These  data  confirmed  again  that  Activin  treatment  at  early  differentiation  time  was  strongly
interfering  with  neural  conversion  that  ES  cell  normally  undergo  when  cultured  in  a  minimal
medium (see the first experiment on Activin  24-hour delay treatment showed in  Figure 5.31 and
Figure 5.33;  see also the RT-PCR data about Oct4 and FGF5 expression in  Figure 5.19B and
immunostaining of Musashi-1 and Oct4 in  Figure 5.20-5.22). Activin treatment slowed-down ES
cell neural differentiation, sustaining Oct4 expression.
Interestingly, the persistence of Oct4-positive cells inside the culture system after Activin treatment
could be prevented by adding Activin with a delay (Delayed treatments) compared to the start of
Wnt-inhibition (Start treatment) (Figure 5.39).  A delay of only 6 hours was already enough to
prevent Activin to inhibit neuralization (44.8% Rax-GFP-positive retinal cells and only 6.1% Oct4-
positive cells, that is a three-fold decrease of undifferentiated Oct4-positive cell ratio). The best
option as a retinal induction treatment was to add Activin at the second half of day2, Step-II, with a
12-hours delay compared to normal treatment (45.2% Rax-GFP-positive retinal cells and only 3%
Oct4-positive  undifferentiated  cells).  Notably,  when  cells  were  treated  with  an  excessive  delay
(Activin 10 ng/ml at the beginning of Step-II, day4, 48 hours after the beginning of Wnt-inhibition
treatment), Activin was no more able to efficiently induce the formation of Rax-positive retinal
progenitors (5.5% Rax-GFP-positive retinal cells) (Figure 5.39 and Figure 5.40). 
This analysis allowed us to identify a precise time window for Activin treatment to induce Rax
expression. The best option to induce retinal neural progenitors without interfering with ES cell
neural conversion was to add Activin in a period included between the second half of day2, Step-II,
and the beginning of day3, Step-II.
254
Results and Discussion  5−Anterior Brain Patterning
255
Figure 5.40: Window of competence of differentiating ES cells to respond to Activin-mediated retinal induction.
Graph shows cell ratios after immunocytodetection of the stem cell marker Oct4 (red columns) and GFP (expressed
under the control of Rax promoter in the Rax-GFP knock-in cell line K/l EB5; green columns), in ES cells treated as
indicated in Figure 5.36. Non treated cells and cells treated with Activin alone were included in the experiment as
negative control. Error bars: standard error. 
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Figure 5.39: Window of competence of differentiating ES cells to respond to Activin-mediated retinal induction.
Immunocytodetection of stem cell marker Oct4 (red) and GFP (expressed under the control of Rax promoter in the
Rax-GFP knock-in cell line K/l EB5; green), in ES cells at the end of Step-II, day6 (8 days of differentiation), after
treatment with Wnt-inhibitor (10 µM IWR-1-Endo; A) or with Wnt-inhibitor plus 10 ng/ml Activin (B-F). Activin
was added to culture medium at the beginning of Step-II, day2 (Start protocol; B), or with a 6, 12, 24 or 48-hour
delay (Delay – DL – protocol, as indicated here and schematized in Figure 5.36; C-F). Nuclei counter-staining was
obtained with DAPI. The best option as a retinal induction treatment was to add Activin at the second half of day2
Step-II, with a 12-hours delay compared to normal treatment (45.2% Rax-GFP-positive retinal cells and only 3%
Oct4-positive undifferentiated cells).
Rax-GFP  Oct4  DAPI
WNTi WNTi+Act10 ST WNTi+Act10 6h DL
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RT-PCR analysis  of neural differentiation/stem cell  markers confirmed these findings. Oct4 and
FGF5  expression  levels  (undifferentiated  stem  cell  and  epiblast  markers,  respectively)  were
particularly high when Activin was added to culture medium at the beginning of the second day of
Step-II (Start treatment); the expression of Oct4 and FGF5 was decreased when cells were allowed
to differentiate without Activin for a longer period (Figure 5.41). Activin also acted as an inducer of
mesodermal  and  endodermal  identity:  Gata4,  Gata6,  T  and  FoxA2  expression  levels  were
particularly high when Activin was used alone (no concomitant Wnt-inhibition treatment).
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Figure  5.41:  Effects of Activin treatment on ES cell differentiation. Graph shows mRNA fold changes of the
neural  progenitor  markers  Nestin,  Pax6  and  Sox2,  of  stem  cell/epiblast  markers  Oct4  and  FGF5,  and  of
meso/endodermal markers Gata4, Gata6, T and FoxA2 as evaluated by RT-PCR, in ES cells (Rax-GFP knock-in
cell line K/l EB5) treated with Wnt-inhibitor (10 µM IWR-1-Endo) plus 10 ng/ml Activin. Cells were analyzed at the
end of Step-II, day 6 (8 days of differentiation). Activin was added at the beginning of Step-II, day 2 (Start protocol;
WNTi+Act10 ST),  or with a 6,  12, 24,48-hour delay (Delay – DL – protocol,  as indicated here in the upper
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The analysis of regional/identity markers by RT-PCR showed that retinal markers Six3, Rax and
Six6 (blue and green color code in Figure 5.42) were strongly expressed when Activin was added
to culture medium with a 6, 12 or 24-hours delay compared to normal  Start treatment. Cortical
markers Tbr1, Emx2 and FoxG1 were not efficiently down-regulated when Activin was added lately
to culture medium (Activin 10 ng/ml at the beginning of day4, Step-II, 48-hours later compared to
normal  Start treatment;  Figure  5.42).  This  suggested  that  two  days  of  Wnt-inhibition  without
concomitant Activin treatment irreversibly led cells toward cortical fate, and also explained why
cells  treated  with  Activin  with  a  48-hours  delay  were  no  more  capable  of  switching-on  Rax
expression (Figure 5.39, Figure 5.40).
We concluded that Activin has a retinal induction effect on differentiating ES cells. Activin can also
inhibit/slow  down ES  cell  neural  differentiation,  but  this  effect  can  be  prevented  by  delaying
Activin  treatment  (around  the  fourth  day  of  differentiation  in  vitro)  and  by  allowing  cells  to
differentiate for a longer period (8 days of culture in vitro after LIF withdrawal).
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Figure 5.42: Window of competence of differentiating ES cells to respond to Activin-mediated retinal induction.
Figure shows mRNA fold changes of cortical markers Tbr1, Emx2 and FoxG1, and of retinal markers Six3, Rax and
Six6, as evaluated by RT-PCR, in ES cells (Rax-GFP knock-in cell line K/l EB5) treated with Wnt-inhibitor (10 µM
IWR-1-Endo), plus 10 ng/ml Activin. Cells were analyzed at the end of Step-II, day6 (8 days of differentiation).
Activin was added to culture medium at the beginning of Step-II, day2 (Start protocol; WNTi+Act10 ST), or with a
6, 12, 24 or 48-hour delay (Delay – DL – protocol, as indicated in Figure 5.36). Cortical markers Tbr1, Emx2 and
FoxG1 were not efficiently down-regulated when Activin was added to culture medium at the beginning of Step-II,
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Bearing these observations in mind, we repeated some combinations of Activin doses (10 ng/ml and
50 ng/ml) plus chemical drugs (BMP-inhibition, Wnt-inhibition and double Wnt/BMP-inhibition).
Cells were allowed to differentiate 8 days in vitro; Activin treatment was performed with a 12-hour
delay compared to chemical drug treatments. ES cells were then analyzed by Rax-GFP and Oct4
double  immunocytodetection.  Non-treated  (0.1%  DMSO-cultured)  cells  and  cells  treated  with
Activin but no chemical drugs were included as negative controls (Figure 5.43).
Cells anteriorized by Wnt-inhibition or by double Wnt/BMP-inhibition, then treated with 10 ng/ml
Activin, gave rise to retinal progenitor-enriched cultures (44.8% and 31.8% Rax-GFP-positive cells,
respectively; Panels in Figure 5.44). The high (50 ng/ml) dose of Activin strongly impaired neural
differentiation (26.8% and 25.8% Oct4-positive cells in WNTi and double WNTi/BMPi cells+50
ng/ml Activin, respectively), despite of the longer differentiation period and of Activin treatment
delay. This suggested that high doses of Activin were deleterious for ES cell neural conversion in
vitro and were instead promoting the maintenance of pluripotency (Figure 5.44; cell countings in
Figure 5.45).
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Figure  5.43:  Experimental scheme for cortical/retinal induction on mouse ES cell  in vitro. The scheme lists
different combinations of Activin doses (10 and 50 ng/ml Activin-A recombinant protein), tested in association with
different  anteriorizing treatments  (Wnt-inhibition,  BMP-inhibition  and double  Wnt/BMP-inhibition).  Cells  were
treated with chemical drugs starting at the beginning of Step-II, day2, and analyzed at the end of Step-II, day6, for
a total of 8 days of  in vitro differentiation after LIF withdrawal. Control untreated cells were cultured in 0.1%
DMSO containing medium. Increasing doses (10 and 50 ng/ml) of Activin protein were added to culture medium
with a 12-hour delay with respect to normal protocol, to allow for efficient neuralization and optimal expression of
retinal markers (see Figure 5.39, Figure 5.40 and Figure 5.41).
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Figure 5.44: Effects of Activin treatment on ES cell differentiation. Panels A-D show immunocytodetection of the
stem cell marker Oct4 (red) and GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell
line K/l EB5; green), in ES cells at the end of Step-II, day6 (8 days of in vitro differentiation after LIF withdrawal),
after treatment with different combinations of Activin doses (10 and 50 ng/ml Activin-A recombinant protein), tested




Panel A Rax-GFP  Oct4
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Activin was added to the culture medium at Step-II, day2, with a 12-hour delay with respect to the starting point for
chemical drug treatments (see scheme in Figure 5.43). Nuclei counter-staining was obtained with DAPI. The best
option  to  drive  Rax  expression  was  to  add  10  ng/ml  Activin  in  combination  with  Wnt-inhibition  or  double
Wnt/BMP-inhibition (44.8% and 31.8% GFP-positive cells, respectively).
BMPi BMPi+Act50
BMPi+Act10 (12h DL)
Panel D Rax-GFP  Oct4
WNTi+BMPi WNTi+BMPi+Act50
WNTi+BMPi+Act10 (12h DL)
Panel C Rax-GFP  Oct4
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As  noticed  before  (see  Figure  5.20),  Activin  treatment  was  not  affecting  ES  cell  neural
differentiation in a strong way when associated to BMP-inhibition, compared to what happened in
other combinations. Oct4-positive cells were only 2.95% in  BMP-inhibition plus 50 ng/ml Activin.
The reason for this difference was not further investigated; anyhow, RT-PCR data showed before
(see  Figure 5.19) suggested that this particular treatment combination (BMP-inhibition+Activin)
steered stem cell fate towards meso/endodermal differentiation, instead of simply slowing-down
neural conversion, and additionally lead to a ventralization of cell culture, as seen by high level of
Shh expression (Figure 5.19).
Control cells were treated with Activin (10 ng/ml and 50 ng/ml) but no concomitant chemical drug-
mediated anteriorization (Figure 5.46). Oct4 staining revealed the anti-neuralizing effect of high
dose  (50  ng/ml)  Activin  treatment  (49.4% Oct4-positive  cells).  Furthermore,  it  was  clear  that
Activin alone was not able to efficiently induce Rax-GFP-positive cells (only 2.9% and 5.2% Rax-
GFP-positive cells after 10 ng/ml and 50 ng/ml Activin treatment, respectively). 
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Figure  5.45:  Effects  of  Activin  treatment  on  ES  cell  differentiation. Graph  shows  cell  ratios  after
immunocytodetection of the stem cell marker Oct4 (red columns) and GFP (expressed under  the control of Rax
promoter in the Rax-GFP knock-in cell line K/l EB5; green columns), in ES cells treated as indicated in  Figure
5.43. Non treated cells and cells treated with 10 or 50 ng/ml Activin alone were included in the experiment. 
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Taken all together, these data strongly suggest a role for Activin as a retinal inducer during ES cell
neural differentiation. 
Activin itself can play other roles during differentiation, first of all as an anti-neuralizing, stemness-
promoting, factor; this effect can be prevented by allowing ES cells to differentiate in absence of
Activin during the first 3.5 days of culture after LIF withdrawal. 
Activin retinal inducing action was exerted only on cells that acquired a forebrain fate via Wnt-
inhibition or double Wnt/BMP-inhibition; Activin was not effective as a retinal inducer when used
alone. This suggests that a previous anteriorization to a forebrain fate was necessary to acquire the
competence to respond to Activin-mediated retinal induction, consistently to what happens in vivo.
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Figure 5.46: Effects of Activin treatment on ES cell differentiation. Images (A-C) show immunocytodetection of
stem cell marker Oct4 (red) and GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell
line K/l EB5; green), in ES cells at the end of Step-II, day6 (8 days of in vitro differentiation after LIF withdrawal).
Nuclei counter-staining was obtained with DAPI. Here are shown non-treated (0.1% DMSO cultured) cells (A) and
cells treated with 10 or 50 ng/ml Activin alone (without concomitant treatment with chemical drugs; (B) and (C)).
Activin alone was not able to efficiently induce Rax-positive retinal cells when used at low dose (10 ng/ml; 2.97%
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6− BMP and Anterior Brain Patterning
A Possible Role for BMP as a Retinal Inducer.
A recently published work on human ES cells showed the involvement of both Activin/Nodal and
BMP signaling  for  the induction  of  eye  field  genes  (Lupo et  al.,  2013).  We demonstrated  that
Activin play a pivotal role in retinal induction also in our in vitro system of mouse ES cell neural
differentiation  (Results,  Chapter  5,  and  Bertacchi  et  al.,  manuscript  in  preparation).  Next,  we
wanted to test a possible role for BMP signaling in retinal induction.
We previously showed that mouse ES cells expressed morphogens belonging to the BMP family
during neural differentiation  in vitro (see Results, Chapters 2 and 3). We also demonstrated that
endogenously produced BMPs can affect ES cells regional fate acquisition; Noggin-mediated BMP
inhibition was necessary and sufficient to acquire a telencephalic identity in our culture system (see
Results, Chapter 3). 
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We decided to test if BMP factors could play a role in retinal induction in cells anteriorized by Wnt-
inhibition. To this purpose, we used a purified recombinant mouse BMP4 protein (R&D System);
Wnt-inhibition  was  performed  by  treating  cells  with  10  μM  IWR-1-Endo,  as  described  for
treatments with Activin.
BMP factors play an important role in sustaining the stemness of pluripotent ES cells (Silva et al.,
2008).  We  tried  to  identify  the  right  dose  of  BMP to  treat  our  cells  without  blocking  their
spontaneous neural differentiation. Cells were treated during Step-II (starting at the beginning of
day2) with increasing doses of BMP4, ranging from 0.2 ng/ml to 5 ng/ml; at the same time, cells
were anteriorized by Wnt-inhibition, starting treatment at the beginning of Step-II, day2. ES cell
neural differentiation was investigated by RT-PCR at the end of Step-II, day4 (total of 6 days of in
vitro differentiation after LIF withdrawal) (Figure 6.4). We found that the higher BMP4 dose (5
ng/ml) was strongly inhibiting neural differentiation, as seen by the high expression level of Oct4
and the low expression level of Nestin (Figure 6.4). Nestin expression was clearly inhibited by
increasing doses of BMP4 in a dose-dependent manner; we thus choose the dose of 1 ng/ml BMP4
as an optimal compromise to treat cells while maintaining a good level of Nestin expression (neural
conversion).
Unfortunately, when we analyzed the expression levels of anterior/retinal markers, we found that
the  presence  of  BMP4  in  culture  medium  was  not  promoting  retinal  differentiation.  BMP4
switched-off the expression of FoxG1, consistently with our previous findings (see Results, Chapter
3; Bertacchi et al., 2013), but was not able to efficiently induce the expression of the retinal markers
Rax and Six6 (Figure 6.2).
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Figure  6.1.  Effects  of  different  doses  of  BMP4 on ES cell  neural  differentiation.  Graph shows  mRNA fold
changes of the pluripotency marker Oct4 and of the neural progenitor marker Nestin, as evaluated by RT-PCR, in
ES cells (E14 control ES cell line) treated with Wnt-inhibitor (10 µM IWR-1-Endo; WNTi), plus increasing doses of
recombinant mouse BMP4 (R&D Systems). BMP ranged from 0.2 ng/ml to 5 ng/ml (WNTi+0.2/0.5/1.0/5.0 BMP).
Cells were treated starting at the beginning of Step-II, day2, and were analyzed at the end of Step-II, day4 (6 days
of differentiation after LIF withdrawal, see Scheme on top). Values are shown as relative to β-Actin expression.
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To consolidate our results, we performed a further experiment, testing a possible synergistic effect
of BMP4 when used in combination with Activin (Figure 6.3). 
Cells were anteriorized by Wnt-inhibition and treated with 10 ng/ml Activin, with 1 ng/ml BMP4,
or with both recombinant proteins. Retinal marker expression was investigated by RT-PCR at Step-
II, day6 (8 days of differentiation). Again, BMP4 was not able to up-regulated the expression level
of retinal markers (Otx2, Six3, Rax and Six6). The compresence of BMP4 together with Activin
was not efficient in terms of retinal induction properties: we obtained intermediate levels of retinal
marker expression, compared to control and to Activin-treated conditions, and this suggested that
BMP4 interfered with the retinal inducing action of Activin (Figure 6.3). We do not know if BMP4
acted  by  specifically  inhibiting  retinal  gene  expression  or  if  it  simply  interfered  with  neural
differentiation.
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Figure  6.2.  Effects  of  BMP4 on the  expression  of  forebrain/retinal  markers.  Graph shows RT-PCR mRNA
quantification of the forebrain/cortical marker FoxG1 and retinal markers (Six3, Rax and Six6) in cells treated
with  Wnt-inhibitor  (10  µM  IWR-1-Endo;  WNTi)  or  with  Wnt-inhibitor+1  ng/ml  BMP4  recombinant  protein
(WNTi+1.0 ng/ml BMP), compared to control cells (cultured in 0.1% DMSO;  Ctrl DMSO). Cells were treated
during Step-II (starting at the beginning of day2) and analyzed at the end of Step-II (end of day4). BMP4 was able
to down-regulate the anterior/cortical marker FoxG1, but did not induced the expression of the retinal markers
Rax, Six3 and Six6. Data were normalized over β-Actin expression. Error bars: standard error. 
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The analysis by flow cytometry using Rax-GFP knock-in cell line confirmed the results obtained by
RT-PCR. Cells were treated with the conditions described above  (Figure 6.3)  and samples were
processed at the end of Step-II, day6 (8 days of differentiation after LIF withdrawal). Treatment
with Wnt-inhibitor+10 ng/ml Activin+1 ng/ml BMP4 produced an intermediate percentage of GFP-
positive cells  (17% GFP-positive cells),  when compared to control  untreated cells  and to  Wnt-
inhibitor+Activin treated cells (4.1% and 36.6% GFP-positive cells, respectively) (Figure 6.4).
We concluded that, differently from what was demonstrated in human ES cell differentiation (Lupo
et al., 2013), BMPs were not efficient retinal inducing signals for differentiating mouse ES cells, at
least in the concentration and conditions tested in our protocol.
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Figure  6.3.  Effects of BMP4 and Activin on the expression of retinal markers.  Graph shows RT-PCR mRNA
quantification of retinal markers (Otx2, Six3, Rax and Six6) in cells treated with Wnt-inhibitor (10 µM IWR-1-
Endo;  WNTi);  WNTi+10 ng/ml Activin (WNTi+10 ng/ml Activin); WNTi+1 ng/ml BMP4 recombinant protein
(WNTi+1 ng/ml BMP); or with Wnt-inhibitor plus both recombinant proteins (WNTi+1 ng/ml BMP+10 ng/ml
Activin),  compared  to  cells  treated  with  the  chemical  drug  alone  (WNTi).  Cells  were  treated  during  Step-II
(starting at the beginning of day2) and analyzed at the end of Step-II (end of day4), as indicated in the Scheme.
Data were normalized on maximum expression. Error bars: standard error.
WNTi WNTi                 
+10 ng/ml Activin
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Figure  6.4.  Rax-GFP expression analysis by flow cytometry after  treatments with different combinations of
Activin/BMP and Wnt-inhibitor. Rax-positive cell ratio quantification by flow cytometry at Step-II, day6 (8 days of
differentiation after LIF withdrawal), using the Rax-GFP knock-in cell line K/l EB5. Graph shows GFP-positive
cell ratios after treatment with different combinations of Activin (10 ng/ml Activin-A), BMP (1 ng/ml BMP4) and
Wnt-inhibitor (10 µM IWR-1-Endo; WNTi), as indicated in Figure 6.3. Control cells were differentiated in 0.1%
DMSO-containing medium (Ctrl). Error bars: standard error.
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7− Dorso-Ventral Patterning of the Diencephalon
How to Control the Dorso-Ventral Identity of Diencephalic Progenitors 
Playing with Shh Pathway.
As Rax gene is also expressed in the ventral diencephalon (Beccari et al., 2013), we decided to
better investigate Rax expression in our culture system and to dissect ES cell dorso/ventral (D/V)
identity in the context of  forebrain patterning/differentiation (Figure 7.1).
Retinal progenitors originate from the lateral wall of diencephalon, and are both Rax-positive and
Pax6-positive  (Wilson  and  Houart,  2004;  Ikeda  et  al.,  2005).  They  are  also  positive  for  the
anterior/dorsal  marker  Otx2  and  for  the  forebrain  marker  Six3  (Ikeda  et  al.,  2005).  Neural
progenitor cells in the ventral diencephalon, on the contrary, are Rax-positive but Pax6-negative
(Ikeda et al., 2005); they are positive for ventral markers such as Nkx2.1 (which is expressed in the
ventral  forebrain)  and  Vax1  (whose  name  stands  for  ventral  anterior  homeobox and  clearly
describes  its  expression  pattern)  (Figure  7.1;  See  also  gene  expression  patterns  on
www.emouseatlas.org).
Neural progenitor D/V identity can be efficiently manipulated by modulating Shh pathway, as we
previously demonstrated also in our protocol (Bertacchi et al., 2013). Shh pathway can be activated
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by SAG treatment  (Smoothened  agonist,  100-150 nM) and blocked by Cyclopamine  treatment
(Cyc, 5 μM; it must be noticed that our cells produced only few amounts of endogenous Shh during
their differentiation, see Results, Chapter 2).
We decided to test if our ES cells were able to exhibit both types of Rax expression, in the context
of  dorsal  identity  (Pax6-positive  retinal  cells)  or  ventral  identity  (Nkx2.1-positive  ventral
diencephalon cells).
Cells were anteriorized by Wnt-inhibition (10 μM IWR-1-Endo starting at the beginning of Step-II,
day2, as previously described for Activin and BMP treatments). At the same time, D/V identity was
controlled  by SAG and  Cyclopamine treatment.  SAG and Cyclopamine  were  added to  culture
medium  together  with  Wnt-inhibitor  (cortical  induction  condition;  see  Results,  Chapter  4)  or
together  with  Wnt-inhibitor  and  Activin  (retinal  induction  condition;  see  Results,  Chapter  5)
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Figure 7.1. Experimental scheme showing the key-markers examined to evaluate the D/V identity
of diencephalic neural progenitors. The figure on the top schematizes the A/P and the D/V axis of
developing forebrain; Shh pathway was previously demonstrated to modulate D/V identity and could
be  used  here  to  drive  the  differentiation  of  ventral  diencephalic  progenitors.  Retinal  progenitors
originate from the lateral wall of diencephalon, and are both Rax- and Pax6-positive; they are also
positive for other eye field transcription factors, such as Six3 and Otx2 (Zuber et al., 2003). Neural
progenitor cells in the ventral  diencephalon, on the contrary,  are Rax-positive but Pax6-negative
(Ikeda et al., 2005); they are positive for ventral markers such as Nkx2.1 and Vax1.
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(Figure 7.2).  Control samples were untreated (DMSO-cultured) cells, or cells treated separately
with single chemical drugs (Figure 7.2).
At the end of Step-II, day6 (after a total of 8 days of differentiation in vitro), cells were fixed and
analyzed  by  double  Rax-GFP/Pax6  and  Rax-GFP/Nkx2.1  immunostainings,  to  investigate  the
production of Pax6/Rax-positive retinal progenitors and Nkx2.1/Rax-positive ventral diencephalic
progenitors, respectively.
Control untreated cells showed no staining for Rax-GFP, consistently with their regional identity
that we previously showed to be predominantly mesencephalic (see Results, Chapter 3; Bertacchi et
al.,  2013; Figure  7.3A).  Only  little  clusters  of  Nkx2.1-positive  cells  were  present  in  control
condition  at  Step-II,  day6 (3.6% Nkx2.1-positive  cells).  A similar  situation  was  found in  cells
treated with Wnt-inhibitor (7.4% Nkx2.1-positive cells; Figure 7.3B).
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Figure 7.2. Experimental scheme for cortical/retinal induction and for D/V identity manipulation
on mouse ES cells in vitro. The scheme lists different combinations of Activin (10 ng/ml Activin-A
recombinant  protein)  and  chemical  drugs  (Wnt-inhibition  –  WNTi –  by  10  μM  IWR-1-Endo
treatment; Shh-inhibition – Cyc – by 5 μM Cyclopamine treatment; Shh-activation – SAG – by 100
nM SAG treatment).  Cells were treated with chemical drugs starting at the beginning of Step-II,
day2, and analyzed at the end of Step-II, day6, for a total of 8 days of in vitro differentiation after
LIF withdrawal. In case of Activin treatment, recombinant protein was added to culture medium with
a  12-hour delay  with  respect  to  chemical  drugs.  Control  untreated  cells  were  cultured  in  0.1%
DMSO containing medium.
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Nkx2.1 expression could be efficiently modulated by performing SAG and Cyclopamine treatments
to activate/repress Shh pathway, respectively. Cyclopamine treatment abolished Nkx2.1 expression,
as the already low number of Nkx2.1-positive cell clusters completely disappeared (0.2% Nkx2.1-
positive  cells;  Figure  7.3D).  On  the  contrary,  SAG  treatment  robustly  switched-on  Nkx2.1
expression (65.3% Nkx2.1-positive cells),  leading to a massive ventralization of the cell culture
(Figure 7.3G,F).
Rax expression was efficiently induced in cells treated with Wnt-inhibitor+10 ng/ml Activin (40.7%
GFP-positive cells;  Figure 7.3E); cells labeled by GFP staining were very rarely co-labeled by
Nkx2.1  staining  (only 2.2% Nkx2.1/GFP-double  positive  cells).  We concluded  that  the  retinal
induction treatment was driving Rax expression in cells  with a lateral/dorsal identity.  This was
further confirmed by the high proportion of Pax6/Rax-GFP double positive cells (32.4%, see below,
Figure 7.6).
Blocking the endogenously produced Shh by the use of Cyclopamine, together with the addition of
Wnt-inhibitor  and  Activin,  caused  the  complete  disappearance  of  the  few  double  positive
Rax/Nkx2.1-positive  cells  that  were  present  in  our  retinal  culture  (0.07% Nkx2.1/GFP-double
positive cells; Figure 7.3H). However, also the efficiency of Rax induction was generally affected
(38.5%  GFP-positive  cells  in  Wnt-inhibitor+Activin,  20.9%  GFP-positive  cells  in  Wnt-
inhibitor+Activin+Cyclopamine; compare Figure 7.3E and Figure 7.3H). Further analysis will be
necessary to understand if this was caused by a possible toxicity after treatment with Cyclopamine,
or if this phenomenon was specific and due to the effect of a complete block of Shh pathway on
Rax-positive cell differentiation. Cell ratios are shown in Figure 7.4.
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Activin alone was not able  to  induce Rax-positive neural  progenitors  (only 2.1% GFP-positive
cells) and showed to have a slight ventralizing effect (10.4% Nkx2.1-positive cells) (Figure 7.3I).
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Figure 7.3. Effects of different combinations of Activin/chemical drugs treatment on ES cell differentiation and
D/V identity. Figures  A-I show immunocytodetection  of  the  diencephalic/retinal  progenitor  marker  Rax (GFP
expressed  under  the  control  of  Rax  promoter  in  the  Rax-GFP knock-in  cell  line  K/l  EB5;  green)  and  of  the
forebrain/diencephalic ventral  marker Nkx2.1 (red),  in ES cells at  the end of  Step-II,  day6 (8 days of  in vitro
differentiation after LIF withdrawal), after treatment with different combinations of Activin and chemical drugs as
indicated in Figure 7.2. Activin was added to the culture medium at Step-II, day2, with a 12-hour delay with respect
to  the  starting  point  for  chemical  drug  treatments.  Nuclei  counter-staining  was  obtained  with  DAPI.  Nkx2.1
expression could be efficiently modulated by performing SAG and Cyclopamine treatments to activate/repress Shh
pathway,  respectively  (C,D,F-H).  SAG acted  not  only  as  an  inducer  of  ventral  identity  (switching-on  Nkx2.1
expression; C,F,G), but also as a potent inducer of Rax expression; this effect was occurring only when SAG was
used in combination with the anteriorizing treatment (Wnt-inhibition) (F). Activin showed a light ventralizing effect
when  used  alone  (I).  Ctrl  DMSO:  control  cells  cultured  in  0.1%  DMSO-containing  medium;  Cyc:  5  μM
Cyclopamine; SAG: 100 nM Shh-Agonist; Activin: 10 ng/ml Activin-A; WNTi: 10 μM IWR-1-Endo.
Rax-GFP  Nkx2.1  DAPI
Ctrl DMSO WNTi 10 μM
WNTi+Activin
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Interestingly,  SAG  acted  not  only  as  an  inducer  of  ventral  identity  (switching-on  Nkx2.1
expression), but also as a potent inducer of Rax expression (Figure 7.5C); this effect was occurring
only  when  SAG  was  used  in  combination  with  the  anteriorizing  treatment  (Wnt-inhibition)
(compare Figure 7.5A and Figure 7.5C). Cells treated with Wnt-inhibitor together with SAG were
both ventralized (87% Nkx2.1-positive cells) and expressing Rax (60.4% Rax-GFP-positive cells),
with a high degree of co-labeling of the two markers (60% Nkx2.1/GFP-double positive cells).
This suggested that Shh pathway was able to switch-on Rax expression, but this action could be
exerted  only  on  anteriorized (forebrain)  cells,  which  were  competent  to  respond  to  this  Shh-
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Figure 7.4. Effects of different combinations of Activin/chemical drugs treatment on ES cell differentiation and
D/V identity. Graph shows cell ratios after immunocytodetection of the diencephalic/retinal progenitor marker Rax
(GFP  expressed  under  the  control  of  Rax  promoter  in  the  Rax-GFP  knock-in  cell  line  K/l  EB5)  and  the
forebrain/diencephalic  ventral  marker  Nkx2.1,  in  ES  cells  at  the  end  of  Step-II,  day6  (8  days  of  in  vitro
differentiation after LIF withdrawal), after treatment with different combinations of Activin and chemical drugs, as
schematized  in Figure  7.2.  Ctrl:  control  cells  cultured  in  0.1%  DMSO-containing  medium;  Cyc:  5  μM
Cyclopamine;  SAG:  100  nM Shh-Agonist;  Act:  10  ng/ml  Activin-A;  WNTi:  10  μM IWR-1-Endo.  Images  are
showed in  Figure 7.3. The percentages of three types of cells are shown here: ventral forebrain progenitor cells
(Nkx2.1-positive, Rax-GFP-negative; red columns), retinal progenitor cells (Rax-positive, Nkx2.1-negative; green
columns) and ventral diencephalic progenitor cells (double positive-cells; yellow columns). 
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mediated Rax induction. Shh activation alone, performed on control cells with a midbrain identity,
was  not  able  to  drive  efficient  Rax  expression  (only  4.6% double  Nkx2.1/GFP-positive  cells;
Figure 7.5A).
The analysis  of Pax6 expression in GFP positive cells (Figure 7.6) was consistent with that of
Nkx2.1, as the two markers showed  a quite good reciprocity of staining (Figure 7.3).
Pax6-positive cell percentage was increased after Wnt-inhibition compared to control cells (55.8%
and  44.5% Pax6-positive  cells,  respectively;  Figure  7.6A  and Figure  7.6B)  and  was  strongly
decreased by SAG treatment (2.1% Pax6-positive cells; Figure 7.6G).
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Figure  7.5.  Effects of different combinations of chemical drug treatments on ES cell differentiation and D/V
identity. Figures A-C show immunocytodetection of the diencephalic/retinal progenitor marker Rax (GFP expressed
under  the  control  of  Rax  promoter  in  the  Rax-GFP  knock-in  cell  line  K/l  EB5;  green)  and  the
forebrain/diencephalic ventral  marker Nkx2.1 (red),  in ES cells at  the end of  Step-II,  day6 (8 days of  in vitro
differentiation after LIF withdrawal). Treatments with different combinations of chemical drugs are indicated in
Figure 7.2. Nuclei counter-staining was obtained with DAPI. SAG acted not only as an inducer of ventral identity
(switching-on  Nkx2.1  expression;  A and  C),  but  also  as  a  potent  inducer  of  Rax  expression;  this  effect  was
occurring only when SAG was used in combination with the anteriorizing treatment (WNTi+SAG,  C).  Only little
clusters of Nkx2.1-positive cells were found in cells treated with Wnt-inhibitor (7.4% Nkx2.1-positive cells; B).
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The  highest  inductive  efficiency  of  Rax-GFP expression  was  found  in  cells  treated  by  Wnt-
inhibition plus SAG (61.6% GFP-positive cells; Figure 7.6F), but few of these cells were marked
by Pax6, whose expression was dramatically inhibited (3.1% Pax6-positive cells, and only 0.6%
GFP/Pax6 double positive cells). This finding confirmed the ventral identity of Rax-positive cells
obtained by Wnt-inhibition plus SAG treatment. Cell ratios are shown in Figure 7.8.
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Figure  7.6.  Effects  of  the  treatment  with  different  combinations  of  Activin/chemical  drugs  on  ES  cell
differentiation and D/V identity. Figures  A-I show immunocytodetection of  the diencephalic/retinal progenitor
marker Rax (as GFP expressed in the Rax-GFP knock-in cell line K/l EB5; green) and the dorsal marker Pax6
(red), in ES cells at the end of Step-II, day6 (8 days of in vitro differentiation after LIF withdrawal), after treatment
with different combinations of Activin and chemical drugs as indicated in  Figure 7.2.  Ctrl DMSO: control cells
cultured in 0.1% DMSO-containing medium; CYC: 5 μM Cyclopamine; SAG: 100 nM Shh-Agonist;  Activin: 10
ng/ml Activin-A; WNTi: 10 μM IWR-1-Endo. Activin was added to culture medium at Step-II, day2, with a 12-hour
delay with respect to the starting point for chemical drug treatments. Nuclei counter-staining was obtained with
DAPI.  Pax6  expression  could  be  efficiently  modulated  by  performing  SAG  and  Cyclopamine  treatments  to
activate/repress Shh pathway, respectively (C,D,F-H).
Rax-GFP  Pax6  DAPI
Ctrl DMSO WNTi 10 μM
WNTi+Activin
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Basically, the only condition promoting the co-expression of Rax together with Pax6 (an index for
bona fide retinal progenitors) was found in cells treated with Wnt-inhibitor plus Activin (36.8%
GFP-positive cells, and 32.4% of GFP/Pax6 co-labeled cells; Figure 7.7). Adding Cyclopamine to
cells treated with Wnt-inhibitor plus Activin slightly decreased the efficiency of retinal induction
(20% GFP/Pax6-double positive cells; Figure 7.6H). 
277
Figure 7.7. Effects of different combinations of Activin and chemical drugs treatments on ES cell differentiation
and D/V identity. Figures  A-D show immunocytodetection of the diencephalic/retinal progenitor marker Rax (as
GFP expressed in the Rax-GFP knock-in cell line K/l EB5; green) and the dorsal marker Pax6 (red), in ES cells at
the end of Step-II,  day6 (8 days of  in vitro differentiation after LIF withdrawal), after treatment with different
combinations of chemical drugs as indicated in Figure 7.2. Nuclei counter-staining was obtained with DAPI. The
treatment with Wnt-inhibitor plus Activin was the only condition efficiently promoting the co-expression of Rax
together with Pax6 (an index for  bona fide retinal progenitors; 36.8% GFP-positive cells;  D). The highest Rax-
GFP-positive cell ratio was found in cells treated by Wnt-inhibition+SAG (61.6% GFP-positive cells; B), but few of
these cells were marked by Pax6.
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The results on Rax expression were confirmed by flow cytometry (Figure 7.9). Rax-GFP knock-in
cell  line  was  treated  with  different  combinations  and doses  of  chemical  drugs  and Activin,  as
indicated; cells were analyzed at Step-II, day6 (that is after 8 days of differentiation in vitro). 
SAG strongly induced Rax expression (Wnt-inhibitor+100 nM SAG; 56.5% GFP-positive cells)
and its effect was partially preserved even when using a ten-time lower dose (Wnt-inhibitor+10 nM
SAG;  24.8% GFP-positive  cells).  Activin  worked  as  a  good inducer  of  Rax  expression  (Wnt-
inhibitor+10  ng/ml  Activin;  29.8%  GFP-positive  cells);  Compared  to  Wnt-inhibitor+Activin
treatment,  Rax expression was enhanced by the compresence of SAG (Wnt-inhibitor+10 ng/ml
Activin+100  nM  SAG;  41.4%  GFP-positive  cells)  and  inhibited  by  the  compresence  of
Cyclopamine (Wnt-inhibitor+10 ng/ml Activin+5 μM Cyclopamine; 17.8% GFP-positive cells) in
the cell culture medium (Figure 7.9).
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Figure  7.8.  Effects  of  the  treatment  with  different  combinations  of  Activin/chemical  drugs  on  ES  cell
differentiation and D/V identity.  Graph shows cell ratios after immunocytodetection as shown in Figure 7.6. The
dorsal marker Pax6 and diencephalic/retinal progenitor marker Rax (GFP in the Rax-GFP knock-in cell line K/l
EB5), were analyzed in ES cells at the end of Step-II, day6 (8 days of in vitro differentiation after LIF withdrawal),
after treatment with different combinations of  Activin and chemical  drugs,  as schematized in  Figure 7.2. Ctrl:
control cells cultured in 0.1% DMSO-containing medium; CYC: 5 μM Cyclopamine; SAG: 100 nM Shh-Agonist;
Actin: 10 ng/ml Activin-A;  WNTi: 10 μM IWR-1-Endo. The percentages of three types of cells are shown here:
dorsal  progenitor  cells  (Pax6-positive,  Rax-GFP-negative;  red  columns),  ventral  diencephalic  progenitor  cells
(Rax-positive, Pax6-negative; green columns) and bona fide retinal progenitor cells (double positive-cells; yellow
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Although  this  aspect  was  not  further  investigated,  we  speculate  that  Activin  could  partially
counteract the action of SAG in inducing Nkx2.1/Rax-positive cells.
By comparing cells treated with Wnt-inhibitor+100 nM SAG to cells treated with Wnt-inhibitor+
SAG+Activin,  we  noticed  a  slight  decrease  of  Rax-GFP-positive  cell  percentage  in  the  latter
condition (56.5% and 41.4% GFP-positive cells, respectively).
This was also evident  by the observation of Nkx2.1/Rax-GFP double immunostaining after the
same  two  treatments;  cells  treated  with  Wnt-inhibitor+SAG  scored  60%  Nkx2.1/GFP-double
positive cells, while cells treated with Wnt-inhibitor+SAG+Activin were 44% double positive for
Nkx2.1/GFP-double. 
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Figure  7.9.  Rax-GFP expression analysis  by flow cytometry after  treatments  with different combinations of
Activin/chemical drugs.  Quantification of Rax-positive cell ratio by flow cytometry at Step-II,  day6 (8 days of
differentiation after LIF withdrawal), using the Rax-GFP knock-in cell line K/l EB5. Graphs A and B show GFP-
positive cell ratios after treatment with different combinations of Activin/chemical drugs. Cyc: 5 μM Cyclopamine;
SAG: 1, 10 or 100 nM Shh-Agonist; Act 10: 10 ng/ml Activin-A; WNTi: 10 μM IWR-1-Endo. 



























































Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
The D/V identity of Rax-positive neural progenitor was also investigated by RT-PCR, measuring
Pax6 (dorsal) and Nkx2.1 (ventral) expression levels (Figure 7.10). Rax expression was strongly
induced  by  SAG  treatment,  even  when  this  Shh  agonist  was  used  at  a  lower  dose  (see  Rax
expression – green columns – after 10 nM or 100 nM SAG treatment,  Figure 7.10A). This effect
was  accompanied  by  a  strong  induction  of  Nkx2.1  expression  (blue  columns)  and  a  marked
silencing of Pax6 expression (yellow columns), compared to control levels in cells  treated with
Wnt-inhibitor (Figure 7.10A). Wnt-inhibitor+Activin treatment was the only condition were Rax
expression was associated with a good level of Pax6 expression (Figure 7.10B). Additionally, the
RT-PCR data  demonstrated  that  Activin  could  partially  block  SAG effect  on  Rax and  Nkx2.1
expression (Figure 7.10A and Figure 7.10B), somehow counteracting the Shh-mediated induction
of Rax-positive ventral cells.
It must be noticed that Cyclopamine treatment repressed Pax6 expression, when compared to the
expression level in cells treated with Wnt-inhibition (Figure 7.10). This was not consistent with the
data from immunocytodetection experiment, where cells treated with Wnt-inhibitor + Cyclopamine
scored a higher ratio of Pax6-positive cells compared to control Wnt-inhibited cells (53.2% and
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Figure  7.10.  Effects of different combinations of Activin/chemical drugs on the expression of D/V patterning
genes. A and B show RT-PCR mRNA quantification of the retinal/diencephalic marker Rax and of the dorso/ventral
markers Pax6 and Nkx2.1, in cells treated a indicated in Figure 7.9. Cyc: 5 μM Cyclopamine; SAG: 10 or 100 nM
Shh-Agonist;  Act10:  10 ng/ml Activin-A;  WNTi:  10 μM IWR-1-Endo. Data were normalized to  the maximum






































Results and Discussion  7−Dorso-Ventral Patterning of the Diencephalon
44.5% Pax6-positive cells, respectively; Figure 7.8). After a careful observation at the microscope,
we noticed that Pax6-positive cells in samples treated with Wnt-inhibitor+Cyclopamine were more
numerous,  but  were  labeled  with a  lower staining  intensity,  when compared to  control  –  Wnt-
inhibition – cells. We speculate that Pax6 could display different level of expression, and this could
be detected by immunostaining at the single cell level but not by RT-PCR, which returns an average
level  of  expression.  We still  do  not  know the  meaning (and the  possible  implications  for  cell
differentiation) for different levels of Pax6 expression inside the cell.
We better determined the identity of our cells along the D/V axis, by measuring the expression of
the dorsal epiphysis marker Bsx1 and that of the ventral diencephalic marker Vax1 (Figure 7.11).
Bsx1 and Vax1 expression levels were normalized on Rax expression level, and are shown here as
ratios;  this  was necessary to  compensate  for  differences  of  Rax-positive  cell  percentage  inside
culture after diverse treatments. For this reason,  dorsal index was obtained by the ratio of Bsx1
expression over the product of Vax1 and Rax expression; vice versa, ventral index was calculated as
the ratio of Vax1 expression over the product of Bsx1 and Rax expression (Figure 7.11).
Dorsal  index  was  higher  in  cells  treated  with  Wnt-inhibitor  alone  or  with  Wnt-
inhibitor+Cyclopamine. On the contrary,  SAG treatment (both at 10 nM and at 100 nM), when
performed together with Wnt-inhibition, caused a marked decrease of dorsal index and a strong
increase of ventral index. This was consistent with a ventral diencephalic identity (Figure 7.11).
Interestingly, dorsal and ventral indexes were both quite stable when Activin was present in the
culture medium. Ventral index, in particular, was not responding to SAG treatment when cells were
simultaneously treated by Activin (Figure 7.11).
These results raised an intriguing hypothesis, that will surely deserve further investigation in our
Lab: Activin seemed to act here as a specific inducer of retinal identity (lateral diencephalon), able
to bypass normal mechanisms of dorsal (Bsx1-positive) vs. ventral (Vax1-positive) specification.
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All  in  all,  we  concluded  that  Rax  expression  can  be  switched-on  during  ES  cell  neural
differentiation in a Petri dish. Both Activin and Shh are able to drive Rax expression in forebrain
neural  progenitors.  However,  while  Activin  can  induce  a  retinal  differentiation  fate  (Rax/Pax6
double positive neural progenitors), Shh pathway activation mainly steers stem cell fate towards a
ventral diencephalic identity (Rax/Nkx2.1 double positive neural progenitors, also expressing the
ventral  marker  Vax1).  The dorsal-most fate,  which is  epiphysis,  can be preserved by inhibiting
endogenous Shh, via Cyclopamine treatment (Rax-positive progenitors expressing the dorsal-most
diencephalic marker Bsx1).
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Figure  7.11. Effects of different combinations of Activin/chemical drugs on the expression of D/V patterning
genes.  Graph  shows  RT-PCR  mRNA  quantification  of  the  dorsal  epiphysis  marker  Bsx1  and  the  ventral
diencephalic marker Vax1, whose expression levels were normalized on that of the retinal/diencephalic marker
Rax. Dorsal index was obtained by the ratio of Bsx1 expression over the product of Vax1 and Rax expression; vice
versa, Ventral index was calculated as the ratio of Vax1 expression over the product of Bsx1 and Rax expression.
Cells were treated as indicated in  Figure 7.9.  Cyc: 5 μM Cyclopamine;  SAG: 1, 10 or 100 nM Shh-Agonist;




















































Results and Discussion  8−Terminal Differentiation of Retinal Cells
8− Terminal Differentiation of Retinal Cells
Efficient Differentiation of Retinal Cells 
by Prolonged Manipulation of Wnt and Activin/Nodal Pathways.
As Rax gene is also expressed both in the ventral diencephalon and in the neural retina, we decided
to better define the identity card of Rax-expressing cells by culturing them for a longer period and
investigating for the expression of late retinal markers.
ES cells were treated with Wnt-inhibitor+10 ng/ml Activin, starting at Step-II, day2, until Step-II
day16, for a total of 18 days of differentiation. This time was previously shown to be the minimal
culture  time  necessary  to  drive  terminal  differentiation  of  mouse  retinal  cells  starting  from
pluripotent stem cells (Ikeda et al., 2005). Then, cells were fixed and analyzed by double GFP (Rax-
GFP-positive  retinal  progenitors)  and  Rhodopsin  (photoreceptors;  Olsson  et  al.,  1992)
immunocytodetection.  No  additional  cell  dissociation/replating  was  performed  during  the  long
culture protocol. An antibody specific for Rhodopsin was tested on mouse P7 retinas (Figure 8.1).
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We found that Rax-GFP-positive neural progenitors were still present in culture after 18 days of
differentiation, forming wide cell clusters inside the culture. However, no strong Rhodopsin staining
was detected.
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Figure 8.1: Rhodopsin immunostaining on mouse retina. A and B show Rhodopsin immunodetection (red), tested
on 15 micron sections of a P7 mouse eye; Rhodopsin specifically labels photoreceptors in outer nuclear layer
(ONL; B shows Rhodopsin labeling at higher magnification). Inner nuclear layer (INL) containing bipolar cells





Results and Discussion  8−Terminal Differentiation of Retinal Cells
In  parallel,  we  tested  some  different  culture  conditions  previously  shown  to  enhance  retinal
progenitor proliferation and/or retinal differentiation (Hicks and Courtois, 1992; Lamba et al., 2006;
Ikeda  et  al.,  2005;  Kelley  et  al.,  1994;  Levine  et  al.,  1997).  Cells  were  treated  with  Wnt-
inhibitor+10 ng/ml Activin during Step-II, then (starting at  the end of Step-II, day6) cells were
cultured  in  control  N2B27 medium (supplemented  with  0.1% DMSO),  or  in  Wnt-inhibitor+10
ng/ml Activin medium, or in medium supplemented with Retinoic acid (100 nM), KSR (Knock-out
Serum Replacement, 1.5%) or Wnt-inhibitor+10 ng/ml Activin+1 ng/ml BMP4. We found that only
the presence of Activin (or of Activin together with BMP4, to a lesser extent) was able to sustain the
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Figure 8.2: Analysis of Rax and Rhodopsin expression in long-term ES cell cultures. A-D: Immunocytodetection
shows GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell line K/l EB5; green in A
and B) and Rhodopsin (red in C and D), in ES cells at the end of Step-II, day16 (18 days of in vitro differentiation
after LIF withdrawal), after treatment with Wnt-inhibitor (10 μM IWR-1-Endo; WNTi) plus 10 ng/ml Activin (Act)
(B and D). Control cells were cultured in 0.1% DMSO-containing medium (Ctrl DMSO; A and C). Nuclei counter-
staining was obtained with DAPI.
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proliferation of Rax-GFP-positive progenitors. Cells treated with Wnt-inhibitor+Activin, but then
cultured in KSR, in Retinoic acid or even in control medium showed low level of Rax-GFP staining
(Figure 8.3). Again, no Rhodopsin staining was detected in all the different conditions (data not
shown).
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Figure 8.3: Effects of Wnt-inhibition, Activin, KSR, Retinoic acid and BMP on Rax expression in long-term ES
cell cultures.  A-E: Immunocytodetection shows GFP (expressed under the control of Rax promoter in the Rax-
GFP knock-in cell line K/l EB5; green), in ES cells at the end of Step-II day16 (18 days of in vitro differentiation
after LIF withdrawal). Cells were treated with Wnt-inhibitor (10 μM IWR-1-Endo;  WNTi) plus 10 ng/ml Activin
until the end of Step-II day6 (8 days of differentiation), then different culture media were tested: control 0.1%
DMSO-containing medium (Ctrl DMSO, A); medium with Wnt-inhibitor+10 ng/ml Activin (same medium used in
the first 10 days of culture;  WNTi+Act, B); medium with Wnt-inhibitor and Activin supplemented with 1 ng/ml
BMP4 (WNTi+Act+BMP, C);  medium supplemented with 1.5% KSR (KSR, D);  finally,  medium with 500 nM
Retinoic acid (Retinoic acid, E). Rax-GFP-positive neural progenitors were still present in culture after 18 days of
differentiation,  but  only  when  Activin  was  maintained  during  long-term  culture.  Nuclei  counter-staining  was
obtained with DAPI.
Rax-GFP  DAPI
Ctrl DMSO WNTi+Act WNTi+Act+BMP
KSR Retinoic acid
Results and Discussion  8−Terminal Differentiation of Retinal Cells
We  suggest  that  prolonged  Activin  treatment  was  responsible  for  Rax-GFP-positive  retinal
progenitor maintenance rather than for new retinal cell induction, because cells cultured in control
medium during Step-II, then treated by WNTi+Activin at a later time windows, were not able to
respond to Activin retinal inducing action (Figure 8.4). This was consistent with the identification
of a narrow time window where cells are sensitive to Activin treatment, located at the beginning of
Step-II (see Figures 39-42 in Chapter 5).
We concluded that Activin signal plays a role in retinal progenitor induction, but is also required for
their maintenance and proliferation in vitro for longer culture periods.
We thus decided to force retinal progenitor differentiation. Neural progenitors can be forced toward
terminal  differentiation  by  culturing  them  in  a  minimal  medium;  chemically  defined  minimal
medium  (containing  N2  and  B27  supplements)  can  be  further  depleted  by  removing  B27
supplement.  Therefore,  cells  were  first  treated  with  Wnt-inhibitor+Activin  in  N2-B27  medium
during Step-II,  then the culture medium was replaced by N2 medium (always containing Wnt-
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Figure 8.4: Effects of Wnt-inhibition, Activin and BMP on Rax expression in long-term ES cell cultures.   A-C:
Immunocytodetection shows GFP (expressed under the control of Rax promoter in the Rax-GFP knock-in cell line
K/l EB5; green), in ES cells at the end of Step-II day16 (18 days of in vitro differentiation after LIF withdrawal).
Cells were cultured in control medium (N2B27 medium+0.1% DMSO) until the end of Step-II day6 (8 days of
differentiation), then treated with Wnt-inhibitor (10 μM IWR-1-Endo) plus 10 ng/ml Activin (WNTi+Act) or with
Wnt-inhibitor+Activin+BMP (1 ng/ml BMP4; WNTi+Act+BMP). Nuclei counter-staining was obtained with DAPI.
Ctrl DMSO WNTi+Act WNTi+Act+BMP
Rax-GFP  DAPI
A B C
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inhibitor and Activin).  Moreover,  the culture protocol  was further  prolonged (up to 22 days  of
culture in vitro) to allow for terminal differentiation. In some experiments we found useful to add
2.5% Serum to culture medium, to allow for cell survival during the final days of culture.
Long-term  ES  cultures  treated  with  Wnt-inhibitor+Activin  or  with  Wnt-inhibitor+
Activin+Cyclopamine  continued  to  express  retinal  markers  Rax  and  Vsx2  after  18/19  days  of
differentiation in vitro (Figure 8.5). Cells additionally started to express Crx, a transcription factor
which is essential for photoreceptor differentiation (Figure  8.5); the expression level of Crx was
particularly high  in  cells  treated  with  Wnt-inhibitor+Activin  and  Cyclopamine.  Serum allowed
better cell survival in long term culture, without strongly affecting the differentiation identity of ES
cells (data not shown and Figure 8.5). Notably, cells treated with Wnt-inhibitor+ SAG expressed
Rax at Step-II, day 16, but failed to express retinal markers Vsx2 and Crx, consistently with their
ventral diencephalic identity (See Results, Chapter 7).
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Figure  8.5:  Analysis  of   retinal  marker  expression in long-term ES cell  cultures.  Graph shows mRNA fold
changes of retinal markers Rax and Vsx2, and of the photoreceptor precursor marker Crx, as evaluated by RT-PCR,
in ES cells (Rax-GFP knock-in cell line K/l EB5) treated with Wnt-inhibitor (10 µM IWR-1-Endo;  WNTi), with
Wnt-inhibitor+10  ng/ml  Activin  (WNTi+Activin),  with  Wnt-inhibitor  plus  Activin  and  5  µM  Cyclopamine
(WNTi+Cyc+Activin) or with Wnt-inhibitor plus 100 nM SAG (WNTi+SAG). Cells were analyzed at the end of
Step-II, day17 (19 days of differentiation). Cells were first cultured in N2-B27 medium during Step-II, then the
culture medium was replaced by N2 medium. Control cells were cultured in 0.1% DMSO-containing medium. Some
sample were cultured in 2.5% Serum containing medium during the final part of the protocol, to allow for optimal




























Results and Discussion  8−Terminal Differentiation of Retinal Cells
Rhodopsin-positive  cells,  which  can  be  considered  as  bona  fide photoreceptors  (Olsson  et  al.,
1992),  appeared  when ES cells  were cultured  until  Step-II,  day20 (22 days  of  differentiation).
Rhodopsin-positive  photoreceptors  were  almost  always  negative  for  GFP  signal,  and  this  is
consistent with the fact that retinal progenitors switch-off Rax expression when they terminally
differentiate (Furukawa et al., 1997).
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Figure  8.6:  Analysis  of  Rax and Rhodopsin  expression  in  long-term ES cell  cultures  differentiated  in  N2
medium. A and B show immunocytodetection for GFP (expressed under the control of Rax promoter in the Rax-
GFP knock-in cell line K/l EB5; green in (A) and Rhodopsin (red in  A and B), in ES cells at the end of Step-II,
day20 (22 days of in vitro differentiation after LIF withdrawal), after treatment with Wnt-inhibitor (10 μM IWR-1-
Endo) plus 10 ng/ml Activin. Cells were first cultured in N2-B27 medium during Step-II, then the culture medium
was replaced by N2 medium. Nuclei counter-staining was obtained with DAPI.
Rhodopsin
Rax-GFP  Rhodopsin  DAPI
A B
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Notably, Rhodopsin-positive cells were placed in close proximity to clusters of Rax-GFP-positive
retinal progenitors (Figure 8.7C and inset), or sometimes were mixed together with them (Figure
8.6A).  No Rhodopsin staining was detected  in  cells  treated with  WNT-inhibitor  or  whit  WNT-
inhibitor+SAG (Figure 8.7A,B).
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Figure  8.7:  Analysis  of  Rax and Rhodopsin  expression  in  long-term ES cell  cultures  differentiated  in  N2
medium + 2.5% Serum. A-C show immunocytodetection for GFP (expressed under the control of Rax promoter in
the Rax-GFP knock-in cell line K/l EB5; green) and Rhodopsin (red), in ES cells at the end of Step-II, day20 (22
days of in vitro differentiation after LIF withdrawal), after treatment with Wnt-inhibitor (10 μM IWR-1-Endo) plus
10 ng/ml Activin, or with Wnt-inhibitor (10 μM IWR-1-Endo) plus 100 nM SAG. Cells were first cultured in N2-B27
medium during Step-II,  then the culture  medium was replaced by 2.5% Serum-containing N2 medium.  Nuclei
counter-staining was obtained with DAPI. Inset shows Rhodopsin-positive cells (arrowheads) when image in C was
observed at higher magnification.








Results and Discussion  8−Terminal Differentiation of Retinal Cells
We  concluded  that  Activin  treatment  during  ES  cell  neural  differentiation  triggered  a  retinal








Translating the Notion of the Default Model 
into an in Vitro Model of Neural Induction and Patterning.
I  established  an  original  method  of  ES  cell  in  vitro neuralization  that  allows  to  obtain  neural
progenitors that undergo all the known sequential steps of neural development – neural induction,
specification  of  positional  identity  and  histological  cell  type,  terminal  differentiation  –  in  a
chemically defined minimal medium (CDMM).
We found that ES cells cultured as adherent cells in CDMM without any added exogenous factor
differentiated  as  neurons  more  efficiently  than  ES  cells  cultured  in  serum-containing  medium
(SCM) during the early phase of differentiation (Step-I) (Figure 1.1). This is consistent with similar
observations reported in the literature (Eiraku et al., 2008; Gaspard et al., 2009; Gratsch & O'Shea,
2002; Watanabe et al., 2005; Wataya et al., 2008) and confirms the notion that a default program of
neuronal differentiation of ES cells exists and can be inhibited by factors contained in serum. We do
not  know  to  what  extent  BMPs,  which  are  present  in  serum  (Kodaira et  al.,  2006),  or  other
morphogens, may account for its inhibitory effects.
Even when differentiated in a chemically defined, morphogen-free culture medium, we found that
mouse ES cells expressed themselves different morphogens during neural differentiation  in vitro,
especially BMPs and Wnts. We reasoned that endogenously produced BMPs could affect ES cell
neuralization. In  fact,  Noggin-mediated  BMP-inhibition  further  strengthened their spontaneous
neural differentiation in a minimal medium. The expression of Zfp521, a key gene for the priming
of neuralization (Kamiya et al., 2011), was highest in Noggin treated cultures compared to any other
culture condition, confirming the crucial role of Noggin in ES cell neural conversion. Furthermore,
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we  found  that  adding  increasing  doses  of  Noggin  to  CDMM during Step-II  supported the
expression of the pan-neuronal markers Ncam and Pax6 and increased the ratios of Pax6-, Nestin-
and Sox1-positive neural progenitors.
We concluded that ES cells, when cultured in the absence of any added morphogen, efficiently
acquired a neuronal fate; this was perfectly in line with the well-known Default model of neural
induction (See Introduction, Wilson and Houart, 2004; Gaspard et al., 2008; Smukler et al., 2006).
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Figure 1.1: Effects of BMPs/Serum on ES cell spontaneous neural conversion in chemically defined
minimal medium.
Conclusions  1−Conclusions
A Plastic and Handy System to Work with: 
ES Cells Recapitulate in vitro the Major Milestones of Brain Development in vivo.
ES cells neuralized in CDMM showed to be capable of acquiring different positional identities,
similarly to the early neural progenitors during the embryonic patterning of the central nervous
system.  This  sort  of  “in  vitro patterning”  of  ES-derived  neural  progenitors  was  affected  by
morphogens and growth factors - either added to CDMM during the differentiation protocol or
produced by the neuralizing ES themselves - or by their  agonists and antagonists.  Notably,  the
effects  on  patterning  were  different  depending  on the  time  of  activation  (or  inhibition)  of  the
different pathways. Most importantly, the type of effect exerted by the manipulation of the protocol
was often consistent with the role of a given type of signaling in embryonic development, if it was
known by in vivo studies. 
ES cells responded to Retinoic acid (RA) and SAG (Shh agonist) by activating posterior and ventral
pathways  of  differentiation,  respectively  (Figure  1.2).  SAG  efficiently  caused  a  strong
ventralization of our cultures, switching-on Nkx2.1 expression in the vast majority of the cells (65-
80% Nkx2.1-positive cells, varying from experiment to experiment). RA had a strong posteriorizing
effect  and led to high expression levels of posterior  Hox genes  HoxB4 and HoxB9, which are
mainly  expressed  in  hindbrain  and  spinal  cord,  respectively.  By  employing  these  well-known
morphogens, we obtained strong evidence that ES cells  in vitro follow and respond to the same
signals found during in vivo embryonic development.
Our observations suggest that the protocol of ES neuralization in CDMM I established might be an
useful  alternative  to  the  embryo  as  model  to  investigate  the  role  of  different  morphogens  and
growth  factors  at  different  times  of  the  neural  differentiation  process  in  establishing  distinct
positional and cell identities. 
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Figure  1.2:  Differentiating  ES  cells
respond  to  well-known  morphogens
(such  as  Shh  and  Retinoic  acid)  by
changing  their  antero-posterior  or
dorso-ventral identity.
Conclusions  1−Conclusions
Endogenously Produced BMPs and Brain Patterning: 
BMP Activity Regulates Regional Differences in Embryonic Fore-Midbrain.
I have addressed the role of BMPs in the anterior-posterior neural patterning. BMP and Noggin
have been deeply studied in early development as important players for neural induction (Wilson
and Houart, 2004). BMP is a the key player of the choice among the primordial embryonic tissues
during  the  earliest  steps  of  embryonic  development  and  BMP inhibitors,  including  Noggin,
orchestrate the spatio-temporal occurrence of neural induction. 
Moreover, a later role for BMP has been suggested in brain patterning, consisting in the inhibition
of an anterior,  default,  identity.  In fact,  classical studies in lower vertebrates showed that BMP
antagonism on Xenopus animal caps generates anterior neural structures (Hawley et al., 1995; Lamb
et  al.,  1993;  Sasai  et  al.,  1995).  In  mouse,  specific  forebrain  defects  in  mice  mutant  for  BMP
antagonists were shown (Bachiller et al., 2000). However, my work is the first study that directly
addresses this issue in a systematic way in neuralized ES cells (Bertacchi et al.,  2013, and this
Thesis).
We found that Noggin acted at two distinct levels of ES cell differentiation: at the level of neural
induction Noggin induced only a slight increase of neural progenitor ratio compared to control cells,
while  at  the  level  of  neural  patterning it  supported a dramatic increase of cells  expressing  the
telencephalic marker FoxG1. Noggin had a profound effect on the positional identity of ES cell-
generated  neurons,  as  it  up-regulated  the  global  gene  expression  of  cortical  genes  and  down-
regulated that of midbrain and hindbrain genes. This indicates that BMPs endogenously produced
by differentiating  ES cell  directly  act  on  the  positional  identity  of  the  neural  progenitors  they
spontaneously generate in a minimal medium, by influencing the anterior-posterior neural identity
(Figure 1.3). 
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A crucial role for BMP in patterning neural structures has been recently suggested in vitro, as
pluripotent cells of Xenopus animal caps acquired anterior neural fate when treated with high doses
of Noggin (Lan et al., 2009; Viczian et al., 2009).  In  fact,  my results  are  consistent  with this
observation and point to the existence of a default, intrinsic program of differentiation of pluripotent
cells that has been conserved through vertebrate evolution and is both neuronal and anterior.
A revisited analysis of mammalian neural induction points to a model in which neural inducing
signals called activators are proposed to impart both neural and anterior identity to the ectoderm. In
this view, events that posteriorize the anterior neural tissue to generate the full range of CNS
structures would occur later, by transformer molecules (Levine & Brivanlou, 2007; Wilson &
Houart, 2004).  According  to  such  a  classical  model,  we  speculate  that  a  primitive  neuronal-
telencephalic fate of ES cells might be further transformed in midbrain by a secondary signaling of
BMP transformers (Figure 1.4), in a similar way to what has been demonstrated for Retinoic acid
(RA) in hindbrain patterning.
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Figure  1.3: The default telencephalic fate of ES cells is transformed in mesencephalic fate by low
doses of endogenously produced BMPs.
Figure  1.4:  BMPs  act  as  transformer factors,  regulating  the  fate  acquisition  in  fore-midbrain
territories.
Conclusions  1−Conclusions
A Novel Protocol for Cortical Induction: 
A Comparison with Already Established Protocols.
To induce a cortical fate, some procedures make use of a feeder layer of stromal cells (Ideguchi et
al.,  2010), or  cell  aggregation  (Eiraku et  al.,  2008).  In  these  studies,  the  factors  that  were
endogenously produced by cells in culture and that might have influenced ES cell differentiation
were not identified. In one of theses studies, ES cell cultured in a minimal medium at a very low
density generated cells with morphological, electrophysiological and molecular features of anterior
neurons (Gaspard et al., 2008). These could be directed toward a cortical fate by treatment with the
Shh antagonist  Cyclopamine,  although neither  Shh secretion  nor  autocrine  action  of  Shh were
directly investigated (Gaspard et al., 2008). I did not observe any strong effect of Cyclopamine on
ES cell dorso-ventral fate. However, we can confirm that ES cell can activate Shh signaling, as
shown by the ventralizing effect described when adding a Shh agonist during Step-II. I hypothesize
that under the low density culture conditions employed by Gaspard et al., an endogenous production
of Shh that was not present in our culture condition was induced.
Eiraku et al. developed a three-dimensional aggregation culture for the self-organized generation of
apico-basally polarized cortical  tissues (Eiraku et  al.,  2008). The generated cortical  neurons are
functional, transplantable, and capable of forming proper long-range connections in vivo and  in
vitro. However, the formation of a three-dimensional structure (the embryoid body) could lead to
the uncontrolled generation of intrinsic gradient of autocrine factors produced by differentiating
cells  themselves.  A 3D structure could also obstacle  the treatment with exogenous morphogens
added  to  culture  medium.  Additionally,  the  Authors  made  use  of  KSR  (knock-out  serum
replacement  supplement)  in  their  protocol;  the  composition  of  this  patented  supplement  is  not
completely  known,  and  its  possible  contribution  to  neural  tissue  patterning  has  never  been
thoroughly investigated.
In any case, ES cells differentiating as a monolayer of adherent cells in a minimal medium devoid
of external signals were never able, to our knowledge, to induce a genuine cortical gene expression
profile,  as  we on  the  contrary  observed  by means  of  Noggin-mediated  BMP-inhibition  in  our
culture system (Bertacchi et al., 2013).
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The Inhibition of Endogenously Produced Wnts: 
A Must for Optimal ES Cell Cortical Conversion.
Inhibition of BMP signaling appears to be a crucial step in forebrain induction, as shown by the
severe defects in the development of the prosencephalon of mice double mutants for of the BMP
inhibitors Chordin and Noggin (Bachiller et al., 2000). However, dual inhibition of Wnt and BMP
signals  has  been proposed to  be  necessary to  confer  head organizer  activity both  in  Zebrafish
(Houart et al., 2002), Xenopus (Glinka et al., 1997; Lupo et al., 2002; Bayramov et al., 2011) and
mouse (del Barco Barrantes et al., 2003).
Although we observed a robust activation of cortical markers and a strong repression of midbrain
genes with the sole inhibition of BMP (Bertacchi et al., 2013), we could not exclude that Wnt-
inhibition  might  be  synergistic  with  BMP-inhibition  in  inducing  a  cortical  fate  in  ES  cells.
Endogenous  Wnt  activity  might  explain  why the  ratios  of  ES cells  treated  with high  doses  of
Noggin that express markers of cortical progenitors (FoxG1, 22%) and of cortical neurons (Tbr1
and Satb2, 30% in total) at the end of Step-III did not account for the total number of Sox1-positive
cells neuralized at step II (90,5 %). Additionally, by analyzing the expression level of key target
genes of BMP and Wnt pathways (ID1 and LEF1 genes, respectively), we found evidence for a
possible  crosstalk  between  the  two  pathways.  This  suggested  that  the  corticalizing effects
previously seen with Noggin-mediated BMP-inhibition, could be, at least in part, due to a secondary
modulation of Wnt signaling pathway.
We then asked whether endogenously produced Wnts in our culture system could contribute to
mask an intrinsic cortical fate of neuralizing ES cells.
For these reasons, I investigated for endogenous Wnt production in our cultures and for possible
effects of Wnt-inhibition via treatment with specific chemical drug IWR-1-Endo. Members of the
Wnt family were expressed during Step-II, and this was clearly correlated with the appearance of
neural progenitors inside the culture. We found that Wnt-inhibition was extremely efficient for ES
cell cortical induction, as we obtained high percentages of both cortical progenitors (54% FoxG1-
positive  cells)  and  cortical  post-mitotic  neurons  (Tbr1  and  Ctip2,  more  than  40%  in  total).
Considering that FoxG1 exclusively labels Nestin-positive neural progenitors, while Tbr1 and Ctip2
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preferentially mark β-Tubulin-III-positive post-mitotic neurons, we can state that the vast majority
of cells in culture were telencephalic/cortical cells after double Wnt/BMP-inhibition.
Additionally,  we highlighted  a  synergistic  effect  of  BMP and Wnt  pathway inhibitions  for  the
acquisition of a cortical fate: double BMP- and Wnt-inhibition showed a stronger down-regulation
of the midbrain markers En1 and Otx2 and a more efficient up-regulation of the cortical markers
FoxG1, Ctip2 and Tbr1, compared to single treatments. 
We concluded that Wnt-inhibition plays a fundamental role in establishing an anterior, telencephalic
fate during ES cells neural differentiation in vitro (Figure 1.5). Our findings are consistent with the
use of Wnt antagonists (such as Dkk-1 recombinant protein) in many neural induction protocols
available in literature, both alone or in association with BMP- or Activin/Nodal-inhibitors, for the
induction of  neural tissues showing an anterior default identity (Eiraku et al., 2008; Ikeda et al.,
2005; Verani et al., 2007; Nicoleau et al., 2013).
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Figure 1.5: BMP and Wnt pathway inhibitions play a synergistic role for the acquisition of a cortical
fate.
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What is Old and What is New: 
Activin as an Inducer of Retinal Identity.
Classical studies showed that Activin plays a pivotal role in mesodermal development. At moderate
concentrations,  Activin  activates  the  expression  of  the  key  gene  for  mesodermal  induction,
Brachyury, while at higher concentrations it induces organizer genes to become expressed. For this
reason, Activin is  used in ES cell  differentiation protocols as an efficient inducer of mesoderm
identity (Cerdan et al., 2012). Additionally, Activin was found to be crucial for endoderm induction
in vitro (Teo et al., 2012; Iwao et al., 2013; Vosough et al., 2013). We detected minimal expression
of early endodermal/mesodermal markers Gata4 and Gata6 in our system after treatment with low
doses of Activin in association with WNT-inhibition. Activin strongly induced the expression of
Gata4 and Gata6 only when used alone or when added at very high doses. This assured us on the
marginal  contribution  of  mesodermal/endodermal  cells  to  the  cultures,  at  least  in  our  Retinal
inducing condition. 
In our hands, Activin induced instead a high expression level of stem cell marker Oct4. We found
that  Activin  acted  by  slowing-down  neural  differentiation  (Figure  1.6).  This  was  particularly
evident when Activin was used in the early phase of neural conversion of the protocol (before the
fourth day of differentiation) or at very high doses (50 and 100 ng/ml). This effect is consistent with
Activin role in maintenance of stem cell pluripotency (Tomizawa et al., 2013; Sakaki-Yumoto et al.,
2013).
We asked whether Activin could play additional roles in ES cell differentiation and possibly in ES
cell patterning. To date, few evidence has been provided for a possible role of Activin as an inducer
of retinal identity. A cue in this direction has been given by Sasai's Lab (Ikeda et al., 2005); their
protocol for the  in vitro generation of retinal progenitors makes use of Activin-A in the culture
medium. Unfortunately, the experimental procedures described in this work did not allow to infer
neither  the  exact  role  for  each  of  molecules  used  nor  the  temporal  competence  of  cells  to
specifically respond to the different signals. In particular, the role of Activin in patterning neural
fate toward a retinal identity was not dissected.
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Conversely Lupo et al. showed the importance of both BMP and Activin/Nodal signaling for eye
field gene induction in differentiating human ES cells, separately investigating their contribution
and time of action on the transcription of early retinal markers (Lupo et al., 2013).
Our experiments (this Thesis and Bertacchi et al., manuscript in preparation) are the first description
and full characterization of a new role of Activin as an inducer of retinal identity in mouse ES cells
(Figure 1.7). The expression of retinal markers was investigated by RT-PCR, immunocytodetection
and  flow  cytometry.  We  found  that  low  doses  (10  ng/ml)  of  Activin  were  able  to  drive  the
expression  of  retinal  markers  Rax,  Six3,  Pax6,  Otx2,  Vsx2  and  Six6,  some  of  which  were
previously shown to play a fundamental role as eye field transcription factors (Zuber et al., 2003).
At the same time, Activin could inhibit the expression of cortical (Emx2 and FoxG1) and midbrain
(En1 and Irx3) genes.
The retinal inducing action of Activin was exerted only on cells that acquired a forebrain fate via
Wnt-inhibition or double Wnt/BMP-inhibition; Activin was not effective as a retinal inducer when
used alone. This suggests that a previous anteriorization to a forebrain fate was necessary to acquire
the competence to respond to Activin-mediated retinal induction (Figure 1.7), consistently to what
happens in in vivo development.
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Figure  1.6:  Effects  of  Activin  on  ES  cell  spontaneous  neural  conversion  in  chemically  defined
minimal medium.
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Further studies will be necessary both to dissect molecular mechanisms controlling Rax expression
in response to Activin treatment, and to unravel the role of Activin in retinal induction in vivo. 
It  must  be also noticed that  cell  culture after our protocol of retinal  induction did not reached
complete  uniformity  (45% Rax-positive  cells  in  the  best  condition  of  Activin  treatment,  after
optimization  of  the  protocol).  Some  other  protocol  of  retinal  induction  /  retinal  culture  and
differentiation have been shown to be more efficient, but they often make use of cell sorting (Ikeda
et al., 2005; Eiraku et al., 2011) or they use already differentiated retinal precursors coming from
the embryo eye primordium or from eye ciliary margin (see as a review Lamba et al., 2008). In our
case, we can hypothesize that some other, still unidentified signals, possibly acting in a synergistic
way together with Activin, might be necessary to obtain a more efficient retinal induction. Insulin-
like growth factor-1 (IGF-1) has already been used as a retinal inducer (Lamba et al., 2010) and
could be a useful morphogen to be tested, both alone or in combination with Activin.
All  in  all,  we  concluded  that  Activin  functions  as  a  retinal  inducer  during  ES  cell  neural
differentiation (Figures 1.7 and 1.10).
Lupo and collaborators additionally showed the importance of BMP signaling for eye field gene
induction  in  differentiating  human  ES  cells,  together  with  Activin  (Lupo  et  al.,  2013).
Unfortunately,  in  our  system we found that  the presence of BMP4 in culture medium was not
promoting retinal differentiation, as BMP4 was not able to efficiently induce Rax expression. We
speculate that intrinsic differences between mouse and human ES cells could be responsible for
some discrepancies when comparing different studies.
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Figure 1.7: Activin's new role as an inducer of retinal identity.
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Retina vs. Ventral Diencephalon: 
Shh and Activin Switch-on Different Kinds of Rax Expression.
An  interesting  finding  of  my  Thesis  is  that  different  morphogens  are  able  to  switch-on  Rax
expression (Figure 1.8). 
Retinal progenitors originate from the lateral wall of diencephalon, and are both Rax-positive and
Pax6-positive  (Wilson  and  Houart,  2004;  Ikeda  et  al.,  2005).  They  are  also  positive  for  the
anterior/dorsal  marker  Otx2  and  for  the  forebrain  marker  Six3  (Ikeda  et  al.,  2005).  Neural
progenitor cells in the ventral diencephalon, on the contrary, are Rax-positive but Pax6-negative
(Ikeda et al., 2005); they are positive for ventral markers such as Nkx2.1 (which is expressed in the
ventral forebrain) and Vax1 (ventral anterior homeobox).
Interestingly, we found that Activin was able to induce the formation of Pax6/Rax double positive
cells,  which  can  be  considered  as  bona fide retinal  progenitors,  while  SAG (Shh-agonist)  was
driving efficient Rax co-expression together with Nkx2.1 and Vax1  (Figure  1.8).  Notably,  both
morphogens  (Activin  and  Shh)  were  able  to  induce  the  expression  of  Rax  only  if  used  in
combination  with  Wnt-inhibitor.  This  suggested  that  only  anteriorized forebrain  cells  were
competent to respond to Activin- or Shh-mediated Rax induction.
Cells treated with Wnt-inhibition together with SAG were both ventralized (87% Nkx2.1-positive
cells) and expressed Rax (60.4% Rax-GFP-positive cells), showing high degree of co-labeling of
the two markers (60% Nkx2.1/GFP-double positive cells). This means that almost all Rax-positive
cells  in this  condition were also Nkx2.1-positive.  A better characterization of the expression of
regional markers will be necessary to complete the identity card of these cells. However, the co-
expression of Rax together with Nkx2.1 and Vax1 is consistent with a ventral diencephalic identity
(rostral hypothalamus cells; Wataya et al, 2008).
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Figure  1.9 and  Figure  1.10 schematize the principal findings described in my Thesis. Some of
these findings are consistent with previous observations present in the literature. We found that ES
cells cultured in the absence of any added morphogen efficiently acquired a neuronal fate, and that
the positional identity of ES-derived neural progenitors can be steered by distinct growth factors
present in  the culture medium, according to the role that these growth factors exert  during the
embryonic development of the central nervous system. This is in line with  the classical  Default
model of neural differentiation (see Introduction). Some data were completely new findings. We
demonstrated that low doses of endogenously produced BMPs and Wnts act as morphogens on
differentiating  ES  cells  and  dampen  an  intrinsic  cortical  fate.  Additionally,  we  discovered  that
Activin  is  an  useful  morphogen  to  induce  retinal  identity  during  mouse  ES cell  neuralization.
Finally, we identified a Shh-mediated induction of Rax expression in the context of forebrain cells.
Taken all together, my data contribute to add some little pieces to the huge enigmatic puzzle of
mouse brain development and patterning.
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Figure 1.8: Control of Rax expression by Activin and Shh signaling pathways.
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Figure 1.9: Early steps in mouse ES cell neural conversion and antero-posterior patterning: Principal
findings in my Thesis.







Abe, E., M. Yamamoto, Y. Taguchi, B. Lecka-Czernik, C. A. O'Brien, A. N. Economides, N. Stahl, R. L.
Jilka  and  S.  C.  Manolagas.  "Essential  Requirement  of  Bmps-2/4  for  Both  Osteoblast  and  Osteoclast
Formation in Murine Bone Marrow Cultures from Adult Mice: Antagonism by Noggin." J Bone Miner Res
15, no. 4 (2000): 663-73.
Acampora, D., V. Avantaggiato, F. Tuorto, P. Barone, H. Reichert, R. Finkelstein and A. Simeone. "Murine
Otx1 and Drosophila Otd Genes Share Conserved Genetic Functions Required in Invertebrate and Vertebrate
Brain Development." Development 125, no. 9 (1998): 1691-702.
Amaya,  E.,  T.  J.  Musci  and M.  W. Kirschner.  "Expression of  a  Dominant  Negative Mutant  of  the  Fgf
Receptor Disrupts Mesoderm Formation in Xenopus Embryos." Cell 66, no. 2 (1991): 257-70.
Andoniadou,  C.  L.  and  J.  P.  Martinez-Barbera.  "Developmental  Mechanisms  Directing  Early  Anterior
Forebrain Specification in Vertebrates." Cell Mol Life Sci 70, no. 20 (2013): 3739-52.
Ariizumi, T. and M. Asashima. "In Vitro Induction Systems for Analyses of Amphibian Organogenesis and
Body Patterning." Int J Dev Biol 45, no. 1 (2001): 273-9.
313
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Aubert, J., H. Dunstan, I. Chambers and A. Smith. "Functional Gene Screening in Embryonic Stem Cells
Implicates Wnt Antagonism in Neural Differentiation." Nat Biotechnol 20, no. 12 (2002): 1240-5.
Bachiller, D., J. Klingensmith, C. Kemp, J. A. Belo, R. M. Anderson, S. R. May, J. A. McMahon, A. P.
McMahon, R. M. Harland, J. Rossant and E. M. De Robertis. "The Organizer Factors Chordin and Noggin
Are Required for Mouse Forebrain Development." Nature 403, no. 6770 (2000): 658-61.
Barberi, T., P. Klivenyi, N. Y. Calingasan, H. Lee, H. Kawamata, K. Loonam, A. L. Perrier, J. Bruses, M. E.
Rubio,  N.  Topf,  V.  Tabar,  N.  L.  Harrison,  M.  F.  Beal,  M.  A.  Moore  and  L.  Studer.  "Neural  Subtype
Specification of Fertilization and Nuclear Transfer Embryonic Stem Cells and Application in Parkinsonian
Mice." Nat Biotechnol 21, no. 10 (2003): 1200-7.
Bayramov, A. V., F. M. Eroshkin, N. Y. Martynova, G. V. Ermakova, E. A. Solovieva and A. G. Zaraisky.
"Novel Functions of Noggin Proteins: Inhibition of Activin/Nodal and Wnt Signaling." Development 138,
no. 24 (2011): 5345-56.
Beccari,  L.,  R.  Marco-Ferreres  and  P.  Bovolenta.  "The  Logic  of  Gene  Regulatory  Networks  in  Early
Vertebrate Forebrain Patterning."Mechanisms of Development 70, no. 130 (2013): 95-111.
Bertacchi, M., L. Pandolfini, E. Murenu, A. Viegi, S. Capsoni, A. Cellerino, A. Messina, S. Casarosa and F.
Cremisi. "The Positional Identity of Mouse Es Cell-Generated Neurons Is Affected by Bmp Signaling." Cell
Mol Life Sci 70, no. 6 (2013): 1095-111.
Bibel, M., J. Richter, E. Lacroix and Y. A. Barde. "Generation of a Defined and Uniform Population of Cns
Progenitors and Neurons from Mouse Embryonic Stem Cells." Nat Protoc 2, no. 5 (2007): 1034-43.
Blumberg, B., J. Bolado, Jr., T. A. Moreno, C. Kintner, R. M. Evans and N. Papalopulu. "An Essential Role
for Retinoid Signaling in Anteroposterior Neural Patterning." Development 124, no. 2 (1997): 373-9.
Bosse,  A.,  A.  Zulch,  M.  B.  Becker,  M.  Torres,  J.  L.  Gomez-Skarmeta,  J.  Modolell  and  P.  Gruss.
"Identification  of  the  Vertebrate  Iroquois  Homeobox Gene  Family with Overlapping  Expression  During
Early Development of the Nervous System." Mech Dev 69, no. 1-2 (1997): 169-81.
Bouhon, I. A., H. Kato, S. Chandran and N. D. Allen. "Neural Differentiation of Mouse Embryonic Stem
Cells in Chemically Defined Medium." Brain Res Bull 68, no. 1-2 (2005): 62-75.
314
Bibliography  1−References
Bouwmeester, T., S. Kim, Y. Sasai, B. Lu and E. M. De Robertis. "Cerberus Is a Head-Inducing Secreted
Factor Expressed in the Anterior Endoderm of Spemann's Organizer." Nature 382, no. 6592 (1996): 595-601.
Briscoe, J. and J. Ericson. "The Specification of Neuronal Identity by Graded Sonic Hedgehog Signalling."
Semin Cell Dev Biol 10, no. 3 (1999): 353-62.
Briscoe, J., A. Pierani, T. M. Jessell and J. Ericson. "A Homeodomain Protein Code Specifies Progenitor Cell
Identity and Neuronal Fate in the Ventral Neural Tube." Cell 101, no. 4 (2000): 435-45.
Britanova,  O.,  S.  Akopov,  S.  Lukyanov,  P.  Gruss  and V.  Tarabykin.  "Novel  Transcription  Factor  Satb2
Interacts with Matrix Attachment Region DNA Elements in a Tissue-Specific Manner and Demonstrates
Cell-Type-Dependent Expression in the Developing Mouse Cns." Eur J Neurosci 21, no. 3 (2005): 658-68.
Bulfone,  A.,  S.  M.  Smiga,  K.  Shimamura,  A.  Peterson,  L.  Puelles  and J.  L.  Rubenstein.  "T-Brain-1:  A
Homolog  of  Brachyury  Whose  Expression  Defines  Molecularly  Distinct  Domains  within  the  Cerebral
Cortex." Neuron 15, no. 1 (1995): 63-78.
Cai, C. and L. Grabel. "Directing the Differentiation of Embryonic Stem Cells to Neural Stem Cells." Dev
Dyn 236, no. 12 (2007): 3255-66.
Cerdan, C., B. A. McIntyre, R. Mechael, M. Levadoux-Martin, J. Yang, J. B. Lee and M. Bhatia. "Activin a
Promotes  Hematopoietic  Fated  Mesoderm Development  through  Upregulation  of  Brachyury  in  Human
Embryonic Stem Cells." Stem Cells Dev 21, no. 15 (2012): 2866-77.
Chambers,  S.  M.,  C.  A.  Fasano,  E.  P.  Papapetrou,  M.  Tomishima,  M.  Sadelain and L.  Studer.  "Highly
Efficient  Neural  Conversion  of  Human  Es  and  Ips  Cells  by  Dual  Inhibition  of  Smad  Signaling."  Nat
Biotechnol 27, no. 3 (2009): 275-80.
Chatzi, C., T. Brade and G. Duester. "Retinoic Acid Functions as a Key Gabaergic Differentiation Signal in
the Basal Ganglia." PLoS Biol 9, no. 4 (2011): e1000609.
Chen, F. and M. R. Capecchi. "Targeted Mutations in Hoxa-9 and Hoxb-9 Reveal Synergistic Interactions."
Dev Biol 181, no. 2 (1997): 186-96.
315
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Chen, Y., L. Huang and M. Solursh. "A Concentration Gradient of Retinoids in the Early Xenopus Laevis
Embryo." Dev Biol 161, no. 1 (1994): 70-6.
Chenn,  A.  and  S.  K.  McConnell.  "Cleavage  Orientation  and  the  Asymmetric  Inheritance  of  Notch1
Immunoreactivity in Mammalian Neurogenesis." Cell 82, no. 4 (1995): 631-41.
Chiba, S., M. S. Kurokawa, H. Yoshikawa, R. Ikeda, M. Takeno, M. Tadokoro, H. Sekino, T. Hashimoto and
N. Suzuki. "Noggin and Basic Fgf Were Implicated in Forebrain Fate and Caudal Fate, Respectively, of the
Neural Tube-Like Structures Emerging in Mouse Es Cell Culture." Exp Brain Res 163, no. 1 (2005): 86-99.
Cho, K. W., E. A. Morita, C. V. Wright and E. M. De Robertis. "Overexpression of a Homeodomain Protein
Confers Axis-Forming Activity to Uncommitted Xenopus Embryonic Cells." Cell 65, no. 1 (1991): 55-64.
Cox, W. G. and A. Hemmati-Brivanlou. "Caudalization of Neural Fate by Tissue Recombination and Bfgf."
Development 121, no. 12 (1995): 4349-58.
Dale, L., G. Howes, B. M. Price and J. C. Smith. "Bone Morphogenetic Protein 4: A Ventralizing Factor in
Early Xenopus Development." Development 115, no. 2 (1992): 573-85.
Dale, L. and J.  M. Slack. "Fate Map for the 32-Cell Stage of Xenopus Laevis." Development 99, no. 4
(1987): 527-51.
DeCamp, D. L.,  T.  M. Thompson, F.  J.  de Sauvage and M. R. Lerner.  "Smoothened Activates Galphai-
Mediated Signaling in Frog Melanophores." J Biol Chem 275, no. 34 (2000): 26322-7.
del Barco Barrantes, I., G. Davidson, H. J. Grone, H. Westphal and C. Niehrs. "Dkk1 and Noggin Cooperate
in Mammalian Head Induction." Genes Dev 17, no. 18 (2003): 2239-44.
Dubrulle, J. and O. Pourquie. "Fgf8 Mrna Decay Establishes a Gradient That Couples Axial Elongation to
Patterning in the Vertebrate Embryo." Nature 427, no. 6973 (2004): 419-22.
Durston,  A. J.,  J.  P.  Timmermans,  W. J.  Hage,  H. F.  Hendriks,  N. J.  de Vries,  M. Heideveld and P.  D.
Nieuwkoop. "Retinoic Acid Causes an Anteroposterior Transformation in the Developing Central Nervous
System." Nature 340, no. 6229 (1989): 140-4.
316
Bibliography  1−References
Echelard, Y., D. J. Epstein, B. St-Jacques, L. Shen, J. Mohler, J. A. McMahon and A. P. McMahon. "Sonic
Hedgehog, a Member of a Family of Putative Signaling Molecules, Is Implicated in the Regulation of Cns
Polarity." Cell 75, no. 7 (1993): 1417-30.
Edmondson, J. C., R. K. Liem, J. E. Kuster and M. E. Hatten. "Astrotactin: A Novel Neuronal Cell Surface
Antigen That Mediates Neuron-Astroglial Interactions in Cerebellar Microcultures." J Cell Biol 106, no. 2
(1988): 505-17.
Eiraku, M., N. Takata, H. Ishibashi, M. Kawada, E. Sakakura, S. Okuda, K. Sekiguchi, T. Adachi and Y.
Sasai.  "Self-Organizing Optic-Cup Morphogenesis in Three-Dimensional  Culture." Nature 472,  no. 7341
(2011): 51-6.
Eiraku, M., K. Watanabe, M. Matsuo-Takasaki, M. Kawada, S. Yonemura, M. Matsumura, T. Wataya, A.
Nishiyama, K. Muguruma and Y. Sasai. "Self-Organized Formation of Polarized Cortical Tissues from Escs
and Its Active Manipulation by Extrinsic Signals." Cell Stem Cell 3, no. 5 (2008): 519-32.
Eisen, M. B., P. T. Spellman, P. O. Brown and D. Botstein. "Cluster Analysis and Display of Genome-Wide
Expression Patterns." Proc Natl Acad Sci U S A 95, no. 25 (1998): 14863-8.
Fishell,  G.  and  M.  E.  Hatten.  "Astrotactin  Provides  a  Receptor  System for  Cns  Neuronal  Migration."
Development 113, no. 3 (1991): 755-65.
Foley,  A.  C.  and  C.  D.  Stern.  "Evolution  of  Vertebrate  Forebrain  Development:  How Many Different
Mechanisms?" J Anat 199, no. Pt 1-2 (2001): 35-52.
Frantz, G. D. and S. K. McConnell. "Restriction of Late Cerebral Cortical Progenitors to an Upper-Layer
Fate." Neuron 17, no. 1 (1996): 55-61.
Fujita,  S.,  M.  Horii,  T.  Tanimura  and  H.  Nishimura.  "H3-Thymidine  Autoradiographic  Studies  on
Cytokinetic Responses to X-Ray Irradiation and to Thio-Tepa in the Neural Tube of Mouse Embryos." Anat
Rec 149,  (1964): 37-48.
Fujita, S., M. Shimada and T. Nakamura. "H3-Thymidine Autoradiographic Studies on the Cell Proliferation
and Differentiation in the External and the Internal Granular Layers of the Mouse Cerebellum." J Comp
Neurol 128, no. 2 (1966): 191-208.
317
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Furue, M., Y. Myoishi, Y. Fukui, T. Ariizumi, T. Okamoto and M. Asashima. "Activin a Induces Craniofacial
Cartilage from Undifferentiated Xenopus Ectoderm in Vitro." Proc Natl Acad Sci U S A 99, no. 24 (2002):
15474-9.
Furukawa, T., C. A. Kozak and C. L. Cepko. "Rax, a Novel Paired-Type Homeobox Gene, Shows Expression
in the Anterior Neural Fold and Developing Retina." Proc Natl Acad Sci U S A 94, no. 7 (1997): 3088-93.
Furuta, Y., D. W. Piston and B. L. Hogan. "Bone Morphogenetic Proteins (Bmps) as Regulators of Dorsal
Forebrain Development." Development 124, no. 11 (1997): 2203-12.
Gallera, J. "Primary Induction in Birds." Adv Morphog 9,  (1971): 149-80.
Gaspard, N., T. Bouschet, A. Herpoel, G. Naeije, J. van den Ameele and P. Vanderhaeghen. "Generation of
Cortical Neurons from Mouse Embryonic Stem Cells." Nat Protoc 4, no. 10 (2009): 1454-63.Gaspard, N., T.
Bouschet, R. Hourez, J. Dimidschstein, G. Naeije, J. van den Ameele, I. Espuny-Camacho, A. Herpoel, L.
Passante, S. N. Schiffmann, A. Gaillard and P. Vanderhaeghen. "An Intrinsic Mechanism of Corticogenesis
from Embryonic Stem Cells." Nature 455, no. 7211 (2008): 351-7.
Gaspard, N., A. Gaillard and P. Vanderhaeghen. "Making Cortex in a Dish: In Vitro Corticopoiesis from
Embryonic Stem Cells." Cell Cycle 8, no. 16 (2009): 2491-6.
Gaspard, N. and P. Vanderhaeghen. "Mechanisms of Neural Specification from Embryonic Stem Cells." Curr
Opin Neurobiol 20, no. 1 (2010): 37-43.
Gerhart, J., M. Danilchik, T. Doniach, S. Roberts, B. Rowning and R. Stewart. "Cortical Rotation of the
Xenopus  Egg:  Consequences  for  the  Anteroposterior  Pattern  of  Embryonic  Dorsal  Development."
Development 107 Suppl,  (1989): 37-51.
Gimlich, R. L. "Cytoplasmic Localization and Chordamesoderm Induction in the Frog Embryo." J Embryol
Exp Morphol 89 Suppl,  (1985): 89-111.
Gimlich, R. L. "Acquisition of Developmental Autonomy in the Equatorial Region of the Xenopus Embryo."
Dev Biol 115, no. 2 (1986): 340-52.
318
Bibliography  1−References
Gimlich,  R.  L.  and  J.  C.  Gerhart.  "Early  Cellular  Interactions  Promote  Embryonic  Axis  Formation  in
Xenopus Laevis." Dev Biol 104, no. 1 (1984): 117-30.
Glaser, T., L. Jepeal, J. G. Edwards, S. R. Young, J. Favor and R. L. Maas. "Pax6 Gene Dosage Effect in a
Family with Congenital Cataracts, Aniridia, Anophthalmia and Central Nervous System Defects." Nat Genet
7, no. 4 (1994): 463-71.
Glinka, A., W. Wu, H. Delius, A. P. Monaghan, C. Blumenstock and C. Niehrs. "Dickkopf-1 Is a Member of
a New Family of Secreted Proteins and Functions in Head Induction." Nature 391, no. 6665 (1998): 357-62.
Glinka,  A.,  W.  Wu,  D.  Onichtchouk,  C.  Blumenstock and C.  Niehrs.  "Head Induction by Simultaneous
Repression of Bmp and Wnt Signalling in Xenopus." Nature 389, no. 6650 (1997): 517-9.
Godsave, S. F., C. H. Koster, A. Getahun, M. Mathu, M. Hooiveld, J. van der Wees, J. Hendriks and A. J.
Durston. "Graded Retinoid Responses in the Developing Hindbrain." Dev Dyn 213, no. 1 (1998): 39-49.
Godsave, S. F. and J. M. Slack. "Clonal Analysis of Mesoderm Induction in Xenopus Laevis." Dev Biol 134,
no. 2 (1989): 486-90.
Graff, J. M., R. S. Thies, J. J. Song, A. J. Celeste and D. A. Melton. "Studies with a Xenopus Bmp Receptor
Suggest That Ventral Mesoderm-Inducing Signals Override Dorsal Signals in Vivo." Cell 79, no. 1 (1994):
169-79.
Grant, S. "Ara-C: Cellular and Molecular Pharmacology." Adv Cancer Res 72,  (1998): 197-233.
Gratsch,  T.  E.  and  K.  S.  O'Shea.  "Noggin  and Chordin  Have  Distinct  Activities  in  Promoting  Lineage
Commitment of Mouse Embryonic Stem (Es) Cells." Dev Biol 245, no. 1 (2002): 83-94.
Green, J. B., H. V. New and J. C. Smith. "Responses of Embryonic Xenopus Cells to Activin and Fgf Are
Separated by Multiple Dose Thresholds and Correspond to Distinct Axes of the Mesoderm." Cell 71, no. 5
(1992): 731-9.
Groppe, J., J. Greenwald, E. Wiater, J. Rodriguez-Leon, A. N. Economides, W. Kwiatkowski, M. Affolter, W.
W. Vale, J. C. Izpisua Belmonte and S. Choe. "Structural Basis of Bmp Signalling Inhibition by the Cystine
Knot Protein Noggin." Nature 420, no. 6916 (2002): 636-42.
319
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Grunz,  H.  and  L.  Tacke.  "Neural  Differentiation  of  Xenopus  Laevis  Ectoderm  Takes  Place  after
Disaggregation and Delayed Reaggregation without Inducer." Cell Differ Dev 28, no. 3 (1989): 211-7.
Guan,  K.,  H.  Chang,  A.  Rolletschek  and  A.  M.  Wobus.  "Embryonic  Stem Cell-Derived  Neurogenesis.
Retinoic Acid Induction and Lineage Selection of Neuronal Cells." Cell Tissue Res 305, no. 2 (2001): 171-6.
Guthrie, S. and A. Lumsden. "Formation and Regeneration of Rhombomere Boundaries in the Developing
Chick Hindbrain." Development 112, no. 1 (1991): 221-9.
Halder, G., P. Callaerts and W. J. Gehring. "New Perspectives on Eye Evolution." Curr Opin Genet Dev 5,
no. 5 (1995): 602-9.
Hatten, M. E. "Riding the Glial Monorail: A Common Mechanism for Glial-Guided Neuronal Migration in
Different Regions of the Developing Mammalian Brain." Trends Neurosci 13, no. 5 (1990): 179-84.
Hawley, S. H., K. Wunnenberg-Stapleton, C. Hashimoto, M. N. Laurent, T. Watabe, B. W. Blumberg and K.
W. Cho. "Disruption of Bmp Signals in Embryonic Xenopus Ectoderm Leads to Direct Neural Induction."
Genes Dev 9, no. 23 (1995): 2923-35.
Hebert, J. M., Y. Mishina and S. K. McConnell. "Bmp Signaling Is Required Locally to Pattern the Dorsal
Telencephalic Midline." Neuron 35, no. 6 (2002): 1029-41.
Hedgcoth, C. and M. Jacobson. "Determination of Nucleoside Composition of Ribonucleic Acid by Thin-
Layer Chromatography." Anal Biochem 25, no. 1 (1968): 55-60.
Hemmati-Brivanlou, A., O. G. Kelly and D. A. Melton. "Follistatin, an Antagonist of Activin, Is Expressed in
the Spemann Organizer and Displays Direct Neuralizing Activity." Cell 77, no. 2 (1994): 283-95.
Hemmati-Brivanlou, A. and D. Melton. "Vertebrate Embryonic Cells Will Become Nerve Cells Unless Told
Otherwise." Cell 88, no. 1 (1997): 13-7.
Hemmati-Brivanlou, A. and D. A. Melton. "A Truncated Activin Receptor Inhibits Mesoderm Induction and
Formation of Axial Structures in Xenopus Embryos." Nature 359, no. 6396 (1992): 609-14.
320
Bibliography  1−References
Hemmati-Brivanlou, A. and D. A. Melton. "Inhibition of Activin Receptor Signaling Promotes Neuralization
in Xenopus." Cell 77, no. 2 (1994): 273-81.
Hemmati-Brivanlou, A., D. A. Wright and D. A. Melton. "Embryonic Expression and Functional Analysis of
a Xenopus Activin Receptor." Dev Dyn 194, no. 1 (1992): 1-11.
Hendrickx, M., X. H. Van and L. Leyns. "Anterior-Posterior Patterning of Neural Differentiated Embryonic
Stem Cells by Canonical Wnts, Fgfs, Bmp4 and Their Respective Antagonists." Dev Growth Differ 51, no. 8
(2009): 687-98.
Hevner,  R.  F.,  L.  Shi,  N.  Justice,  Y.  Hsueh,  M.  Sheng,  S.  Smiga,  A.  Bulfone,  A.  M.  Goffinet,  A.  T.
Campagnoni and J. L. Rubenstein. "Tbr1 Regulates Differentiation of the Preplate and Layer 6." Neuron 29,
no. 2 (2001): 353-66.
Hicks, D. and Y. Courtois. "Fibroblast Growth Factor Stimulates Photoreceptor Differentiation in Vitro." J
Neurosci 12, no. 6 (1992): 2022-33.
Hollnagel, A., V. Oehlmann, J. Heymer, U. Ruther and A. Nordheim. "Id Genes Are Direct Targets of Bone
Morphogenetic Protein Induction in Embryonic Stem Cells." J Biol Chem 274, no. 28 (1999): 19838-45.
Houart,  C.,  L.  Caneparo,  C.  Heisenberg,  K.  Barth,  M.  Take-Uchi and S.  Wilson.  "Establishment of  the
Telencephalon During Gastrulation by Local Antagonism of Wnt Signaling." Neuron 35, no. 2 (2002): 255-
65.
Ideguchi,  M.,  T.  D.  Palmer,  L.  D.  Recht  and  J.  M.  Weimann.  "Murine  Embryonic  Stem Cell-Derived
Pyramidal  Neurons  Integrate  into  the  Cerebral  Cortex  and  Appropriately  Project  Axons  to  Subcortical
Targets." J Neurosci 30, no. 3 (2010): 894-904.
Idelson,  M.,  R.  Alper,  A.  Obolensky,  E.  Ben-Shushan,  I.  Hemo,  N.  Yachimovich-Cohen,  H.  Khaner,  Y.
Smith, O. Wiser, M. Gropp, M. A. Cohen, S. Even-Ram, Y. Berman-Zaken, L. Matzrafi,  G. Rechavi,  E.
Banin and B. Reubinoff. "Directed Differentiation of Human Embryonic Stem Cells into Functional Retinal
Pigment Epithelium Cells." Cell Stem Cell 5, no. 4 (2009): 396-408.
321
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Iemura, S., T. S. Yamamoto, C. Takagi, H. Uchiyama, T. Natsume, S. Shimasaki, H. Sugino and N. Ueno.
"Direct Binding of Follistatin to a Complex of Bone-Morphogenetic Protein and Its Receptor Inhibits Ventral
and Epidermal Cell Fates in Early Xenopus Embryo." Proc Natl Acad Sci U S A 95, no. 16 (1998): 9337-42.
Ikeda, H., F. Osakada, K. Watanabe, K. Mizuseki, T. Haraguchi, H. Miyoshi, D. Kamiya, Y. Honda, N. Sasai,
N.  Yoshimura,  M.  Takahashi  and  Y.  Sasai.  "Generation  of  Rx+/Pax6+  Neural  Retinal  Precursors  from
Embryonic Stem Cells." Proc Natl Acad Sci U S A 102, no. 32 (2005): 11331-6.
Isaacs, H. V., D. Tannahill and J. M. Slack. "Expression of a Novel Fgf in the Xenopus Embryo. A New
Candidate Inducing Factor for Mesoderm Formation and Anteroposterior Specification." Development 114,
no. 3 (1992): 711-20.
Iwao, T.,  M. Toyota, Y. Miyagawa, H. Okita, N. Kiyokawa, H. Akutsu, A. Umezawa, K. Nagata and T.
Matsunaga. "Differentiation of Human Induced Pluripotent Stem Cells into Functional Enterocyte-Like Cells
Using a Simple Method." Drug Metab Pharmacokinet,  (2013).
Jacobson, C. O. "Reactivation of DNA Synthesis in Mammalian Neuron Nuclei after Fusion with Cells of an
Undifferentiated Fibroblast Line." Exp Cell Res 53, no. 1 (1968): 316-8.
Jessell, T. M. "Neuronal Specification in the Spinal Cord: Inductive Signals and Transcriptional Codes." Nat
Rev Genet 1, no. 1 (2000): 20-9.
Jones, C.  M., K. M. Lyons, P. M. Lapan,  C. V. Wright and B. L.  Hogan. "Dvr-4 (Bone Morphogenetic
Protein-4) as a Posterior-Ventralizing Factor in Xenopus Mesoderm Induction." Development 115, no.  2
(1992): 639-47.
Jordan, T., I. Hanson, D. Zaletayev, S. Hodgson, J. Prosser, A. Seawright, N. Hastie and V. van Heyningen.
"The Human Pax6 Gene Is Mutated in Two Patients with Aniridia." Nat Genet 1, no. 5 (1992): 328-32.
Kamiya, D., S. Banno, N. Sasai, M. Ohgushi, H. Inomata, K. Watanabe, M. Kawada, R. Yakura, H. Kiyonari,
K.  Nakao,  L.  M.  Jakt,  S.  Nishikawa  and  Y.  Sasai.  "Intrinsic  Transition  of  Embryonic  Stem-Cell
Differentiation into Neural Progenitors." Nature 470, no. 7335 (2011): 503-9.
322
Bibliography  1−References
Kawasaki,  H., K. Mizuseki, S. Nishikawa, S. Kaneko, Y. Kuwana, S. Nakanishi, S. I. Nishikawa and Y.
Sasai.  "Induction  of  Midbrain  Dopaminergic  Neurons  from Es  Cells  by Stromal  Cell-Derived  Inducing
Activity." Neuron 28, no. 1 (2000): 31-40.
Keller,  R.,  J. Shih, A. K. Sater and C. Moreno. "Planar Induction of Convergence and Extension of the
Neural Plate by the Organizer of Xenopus." Dev Dyn 193, no. 3 (1992): 218-34.
Keller, S., J. Nickel, J. L. Zhang, W. Sebald and T. D. Mueller. "Molecular Recognition of Bmp-2 and Bmp
Receptor Ia." Nat Struct Mol Biol 11, no. 5 (2004): 481-8.
Kelley, M. W., J. K. Turner and T. A. Reh. "Retinoic Acid Promotes Differentiation of Photoreceptors in
Vitro." Development 120, no. 8 (1994): 2091-102.
Khokha, M. K., J. Yeh, T. C. Grammer and R. M. Harland. "Depletion of Three Bmp Antagonists from
Spemann's Organizer Leads to a Catastrophic Loss of Dorsal Structures." Dev Cell 8, no. 3 (2005): 401-11.
Kinney, J. W., C. N. Davis, I. Tabarean, B. Conti, T. Bartfai and M. M. Behrens. "A Specific Role for Nr2a-
Containing Nmda Receptors in the Maintenance of Parvalbumin and Gad67 Immunoreactivity in Cultured
Interneurons." J Neurosci 26, no. 5 (2006): 1604-15.
Knoth,  R.,  I.  Singec,  M.  Ditter,  G.  Pantazis,  P.  Capetian,  R.  P.  Meyer,  V.  Horvat,  B.  Volk  and  G.
Kempermann. "Murine Features of Neurogenesis in the Human Hippocampus across the Lifespan from 0 to
100 Years." PLoS One 5, no. 1 (2010): e8809.
Kodaira, K., M. Imada, M. Goto, A. Tomoyasu, T. Fukuda, R. Kamijo, T. Suda, K. Higashio and T. Katagiri.
"Purification and Identification of a Bmp-Like Factor from Bovine Serum." Biochem Biophys Res Commun
345, no. 3 (2006): 1224-31.
Kolm, P. J., V. Apekin and H. Sive. "Xenopus Hindbrain Patterning Requires Retinoid Signaling." Dev Biol
192, no. 1 (1997): 1-16.
Kolm, P. J. and H. L. Sive. "Retinoids and Posterior Neural Induction: A Reevaluation of Nieuwkoop's Two-
Step Hypothesis." Cold Spring Harb Symp Quant Biol 62,  (1997): 511-21.
323
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Komada,  M.  "Sonic  Hedgehog  Signaling  Coordinates  the  Proliferation  and  Differentiation  of  Neural
Stem/Progenitor Cells by Regulating Cell Cycle Kinetics During Development of the Neocortex." Congenit
Anom (Kyoto) 52, no. 2 (2012): 72-7.
Komada,  M.,  H.  Saitsu,  M.  Kinboshi,  T.  Miura,  K.  Shiota  and  M.  Ishibashi.  "Hedgehog  Signaling  Is
Involved in Development of the Neocortex." Development 135, no. 16 (2008): 2717-27.
Komuro, H. and P. Rakic. "Selective Role of N-Type Calcium Channels in Neuronal Migration." Science
257, no. 5071 (1992): 806-9.
Lamb, T. M. and R. M. Harland. "Fibroblast Growth Factor Is a Direct Neural Inducer, Which Combined
with Noggin Generates Anterior-Posterior Neural Pattern." Development 121, no. 11 (1995): 3627-36.
Lamb, T. M., A. K. Knecht, W. C. Smith, S. E. Stachel, A. N. Economides, N. Stahl, G. D. Yancopolous and
R. M. Harland. "Neural Induction by the Secreted Polypeptide Noggin." Science 262, no. 5134 (1993): 713-
8.
Lamba,  D.  A.,  J.  Gust  and  T.  A.  Reh.  "Transplantation  of  Human  Embryonic  Stem  Cell-Derived
Photoreceptors Restores Some Visual Function in Crx-Deficient Mice." Cell Stem Cell 4, no. 1 (2009): 73-9.
Lamba, D. A., M. O. Karl, C. B. Ware and T. A. Reh. "Efficient Generation of Retinal Progenitor Cells from
Human Embryonic Stem Cells." Proc Natl Acad Sci U S A 103, no. 34 (2006): 12769-74.
Lamba, D. A., A. McUsic, R. K. Hirata, P. R. Wang, D. Russell and T. A. Reh. "Generation, Purification and
Transplantation of Photoreceptors Derived from Human Induced Pluripotent Stem Cells." PLoS One 5, no. 1
(2010): e8763.
Lamba, D., M. Karl and T. Reh. "Neural Regeneration and Cell Replacement: A View from the Eye." Cell
Stem Cell 2, no. 6 (2008): 538-49.
Lan, L., A. Vitobello, M. Bertacchi, F. Cremisi, R. Vignali, M. Andreazzoli, G. C. Demontis, G. Barsacchi
and S. Casarosa. "Noggin Elicits Retinal Fate in Xenopus Animal Cap Embryonic Stem Cells." Stem Cells
27, no. 9 (2009): 2146-52.
324
Bibliography  1−References
Lee, J. E., S. M. Hollenberg, L. Snider, D. L. Turner, N. Lipnick and H. Weintraub. "Conversion of Xenopus
Ectoderm into Neurons by Neurod, a Basic Helix-Loop-Helix Protein." Science 268, no. 5212 (1995): 836-
44.
Lee, S. H., N. Lumelsky, L. Studer, J. M. Auerbach and R. D. McKay. "Efficient Generation of Midbrain and
Hindbrain Neurons from Mouse Embryonic Stem Cells." Nat Biotechnol 18, no. 6 (2000): 675-9.
Levine, A. J. and A. H. Brivanlou. "Proposal of a Model of Mammalian Neural Induction." Dev Biol 308, no.
2 (2007): 247-56.
Levine,  E.  M.,  H.  Roelink,  J.  Turner  and  T.  A.  Reh.  "Sonic  Hedgehog  Promotes  Rod  Photoreceptor
Differentiation in Mammalian Retinal Cells in Vitro." J Neurosci 17, no. 16 (1997): 6277-88.
Leyns, L., T. Bouwmeester, S. H. Kim, S. Piccolo and E. M. De Robertis. "Frzb-1 Is a Secreted Antagonist of
Wnt Signaling Expressed in the Spemann Organizer." Cell 88, no. 6 (1997): 747-56.
Li, E., H. M. Sucov, K. F. Lee, R. M. Evans and R. Jaenisch. "Normal Development and Growth of Mice
Carrying a Targeted Disruption of the Alpha 1 Retinoic Acid Receptor Gene." Proc Natl Acad Sci U S A 90,
no. 4 (1993): 1590-4.
Liem, K. F., Jr., G. Tremml and T. M. Jessell. "A Role for the Roof Plate and Its Resident Tgfbeta-Related
Proteins in Neuronal Patterning in the Dorsal Spinal Cord." Cell 91, no. 1 (1997): 127-38.
Liem, K. F., Jr.,  G. Tremml, H. Roelink and T. M. Jessell. "Dorsal Differentiation of Neural Plate Cells
Induced by Bmp-Mediated Signals from Epidermal Ectoderm." Cell 82, no. 6 (1995): 969-79.
Livesey, F. J. and C. L. Cepko. "Vertebrate Neural Cell-Fate Determination: Lessons from the Retina." Nat
Rev Neurosci 2, no. 2 (2001): 109-18.
Lupo, G., W. A. Harris,  G. Barsacchi and R. Vignali. "Induction and Patterning of the Telencephalon in
Xenopus Laevis." Development 129, no. 23 (2002): 5421-36.
325
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Lupo, G., C. Novorol, J. R. Smith, L. Vallier, E. Miranda, M. Alexander, S. Biagioni, R. A. Pedersen and W.
A. Harris. "Multiple Roles of Activin/Nodal, Bone Morphogenetic Protein, Fibroblast Growth Factor and
Wnt/Beta-Catenin Signalling in the Anterior Neural Patterning of Adherent Human Embryonic Stem Cell
Cultures." Open Biol 3, no. 4 (2013): 120167.
MacLaren, R. E., R. A. Pearson, A. MacNeil, R. H. Douglas, T. E. Salt, M. Akimoto, A. Swaroop, J. C.
Sowden and R. R. Ali. "Retinal Repair by Transplantation of Photoreceptor Precursors." Nature 444, no.
7116 (2006): 203-7.
Malatesta, P., M. Gotz, G. Barsacchi, J. Price, R. Zoncu and F. Cremisi. "Pc3 Overexpression Affects the
Pattern of Cell Division of Rat Cortical Precursors." Mech Dev 90, no. 1 (2000): 17-28.
Mangale, V. S., K. E. Hirokawa, P. R. Satyaki, N. Gokulchandran, S. Chikbire, L. Subramanian, A. S. Shetty,
B. Martynoga, J. Paul, M. V. Mai, Y. Li, L. A. Flanagan, S. Tole and E. S. Monuki. "Lhx2 Selector Activity
Specifies Cortical Identity and Suppresses Hippocampal Organizer Fate." Science 319, no. 5861 (2008): 304-
9.
Mathers,  P.  H.,  A.  Grinberg,  K.  A.  Mahon and M. Jamrich.  "The Rx Homeobox Gene Is  Essential  for
Vertebrate Eye Development." Nature 387, no. 6633 (1997): 603-7.
Matsunami,  H. and M. Takeichi.  "Fetal  Brain Subdivisions Defined by R- and E-Cadherin Expressions:
Evidence for the Role of Cadherin Activity in Region-Specific, Cell-Cell Adhesion." Dev Biol 172, no. 2
(1995): 466-78.
McConnell, S. K. and C. E. Kaznowski. "Cell Cycle Dependence of Laminar Determination in Developing
Neocortex." Science 254, no. 5029 (1991): 282-5.
McGrew, L. L., S. Hoppler and R. T. Moon. "Wnt and Fgf Pathways Cooperatively Pattern Anteroposterior
Neural Ectoderm in Xenopus." Mech Dev 69, no. 1-2 (1997): 105-14.
McGrew,  L.  L.,  C.  J.  Lai  and  R.  T.  Moon.  "Specification  of  the  Anteroposterior  Neural  Axis  through




McNeish,  J.,  M.  Roach,  J.  Hambor,  R.  J.  Mather,  L.  Weibley,  J.  Lazzaro,  J.  Gazard,  J.  Schwarz,  R.
Volkmann, D. Machacek, S. Stice, L. Zawadzke, C. O'Donnell and R. Hurst. "High-Throughput Screening in
Embryonic  Stem Cell-Derived  Neurons  Identifies  Potentiators  of  Alpha-Amino-3-Hydroxyl-5-Methyl-4-
Isoxazolepropionate-Type Glutamate Receptors." J Biol Chem 285, no. 22 (2010): 17209-17.
Mitsui, K., Y. Tokuzawa, H. Itoh, K. Segawa, M. Murakami, K. Takahashi, M. Maruyama, M. Maeda and S.
Yamanaka. "The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and
Es Cells." Cell 113, no. 5 (2003): 631-42.
Munoz-Sanjuan, I. and A. H. Brivanlou. "Neural Induction, the Default Model and Embryonic Stem Cells."
Nat Rev Neurosci 3, no. 4 (2002): 271-80.
Nadri, S., M. Soleimani, R. H. Hosseni, M. Massumi, A. Atashi and R. Izadpanah. "An Efficient Method for
Isolation of Murine Bone Marrow Mesenchymal Stem Cells." Int J Dev Biol 51, no. 8 (2007): 723-9.
Nicoleau,  C.,  C. Varela,  C. Bonnefond,  Y. Maury,  A. Bugi, L.  Aubry,  P.  Viegas, F. Bourgois-Rocha,  M.
Peschanski and A. L. Perrier. "Embryonic Stem Cells Neural Differentiation Qualifies the Role of Wnt/Beta-
Catenin Signals in Human Telencephalic Specification and Regionalization." Stem Cells 31, no. 9 (2013):
1763-1774.
Niehrs, C. "Regionally Specific Induction by the Spemann-Mangold Organizer." Nat Rev Genet 5, no. 6
(2004): 425-34.
Niwa,  H.,  J.  Miyazaki  and  A.  G.  Smith.  "Quantitative  Expression  of  Oct-3/4  Defines  Differentiation,
Dedifferentiation or Self-Renewal of Es Cells." Nat Genet 24, no. 4 (2000): 372-6.
Nordgard, O., J. T. Kvaloy, R. K. Farmen and R. Heikkila. "Error Propagation in Relative Real-Time Reverse
Transcription  Polymerase  Chain  Reaction  Quantification  Models:  The  Balance  between  Accuracy  and
Precision." Anal Biochem 356, no. 2 (2006): 182-93.
O'Rourke,  N. A.,  M. E.  Dailey,  S.  J.  Smith and S.  K.  McConnell.  "Diverse Migratory Pathways  in the
Developing Cerebral Cortex." Science 258, no. 5080 (1992): 299-302.
327
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Okabayashi, K. and M. Asashima. "Tissue Generation from Amphibian Animal Caps." Curr Opin Genet Dev
13, no. 5 (2003): 502-7.
Okano, H., H. Kawahara, M. Toriya, K. Nakao, S. Shibata and T. Imai. "Function of Rna-Binding Protein
Musashi-1 in Stem Cells." Exp Cell Res 306, no. 2 (2005): 349-56.
Oliver, G., A. Mailhos, R. Wehr, N. G. Copeland, N. A. Jenkins and P. Gruss. "Six3, a Murine Homologue of
the Sine Oculis Gene, Demarcates the Most Anterior Border of the Developing Neural Plate and Is Expressed
During Eye Development." Development 121, no. 12 (1995): 4045-55.
Olsson, J. E., J. W. Gordon, B. S. Pawlyk, D. Roof, A. Hayes, R. S. Molday, S. Mukai, G. S. Cowley, E. L.
Berson  and T.  P.  Dryja.  "Transgenic  Mice  with  a  Rhodopsin  Mutation  (Pro23his):  A Mouse  Model  of
Autosomal Dominant Retinitis Pigmentosa." Neuron 9, no. 5 (1992): 815-30.
Osakada, F.,  H. Ikeda, M. Mandai,  T. Wataya, K. Watanabe, N. Yoshimura, A. Akaike, Y. Sasai and M.
Takahashi.  "Toward the Generation of Rod and Cone Photoreceptors from Mouse,  Monkey and Human
Embryonic Stem Cells." Nat Biotechnol 26, no. 2 (2008): 215-24.
Papalopulu, N., J. D. Clarke, L. Bradley, D. Wilkinson, R. Krumlauf and N. Holder. "Retinoic Acid Causes
Abnormal  Development  and  Segmental  Patterning  of  the  Anterior  Hindbrain  in  Xenopus  Embryos."
Development 113, no. 4 (1991): 1145-58.
Parr, B. A., M. J. Shea, G. Vassileva and A. P. McMahon. "Mouse Wnt Genes Exhibit Discrete Domains of
Expression in the Early Embryonic Cns and Limb Buds." Development 119, no. 1 (1993): 247-61.
Pera,  E.  M.  and  M.  Kessel.  "Patterning  of  the  Chick  Forebrain  Anlage  by  the  Prechordal  Plate."
Development 124, no. 20 (1997): 4153-62.
Pera, E. M., O. Wessely, S. Y. Li and E. M. De Robertis. "Neural and Head Induction by Insulin-Like Growth
Factor Signals." Dev Cell 1, no. 5 (2001): 655-65.
Perea-Gomez, A., F. D. Vella, W. Shawlot, M. Oulad-Abdelghani, C. Chazaud, C. Meno, V. Pfister, L. Chen,
E.  Robertson,  H. Hamada,  R.  R.  Behringer and S.  L.  Ang.  "Nodal  Antagonists  in the Anterior Visceral
Endoderm Prevent the Formation of Multiple Primitive Streaks." Dev Cell 3, no. 5 (2002): 745-56.
328
Bibliography  1−References
Pfaffl, M. W., G. W. Horgan and L. Dempfle. "Relative Expression Software Tool (Rest) for Group-Wise
Comparison and Statistical Analysis of Relative Expression Results in Real-Time Pcr." Nucleic Acids Res
30, no. 9 (2002): e36.
Piao, X., R. S. Hill, A. Bodell, B. S. Chang, L. Basel-Vanagaite, R. Straussberg, W. B. Dobyns, B. Qasrawi,
R. M. Winter, A. M. Innes, T. Voit, M. E. Ross, J. L. Michaud, J. C. Descarie, A. J. Barkovich and C. A.
Walsh. "G Protein-Coupled Receptor-Dependent Development of Human Frontal Cortex." Science 303, no.
5666 (2004): 2033-6.
Piccolo, S., E. Agius, L. Leyns, S. Bhattacharyya, H. Grunz, T. Bouwmeester and E. M. De Robertis. "The
Head Inducer Cerberus Is a Multifunctional Antagonist of Nodal, Bmp and Wnt Signals." Nature 397, no.
6721 (1999): 707-10.
Piccolo,  S.,  Y.  Sasai,  B.  Lu and E.  M. De Robertis.  "Dorsoventral  Patterning in Xenopus:  Inhibition of
Ventral Signals by Direct Binding of Chordin to Bmp-4." Cell 86, no. 4 (1996): 589-98.
Pierani, A., S. Brenner-Morton, C. Chiang and T. M. Jessell. "A Sonic Hedgehog-Independent, Retinoid-
Activated Pathway of Neurogenesis in the Ventral Spinal Cord." Cell 97, no. 7 (1999): 903-15.
Placzek, M., M. Tessier-Lavigne, T. Yamada, T. Jessell and J. Dodd. "Mesodermal Control of Neural Cell
Identity: Floor Plate Induction by the Notochord." Science 250, no. 4983 (1990): 985-8.
Pownall, M. E., A. S. Tucker, J. M. Slack and H. V. Isaacs. "Efgf, Xcad3 and Hox Genes Form a Molecular
Pathway That Establishes the Anteroposterior Axis in Xenopus." Development 122, no. 12 (1996): 3881-92.
Quiring, R., U. Walldorf, U. Kloter and W. J. Gehring. "Homology of the Eyeless Gene of Drosophila to the
Small Eye Gene in Mice and Aniridia in Humans." Science 265, no. 5173 (1994): 785-9.
Rakic, P. "Mode of Cell Migration to the Superficial Layers of Fetal Monkey Neocortex." J Comp Neurol
145, no. 1 (1972): 61-83.
Rakic,  P.  "Neurons in Rhesus Monkey Visual  Cortex:  Systematic Relation between Time of Origin and
Eventual Disposition." Science 183, no. 4123 (1974): 425-7.
329
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Rakic, P. "Role of Cell Interaction in Development of Dendritic Patterns." Adv Neurol 12,  (1975): 117-34.
Rakic, P. "Evolution of the Neocortex: A Perspective from Developmental Biology." Nat Rev Neurosci 10,
no. 10 (2009): 724-35.
Rakic, P. and R. L. Sidman. "Weaver Mutant Mouse Cerebellum: Defective Neuronal Migration Secondary
to Abnormality of Bergmann Glia." Proc Natl Acad Sci U S A 70, no. 1 (1973): 240-4.
Ralph, P. and I. Nakoinz. "Direct Toxic Effects of Immunopotentiators on Monocytic, Myelomonocytic, and
Histiocytic or Macrophage Tumor Cells in Culture." Cancer Res 37, no. 2 (1977): 546-50.
Ramirez-Solis,  R.,  H. Zheng, J.  Whiting, R. Krumlauf and A. Bradley.  "Hoxb-4 (Hox-2.6) Mutant Mice
Show Homeotic Transformation of a Cervical Vertebra and Defects in the Closure of the Sternal Rudiments."
Cell 73, no. 2 (1993): 279-94.
Regad,  T.,  M.  Roth,  N.  Bredenkamp,  N.  Illing  and  N.  Papalopulu.  "The  Neural  Progenitor-Specifying
Activity of Foxg1 Is Antagonistically Regulated by Cki and Fgf." Nat Cell Biol 9, no. 5 (2007): 531-40.
Reversade, B., H. Kuroda, H. Lee, A. Mays and E. M. De Robertis. "Depletion of Bmp2, Bmp4, Bmp7 and
Spemann Organizer Signals Induces Massive Brain Formation in Xenopus Embryos." Development 132, no.
15 (2005): 3381-92.
Roelink, H., A. Augsburger, J. Heemskerk, V. Korzh, S. Norlin, A. Ruiz i Altaba, Y. Tanabe, M. Placzek, T.
Edlund, T. M. Jessell and et al. "Floor Plate and Motor Neuron Induction by Vhh-1, a Vertebrate Homolog of
Hedgehog Expressed by the Notochord." Cell 76, no. 4 (1994): 761-75.
Roelink, H., J. A. Porter, C. Chiang, Y. Tanabe, D. T. Chang, P. A. Beachy and T. M. Jessell. "Floor Plate and
Motor Neuron Induction by Different Concentrations of the Amino-Terminal Cleavage Product  of Sonic
Hedgehog Autoproteolysis." Cell 81, no. 3 (1995): 445-55.
Ruiz  i  Altaba,  A.  and  T.  Jessell.  "Retinoic  Acid  Modifies  Mesodermal  Patterning  in  Early  Xenopus
Embryos." Genes Dev 5, no. 2 (1991): 175-87.
330
Bibliography  1−References
Sakaki-Yumoto,  M.,  J.  Liu,  M.  Ramalho-Santos,  N.  Yoshida  and R.  Derynck.  "Smad2  Is  Essential  for
Maintenance of the Human and Mouse Primed Pluripotent Stem Cell State." J Biol Chem 288, no. 25 (2013):
18546-60.
Saldanha, A. J. "Java Treeview--Extensible Visualization of Microarray Data." Bioinformatics 20, no. 17
(2004): 3246-8.
Sansom, S. N. and F. J. Livesey. "Gradients in the Brain: The Control of the Development of Form and
Function in the Cerebral Cortex." Cold Spring Harb Perspect Biol 1, no. 2 (2009): a002519.
Sasai, Y., B. Lu, H. Steinbeisser and E. M. De Robertis. "Regulation of Neural Induction by the Chd and
Bmp-4 Antagonistic Patterning Signals in Xenopus." Nature 377, no. 6551 (1995): 757.
Sasai, Y., B. Lu, H. Steinbeisser, D. Geissert, L. K. Gont and E. M. De Robertis. "Xenopus Chordin: A Novel
Dorsalizing Factor Activated by Organizer-Specific Homeobox Genes." Cell 79, no. 5 (1994): 779-90.
Sato,  S.  M.  and  T.  D.  Sargent.  "Development  of  Neural  Inducing  Capacity  in  Dissociated  Xenopus
Embryos." Dev Biol 134, no. 1 (1989): 263-6.
Sausedo, R. A., J. L. Smith and G. C. Schoenwolf. "Role of Nonrandomly Oriented Cell Division in Shaping
and Bending of the Neural Plate." J Comp Neurol 381, no. 4 (1997): 473-88.
Schoenwolf, G. C. and I. S. Alvarez. "Roles of Neuroepithelial Cell Rearrangement and Division in Shaping
of the Avian Neural Plate." Development 106, no. 3 (1989): 427-39.
Sharpe, C. R. "Retinoic Acid Can Mimic Endogenous Signals Involved in Transformation of the Xenopus
Nervous System." Neuron 7, no. 2 (1991): 239-47.
Silva,  J.,  O.  Barrandon,  J.  Nichols,  J.  Kawaguchi,  T.  W.  Theunissen  and  A.  Smith.  "Promotion  of
Reprogramming to Ground State Pluripotency by Signal Inhibition." PLoS Biol 6, no. 10 (2008): e253.
Simeone, A., D. Acampora, M. Gulisano, A. Stornaiuolo and E. Boncinelli. "Nested Expression Domains of
Four Homeobox Genes in Developing Rostral Brain." Nature 358, no. 6388 (1992): 687-90.
331
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Sive,  H.  L.  and  P.  F.  Cheng.  "Retinoic  Acid  Perturbs  the  Expression  of  Xhox.Lab  Genes  and  Alters
Mesodermal Determination in Xenopus Laevis." Genes Dev 5, no. 8 (1991): 1321-32.
Sive, H. L., B. W. Draper, R. M. Harland and H. Weintraub. "Identification of a Retinoic Acid-Sensitive
Period During Primary Axis Formation in Xenopus Laevis." Genes Dev 4, no. 6 (1990): 932-42.
Smith, J. L. and G. C. Schoenwolf. "Notochordal Induction of Cell Wedging in the Chick Neural Plate and
Its Role in Neural Tube Formation." J Exp Zool 250, no. 1 (1989): 49-62.
Smith, W. C. and R. M. Harland. "Expression Cloning of Noggin, a New Dorsalizing Factor Localized to the
Spemann Organizer in Xenopus Embryos." Cell 70, no. 5 (1992): 829-40.
Smukler, S. R., S. B. Runciman, S. Xu and D. van der Kooy. "Embryonic Stem Cells Assume a Primitive
Neural Stem Cell Fate in the Absence of Extrinsic Influences." J Cell Biol 172, no. 1 (2006): 79-90.
Stoykova, A. and P. Gruss. "Roles of Pax-Genes in Developing and Adult Brain as Suggested by Expression
Patterns." J Neurosci 14, no. 3 Pt 2 (1994): 1395-412.
Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L.
Pomeroy, T. R. Golub, E. S. Lander and J. P. Mesirov. "Gene Set Enrichment Analysis: A Knowledge-Based
Approach for Interpreting Genome-Wide Expression Profiles." Proc Natl Acad Sci U S A 102, no. 43 (2005):
15545-50.
Suzuki, A., R. S. Thies, N. Yamaji, J. J. Song, J. M. Wozney, K. Murakami and N. Ueno. "A Truncated Bone
Morphogenetic Protein Receptor Affects Dorsal-Ventral Patterning in the Early Xenopus Embryo." Proc Natl
Acad Sci U S A 91, no. 22 (1994): 10255-9.
Taipale, J., J. K. Chen, M. K. Cooper, B. Wang, R. K. Mann, L. Milenkovic, M. P. Scott and P. A. Beachy.
"Effects of Oncogenic Mutations in Smoothened and Patched Can Be Reversed by Cyclopamine." Nature
406, no. 6799 (2000): 1005-9.
Taira, M., J.  P.  Saint-Jeannet  and I.  B. Dawid. "Role of the Xlim-1 and Xbra Genes in Anteroposterior




Takahashi, K. and S. Yamanaka. "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult
Fibroblast Cultures by Defined Factors." Cell 126, no. 4 (2006): 663-76.
Teo, A. K., Y. Ali, K. Y. Wong, H. Chipperfield, A. Sadasivam, Y. Poobalan, E. K. Tan, S. T. Wang, S.
Abraham,  N.  Tsuneyoshi,  L.  W.  Stanton  and N.  R.  Dunn.  "Activin  and Bmp4 Synergistically Promote
Formation of Definitive Endoderm in Human Embryonic Stem Cells." Stem Cells 30, no. 4 (2012): 631-42.
Toivonen, S. and L. Saxen. "The Simultaneous Inducing Action of Liver and Bone-Marrow of the Guinea-
Pig in Implantation and Explantation Experiments with Embryos of Triturus." Exp Cell Res, no. Suppl 3
(1955): 346-57.
Tomizawa, M., F. Shinozaki, T. Sugiyama, S. Yamamoto, M. Sueishi and T. Yoshida. "Activin a Is Essential
for Feeder-Free Culture of Human Induced Pluripotent Stem Cells." J Cell Biochem 114, no. 3 (2013): 584-
8.
Tropepe,  V.,  S.  Hitoshi,  C.  Sirard,  T.  W.  Mak,  J.  Rossant  and  D.  van  der  Kooy.  "Direct  Neural  Fate
Specification  from Embryonic  Stem Cells:  A Primitive  Mammalian  Neural  Stem Cell  Stage  Acquired
through a Default Mechanism." Neuron 30, no. 1 (2001): 65-78.
Tsuneyoshi, N., E. K. Tan, A. Sadasivam, Y. Poobalan, T. Sumi, N. Nakatsuji, H. Suemori and N. R. Dunn.
"The Smad2/3 Corepressor Snon Maintains Pluripotency through Selective Repression of Mesendodermal
Genes in Human Es Cells." Genes Dev 26, no. 22 (2012): 2471-6.
Turner, D. L. and C. L. Cepko. "A Common Progenitor for Neurons and Glia Persists in Rat Retina Late in
Development." Nature 328, no. 6126 (1987): 131-6.
Veien, E. S., J. S. Rosenthal, R. C. Kruse-Bend, C. B. Chien and R. I. Dorsky. "Canonical Wnt Signaling Is
Required for the Maintenance of Dorsal Retinal Identity." Development 135, no. 24 (2008): 4101-11.
Verani, R., I. Cappuccio, P. Spinsanti, R. Gradini, A. Caruso, M. C. Magnotti, M. Motolese, F. Nicoletti and
D. Melchiorri. "Expression of the Wnt Inhibitor Dickkopf-1 Is Required for the Induction of Neural Markers
in Mouse Embryonic Stem Cells Differentiating in Response to Retinoic Acid." J Neurochem 100, no. 1
(2007): 242-50.
333
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
Viczian, A. S., E. C. Solessio, Y. Lyou and M. E. Zuber. "Generation of Functional Eyes from Pluripotent
Cells." PLoS Biol 7, no. 8 (2009): e1000174.
Vosough, M., E. Omidinia, M. Kadivar, M. A. Shokrgozar, B. Pournasr, N. Aghdami and H. Baharvand.
"Generation  of  Functional  Hepatocyte-Like  Cells  from  Human  Pluripotent  Stem  Cells  in  a  Scalable
Suspension Culture." Stem Cells Dev 22, no. 20 (2013): 2693-2705.
Walsh, C. and C. L. Cepko. "Clonally Related Cortical Cells Show Several Migration Patterns." Science 241,
no. 4871 (1988): 1342-5.
Wang, S.,  M. Krinks, K. Lin, F. P. Luyten and M. Moos, Jr. "Frzb, a Secreted Protein Expressed in the
Spemann Organizer, Binds and Inhibits Wnt-8." Cell 88, no. 6 (1997): 757-66.
Wassarman, P. M., T. E. Ukena, W. J. Josefowicz, G. E. Letourneau and M. J. Karnovsky. "Cytochalasin B-
Induced Pseudo-Cleavage of Mouse Oocytes  in  Vitro.  Ii.  Studies  of the  Mechanism and Morphological
Consequences of Pseudocleavage." J Cell Sci 26,  (1977): 323-37.
Watanabe, K., D. Kamiya, A. Nishiyama, T. Katayama, S. Nozaki, H. Kawasaki, Y. Watanabe, K. Mizuseki
and  Y.  Sasai.  "Directed  Differentiation  of  Telencephalic  Precursors  from Embryonic  Stem Cells."  Nat
Neurosci 8, no. 3 (2005): 288-96.
Wataya,  T.,  S.  Ando,  K.  Muguruma,  H.  Ikeda,  K.  Watanabe,  M.  Eiraku,  M.  Kawada,  J.  Takahashi,  N.
Hashimoto  and  Y.  Sasai.  "Minimization  of  Exogenous  Signals  in  Es  Cell  Culture  Induces  Rostral
Hypothalamic Differentiation." Proc Natl Acad Sci U S A 105, no. 33 (2008): 11796-801.
Wichterle, H., I. Lieberam, J. A. Porter and T. M. Jessell. "Directed Differentiation of Embryonic Stem Cells
into Motor Neurons." Cell 110, no. 3 (2002): 385-97.
Wilson, P. A. and A. Hemmati-Brivanlou. "Induction of Epidermis and Inhibition of Neural Fate by Bmp-4."
Nature 376, no. 6538 (1995): 331-3.




Wurst, W., A. B. Auerbach and A. L. Joyner. "Multiple Developmental Defects in Engrailed-1 Mutant Mice:
An Early Mid-Hindbrain Deletion and Patterning Defects in Forelimbs and Sternum." Development 120, no.
7 (1994): 2065-75.
Xuan, S., C. A. Baptista, G. Balas, W. Tao, V. C. Soares and E. Lai. "Winged Helix Transcription Factor Bf-1
Is Essential for the Development of the Cerebral Hemispheres." Neuron 14, no. 6 (1995): 1141-52.
Yamada, T., S. L. Pfaff, T. Edlund and T. M. Jessell. "Control of Cell Pattern in the Neural Tube: Motor
Neuron Induction by Diffusible Factors from Notochord and Floor Plate." Cell 73, no. 4 (1993): 673-86.
Yamada, T., M. Placzek, H. Tanaka, J. Dodd and T. M. Jessell. "Control of Cell Pattern in the Developing
Nervous System: Polarizing Activity of the Floor Plate and Notochord." Cell 64, no. 3 (1991): 635-47.
Yang, Y. P. and J. Klingensmith. "Roles of Organizer Factors and Bmp Antagonism in Mammalian Forebrain
Establishment." Dev Biol 296, no. 2 (2006): 458-75.
Ying, Q. L. and A. G. Smith. "Defined Conditions for Neural Commitment and Differentiation." Methods
Enzymol 365,  (2003): 327-41.
Ying, Q. L., J. Wray, J. Nichols, L. Batlle-Morera, B. Doble, J. Woodgett, P. Cohen and A. Smith. "The
Ground State of Embryonic Stem Cell Self-Renewal." Nature 453, no. 7194 (2008): 519-23.
Yu, P. B., C. C. Hong, C. Sachidanandan, J. L. Babitt, D. Y. Deng, S. A. Hoyng, H. Y. Lin, K. D. Bloch and
R. T. Peterson. "Dorsomorphin Inhibits Bmp Signals Required for Embryogenesis and Iron Metabolism."
Nat Chem Biol 4, no. 1 (2008): 33-41.
Zhang, R. L., Z. G. Zhang, L. Zhang and M. Chopp. "Proliferation and Differentiation of Progenitor Cells in
the Cortex and the Subventricular Zone in the Adult Rat after Focal Cerebral Ischemia." Neuroscience 105,
no. 1 (2001): 33-41.
Zimmerman, L. B., J. M. De Jesus-Escobar and R. M. Harland. "The Spemann Organizer Signal Noggin
Binds and Inactivates Bone Morphogenetic Protein 4." Cell 86, no. 4 (1996): 599-606.
Zuber, M. E., G. Gestri, A. S. Viczian, G. Barsacchi and W. A. Harris. "Specification of the Vertebrate Eye by




Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
338
Acknowledgments  1−Special Thanks
1− Special Thanks
I  still  don't  understand if  PhD stands for “Philosophiae Doctor” or rather  for “Permanent head
Damage”, as I read on the Internet. Sure enough it has been pretty hard! And writing this Thesis did
not improve the fitness of my past Summer. Anyhow, my sincere thanks goes...
To Elena and Silvia, sharing caffeine and... (mis)adventures. To Giuseppe, Michele, Roberto, Nicola
and  Luca,  sharing  caffeine  and...  chats.  Then  to  Matteo,  sharing  train  trips,  mountains  and
photographs.  To my dear  Ombretta,  sharing  home,  post-it  notes,  movies  and everyday life.  To
Emiliano, sharing laughs. And to Tanya, sharing colors and smiles.
To Federico, a very good boss (after all). To Simona, for the same reason.
To Aurora, who showed me the darkness all around, and to Daniele, who helped me understand that
there's light everywhere, as well.
To Elisa (twin), who's always next to me, even being so distant.
To Lorena, Francesca and Daria, 'cause having lunch on the grass in a sunny day can be a very
special moment. To Milena, who's never upset. And to Manuela, sharing fun at congresses (and
even back to normal routine).
To everyone in the Lab, especially Cristina, Valentina and Antonella. 
And to my Family, for being so patient with me.
Thanks.
339
Michele Bertacchi Neural differentiation of  mouse embryonic stem cells
340
